The Scotts Miracle-Gro Company Form 10-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
|
|
( X ) |
ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended September 30, 2005
OR
|
|
( ) |
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period
from to
Commission file number 1-13292
The Scotts Miracle-Gro Company
(Exact name of Registrant as Specified in Its Charter)
|
|
|
Ohio
|
|
31-1414921 |
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.)
|
|
14111 Scottslawn Road,
Marysville, Ohio
|
|
43041 |
|
(Address of Principal Executive
Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area
code: 937-644-0011
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Each Class |
|
Name of Each Exchange On Which Registered |
|
|
|
Common Shares, without par value
|
|
New York Stock Exchange
|
Securities registered pursuant to Section 12(g) of the
Act: None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes X No .
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the
Act. Yes No X .
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes X No .
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K (§229.405
of this chapter) is not contained herein, and will not be
contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by
reference in Part III of this Form 10-K or any
amendment to this Form 10-K. ( )
Indicate by check mark whether the registrant is an accelerated
filer (as defined in Rule 12b-2 of the
Act). Yes X No .
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the
Act). Yes No X .
The aggregate market value of Common Shares (the only common
equity of the registrant) held by non-affiliates of the
registrant computed by reference to the price at which Common
Shares were last sold as of the last business day of the
registrants most recently completed second fiscal quarter
(April 2, 2005) was approximately $1,565,288,000
The number of Common Shares of the registrant outstanding as of
December 1, 2005 was 68,004,962.
DOCUMENT INCORPORATED BY REFERENCE:
Portions of the definitive Proxy Statement for
Registrants 2006 Annual Meeting of Shareholders to be held
January 26, 2006, are incorporated by reference into
Part III hereof.
TABLE OF CONTENTS
PART I
ITEM 1. BUSINESS
General
The Scotts Miracle-Gro Company, an Ohio corporation
(Scotts Miracle-Gro and, together with its
subsidiaries, the Company), is the combination of
two of the most innovative companies in the consumer lawn and
garden market: O.M. Scott & Sons, which traces its
heritage back to a company founded by O.M. Scott in Marysville,
Ohio in 1868, and Sterns Miracle-Gro Products, Inc., which
traces its history back to a company formed on Long Island by
Horace Hagedorn and his partner in 1951. Today, we believe the
Scotts®, Turf Builder®,
Miracle-Gro®, Ortho® and
Smith & Hawken® brands are among the
most widely recognized brands in the U.S. consumer lawn and
garden and outdoor living categories. We are also
Monsantos exclusive agent for the marketing and
distribution of consumer Roundup®* non-selective
herbicide products within the United States and other
contractually specified countries.
In fiscal 1995, through a merger transaction, The Scotts Company
and Miracle-Gro became one of several consolidations of other
leading brands in the lawn and garden industry in North America
and Europe. In the late 1990s, we completed several
acquisitions in Europe, which gave us well-known brands in
France, Germany and the United Kingdom. In fiscal 1999, we
acquired the Ortho® brand and exclusive rights
to market the consumer Roundup® brand, thereby
adding industry-leading pesticides to our controls portfolio. We
have also rapidly expanded into the lawn care service industry
with the launch of Scotts LawnService® in fiscal
1997, and have made approximately 50 acquisitions of local and
regional lawn care businesses to provide a platform for our
rapid expansion throughout the U.S. In October 2004, we
entered the fast growing outdoor living category through the
acquisition of Smith & Hawken®.
We believe that our market leadership in the lawn and garden
category is driven by our widely-recognized brands,
consumer-focused marketing, superior product performance, supply
chain excellence, highly knowledgeable field sales and
merchandising organization, and the strength of our
relationships with major retailers in our product categories.
We maintain an Internet website at
http://www.investor.scotts.com (this uniform resource locator,
or URL, is an inactive textual reference only and is not
intended to incorporate our website into this Form 10-K).
We file reports with the Securities and Exchange Commission (the
SEC) and make available, free of charge, on or
through our website, our annual reports on Form 10-K,
quarterly reports on Form 10-Q, current reports on
Form 8-K, proxy and information statements and amendments
to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended, as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the
SEC.
On March 18, 2005, we consummated the restructuring of our
corporate structure into a holding company structure by merging
The Scotts Company (Scotts) which had been the
public company, into a newly-created, wholly-owned, second-tier
Ohio limited liability company, The Scotts Company LLC
(Scotts LLC), pursuant to the Agreement and Plan of
Merger, dated as of December 13, 2004 (the Merger
Agreement), among Scotts, Scotts LLC and Scotts
Miracle-Gro. As a result of this restructuring merger, each of
Scotts common shares issued and outstanding immediately
prior to the consummation of the restructuring merger was
automatically converted into one fully paid and nonassessable
common share of Scotts Miracle-Gro. Scotts Miracle-Gro became
the public company successor to Scotts and Scotts LLC a direct,
wholly-owned subsidiary of Scotts Miracle-Gro. The restructuring
merger did not affect the new parent holding companys
management, corporate governance or capital stock structure. In
addition, the consolidated assets and liabilities of Scotts
Miracle-Gro and its subsidiaries (including Scotts LLC)
immediately after the restructuring merger were the same as the
consolidated assets and liabilities of Scotts and its
subsidiaries immediately before the restructuring merger.
Competitive Strengths
We believe we are the worlds largest marketer of branded
consumer lawn and garden fertilizers, control products and
value-added growing media products. We have been able to achieve
our market
|
|
* |
Roundup® is a registered trademark of Monsanto
Technology LLC, a company affiliated with Monsanto Company. |
2
leading position through the combination of strategic
acquisitions and organic growth by driving category expansion
and capturing increased market share with product innovation and
award-winning advertising campaigns. Our portfolio of consumer
brands in North America includes the following:
|
|
|
Category |
|
Brands |
|
Lawns
|
|
Scotts®; Turf
Builder®
|
Gardens
|
|
Miracle-Gro®;
Osmocote®
|
Growing Media
|
|
Miracle-Gro®;
Scotts®; Hyponex®;
Earthgro®; SuperSoil® (acquired
October 3, 2005)
|
Grass Seed
|
|
Scotts®; Turf
Builder®
|
Controls
|
|
Ortho®;
Roundup®
|
Outdoor Living
|
|
Smith &
Hawken® (acquired October 2, 2004)
|
Wild Bird Food
|
|
Morning Song®
(acquired November 18, 2005)
|
In addition, we have the following significant brands in Europe:
Miracle-Gro® plant fertilizers,
Weedol® and Pathclear®
herbicides, EverGreen® lawn fertilizers and
Levington® growing media in the United Kingdom;
KB® and Fertiligène® in
France; Celaflor®, Nexa-Lotte®
and Substral® in Germany and Austria; and
ASEF®, KB® and
Substral® in Belgium, the Netherlands and
Luxembourg (the Benelux countries).
Roundup® is also a significant brand in the
United Kingdom, France, Germany and other European markets.
Business Segments
In fiscal 2005, we divided our business into the following
reportable segments:
|
|
|
|
|
North America; |
|
|
|
Scotts LawnService®; |
|
|
|
International; and |
|
|
|
Corporate & Other. |
These reportable segments are consistent with how the segments
report to and are managed by our senior management. Financial
information about these segments for the three years ended
September 30, 2005 is presented in Note 21 of the
Notes to Consolidated Financial Statements.
North America
In our North America segment, we manufacture and market products
that provide fast, easy and effective assistance to homeowners
who seek to nurture beautiful, weed- and pest-free lawns,
gardens and indoor plants. These products are sold under brand
names that people know and trust, and that incorporate many of
the best technologies available. In addition, we manufacture and
market a broad line of professional products designed to meet
the specific needs of commercial nurseries, greenhouses and
specialty crop growers in North America. Our products include:
Lawn Fertilizers We
sell a complete line of granular lawn fertilizer and combination
products which include fertilizer and crabgrass control, weed
control or pest control under the Scotts® Turf
Builder® brand name. The Turf
Builder® line of products is designed to make it
easy for do-it-yourself consumers to select and properly apply
the right product in the right quantity for their lawns.
Plant Foods We sell
a complete line of plant foods under the
Miracle-Gro® brand name. The leading product is
a water-soluble plant food that, when dissolved in water,
creates a diluted nutrient solution which is poured over plants
or sprayed through an applicator and is rapidly absorbed by a
plants roots and leaves. Miracle-Gro®
products are specially formulated to give different kinds of
plants the right kind of nutrition. The
Miracle-Gro® Garden Feeder provides consumers
with an easy, fast and effective way to feed all the plants in
their garden. We also have a high-quality, slow-release line of
Miracle-Gro® plant
3
foods for extended feeding convenience sold as
Miracle-Gro® Shake N
Feed® Continuous Release Plant Food.
Growing Media We
sell a complete line of growing media products for indoor and
outdoor uses under the Miracle-Gro®,
Scotts®, Hyponex®,
Earthgro® and Nature Scapes®
brand names, as well as other labels. These products include
potting mix, garden soils, topsoil, manures, sphagnum peat and
decorative barks and mulches. The addition of the
Miracle-Gro® brand name and fertilizer to
potting mix and garden soils has turned previously low-margin
commodity products into value-added category leaders. Effective
October 3, 2005, we acquired SuperSoil® and
related strong West Coast brands via the acquisition of Rod
McLellan Company (RMC).
Controls We sell a
broad line of weed control, indoor and outdoor pest control and
plant disease control products under the Ortho®
brand name. Ortho® products are available in
aerosol, liquid ready-to-use, concentrated, granular and dust
forms. Ortho® control products include
Weed-B-Gon®, Weed-B-Gon
Maxtm,
Bug B Gon®
Maxtm,
Home Defense®
Maxtm,
Ortho® Season-Long Grass & Weed Killer,
Brush-B-Gon®, RosePride®,
Ortho-Klor® and Orthene® Fire
Ant Killer.
In fiscal 1999, we entered into a long-term marketing agreement
with Monsanto and became Monsantos exclusive agent for the
marketing and distribution of consumer Roundup®
non-selective herbicide products in the consumer lawn and garden
market within the United States and other specified countries,
including Australia, Austria, Canada, France, Germany, Belgium,
Holland and the United Kingdom.
Other Consumer Products
We manufacture and market several
lines of high-quality lawn spreaders under the
Scotts® brand name
EdgeGuard® Total Performance spreaders,
SpeedyGreen® rotary spreaders,
AccuGreen® drop spreaders and Handy
Green® II handheld spreaders. We sell a
line of hose-end applicators for water-soluble plant foods such
as Miracle-Gro® products, a line of pottery
products, and lines of applicators under the
Ortho®, Dial N
Spray®, and Pull N
Spray® trademarks for the diluted application of
control products sold in the concentrated form. We also sell
numerous varieties and blends of high-quality grass seed, many
of them proprietary, designed for different conditions and
geographies. These consumer grass seed products are sold under
the Scotts® Pure Premium®,
Scotts® Turf Builder®,
Scotts® and PatchMaster® brands.
Wild Bird Food
Effective November 18, 2005,
the Company acquired Gutwein & Co., Inc.
(Gutwein). Through its Morning Song®
brand, Gutwein is a leader in the growing United States wild
bird food category, generating approximately $80.0 million
in annual revenues. Morning Song® products are
sold at leading mass retailers, grocery, pet and general
merchandise stores.
North American Professional
We sell professional products to
commercial nurseries, greenhouses and specialty crop growers in
North America, the Caribbean and throughout Latin America, the
Far East, New Zealand and Japan. Our professional products
include a broad line of sophisticated controlled-release
fertilizers, water-soluble fertilizers, pesticide products and
wetting agents which are sold under brand names that include
Banrot®, Miracle-Gro®,
Osmocote®, Peters®,
Poly-S®, Rout®,
ScottKote®, Sierrablen®,
Shamrock® and Sierra®.
Canada We believe we
are the leading marketer of branded consumer lawn and garden
products in the Canadian market. We sell a full range of lawn
and garden fertilizer, control products, grass seed, spreaders,
and value-added growing media products under the
Scotts®, Turf Builder®, Miracle
Gro®, Killex®, and
Roundup® brands.
Scotts
LawnService®
We provide residential lawn care, lawn aeration, tree and shrub
care and external pest control services through our Scotts
LawnService® business in the United States.
These services consist primarily of fertilizer, weed control,
pest control and disease control applications. As of
September 30, 2005, Scotts LawnService® had
77 company-operated locations serving 38 metropolitan
markets and 76 independent franchises primarily operating in
secondary markets.
4
International
In our International segment, we sell consumer lawn and garden
products in over 25 countries outside of North America. We also
sell a broad line of professional products throughout Europe to
commercial nurseries, greenhouses and specialty retailers.
Our International products and brand names vary from country to
country depending upon the brand name strength and the nature of
our strategic relationships in a given country. For example, in
the United Kingdom, we sell Miracle-Gro® plant
fertilizers, Weedol® and
Pathclear® herbicides,
EverGreen® lawn fertilizers and
Levington® growing media. Our other
International brands include KB® and
Fertiligène® in France,
Celaflor®, Nexa-Lotte® and
Substral® in Germany and Austria, and
ASEF®, KB® and
Substral® in the Benelux countries. As noted
earlier, Roundup® is also a significant brand in
Europe.
For information concerning risks attendant to our foreign
operations, please see ITEM 1A. RISK FACTORS
Cautionary Statement on Forward-Looking Statements
European Economic Conditions and Foreign Currency
Exposures.
Corporate & Other
Smith & Hawken®
Effective October 2, 2004, we
acquired Smith & Hawken®, a leading
brand in the fast growing outdoor living and gardening lifestyle
category. Smith & Hawken® products,
which include high-end outdoor furniture, pottery, garden tools,
gardening containers and live goods, are sold in the United
States through its 57 retail stores, as well as through catalog
and Internet sales. For further details concerning the
acquisition of this business, please refer to Note 5 of the
Notes to Consolidated Financial Statements.
Research and Development
We believe strongly in the benefits of research and development,
and we continually invest in research and development to improve
existing or develop new products, manufacturing processes and
packaging and delivery systems. Our spending on research and
development was $30.5 million, $34.4 million and
$30.4 million in fiscal 2005, fiscal 2004, and fiscal 2003,
respectively. We believe that our long-standing commitment to
innovation has benefited us, as evidenced by a portfolio of
patents worldwide that support many of our fertilizers, grass
seeds and application devices. In addition to the benefits of
our own research and development, we benefit from the research
and development activities of our suppliers.
Our research and development worldwide headquarters is located
at the Dwight G. Scott Research Center in Marysville, Ohio. We
also have research and development facilities in Levington, the
United Kingdom; Chazay, France; Heerlen, the Netherlands and
Sydney, Australia, as well as several research field stations
located throughout the United States.
Biotechnology
We believe that the development and commercialization of
innovative products is an important key to our continued success.
We have a long history of dedication to responsible research in
search of more effective and easier-to-use products that are
preferred by consumers and are better for the environment. In
particular, we have worked for over 75 years to create
better products for the establishment and maintenance of
turfgrass. Plant breeding has been a part of that research and
development for the past 50 years. We remain dedicated to
being the technology leader in turfgrass products. Today, that
dedication results in research into products that can be
enhanced, not only with traditional plant breeding, but also
with proven agricultural biotechnology. This research offers the
long-term promise of grasses that require less maintenance, less
water, and are even better for the environment.
Before products enhanced with biotechnology may be sold in the
United States, it must be deregulated by appropriate
governmental agencies. Deregulation involves compliance with the
rules and regulations of, and cooperation with, the United
States Department of Agriculture, Animal and Plant Health
Inspection Service (the USDA), the United States
Environmental Protection Agency (the U.S. EPA)
and/or the Food and Drug Administration (the FDA).
As part of the deregulation process for any product
5
enhanced with biotechnology, we are required to present evidence
to the USDA in the form of scientifically rigorous studies
showing that the product poses no additional toxicological or
ecological risk than products of the same species that have not
been enhanced with biotechnology. We are also required to
satisfy other agencies, such as the U.S. EPA and the FDA,
as to their appropriate areas of regulatory authority. This
process typically takes years to complete and also includes at
least two opportunities for public comment. Therefore, any
enhanced product for which we seek commercialization through
submission of a petition for deregulation will be subjected to
rigorous and thorough governmental regulatory review.
We submitted a petition for deregulation of a non-residential
turfgrass product enhanced with biotechnology to the USDA on
April 30, 2002. This turfgrass has been shown, through our
research trials, to provide simple, more flexible and better
weed control for golf courses in a manner we believe is more
environmentally friendly. The USDA requested additional
information and data. We determined it was more expedient to
withdraw the petition and submit a revised petition that
addressed the USDAs requests than to amend the current
petition. On October 3, 2002, we withdrew our petition. We
prepared a revised petition that we believe addresses the
USDAs requests and submitted it on April 14, 2003.
The USDA has a variety of options in adjudicating a petition to
deregulate a biotechnology-derived plant product.
The USDA has decided to employ the formal Environmental Impact
Statement (EIS) process to judge the acceptability
of our petition for deregulation. We welcome this process as the
most thorough evaluative step available to the USDA.
We believe there is a substantial market for turfgrass products
enhanced with biotechnology, and our product, if approved, can
capture a significant portion of this market. However, there can
be no assurance our petition for deregulation of this product
will be approved, or if approved and commercially introduced,
this product will generate any revenues or contribute to our
earnings.
Trademarks, Patents and Licenses
The Scotts®, Miracle-Gro®,
Hyponex®, Smith &
Hawken® and Ortho® brand names
and logos, as well as a number of product trademarks, including
Turf Builder®, Osmocote® and
Peters®, are federally and/or internationally
registered and are considered material to our business. We
regularly monitor our trademark registrations, which are
generally effective for ten years, so we can renew those nearing
expiration.
As of September 30, 2005, we held 99 issued patents in the
United States covering fertilizer, chemical and growing media
compositions and processes; grass varieties; and applicator and
sprayer devices. Many of these have similar patents which have
also been issued internationally, bringing our total worldwide
patent portfolio to 446. United States and International patents
provide patent protection generally extending to 20 years
from the date of filing, subject to the payment of applicable
governmental maintenance and annuity fees. Accordingly, many of
our patents will extend well into the next decade.
In addition, we continue to file new patent applications each
year. Currently, we have 145 pending patent applications,
worldwide, including 12 applications that have been allowed for
issuance of patents. We also hold exclusive and non-exclusive
patent licenses from various raw material suppliers, permitting
the use and sale of additional patented fertilizers and
pesticides.
During fiscal 2005, we were granted 22 United States and foreign
national patents. Representative of the patent coverage provided
by these new patents are coated fertilizers that are
specifically formulated to act as starter fertilizers for new
plantings; coated fertilizers having coatings that can be
triggered to begin nutrient release at specific times; and
growing media prepared from surfactants mixed with coir material
to provide controlled-nutrient-release characteristics.
Internationally, we continue to extend patent coverage of our
core fertilizer technologies including controlled-release and
water-soluble products and the like. We also are extending
protection of our developments in regard to aquaculture, growing
media, applicator and sprayer technologies to additional
countries within our Canadian, European and Asia/ Pacific
markets. Significant accomplishments are the extension of our
coir/peat international patent coverage, our
Grasshopper applicator products within the European
markets, our Pull N Spray sprayer in New
Zealand and additional coverage of our Ortho applicator
technology in both Canada and Japan.
Three United States patents expired in fiscal 2005. The first
patent covered the Accu Pro 2000 Rotary Spreader and the SR 2000
Rotary Spreader. The second patent covered a combination
fertilizer/growth regulator composition and process for treating
turf. The third patent was an expansion of the second
6
patent and covered the treatment of all vegetation with the
combination fertilizer composition. The loss of these patents is
not expected to materially affect our business. We have one
patent currently being opposed by a third party in Europe. In
regard to this opposed patent, the European Patent Office (the
EPO) in calendar year 2004 rendered a favorable
decision. However, the opposing party has appealed that
decision. A ruling on the appeal is not expected until calendar
year 2006. An unfavorable ruling by the EPO in the appeal could
materially affect our indoor pest control market share in
Germany.
Roundup® Marketing Agreement
Under the terms of the marketing agreement with Monsanto, we are
Monsantos exclusive agent for the marketing and
distribution of consumer Roundup® products (with
additional rights to new products containing glyphosate or other
similar non-selective herbicides) in the consumer lawn and
garden market within the United States and other specified
countries, including Australia, Austria, Canada, France, Germany
and the United Kingdom.
Under the marketing agreement, we and Monsanto are jointly
responsible for developing global consumer and trade marketing
programs for consumer Roundup®. We have assumed
responsibility for sales support, merchandising, distribution
and logistics for Roundup®. Monsanto continues
to own the consumer Roundup® business and
provides significant oversight of its brand. In addition,
Monsanto continues to own and operate the agricultural
Roundup® business.
We are compensated under the marketing agreement based on the
success of the consumer Roundup® business in the
markets covered by the agreement. We receive a graduated
commission to the extent that the earnings before interest and
taxes of the consumer Roundup® business in the
included markets exceeds specified thresholds. Regardless of
these earnings, we are required to make an annual contribution
payment against the overall expenses of the
Roundup® business. In fiscal 2005, the
contribution payment as required by the agreement was
$23.8 million. For fiscal 2006, and until 2018 or the
earlier termination of the agreement, the minimum annual
contribution payment will be $20 million.
The gross commission earned under the marketing agreement, the
contribution payments to Monsanto and the amortization of the
initial marketing fee paid to Monsanto are included in net sales
in the Companys Statements of Operations. For fiscal 2005
and fiscal 2004, the net amount earned under the marketing
agreement was an expense of $5.3 million (including a
$45.7 million charge for contribution payments previously
deferred under the marketing agreement), and income of
$28.5 million, respectively. For further details, see
Note 3 of the Notes to Consolidated Financial Statements.
The marketing agreement has no definite term, except as it
relates to the European Union countries. With respect to the
European Union countries, the term of the marketing agreement
has been extended through September 30, 2008. The parties
may agree to renew the agreement with respect to the European
Union countries for two successive terms ending on
September 30, 2015 and 2018, with a separate determination
being made by the parties at least six months prior to the
expiration of each such term as to whether to commence a
subsequent renewal term. However, if Monsanto does not agree to
either of the remaining renewal terms with respect to the
European Union countries, the commission structure will be
renegotiated within the terms of the marketing agreement.
Monsanto has the right to terminate the marketing agreement upon
certain specified events of default by us, including an uncured
material breach, material fraud, material misconduct or
egregious injury to the Roundup® brand. Monsanto
also has the right to terminate the agreement upon a change of
control of Monsanto or the sale of the consumer
Roundup® business. In addition, Monsanto may
terminate the agreement within specified regions, including
North America, for specified declines in the consumer
Roundup® business.
We have rights similar to Monsantos to terminate the
marketing agreement upon an uncured material breach, material
fraud or material willful misconduct by Monsanto. In addition,
we may terminate the agreement upon Monsantos sale of the
consumer Roundup® business or in certain other
circumstances, in which case we would not be able to collect the
termination fee described below.
If Monsanto terminates the marketing agreement upon a change of
control of Monsanto or the sale of the consumer
Roundup® business prior to September 30,
2008, we will be entitled to a termination fee in excess of
$100 million. If we terminate the agreement upon an uncured
material breach, material fraud or
7
material willful misconduct by Monsanto, we will be entitled to
receive a termination fee in excess of $100 million if the
termination occurs prior to September 30, 2008. The
termination fee declines over time from in excess of
$100 million to a minimum of $16 million for
terminations between September 30, 2008 and
September 30, 2018.
Monsanto has agreed to provide us with notice of any proposed
sale of the consumer Roundup® business, allow us
to participate in the sale process and negotiate in good faith
with us with respect to a sale. In the event we acquire the
consumer Roundup® business in such a sale, we
would receive credit against the purchase price in the amount of
the termination fee that would otherwise have been paid to us
upon termination by Monsanto of the marketing agreement upon the
sale. If Monsanto decides to sell the consumer
Roundup® business to another party, we must let
Monsanto know whether we intend to terminate the marketing
agreement and forfeit any right to a termination fee or whether
we will agree to continue to perform under the agreement on
behalf of the purchaser, unless and until the purchaser
terminates our services and pays any applicable termination fee.
Competition
Each of our segments participates in markets that are highly
competitive. Many of our competitors sell their products at
prices lower than ours, and we compete primarily on the basis of
product quality, product performance, supply chain
effectiveness, value, brand strength and advertising.
In the North American consumer do-it-yourself lawn and garden
markets and pest control markets, we compete primarily against
control label products as well as branded products.
Control label products are those sold under a
retailer-owned label or a supplier-owned label, which are sold
exclusively at a specific retail chain. The control label
products that we compete with include Vigoro®
products sold at Home Depot, Sta-Green® products
sold at Lowes, and KGro® products sold at
Kmart. Our competitors in branded lawn and garden products and
the consumer pest control markets include Spectrum Brands, Bayer
AG, Central Garden & Pet Company, Garden Tech, Enforcer
Products, Inc., Green Light Company and Lebanon Chemical Corp.
With respect to growing media products, in addition to
nationally distributed, branded competitive products, we face
competition from regional competitors who compete primarily on
the basis of price for commodity growing media business.
In the North American professional horticulture markets, we face
a broad range of competition from numerous companies ranging in
size from multi-national chemical and fertilizer companies such
as Dow AgroSciences Company, Uniroyal Chemical Corporation and
Chisso-Asahi Fertilizer Co. Ltd., to smaller, specialized
companies such as Pursell Technologies, Inc., Sun
Gro-U.S. (a division of Hines Horticulture, Inc.) and
Fafard, Inc. Some of these competitors have significant
financial resources and research departments.
We believe we have the second largest market share position in
the U.S. do-it-for-me lawn care service market. We compete
against TruGreen-ChemLawn®, a division of
ServiceMaster, which we believe has the leading market share in
the U.S. lawn care service market and has a substantially
larger share of this market than Scotts
LawnService®, as well as numerous regional and
local lawn care services operations.
Internationally, we face strong competition in the consumer
do-it-yourself lawn and garden market, particularly in Europe.
Our competitors in the European Union include Bayer AG,
Kali & Salz (which owns the Compo, Algoflash brands)
and a variety of local companies.
The International professional horticulture markets in which we
compete are also very competitive, particularly the markets for
controlled-release and water-soluble fertilizer products. We
have numerous U.S. and European competitors in these
international markets, including Pursell Industries, Inc., Compo
GmbH, a subsidiary of Kali & Salz, Norsk Hydro ASA,
Haifa Chemicals Ltd. and Kemira Oyj.
Significant Customers
Approximately 70% of our worldwide net sales in fiscal 2005 were
made by our North America segment. Within the North America
segment, approximately 33% of our net sales in fiscal 2005 were
made to Home Depot, 17% to Wal*Mart and 14% to Lowes. We
face strong competition for the business of these
8
significant customers. The loss of any of these customers or a
substantial decrease in the volume or profitability of our
business with any of these customers could have a material
adverse effect on our earnings and profits.
Strategic Initiatives
The Company has developed a strategic plan that refocuses its
efforts and capitalizes on its strengths to further own the
relationship with its consumers and distance itself from the
competition. The execution of this strategy will sustain future
growth and further secure the Companys franchise. The
critical elements of this strategy are as follows.
Profit and Marketing Improvement
Plan
In fiscal 2005, we initiated a plan to significantly strengthen
the Company. Over the course of the next two years, we expect to
reduce purchasing and selling, general and administrative costs
by reducing headcount and implementing better business
processes. Savings generated by these initiatives will be shared
between improving operating profits and supporting our brand
with increased marketing and innovation. In addition, to our
base earnings growth of 10 to 12 percent, we anticipate
that fiscal 2006 annual pre-tax earnings will increase by $25 to
$30 million as a result of savings associated with this
initiative. An additional $25 to $30 million of savings will be
re-invested in fiscal 2006 behind our brands to strengthen the
relationships with our consumers and retail partners.
Exploiting New Lawn & Garden
Opportunities
We believe that the power of our brands provides us with
significant opportunities to expand our business into adjacent
lawn and garden categories. In October 2004, we acquired
Smith & Hawken®, a leading brand in the
fast growing outdoor living and gardening lifestyle category.
The addition of the Smith & Hawken®
brand and its network of retail stores, catalog and Internet
sales will be the foundation for our future expansion into
outdoor living categories. In November 2005, we
acquired Gutwein whose Morning Song® brand is a
leader in the wild bird food category. This is the
Companys entrance into this attractive and growing
category.
Strengthen our International
Business
We have explored the strategic options for our international
business and determined that the best option for maximizing
shareholder value is to sharpen our focus for the business by:
(i) improving our competitive position; (ii) reducing
costs in the business to improve profitability and to allow for
marketing investments; and (iii) realigning the
organization to better leverage our knowledge of the marketplace
and the consumer. We plan to achieve these goals through a
variety of initiatives, including reducing the complexity of the
business and the product portfolio, improving supply chain
efficiency and effectiveness, and aggressively pursuing new
business opportunities.
Expanding Scotts
LawnService®
The number of lawn owners who want to maintain their lawns and
gardens but do not want to do it themselves represents a
significant portion of the total market. We recognize that our
portfolio of well-known brands provides us with a unique ability
to extend our business into lawn and garden services and the
strength of our brands provides us with a significant
competitive advantage in acquiring new customers. We have spent
the past several years developing our Scotts
LawnService® business model. The business has
grown significantly from revenues of $42 million in fiscal
2001 to revenues of $159.8 million in fiscal 2005. This
growth has come from geographic expansion, acquisitions and
organic growth fueled by our highly effective direct marketing
programs. We invested $6.4 million in lawn service
acquisitions in fiscal 2005. We anticipate continuing to make
selective acquisitions in fiscal 2006 and beyond. Significant
investments will continue to be made in the Scotts
LawnService® business infrastructure in order to
continually improve our customer service throughout the
organization and leverage scale economies as we continue to grow.
9
Seasonality and Backlog
Our business is highly seasonal with approximately 73% of our
net sales occurring in our combined second and third quarters of
both fiscal 2005 and fiscal 2004.
Consistent with prior years, we anticipate significant orders
for the upcoming spring season will start to be received late in
the winter and continue through the spring season. Historically,
substantially all orders are received and shipped within the
same fiscal year with minimal carryover of open orders at the
end of the fiscal year.
Raw Materials
We purchase raw materials for our products from various sources
that we presently consider to be adequate, and no one source is
considered essential to any of our segments or to our business
as a whole. We are subject to market risk from fluctuating
market prices of certain raw materials, including urea and other
chemicals as well as paper and plastic products. Our objectives
surrounding the procurement of these materials are to ensure
continuous supply and to minimize costs. We seek to achieve
these objectives through negotiation of contracts with favorable
terms directly with vendors. In general, we do not enter into
forward contracts or other market instruments as a means of
minimizing our risk exposures on these materials but, when
appropriate, we will procure a certain percentage of our needs
in advance of the season to secure pre-determined prices.
Occasionally, we do hedge certain commodities to ensure seasonal
material supplies and control costs.
Manufacturing and Distribution
We manufacture products for our North American consumer business
at our facilities in Marysville, Ohio; Ft. Madison, Iowa
and Temecula, California, as well as use a number of third party
contract packers in the United States and Canada. In addition,
the Company manufactures growing media products in 26 regional
facilities located throughout North America. The primary
distribution centers for our North American consumer business
are managed by the Company and strategically placed across the
United States.
We also manufacture horticultural products for our North America
and International professional businesses at a leased fertilizer
manufacturing facility in Charleston, South Carolina and a
Company-owned site in Heerlen, the Netherlands. Certain products
are also produced for our professional businesses at other
Company-owned facilities and subcontractors in the United States
and Europe. The majority of shipments to customers are made via
common carriers or through distributors in the United States and
a network of public warehouses and distributors in Europe.
We manufacture the non-growing media products for our
International business at our facilities in Howden, the United
Kingdom and Bourth, France. We also utilize a number of third
party contract packers. The primary distribution centers for our
International businesses are located in the United Kingdom,
France and Germany and are managed by a logistics provider.
The growing media products for our International segment are
produced at our facilities in Hatfield, the United Kingdom and
Hautmont, France and at a number of third party contract
packers. Growing media products are generally shipped direct
without passing through either a distribution center or mixing
warehouse.
Employees
As of September 30, 2005, we employed 4,289 full-time
employees in the United States and an additional
1,002 full-time employees located outside the United
States. During peak sales and production periods, we utilize
seasonal and temporary labor.
None of our U.S. employees are members of a union.
Approximately 45 of our full-time U.K. employees are members of
the Transport and General Workers Union and have full collective
bargaining rights. An undisclosed number of our full-time
employees at our office in Ecully, France are members of the
Confederation Francaise Democratique du Travail and
Confederation Generale du Travail, participation in which is
confidential under French law. In addition, a number of union
and non-union full-time employees are members of works councils
at three sites in Bourth, Hautmont and Ecully, France, and a
10
number of non-union employees are members of works councils in
Ingelheim, Germany. In the Waardenburg office in the
Netherlands, a small number of the approximately 130 employees
are members of a workers union, but we are not responsible for
collective bargaining negotiations with this union. In the
Netherlands, we are governed by the Works Councils Act with
respect to the union. Works councils represent employees on
labor, employment matters and manage social benefits.
We believe we have good relationships with our employees in the
United States, and both unionized and non-unionized
International employees.
Environmental and Regulatory Considerations
Local, state, federal and foreign laws and regulations relating
to environmental matters affect us in several ways. In the
United States, all products containing pesticides must be
registered with the U.S. EPA (and similar state agencies)
before they can be sold. The inability to obtain or the
cancellation of any such registration could have an adverse
effect on our business, the severity of which would depend on
the products involved, whether another product could be
substituted and whether our competitors were similarly affected.
We attempt to anticipate regulatory developments and maintain
registrations of, and access to, substitute active ingredients,
but there can be no assurance that we will continue to be able
to avoid or minimize these risks. Fertilizer and growing media
products are also subject to state and foreign labeling
regulations. Our manufacturing operations are subject to waste,
water and air quality permitting and other regulatory
requirements of federal and state agencies.
The Food Quality Protection Act, enacted by the
U.S. Congress in August 1996, establishes a standard for
food-use pesticides, which standard is the reasonable certainty
that no harm will result from the cumulative effects of
pesticide exposures. Under this Act, the U.S. EPA is
evaluating the cumulative risks from dietary and non-dietary
exposures to pesticides. The pesticides in our products, certain
of which may be used on crops processed into various food
products, are typically manufactured by independent third
parties and continue to be evaluated by the U.S. EPA as
part of this exposure risk assessment. The U.S. EPA or the
third party registrant may decide that a pesticide we use in our
products will be limited or made unavailable to us. We cannot
predict the outcome or the severity of the effect of these
continuing evaluations.
In addition, the use of certain pesticide and fertilizer
products is regulated by various local, state, federal and
foreign environmental and public health agencies. These
regulations may include requirements that only certified or
professional users apply the product or that certain products be
used only on certain types of locations (such as not for
use on sod farms or golf courses), may require users to
post notices on properties to which products have been or will
be applied, may require notification to individuals in the
vicinity that products will be applied in the future or may ban
the use of certain ingredients. We believe we are operating in
substantial compliance with, or taking action aimed at ensuring
compliance with, these laws and regulations.
State and federal authorities generally require growing media
facilities to obtain permits (sometimes on an annual basis) in
order to harvest peat and to discharge storm water run-off or
water pumped from peat deposits. The state permits typically
specify the condition in which the property must be left after
the peat is fully harvested, with the residual use typically
being natural wetland habitats combined with open water areas.
We are generally required by these permits to limit our
harvesting and to restore the property consistent with the
intended residual use. In some locations, these facilities have
been required to create water retention ponds to control the
sediment content of discharged water.
Regulations and environmental concerns also exist surrounding
peat extraction in the United Kingdom and the European Union. In
August 2000, English Nature, the nature conservation advisory
body to the United Kingdom government, notified us that three of
our peat harvesting sites in the United Kingdom were under
consideration as possible Special Areas of
Conservation under European Union law. In April 2002,
working in conjunction with Friends of the Earth (United
Kingdom), we reached agreement with English Nature to transfer
our interests in the properties and for the immediate cessation
of all but a limited amount of peat extraction on one of the
three sites. As a result of this agreement, we have withdrawn
our objection to the proposed European designations as Special
Areas of Conservation and will undertake restoration work on the
sites, for which we will receive additional consideration from
English
11
Nature. We believe we have sufficient raw material supplies
available to replace the peat extracted from such sites.
Regulatory Actions
In 1997, the Ohio Environmental Protection Agency (the
Ohio EPA) initiated an enforcement action against us
with respect to alleged surface water violations and inadequate
treatment capabilities at our Marysville, Ohio facility and
seeking corrective action under the federal Resource
Conservation and Recovery Act. The action relates to several
discontinued on-site disposal areas, which date back to the
early operations of the Marysville facility that we had already
been assessing and, in some cases, remediating, on a voluntary
basis. We are remediating the Marysville site under the terms of
a consent order under the oversight of the Ohio EPA.
We are negotiating with the Philadelphia District of the
U.S. Army Corps of Engineers regarding the terms of site
remediation and the resolution of the Corps civil penalty
demand in connection with our prior peat harvesting operations
at our Lafayette, New Jersey facility.
At September 30, 2005, $3.3 million was accrued for
the environmental and regulatory matters described herein, the
majority of which is for site remediation. Most of the costs
accrued as of September 30, 2005 are expected to be paid
through fiscal 2007; however, payments could be made for a
period thereafter.
We believe the amounts accrued as of September 30, 2005 are
adequate to cover our known environmental exposures based on
current facts and estimates of likely outcome. However, the
adequacy of these accruals is based on several significant
assumptions, including the following:
|
|
|
|
|
that we have identified all of the significant sites that must
be remediated; |
|
|
|
that there are no significant conditions of potential
contamination that are unknown to us; and |
|
|
|
that with respect to the agreed judicial Consent Order in Ohio,
the potentially contaminated soil can be remediated in place
rather than having to be removed and only specific stream
segments will require remediation as opposed to the entire
stream. |
If there is a significant change in the facts and circumstances
surrounding these assumptions, it could have a material impact
on the ultimate outcome of these matters and our results of
operations, financial position and cash flows.
During fiscal 2005, fiscal 2004, and fiscal 2003, we expensed
approximately $3.7 million, $3.3 million, and
$1.5 million for environmental matters. There were no
material capital expenditures in fiscal 2005, fiscal 2004 or
fiscal 2003 related to environmental or regulatory matters.
Financial Information About Geographic Areas
For certain information concerning our international revenues
and long-lived assets, see ITEM 7. MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS and Note 21 of the Notes to Consolidated
Financial Statements.
ITEM 1A. RISK FACTORS
Cautionary Statement on Forward-Looking Statements
We have made and will make forward-looking
statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 in our 2005 Annual Report, in this Annual
Report on Form 10-K and in other contexts relating to
future growth and profitability targets and strategies designed
to increase total shareholder value. Forward-looking statements
also include, but are not limited to, information regarding our
future economic and financial condition, the plans and
objectives of our management and our assumptions regarding our
performance and these plans and objectives.
The Private Securities Litigation Reform Act of 1995 provides a
safe harbor for forward-looking statements to
encourage companies to provide prospective information, so long
as those statements are
12
identified as forward-looking and are accompanied by meaningful
cautionary statements identifying important factors that could
cause actual results to differ materially from those discussed
in the forward-looking statements. We desire to take advantage
of the safe harbor provisions of that Act.
Some forward-looking statements that we make in our 2005 Annual
Report, in this Annual Report on Form 10-K and in other
contexts represent challenging goals for our company, and the
achievement of these goals is subject to a variety of risks and
assumptions and numerous factors beyond our control. Important
factors that could cause actual results to differ materially
from the forward-looking statements we make are described below.
All forward-looking statements attributable to us or persons
working on our behalf are expressly qualified in their entirety
by the following cautionary statements.
Products
Perceptions that the products we produce and market are not safe
could adversely affect us and contribute to the risk we will be
subjected to legal action. We manufacture and market a number of
complex chemical products, such as fertilizers, growing media,
herbicides and pesticides, bearing our brand names. On occasion,
allegations are made that some of our products have failed to
perform up to expectations or have caused damage or injury to
individuals or property. Based on reports of contamination at a
third party suppliers vermiculite mine, the public may
perceive that some of our products manufactured in the past
using vermiculite are or may also be contaminated. Public
perception that our products are not safe, whether justified or
not, could impair our reputation, involve us in litigation,
damage our brand names and have a material adverse affect on our
business.
Weather and Seasonality
Weather conditions in North America and Europe can have a
significant impact on the timing of sales in the spring selling
season and overall annual sales. An abnormally wet and/or cold
spring throughout North America or Europe could adversely affect
both fertilizer and pesticide sales and, therefore, our
financial results. Because our products are used primarily in
the spring and summer, our business is highly seasonal. For the
past three fiscal years, more than 70% of our net sales have
occurred in the second and third fiscal quarters combined. Our
working capital needs and borrowings peak toward the end of our
second fiscal quarter because we are incurring expenditures in
preparation for the spring selling season while the majority of
our revenue collections occur in our third fiscal quarter. If
cash on hand is insufficient to pay our obligations as they come
due, including interest payments or operating expenses, at a
time when we are unable to draw on our credit facility, this
seasonality could have a material adverse effect on our ability
to conduct our business. Adverse weather conditions could
heighten this risk.
Competition
Each of our segments participates in markets that are highly
competitive. Many of our competitors sell their products at
prices lower than ours, and we compete primarily on the basis of
product quality, product performance, value, brand strength,
supply chain competency and advertising. Some of our competitors
have significant financial resources. The strong competition
that we face in all of our markets may prevent us from achieving
our revenue goals, which may have a material adverse affect on
our financial condition and results of operations.
Customer Concentration
North America segment net sales represented approximately 70% of
our worldwide net sales in fiscal 2005. Our top three North
American retail customers together accounted for 64% of our
North America segment fiscal 2005 net sales and 80% of our
outstanding accounts receivable as of September 30, 2005.
Home Depot, Wal*Mart and Lowes represented approximately
33%, 17% and 14%, respectively, of our fiscal 2005 North America
net sales. The loss of, or reduction in orders from, Home Depot,
Wal*Mart, Lowes or any other significant customer could
have a material adverse effect on our business and our financial
results, as could customer disputes regarding shipments, fees,
merchandise condition or related matters. Our inability to
collect accounts receivable from any of these customers could
also have a material adverse affect on our financial condition
and results of operations.
13
We do not have long-term sales agreements or other contractual
assurances as to future sales to any of our major retail
customers. In addition, continued consolidation in the retail
industry has resulted in an increasingly concentrated retail
base. To the extent such concentration continues to occur, our
net sales and income from operations may be increasingly
sensitive to deterioration in the financial condition of, or
other adverse developments involving our relationship with, one
or more customers.
Significant Agreement
If we were to commit a serious default under the marketing
agreement with Monsanto for consumer Roundup®
products, Monsanto may have the right to terminate the
agreement. If Monsanto were to terminate the marketing agreement
for cause, we would not be entitled to any termination fee, and
we would lose all, or a significant portion, of the significant
source of earnings and overhead expense absorption the marketing
agreement provides. Monsanto may also be able to terminate the
marketing agreement within a given region, including North
America, without paying us a termination fee if sales to
consumers in that region decline: (1) over a cumulative
three fiscal year period; or (2) by more than 5% for each
of two consecutive years.
Debt
We have a significant amount of debt that could adversely affect
our financial health and prevent us from fulfilling our
obligations. Our substantial indebtedness could have important
consequences. For example, it could:
|
|
|
|
|
make it more difficult for us to satisfy our obligations under
outstanding indebtedness and otherwise; |
|
|
|
increase our vulnerability to general adverse economic and
industry conditions; |
|
|
|
require us to dedicate a substantial portion of cash flows from
operating activities to payments on our indebtedness, which
would reduce the cash flows available to fund working capital,
capital expenditures, advertising, research and development
efforts and other general corporate requirements; |
|
|
|
limit our flexibility in planning for, or reacting to, changes
in our business and the industry in which we operate; |
|
|
|
place us at a competitive disadvantage compared to our
competitors that have less debt; |
|
|
|
limit our ability to borrow additional funds; and |
|
|
|
expose us to risks inherent in interest rate fluctuations
because some of our borrowings are at variable rates of
interest, which could result in higher interest expense in the
event of increases in interest rates. |
Our ability to make payments on and to refinance our
indebtedness and to fund planned capital expenditures,
acquisitions, dividends and the planned five-year stock
repurchase plan will depend on our ability to generate cash in
the future. This, to some extent, is subject to general
economic, financial, competitive, legislative, regulatory and
other factors that are beyond our control.
We cannot provide assurance that our business will generate
sufficient cash flow from operating activities or that future
borrowings will be available to us under our credit facility in
amounts sufficient to enable us to pay our indebtedness or to
fund our other liquidity needs. We may need to refinance all or
a portion of our indebtedness, on or before maturity. We cannot
assure you that we would be able to refinance any of our
indebtedness on commercially reasonable terms or at all.
Our credit facility contains restrictive covenants and cross
default provisions that require us to maintain specified
financial ratios. Our ability to satisfy those financial ratios
can be affected by events beyond our control, and we cannot be
assured we will satisfy those ratios. A breach of any of these
financial ratio covenants or other covenants could result in a
default. Upon the occurrence of an event of default, the lenders
could elect to declare the applicable outstanding indebtedness
due immediately and payable and terminate all commitments to
extend further credit. We cannot be sure that our lenders would
waive a default or that we could pay the indebtedness in full if
it were accelerated.
14
Equity Ownership Concentration
Hagedorn Partnership, L.P. beneficially owned approximately 31%
of our outstanding common shares as of December 1, 2005,
and has sufficient voting power to significantly influence the
election of directors and the approval of other actions
requiring the approval of our shareholders.
Regulatory and Environmental
Local, state, federal and foreign laws and regulations relating
to environmental matters affect us in several ways. In the
United States, all products containing pesticides must be
registered with the U.S. EPA (and similar state agencies)
before they can be sold. The inability to obtain or the
cancellation of any such registration could have an adverse
effect on our business, the severity of which would depend on
the products involved, whether another product could be
substituted and whether our competitors were similarly affected.
We attempt to anticipate regulatory developments and maintain
registrations of, and access to, substitute active ingredients,
but there can be no assurance that we will continue to be able
to avoid or minimize these risks.
The Food Quality Protection Act, enacted by the
U.S. Congress in August 1996, establishes a standard for
food-use pesticides, which standard is the reasonable certainty
that no harm will result from the cumulative effect of pesticide
exposures. Under this Act, the U.S. EPA is evaluating the
cumulative risks from dietary and non-dietary exposures to
pesticides. The pesticides in our products, certain of which may
be used on crops processed into various food products, are
typically manufactured by independent third parties and continue
to be evaluated by the U.S. EPA as part of this exposure
risk assessment. The U.S. EPA or the third party registrant
may decide that a pesticide we use in our products will be
limited or made unavailable to us. For example, in December
2000, the U.S. EPA reached agreement with various parties,
including manufacturers of the active ingredient diazinon,
regarding a phased withdrawal from retailers by December 2004 of
residential uses of products containing diazinon, also used in
our lawn and garden products. We cannot predict the outcome or
the severity of the effect of their continuing evaluations.
In addition, the use of certain pesticide and fertilizer
products is regulated by various local, state, federal and
foreign environmental and public health agencies. These
regulations may include requirements that only certified or
professional users apply the product or that certain products be
used only on certain types of locations, may require users to
post notices on properties to which products have been or will
be applied, may require notification to individuals in the
vicinity that products will be applied in the future or may ban
the use of certain ingredients. Even if we are able to comply
with all such regulations and obtain all necessary
registrations, we cannot assure you that our products,
particularly pesticide products, will not cause injury to the
environment or to people under all circumstances. The costs of
compliance, remediation or products liability have adversely
affected operating results in the past and could materially
affect future quarterly or annual operating results.
The harvesting of peat for our growing media business has come
under increasing regulatory and environmental scrutiny. In the
United States, state regulations frequently require us to limit
our harvesting and to restore the property to an agreed-upon
condition. In some locations, we have been required to create
water retention ponds to control the sediment content of
discharged water. In the United Kingdom, our peat extraction
efforts are also the subject of legislation.
In addition to the regulations already described, local, state,
federal and foreign agencies regulate the disposal, handling and
storage of waste, air and water discharges from our facilities.
The adequacy of our current environmental reserves and future
provisions is based on our operating in substantial compliance
with applicable environmental and public health laws and
regulations and several significant assumptions:
|
|
|
|
|
that we have identified all of the significant sites that must
be remediated; |
|
|
|
that there are no significant conditions of potential
contamination that are unknown to us; and |
|
|
|
that with respect to the agreed judicial Consent Order in Ohio,
the potentially contaminated soil can be remediated in place
rather than having to be removed and only specific stream
segments will require remediation as opposed to the entire
stream. |
15
If there is a significant change in the facts and circumstances
surrounding these assumptions or if we are found not to be in
substantial compliance with applicable environmental and public
health laws and regulations, it could have a material impact on
future environmental capital expenditures and other
environmental expenses and our results of operations, financial
position and cash flows.
European Economic Conditions and Foreign Currency
Exposures
We currently operate manufacturing, sales and service facilities
outside of North America, particularly in the United Kingdom,
Germany, France and the Netherlands. In fiscal 2005,
International net sales accounted for approximately 18% of our
total net sales. Accordingly, we are subject to risks associated
with operations in foreign countries, including:
|
|
|
|
|
fluctuations in currency exchange rates; |
|
|
|
limitations on the remittance of dividends and other payments by
foreign subsidiaries; |
|
|
|
additional costs of compliance with local regulations; and |
|
|
|
historically, in certain countries, higher rates of inflation
than in the United States. |
In addition, our operations outside the United States are
subject to the risk of new and different legal and regulatory
requirements in local jurisdictions, potential difficulties in
staffing and managing local operations and potentially adverse
tax consequences. The costs related to our international
operations could adversely affect our operations and financial
results in the future.
Restructuring Activities
In June 2005, we commenced a long-term strategic improvement
plan, focused on improving organizational effectiveness,
implementing better business processes and reducing Selling,
General and Administrative (S,G&A) expenses.
This reorganization places significant pressure on many
S,G&A functions to reduce headcount and streamline
activities. While management believes these efforts will
ultimately generate even stronger financial results, there can
be no assurance that the plan will achieve all of its expected
savings and that unanticipated difficulties may be encountered
in executing the plan.
Cost Pressures
Our ability to manage our cost structure can be adversely
affected by movements in commodity and other raw material
prices, such as those experienced in fiscal 2005. Market
conditions may limit the Companys ability to raise selling
prices to offset increases in our input costs. The uniqueness of
our technologies can limit our ability to locate alternative
supplies for certain products. For certain materials, new
sources of supply may have to be qualified under regulatory
standards, which can require additional investment and delay
bringing the product to market.
Manufacturing
We use a combination of internal and outsourced facilities to
manufacture our products. We are subject to the inherent risks
in such activities, including product quality, safety, licensing
requirements and other regulatory issues, environmental events,
loss or impairment of key manufacturing sites, disruptions in
logistics, labor disputes and industrial accidents. Furthermore,
we are subject to natural disasters and other factors over which
the Company has no control.
Acquisitions
From time to time we make strategic acquisitions, including the
October 2004 acquisition of Smith &
Hawken®, the October 2005 acquisition of Rod
McLellan Company (RMC) and the November 2005 acquisition of
Gutwein (Morning Song®). Acquisitions have
inherent risks, such as obtaining necessary regulatory
approvals, retaining key personnel, integration of the acquired
business, and achievement of planned synergies and projections.
16
ITEM 1B. UNRESOLVED STAFF COMMENTS
None
ITEM 2. PROPERTIES
We lease land from the Union County Community Improvement
Corporation in Marysville, Ohio for our headquarters and for our
research and development facilities. We own property in
Marysville, Ohio for our manufacturing and distribution
facilities. Combined, these facilities are situated on
approximately 875 acres of land.
The North America segment owns two additional research
facilities located in Apopka, Florida; and Gervais, Oregon. We
own a production facility, which encompasses 27 acres, in
Fort Madison, Iowa and lease a spreader and other durable
components manufacturing facility in Temecula, California. We
also lease a controlled-release fertilizer manufacturing
facility in Charleston, South Carolina. We operate 24 growing
media facilities in North America 19 of which are
owned by us and five of which are leased. Most of our growing
media facilities include production lines, warehouses, offices
and field processing areas. We lease sales offices in Atlanta,
Georgia; Troy, Michigan; Mooresville, North Carolina; Rolling
Meadows, Illinois; and Bentonville, Arkansas. We also lease a
facility in Mississauga, Ontario that serves as the headquarters
for our Canadian subsidiary.
Scotts LawnService® conducts its company-owned
operations from 77 leased facilities, primarily office/warehouse
units in industrial/office parks, across the United States
serving 38 metropolitan markets.
Smith & Hawken® operates 57 retail
stores, all leased facilities primarily in shopping centers
across the United States. It leases its main headquarters in
Novato, California.
The International segment leases its U.K. office, located in
Godalming (Surrey); its French headquarters and local operations
office, located in Ecully; a German office, located in
Ingelheim; an Austrian office, located in Salzburg; an
Australian office, located in Baulkan Hills (New South Wales);
and a Canadian office located in Toronto. We own manufacturing
facilities in Howden and Hatfield (East Yorkshire) in the United
Kingdom. We also own a blending and bagging facility for growing
media in Hautmont, France; and a plant in Bourth, France, that
we use for formulating, blending and packaging control products
for the consumer market. We lease a research and development
facility in Chazay, France. Our site in Heerlen, the Netherlands
is both a distribution center and a manufacturing site for
coated fertilizers for the consumer and professional markets. We
own the land and the building for the manufacturing facility,
but lease the distribution center building. We own research and
development facilities in Levington and Bramford in the United
Kingdom. We lease a sales office in Sint Niklaas, Belgium.
We lease warehouse space throughout the United States and
continental Europe as needed.
We believe that our facilities are adequate to serve their
intended purposes at this time and that our property leasing
arrangements are satisfactory.
ITEM 3. LEGAL PROCEEDINGS
As noted in the discussion in ITEM
1. BUSINESS Environmental and Regulatory
Considerations and ITEM 1. BUSINESS
Regulatory Actions, we are involved in several pending
environmental matters. We believe that our assessment of
contingencies is reasonable and that related reserves, in the
aggregate, are adequate; however, there can be no assurance that
the final resolution of these matters will not have a material
adverse affect on our results of operations, financial position
and cash flows.
17
Legal proceedings resolved during fiscal 2005:
Aventis
|
|
|
AgrEvo Environmental Health, Inc. v. The Scotts Company,
et al. (Southern District of New York) |
|
|
|
The Scotts Company v. Aventis S.A. and Starlink
Logistics, Inc. (Southern District of Ohio) |
|
|
|
A jury trial was held in New York from May 23, 2005 to
June 13, 2005 in the case originally filed by AgrEvo
Environmental Health, Inc. (which subsequently changed its name
to Aventis Environmental Science USA LP). The jury rejected all
of plaintiffs antitrust claims and all but one of its
contract claims, an undisputed, minor claim for non-payment of
invoices of approximately $194,000. |
|
|
On September 30, 2005, sanofi-aventis Group S.A., the
successor to Aventis, S.A. and Aventis Environmental Science USA
LP and the parent of Starlink Logistics, Inc. (collectively,
Aventis) paid to the Company in full and final
settlement of all the outstanding claims between the Company and
Aventis approximately $10 million. Of this amount,
$8.9 million of the settlement is recorded in
Impairment, restructuring and other charges within
the Consolidated Statements of Operations (see Note 4 of
the Notes to Consolidated Financial Statements). The payment by
Aventis, and the agreement signed in connection with the
settlement, terminates Aventis post-trial motions and
appeals in New York and brings to a conclusion all litigation
between the companies. |
Central Garden & Pet Company
|
|
|
The Scotts Company v. Central Garden (Southern District
of Ohio) |
|
|
|
Central Garden v. The Scotts Company &
Pharmacia (Northern District of California) |
|
|
|
In regards to this matter and related litigation against Central
Garden & Pet Company (Central Garden), on
April 12, 2005, the Sixth Circuit modified in part and
affirmed the trial courts judgment providing for a net
award of approximately $15 million to the Company, which we
received on July 15, 2005. The Company has recognized the
satisfaction of this judgment in its financial results for the
period ended July 2, 2005. Details of how the
$15 million was reflected in our financial statements are
presented in Note 16 of the Notes to Consolidated Financial
Statements. This brings to a conclusion all pending litigation
between the Company and Central Garden including the previously
pending antitrust case in the Northern District of California in
which the Company prevailed. |
Pending material legal proceedings are as follows:
U.S. Horticultural Supply, Inc. (F/ K/ A E.C. Geiger,
Inc.)
On November 5, 2004, U.S. Horticultural Supply
(Geiger) filed suit against the Company in the
U.S. District Court for the Eastern District of
Pennsylvania. This complaint alleges that the Company conspired
with another distributor, Griffin Greenhouse Supplies, Inc., to
restrain trade in the horticultural products market, in
violation of Sections 1 and 57 of the Sherman Antitrust Act.
The Company believes that all of Geigers claims are
without merit and intends to vigorously defend against them. If
any of the above actions are determined adversely to the
Company, the result could have a material adverse effect on the
Companys results of operations, financial position and
cash flows. Any potential exposure that the Company may face
cannot be reasonably estimated. Therefore, no accrual has been
established related to this matter.
Other
The Company has been named a defendant in a number of cases
alleging injuries that the lawsuits claim resulted from exposure
to asbestos-containing products, apparently based on the
Companys historic use of vermiculite in certain of its
products. The complaints in these cases are not specific about
the plaintiffs contacts with the Company or its products.
The Company in each case is one of numerous defendants and none
of the claims seeks damages from the Company alone. The Company
believes that the claims against it are without merit and is
vigorously defending them. It is not currently possible to
reasonably estimate a probable loss, if any, associated with the
cases and, accordingly, no accrual or reserves have been
recorded in the Companys consolidated financial
statements. There can be no
18
assurance that these cases, whether as a result of adverse
outcomes or as a result of significant defense costs, will not
have a material adverse effect on the Company, its financial
condition or its results of operations.
The Company is reviewing agreements and policies that may
provide insurance coverage or indemnity as to these claims and
is pursuing coverage under some of these agreements, although
there can be no assurance of the results of these efforts.
We are involved in other lawsuits and claims which arise in the
normal course of our business. In our opinion, these claims
individually and in the aggregate are not expected to result in
a material adverse effect on our results of operations,
financial position or cash flows.
19
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY
HOLDERS
There were no matters submitted to a vote of the security
holders of The Scotts Miracle-Gro Company during the fourth
quarter of fiscal 2005.
SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE
REGISTRANT
The executive officers of The Scotts Miracle-Gro Company, their
positions and, as of December 9, 2005, their ages and years
with the Company (and its predecessors) are set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years with |
Name |
|
Age |
|
Position(s) Held |
|
Company |
|
James Hagedorn
|
|
|
50 |
|
|
Chief Executive Officer and
Chairman of the Board
|
|
|
18 |
|
Robert F. Bernstock
|
|
|
55 |
|
|
President
|
|
|
2 |
|
Christopher L. Nagel
|
|
|
43 |
|
|
Executive Vice President and Chief
Financial Officer
|
|
|
7 |
|
David M. Aronowitz
|
|
|
49 |
|
|
Executive Vice President, General
Counsel and Corporate Secretary
|
|
|
7 |
|
Denise S. Stump
|
|
|
51 |
|
|
Executive Vice President, Global
Human Resources
|
|
|
5 |
|
Executive officers serve at the discretion of the Board of
Directors and pursuant to employment agreements or other
arrangements.
The business experience of each of the individuals listed above
during at least the past five years is as follows:
Mr. Hagedorn was named Chief Executive Officer and Chairman
of the Board of The Scotts Miracle-Gro Company on
December 9, 2005. He was originally named Chairman of the
Board of The Scotts Company in January 2003 and became Chairman
of the Board of The Scotts Miracle-Gro Company in March 2005. He
was named President and Chief Executive Officer of The Scotts
Company in May 2001, which was merged into The Scotts Company
LLC in March 2005. He was also appointed President and Chief
Executive Officer of The Scotts Miracle-Gro Company in March
2005. He served as President and Chief Operating Officer of The
Scotts Company from April 2000 to May 2001. He also serves as a
director for Farms For City Kids Foundation, Inc., Nurse Family
Partnership, The CDC Foundation, Embry Riddle/ Aeronautical
University, Northshore University Hospital (New York), Scotts
Miracle-Gro Foundation and the Intrepid Sea-Air-Space Museum,
all charitable organizations. Mr. Hagedorn is the brother
of Katherine Hagedorn Littlefield, a director of The Scotts
Miracle-Gro Company.
Mr. Bernstock was named President of The Scotts Miracle-Gro
Company on December 9, 2005. He was named President and
Chief Operating Officer of The Scotts Company LLC in October
2005. Mr. Bernstock was named Executive Vice President of
The Scotts Miracle-Gro Company in March 2005. Mr. Bernstock
served as Executive Vice President and President, North America
of The Scotts Company LLC and its predecessor The Scotts Company
from June 2003 to October 2005. Mr. Bernstock served as
Senior Vice President & General Manager Air
Fresheners, Food Products & Branded Commercial Markets
of Dial Corporation (Dial), a manufacturer and
marketer of soap products, laundry detergents, air fresheners
and canned meats, from October 2002 to May 2003. From January
2002 to September 2002, he served as Special Advisor to the
Chairman and Chief Executive Officer of Verticalnet, Inc., a
provider of collaborative supply chain solutions software, and
as a consultant to Dial. From January 2001 to January 2002,
Mr. Bernstock served as Acting Chairman, President and
Chief Executive Officer of Atlas Commerce, Inc.
(Atlas), a provider of collaborative supply chain
solutions software, prior to the acquisition of Atlas by
Verticalnet, Inc., in January 2002. From March 1998 to January
2001, he served as President, Chief Executive Officer and a
Director of Vlasic Foods International Inc.
(Vlasic), a producer, marketer and distributor of
branded convenience food products. On January 29, 2001,
Vlasic and its United States operating subsidiaries filed
voluntary petitions for reorganization relief pursuant to
Chapter 11 of the United States Bankruptcy Code. From July
1997 to March 1998, Mr. Bernstock served as Executive Vice
President of Campbell Soup Company, a manufacturer and marketer
of prepared food products, and President of its
U.S. Grocery Division. Mr. Bernstock serves as a
director of Verticalnet, Inc. and The Pantry, Inc., both public
companies and of SecureSheet Technologies, LLC, a private
company.
20
Mr. Nagel was named Executive Vice President and Chief
Financial Officer of The Scotts Miracle-Gro Company in March
2005. Mr. Nagel was named Executive Vice President in
February 2003 and Chief Financial Officer in January 2003 of The
Scotts Company, which was merged into The Scotts Company LLC in
March 2005. From August 2001 to January 2003, he served as
Senior Vice President, North America and Corporate Finance of
The Scotts Company. From September 1998 to August 2001,
Mr. Nagel served as Vice President and Corporate Controller
of The Scotts Company. Mr. Nagel serves as a director of
the Leukemia & Lymphoma Society, Central Ohio Chapter,
a charitable organization.
Mr. Aronowitz was named Executive Vice President, General
Counsel and Corporate Secretary of The Scotts Miracle-Gro
Company in March 2005. He was previously named Executive Vice
President, General Counsel and Secretary of The Scotts Company
in October 2001, which was merged into The Scotts Company LLC in
March 2005. He was Senior Vice President, Assistant General
Counsel and Assistant Secretary of The Scotts Company from
February 2000 to October 2001.
Ms. Stump was named Executive Vice President, Global Human
Resources of The Scotts Miracle-Gro Company in March 2005.
Ms. Stump was named Executive Vice President, Global Human
Resources of The Scotts Company in February 2003, which was
merged into The Scotts Company LLC in March 2005. She was named
Senior Vice President, Global Human Resources of The Scotts
Company in October 2002. From July 2001 until October 2002,
Ms. Stump served as Vice President, Human Resources North
America, of The Scotts Company. From September 2000 until July
2001, Ms. Stump served as Vice President, Human Resources
Technology and Operations of The Scotts Company.
21
PART II
|
|
ITEM 5. |
MARKET FOR REGISTRANTS COMMON EQUITY, RELATED
STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY
SECURITIES |
The common shares of The Scotts Miracle-Gro Company trade on the
New York Stock Exchange under the symbol SMG. The
quarterly share prices have been adjusted to reflect the 2-for-1
stock split on November 9, 2005 to shareholders of record
on November 2, 2005.
|
|
|
|
|
|
|
|
|
|
|
Sale Prices |
|
|
|
|
|
High |
|
Low |
|
FISCAL 2005
|
|
|
|
|
|
|
|
|
First quarter
|
|
$ |
36.83 |
|
|
$ |
30.95 |
|
Second quarter
|
|
$ |
36.19 |
|
|
$ |
33.29 |
|
Third quarter
|
|
$ |
36.56 |
|
|
$ |
33.55 |
|
Fourth quarter
|
|
$ |
43.97 |
|
|
$ |
36.19 |
|
|
FISCAL 2004
|
|
|
|
|
|
|
|
|
First quarter
|
|
$ |
30.10 |
|
|
$ |
27.63 |
|
Second quarter
|
|
$ |
31.98 |
|
|
$ |
28.92 |
|
Third quarter
|
|
$ |
34.28 |
|
|
$ |
30.93 |
|
Fourth quarter
|
|
$ |
32.10 |
|
|
$ |
28.01 |
|
On June 22, 2005, The Scotts Miracle-Gro Company announced
that its Board of Directors had approved the establishment of a
quarterly cash dividend. The $0.50 per share (adjusted for the
2-for-1 stock split distributed November 9, 2005) annual
dividend is to be paid in quarterly increments beginning in the
fourth quarter of fiscal 2005. The first and second of these
quarterly dividends were paid on September 1, 2005 and
December 1, 2005.
The payment of future dividends, if any, on the common shares
will be determined by the Board of Directors of The Scotts
Miracle-Gro Company in light of conditions then existing,
including the Companys earnings, financial condition and
capital requirements, restrictions in financing agreements,
business conditions and other factors.
As of November 17, 2005, there were approximately
42,500 shareholders including holders of record and our
estimate of beneficial holders.
Neither The Scotts Miracle-Gro Company nor any affiliated
purchaser, as defined in Rule 10b-18(a)(3) under the
Securities Exchange Act of 1934, as amended, purchased any
common shares of The Scotts Miracle-Gro Company during the
fiscal quarter ended September 30, 2005. On
October 27, 2005, The Scotts Miracle-Gro Company announced
that its Board of Directors had approved a $500 million share
repurchase program. This repurchase program is authorized for
five years and we currently anticipate allocating approximately
$100 million per year to the program.
22
ITEM 6. SELECTED FINANCIAL DATA
Five-Year Summary(1)(2)
For the fiscal year ended September 30,
(in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005(3) |
|
|
2004 |
|
2003 |
|
2002 |
|
2001 |
|
OPERATING RESULTS(4):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$ |
2,369.3 |
|
|
|
$ |
2,106.5 |
|
|
$ |
1,941.6 |
|
|
$ |
1,772.9 |
|
|
$ |
1,697.9 |
|
|
Gross profit
|
|
|
860.4 |
|
|
|
|
792.4 |
|
|
|
701.7 |
|
|
|
649.4 |
|
|
|
613.6 |
|
|
Income from operations
|
|
|
200.9 |
|
|
|
|
252.8 |
|
|
|
231.6 |
|
|
|
238.4 |
|
|
|
113.4 |
|
|
Income from continuing operations
(net of tax)
|
|
|
100.4 |
|
|
|
|
100.5 |
|
|
|
103.2 |
|
|
|
100.5 |
|
|
|
13.9 |
|
|
Net income
|
|
|
100.6 |
|
|
|
|
100.9 |
|
|
|
103.8 |
|
|
|
82.5 |
|
|
|
15.5 |
|
|
Depreciation and amortization
|
|
|
67.2 |
|
|
|
|
57.7 |
|
|
|
52.2 |
|
|
|
43.5 |
|
|
|
63.6 |
|
FINANCIAL POSITION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
|
301.6 |
|
|
|
|
396.7 |
|
|
|
364.4 |
|
|
|
278.3 |
|
|
|
249.1 |
|
|
Current ratio
|
|
|
1.6 |
|
|
|
|
1.9 |
|
|
|
1.8 |
|
|
|
1.6 |
|
|
|
1.5 |
|
|
Property, plant and equipment, net
|
|
|
337.0 |
|
|
|
|
328.0 |
|
|
|
338.2 |
|
|
|
329.2 |
|
|
|
310.7 |
|
|
Total assets
|
|
|
2,018.9 |
|
|
|
|
2,047.8 |
|
|
|
2,030.3 |
|
|
|
1,914.1 |
|
|
|
1,854.8 |
|
|
Total debt to total book
capitalization
|
|
|
27.7 |
% |
|
|
|
41.9 |
% |
|
|
51.0 |
% |
|
|
58.3 |
% |
|
|
63.7 |
% |
|
Total debt
|
|
|
393.5 |
|
|
|
|
630.6 |
|
|
|
757.6 |
|
|
|
829.4 |
|
|
|
887.8 |
|
|
Total shareholders equity
|
|
|
1,026.2 |
|
|
|
|
874.6 |
|
|
|
728.2 |
|
|
|
593.9 |
|
|
|
506.2 |
|
CASH FLOWS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
226.7 |
|
|
|
|
214.2 |
|
|
|
216.1 |
|
|
|
238.9 |
|
|
|
65.7 |
|
|
Investments in property, plant and
equipment
|
|
|
40.4 |
|
|
|
|
35.1 |
|
|
|
51.8 |
|
|
|
57.0 |
|
|
|
63.4 |
|
|
Cash invested in acquisitions,
including seller note payments
|
|
|
84.6 |
|
|
|
|
20.5 |
|
|
|
57.1 |
|
|
|
63.0 |
|
|
|
37.6 |
|
PER SHARE DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share(5)
|
|
$ |
1.51 |
|
|
|
$ |
1.56 |
|
|
$ |
1.68 |
|
|
$ |
1.41 |
|
|
$ |
0.27 |
|
|
Diluted earnings per common share(5)
|
|
|
1.47 |
|
|
|
|
1.52 |
|
|
|
1.62 |
|
|
|
1.30 |
|
|
|
0.25 |
|
|
Total cash dividends
|
|
|
8.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends per share
|
|
$ |
0.125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock price at year-end
|
|
|
43.97 |
|
|
|
|
32.08 |
|
|
|
27.35 |
|
|
|
20.85 |
|
|
|
17.05 |
|
|
Stock price range High
|
|
|
43.97 |
|
|
|
|
34.28 |
|
|
|
28.85 |
|
|
|
25.18 |
|
|
|
23.55 |
|
|
Stock price range Low
|
|
|
30.95 |
|
|
|
|
27.63 |
|
|
|
21.77 |
|
|
|
17.23 |
|
|
|
14.44 |
|
OTHER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA(6)
|
|
|
268.1 |
|
|
|
|
310.5 |
|
|
|
283.8 |
|
|
|
281.9 |
|
|
|
177.0 |
|
|
Interest coverage (EBITDA/interest
expense)(6)
|
|
|
6.3 |
|
|
|
|
3.3 |
|
|
|
4.1 |
|
|
|
3.7 |
|
|
|
2.0 |
|
|
Weighted average common shares
outstanding
|
|
|
66.8 |
|
|
|
|
64.7 |
|
|
|
61.8 |
|
|
|
58.6 |
|
|
|
56.8 |
|
|
Common shares and dilutive
potential common shares used in diluted EPS calculation
|
|
|
68.6 |
|
|
|
|
66.6 |
|
|
|
64.3 |
|
|
|
63.3 |
|
|
|
60.8 |
|
|
|
(1) |
All common share and per share information presented in the
above five-year summary have been adjusted to reflect the
2-for-1 stock split of the common shares which was distributed
on November 9, 2005 to shareholders of record on
November 2, 2005. |
|
|
(2) |
The information presented for all periods in the above five-year
summary has been adjusted to reflect: (a) as net sales,
amounts previously reported as net commission from the
Roundup® marketing agreement, and (b) as
net sales and cost of sales, certain reimbursements and costs
associated with the marketing agreement on a gross basis that
was previously reported on a net basis, with no effect to net
income. For further discussion of these adjustments, see
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS and
Note 3 of the Notes to Consolidated Financial Statements
included in this Annual Report on Form 10-K. |
|
|
(3) |
Fiscal 2005 includes Smith & Hawken®
from the October 2, 2004 date of acquisition. See further
discussion of acquisitions in ITEM 1. BUSINESS
and in Note 5 of the Notes to Consolidated Financial
Statements included in this Annual Report on Form 10-K. |
23
|
|
(4) |
Operating results includes the following items segregated by
accounts effected on the Consolidated Statements of Operations
included with the Consolidated Financial Statements included in
this Annual Report on Form 10-K. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the fiscal year ended September 30, |
|
|
|
|
|
2005 |
|
2004 |
|
2003 |
|
2002 |
|
2001 |
|
Net sales includes the following
relating to the Roundup® Marketing Agreement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net commission (expense) income
|
|
$ |
(5.3 |
) |
|
$ |
28.5 |
|
|
$ |
17.6 |
|
|
$ |
16.2 |
|
|
$ |
20.8 |
|
|
Reimbursements associated with the
Marketing Agreement
|
|
|
40.7 |
|
|
|
40.1 |
|
|
|
36.3 |
|
|
|
33.0 |
|
|
|
32.3 |
|
|
Deferred contribution charge (see
Managements Discussion and Analysis and Note 3 of Notes to
Consolidated Financial Statements included in this Annual Report
on Form 10-K)
|
|
|
(45.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs associated with the Marketing
Agreement
|
|
|
40.7 |
|
|
|
40.1 |
|
|
|
36.3 |
|
|
|
33.0 |
|
|
|
32.3 |
|
|
Restructuring and other charges
(income)
|
|
|
(0.3 |
) |
|
|
0.6 |
|
|
|
9.1 |
|
|
|
1.7 |
|
|
|
7.3 |
|
SG&A includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other charges
|
|
|
9.8 |
|
|
|
9.1 |
|
|
|
8.0 |
|
|
|
8.1 |
|
|
|
75.7 |
|
|
U.K. and other impairment charges
|
|
|
23.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to refinancings
|
|
|
1.3 |
|
|
|
45.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative effect of accounting for
intangible assets, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18.5 |
) |
|
|
|
|
|
|
(5) |
Basic and diluted earnings per share would have been as follows
if the accounting change for intangible assets adopted in the
fiscal year beginning October 1, 2001, had been adopted as
of October 1, 2000: |
|
|
|
|
|
|
|
For the fiscal year ended |
|
|
September 30, 2001 |
|
Income available to common
shareholders
|
|
$ |
32.1 |
|
Basic earnings per share
|
|
|
0.57 |
|
Diluted earnings per share
|
|
|
0.53 |
|
|
|
(6) |
EBITDA is defined as income from operations, plus depreciation
and amortization. We believe that EBITDA provides additional
information for determining our ability to meet debt service
requirements. EBITDA does not represent and should not be
considered as an alternative to net income or cash flow from
operations as determined by accounting principles generally
accepted in the United States of America, and EBITDA does not
necessarily indicate whether cash flow will be sufficient to
meet cash requirements. EBITDA margin is calculated as EBITDA
divided into net sales. Our measure of EBITDA, which may not be
similar to other similarly titled captions used by other
companies, excludes $24.9 million of cash expenses related
to the refinancings of our credit facility and redemption our
85/8% subordinated
notes in fiscal 2004. These expenses have been excluded since
they are deemed to be financing related costs that are typically
excluded from the presentation of EBITDA and the definitions
used by our lenders to evaluate the Companys compliance
with its debt agreements. A numeric reconciliation of EBITDA to
income from operations is as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the fiscal year ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
| |
Income from operations
|
|
$ |
200.9 |
|
|
$ |
252.8 |
|
|
$ |
231.6 |
|
|
$ |
238.4 |
|
|
$ |
113.4 |
|
Depreciation and amortization
|
|
|
67.2 |
|
|
|
57.7 |
|
|
|
52.2 |
|
|
|
43.5 |
|
|
|
63.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$ |
268.1 |
|
|
$ |
310.5 |
|
|
$ |
283.8 |
|
|
$ |
281.9 |
|
|
$ |
177.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24
|
|
ITEM 7. |
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS |
The purpose of this discussion is to provide an understanding of
the Companys financial results and condition by focusing
on changes in certain key measures from year to year.
Managements Discussion and Analysis (MD&A) is
organized in the following sections:
|
|
|
|
|
Executive summary |
|
|
|
Results of operations |
|
|
|
Liquidity and capital resources |
|
|
|
Critical accounting policies and estimates |
|
|
|
Managements outlook |
On November 9, 2005, The Scotts Miracle-Gro Company
distributed a 2-for-1 stock split of the common shares to
shareholders of record on November 2, 2005. At the end of
fiscal 2005, on a split-adjusted basis, The Scotts Miracle-Gro
Company had approximately 68.6 million diluted common
shares outstanding. To enhance comparability going forward, all
share and per share information referred to in this MD&A and
elsewhere in this Annual Report on Form 10-K have been
adjusted to reflect this stock split for all periods presented.
Effective with the fiscal 2005 Form 10-K and 2005 Annual
Report to Shareholders, we have made changes to our Consolidated
Statements of Operations, which management believes improves the
overall presentation. With respect to the Amended and Restated
Exclusive Agency and Marketing Agreement (the Marketing
Agreement) with Monsanto Company (Monsanto),
we have made two presentational changes. First, we have
reclassified as net sales the amounts previously reported as net
commission from the Marketing Agreement. Second, net sales and
cost of sales have been adjusted to reflect certain
reimbursements and costs associated with the Marketing Agreement
on a gross basis that was previously reported on a net basis,
with no effect on gross profit or net income. See further
details regarding these matters in Note 3 of the Notes to
Consolidated Financial Statements. Furthermore, we have
simplified the presentation of selling, general and
administrative expenses presented on the face of the
Consolidated Statements of Operations. Details of this line item
are included in the Results of Operations section of this
MD&A.
Executive Summary
We are dedicated to delivering strong, consistent financial
results and outstanding shareholder returns by providing
consumers with products of superior quality and value to enhance
their outdoor living environments. We are a leading manufacturer
and marketer of consumer branded products for lawn and garden
care and professional horticulture in North America and Europe.
We are Monsantos exclusive agent for the marketing and
distribution of consumer Roundup® non-selective
herbicide products within the United States and other
contractually specified countries. We have a presence in
Australia, the Far East, Latin America and South America. Also,
in the United States, we operate what we believe to be the
second largest residential lawn service business, Scotts
LawnService®. In fiscal 2005, our operations
were divided into the following reportable segments: North
America, Scotts LawnService®, International, and
Corporate & Other. The Corporate & Other
segment consists of the recently acquired Smith &
Hawken® business and corporate general and
administrative expenses.
As a leading consumer branded lawn and garden company, we focus
our consumer marketing efforts, including advertising and
consumer research, on creating consumer demand to pull products
through the retail distribution channels. In the past three
years, we have spent approximately 5% of our net sales annually
on media advertising to support and promote our products and
brands. We have applied this consumer marketing focus for the
past several years, and we believe that we receive a significant
return on these marketing expenditures. We expect we will
continue to focus our marketing efforts toward the consumer and
make additional targeted investments in consumer marketing
expenditures in the future to continue to drive market share and
sales growth. In fiscal 2006, we expect to increase advertising
spending by 18% to 20% as we reinvest a portion of our selling,
general and administrative cost savings to strengthen our brands.
25
Our sales are susceptible to global weather conditions. For
instance, periods of wet weather can adversely impact sales of
certain products, while increasing demand for other products. We
believe that our past acquisitions have somewhat diversified
both our product line risk and geographic risk to weather
conditions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent Net Sales |
|
|
by Quarter |
|
|
|
|
|
2005 |
|
2004 |
|
2003 |
|
First Quarter
|
|
|
10.4 |
% |
|
|
8.7 |
% |
|
|
9.0 |
% |
Second Quarter
|
|
|
34.3 |
% |
|
|
35.2 |
% |
|
|
35.1 |
% |
Third Quarter
|
|
|
38.0 |
% |
|
|
38.2 |
% |
|
|
37.7 |
% |
Fourth Quarter
|
|
|
17.3 |
% |
|
|
17.9 |
% |
|
|
18.2 |
% |
Due to the nature of our lawn and garden business, significant
portions of our shipments occur in the second and third fiscal
quarters. Over the past few years, retailers have reduced their
pre-season inventories by relying on us to deliver products
in season when consumers seek to buy our products.
Management focuses on a variety of key indicators and operating
metrics to monitor the health and performance of our business.
These metrics include consumer purchases (point-of-sale data),
market share, net sales (including volume, pricing and foreign
exchange), gross profit margins, income from operations, net
income and earnings per share. To the extent applicable, these
measures are evaluated with and without impairment,
restructuring and other charges. We also focus on measures to
optimize cash flow and return on invested capital, including the
management of working capital and capital expenditures.
The 2005 long-term strategic improvement plan, initiated in June
2005, is focused on improving organizational effectiveness,
implementing better business processes, reducing selling,
general and administrative (S,G&A) expenses, and increasing
spending on consumer marketing and innovation. While we have
generated strong financial performance over the past several
years, management believes even better results can be achieved.
We recently announced that we expect the strategic improvement
plan will increase annual pre-tax earnings by $25 to
$30 million beginning in fiscal 2006, exclusive of
restructuring costs that will likely extend into the first half
of fiscal 2006, with an additional $25 to $30 million of
savings being reinvested in consumer marketing, technology and
innovation.
Beginning in fiscal 2002, we embarked on an International Profit
Improvement Plan. This effort has been focused on reorganization
and rationalization of our European supply chain, increased
sales force productivity, and a shift to pan-European category
management of our product portfolio. While International
profitability had improved through fiscal 2004, last year we
announced we were exploring all options for our International
business, with the goal of improving shareholder value. After
exploring various alternatives, we have decided that continued
ownership and investment in our International business is the
best alternative based on the current facts and circumstances.
Our International efforts in fiscal 2006 and beyond will be
focused on improving our competitive position, reducing costs
within the business and realigning the organization to better
leverage our knowledge of the market place and the consumer.
We continue to view strategic acquisitions as a means to enhance
our strong core businesses. In October 2004, we invested
$73.6 million in the acquisition of Smith &
Hawken®, a leading brand in the outdoor living
and gardening lifestyle category. We are pleased with the
direction this business is headed after the first year of
ownership, having already made a number of significant
improvements in the operations of the business, including supply
chain execution and marketing and merchandising strategy, which
will improve profitability.
We continue to invest in the growth of our Scotts
LawnService® business, including three
acquisitions in fiscal 2005 totaling $6.4 million. Over the
past five years, we have invested over $95 million to
expand Scotts LawnService® via acquisitions.
Subsequent to the fiscal 2005 year-end, we completed two
acquisitions. Effective October 3, 2005, we acquired all
the outstanding shares of Rod McLellan Company (RMC) for a
total of $22 million. RMC is a leading branded producer and
marketer of soil and landscape products in the western
U.S. This business will be integrated into our existing
Growing Media business. Effective November 18, 2005, we
acquired Gutwein & Co. Inc. (Gutwein), for
approximately $77 million in cash. Through its Morning
Song® brand,
26
Gutwein is a leader in the growing U.S. wild bird food
category, generating approximately $80 million in annual
revenues. Morning Song® products are sold at
leading mass retailers, grocery, pet and general merchandise
stores. This is our first acquisition in the wild bird food
category and we are excited about the opportunity to leverage
the strengths of both organizations to drive continued growth in
this category.
Prior to fiscal 2005, we had not paid dividends on our common
shares. Based on the levels of cash flow generated by our
business in recent years and our improving financial condition,
on June 22, 2005, we announced that The Scotts Miracle-Gro
Companys Board of Directors approved an annual dividend of
50-cents per share, to be paid in 12.5-cent quarterly increments
beginning in the fourth quarter of fiscal 2005. Our first and
second quarterly dividends were paid on September 1, 2005
and December 1, 2005, respectively. In addition to the
2-for-1 stock split noted earlier, on October 27, 2005, The
Scotts Miracle-Gro Company announced that its Board of Directors
approved a $500 million share repurchase program. This
repurchase program is authorized for five years and we currently
anticipate allocating approximately $100 million per year
to the program.
Results of Operations
The following table sets forth the components of income and
expense as a percentage of net sales for the three years ended
September 30, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
2004 |
|
2003 |
|
Net sales
|
|
|
100.0 |
% |
|
|
|
100.0 |
% |
|
|
100.0 |
% |
Cost of sales
|
|
|
63.7 |
|
|
|
|
62.4 |
|
|
|
63.4 |
|
Restructuring and other charges
|
|
|
0.0 |
|
|
|
|
0.0 |
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
36.3 |
|
|
|
|
37.6 |
|
|
|
36.1 |
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
26.7 |
|
|
|
|
25.7 |
|
|
|
24.4 |
|
Impairment, restructuring and other
charges
|
|
|
1.4 |
|
|
|
|
0.4 |
|
|
|
0.4 |
|
Other income, net
|
|
|
(0.3 |
) |
|
|
|
(0.5 |
) |
|
|
(0.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
8.5 |
|
|
|
|
12.0 |
|
|
|
11.9 |
|
Costs related to refinancings
|
|
|
0.1 |
|
|
|
|
2.2 |
|
|
|
0.0 |
|
Interest expense
|
|
|
1.8 |
|
|
|
|
2.3 |
|
|
|
3.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
6.6 |
|
|
|
|
7.5 |
|
|
|
8.3 |
|
Income taxes
|
|
|
2.4 |
|
|
|
|
2.8 |
|
|
|
3.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
4.2 |
|
|
|
|
4.7 |
|
|
|
5.3 |
|
Income from discontinued operations
|
|
|
0.0 |
|
|
|
|
0.0 |
|
|
|
0.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
4.2 |
% |
|
|
|
4.7 |
% |
|
|
5.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
Consolidated net sales for fiscal 2005 increased 12.3% to
$2.37 billion from $2.11 billion in fiscal 2004.
Excluding the impact of Smith &
Hawken®, fiscal 2005 net sales were
$2.21 billion, an increase of 4.7%. Net price increases and
foreign exchange rate changes accounted for 1.9% and 1.2% of the
annual increase in net sales, respectively. North America
segment sales grew 6.4% to $1.67 billion, 4.2% from volume
growth and 2.3% on net pricing. Scotts
LawnService® net sales were $159.8 million
in fiscal 2005, up 18.2% from fiscal 2004, driven by volume and
pricing growth of 15.0%, with acquisitions accounting for the
balance of the revenue growth. International segment sales
increased by 6.1% to $430.3 million in fiscal 2005, 1.6%
from volume growth and 4.5% attributable to the positive impact
of foreign exchange rates. In fiscal 2004, worldwide net sales
totaled $2.11 billion, an increase of 8.8% compared to
fiscal 2003. Positive impacts from foreign exchanges rates
contributed 2.3% to sales growth, while the impact of changes in
selling prices was not material to fiscal 2004.
Gross Profit
Fiscal 2005 gross profit margins declined 130 basis points
compared to fiscal 2004. The Roundup® marketing
agreement contribution charge of $45.7 million discussed in
detail below reduced fiscal 2005
27
gross margin by approximately 90 basis points.
Smith & Hawken® has gross margins below
the Companys average, accounting for approximately
30 basis points of the decline. From an operating segment
standpoint, North America gross margins increased 50 basis
points, primarily on a higher net Roundup®
commission, while pricing offset increased commodity costs.
Scotts LawnService® gross margins improved as
frontline labor and supervisory productivity and fleet
management improvements offset higher fuel costs. Gross margins
declined in the International segment primarily due to higher
commodity and supply chain costs.
Gross margins include the net commission from the
Roundup® marketing agreement, which in fiscal
2005 was a net expense of $5.3 million. In the third
quarter of fiscal 2005, the Company recorded a charge of
$45.7 million to reflect a liability for the outstanding
balance of the deferred contribution amounts payable to Monsanto
under the Roundup® marketing agreement.
Previously, we had not recognized the contribution amounts
deferred under the Roundup® marketing agreement
until such deferred amounts were paid, based on
managements evaluation of the surrounding facts and
circumstances. We now believe it is appropriate to record the
liability based on numerous factors, including the recent strong
financial performance of the Roundup® business.
In October 2005, the then outstanding balance of deferred
contribution amount was paid to Monsanto, providing savings to
us because this liability carried 8.0% interest compared to our
interest rate on incremental borrowings of approximately 5.0%.
Excluding this charge, the commission would have been
$40.4 million for fiscal 2005, compared with
$28.5 million a year earlier. The increase in the
pre-charge net Roundup® commission was primarily
attributable to the strong sales profitability of this brand in
fiscal 2005.
Gross profit margins for fiscal 2004 increased 150 basis
points versus fiscal 2003. Gross profit margins were higher in
all three segments, as favorable product mix and operating
efficiencies more than offset cost pressures primarily from
higher fuel and commodity costs, including urea. Lastly,
restructuring and other expense in fiscal 2003 costs of sales,
primarily related to International supply initiatives,
contributed approximately 50 basis points to the fiscal
2004 gross profit margin improvement.
Selling, General and Administrative Expenses (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
|
2003 | |
| |
Advertising
|
|
$ |
122.5 |
|
|
|
$ |
105.0 |
|
|
$ |
97.7 |
|
Selling, general and administrative
|
|
|
486.6 |
|
|
|
|
419.6 |
|
|
|
361.8 |
|
Stock-based compensation
|
|
|
9.9 |
|
|
|
|
7.8 |
|
|
|
4.8 |
|
Amortization of intangibles
|
|
|
14.8 |
|
|
|
|
8.3 |
|
|
|
8.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
633.8 |
|
|
|
$ |
540.7 |
|
|
$ |
472.9 |
|
|
|
|
|
|
|
|
|
|
|
|
Advertising expenses in fiscal 2005 were $122.5 million, an
increase of $17.5 million from fiscal 2004. Excluding the
impact of Smith & Hawken®, advertising
expense was 5.0% of net sales in fiscal 2005 compared to 5.2% in
fiscal 2004. Increases in media spending in North America and
Scotts LawnService® were offset by more focused
International media spending. In fiscal 2004, advertising
expenses increased $7.3 million from fiscal 2003. Excluding
foreign exchange impacts, fiscal 2004 advertising increased
$4.6 million or 4.7%, roughly in line with the growth in
net sales. The dollar spending increase was focused on
Ortho® products and Canada in North America, and
Evergreen® lawn fertilizer in the United Kingdom.
S,G&A expenses in fiscal 2005 were $486.6 million
compared to $419.6 million in fiscal 2004. Excluding
Smith & Hawken®, S,G&A spending was
$450.3 million, an increase of $30.7 million or 7.3%.
This increase was primarily the result of outside legal fees
associated with litigation matters, Sarbanes-Oxley associated
compliance costs, expansion of Scotts
LawnService®, foreign exchange rates and
incremental North America selling expense (primarily for
increased home center support), partially offset by lower
non-restructuring severance costs in North America and
International. In fiscal 2004, S,G&A spending increased
$57.8 million or 16.0%. This increase was primarily due to
investments in North America marketing research and in-store
merchandising to support growth in the home center channel,
increased sales and management incentives (resulting from
improved performance against incentive targets), higher legal
costs and foreign exchange rates.
28
We began expensing stock options commencing with grants issued
in fiscal 2003. The majority of stock options vest over a
three-year period subsequent to the grant date, so the expense
associated with an option grant is generally recognized ratably
over three years. As such, 2005 is the first year that includes
a full charge for three years of option grants. Forfeitures
reduced the fiscal 2005 expense by approximately
$2.2 million.
Amortization of intangibles increased in fiscal 2005, primarily
as a result of a comprehensive review of intangibles and
corrections to the accumulated amortization of certain
intangible assets. Recent acquisitions, primarily
Smith & Hawken® and Scotts
LawnService® locations, also contributed to this
increase.
Impairment, Restructuring and Other Charges, net (in
millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
|
2003 | |
| |
Impairment charges
|
|
$ |
23.4 |
|
|
|
$ |
|
|
|
$ |
|
|
Restructuring severance
and related
|
|
|
26.3 |
|
|
|
|
9.1 |
|
|
|
8.0 |
|
Litigation related income
|
|
|
(16.8 |
) |
|
|
|
|
|
|
|
|
|
Other
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
33.2 |
|
|
|
$ |
9.1 |
|
|
$ |
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
Impairment, restructuring and other charges in fiscal 2005 were
the result of several significant events. In the first quarter
of fiscal 2005, we completed our annual impairment analysis of
goodwill and indefinite-lived intangible assets and determined
that tradenames associated with our consumer business in the
United Kingdom were impaired. The reduction in the value of the
tradenames has resulted primarily from a decline in the
profitability of the U.K. growing media business and unfavorable
category mix trends. Although management is developing
strategies focused on significantly improving the profitability
of the United Kingdom business, an assessment of future cash
flows indicated that an impairment charge against the book value
of the tradenames was appropriate. Accordingly, an impairment
charge of $22.0 million was recorded in the first quarter
of fiscal 2005. No impairment charge was recorded in fiscal 2004.
Fiscal 2005 restructuring charges for severance and related
costs were primarily associated with our fiscal 2005 long-term
strategic improvement plan. As a result of this program,
approximately 110 associates accepted early retirement or were
severed during the last four months of fiscal 2005. Fiscal 2004
restructuring charges consisted of $6.1 million related to
the restructuring of our International management team and
$3.0 million related to outsourcing of our data center and
application software functions. Fiscal 2003 restructuring
charges were related to our International profit improvement
plan and the exiting of an administrative facility in North
America.
Litigation related income is attributable to two separate
matters in fiscal 2005. In the fourth quarter of fiscal 2001, as
a result of collection concerns, we recorded a reserve against
accounts receivable from Central Garden & Pet Company
(Central Garden). This charge was recorded in impairment,
restructuring and other changes, net. After nearly five years of
pursuing collection of these receivables via litigation, we
received payment totaling $15.0 million on July 14,
2005. As a result, we reversed $7.9 million of the Central
Garden reserve recorded in fiscal 2001. In September 2005, we
reached a settlement with sanofi-aventis related to our
litigation of matters related to the Aventis business. In
relation to this settlement, we received a net $8.9 million
settlement on September 30, 2005.
Other Income, net
Other income, net was $7.5 million for fiscal 2005,
compared to $10.2 million in fiscal 2004. Other income for
fiscal 2005 resulted primarily from $4.1 million awarded to
us as part of the Central Garden judgment discussed above and
royalty income, partially offset by foreign currency losses.
Other income in fiscal 2004 and fiscal 2003 was attributable to
royalty income, gains on foreign currency transactions, Scotts
LawnService® franchise fees and cost subsidies
related to the sale of peat bogs in the United Kingdom, for
which a portion of the cost benefit was historically recorded as
other income (fiscal 2004 was the final year we received such
subsidies.)
29
Income from Operations
Income from operations in fiscal 2005 was $200.9 million,
compared to $252.8 million in fiscal 2004. As noted above,
income from operations in fiscal 2005 includes the following
charges: (1) $45.7 million related to the
Roundup® deferred contribution charge;
(2) a $22.0 million charge for impairment of U.K.
intangibles; and (3) $26.3 million in restructuring
charges. These were partially offset by $16.8 million of
litigation related income as discussed above. The remainder of
the change in income from operations is attributable to higher
net sales and gross profit margins, and significantly higher
earnings from the Roundup® marketing agreement,
partially offset by higher legal and Sarbanes-Oxley compliance
costs and sales force investments in North America.
Income from operations in fiscal 2004 increased
$21.2 million from fiscal 2003, which was partially
attributable to a $7.4 million reduction in restructuring
and other charges, in Cost of Sales and S,G&A combined.
Fiscal 2004 included $9.8 million in restructuring
activities, primarily related to restructuring of the
International management team and outsourcing of certain
technology functions. The remainder of the change in income from
operations is attributable to higher net sales and gross profit
margins, and significantly higher earnings from the
Roundup® marketing agreement, partially offset
by investments in media advertising and higher S,G&A
expenses.
Interest Expense and Refinancing Activities
We have refinanced our debt arrangements several times over the
past two years to take advantage of our improving financial
position and favorable market conditions. In October 2003, we
tendered nearly all of our $400 million then outstanding
senior subordinated notes that bore interest at
85/8%
and issued $200 million of new senior subordinated notes
bearing interest at
65/8%.
At the time, we also secured a new credit facility at more
favorable terms than our previous arrangement. Refinancing costs
associated with these transactions were $44.3 million,
including premiums paid on the redemption of the
85/8% notes,
write-off of previously deferred financing and treasury lock
costs and transactions fees. In August 2004, we refinanced the
term loan facility under a new credit agreement with new term
loans, providing for improved terms and borrowing costs. Costs
charged associated with this refinancing were $1.2 million.
In July 2005, we entered into a new credit agreement that
provided for a significantly increased revolving credit facility
and allowed us to repay our outstanding term notes, again
providing for improved terms and borrowing costs. Costs charged
against income from operations associated with this refinancing
were $1.3 million.
Interest expense decreased from $48.8 million in fiscal
2004 to $41.5 million in fiscal 2005. The decrease in
interest expense was primarily attributable to a
$113.9 million reduction in average borrowings, coupled
with nine basis point reduction in our weighted average interest
rate to 5.83%.
In fiscal 2004, interest expense decreased $20.4 million
compared to fiscal 2003. The decrease in interest expense was
due to a $107.0 million reduction in average borrowings
coupled with a reduction in our weighted average interest rate
(from 7.42% in fiscal 2003 to 5.92% in fiscal 2004) resulting
from more favorable borrowing arrangement terms as secured by
the debt refinancings and a favorable interest rate environment.
Income Taxes
The effective tax rate for fiscal 2005 was 36.5% compared to
36.7% in fiscal 2004 and 36.5% in fiscal 2003. In fiscal 2005,
our income tax rate benefited primarily as a result of favorable
developments related to prior year foreign tax exposures. In
fiscal 2004, our effective tax rate benefited from an adjustment
of state deferred income taxes resulting from a detailed review
of state effective tax rates and increased utilization of
foreign tax credits. The effective tax rate in fiscal 2003 was
favorably impacted by an adjustment of state deferred income
taxes resulting from a detailed review of state effective tax
rates, and increased utilization of foreign tax credits. We
anticipate the effective tax rate will be 37.0% to 37.5% going
forward.
30
Net Income and Earnings per Share
We reported income from continuing operations of
$100.4 million in fiscal 2005, compared to
$100.5 million in fiscal 2004. Income from discontinued
operations pertains to the disposal of our professional growing
media business at the end of fiscal 2004. Reported net income,
including income from discontinued operations, decreased from
$100.9 million or $1.52 per diluted share in fiscal
2004 to $100.6 million or $1.47 per diluted share in
fiscal 2005. As described in the Income from Operations
discussion, the benefit from solid sales growth in fiscal 2005
was offset by significant Roundup®, impairment
and restructuring charges. Average diluted shares outstanding
increased from 66.6 million in fiscal 2004 to
68.6 million in fiscal 2005, due to option exercises and
the impact on common stock equivalents of a higher average share
price.
In fiscal 2004, we reported income from continuing operations of
$100.5 million, compared to $103.2 million in fiscal
2003. Reported net income, including income from discontinued
operations, decreased from $103.8 million or $1.62 per
share in fiscal 2003 to $100.9 million or $1.52 per
share in fiscal 2004. The increase in income from operations in
2004 compared to 2003 as described above and a significant
reduction in interest expense were offset by costs associated
with debt refinancings in 2004. Average diluted shares
outstanding increased from 64.3 million in fiscal 2003 to
66.6 million in fiscal 2004, due to option exercises and
the impact on common stock equivalents of a higher average share
price.
Segment Results
In fiscal 2005, our operations were divided into the following
reportable segments: North America, Scotts
LawnService®, International, and
Corporate & Other. The Corporate & Other
segment consists of the recently acquired Smith &
Hawken® business and corporate general and
administrative expenses. Segment performance is evaluated based
on several factors, including income from operations before
amortization, and impairment, restructuring and other charges,
which is a non-GAAP financial measure. Management uses this
measure of operating profit to gauge segment performance because
we believe this measure is the most indicative of performance
trends and the overall earnings potential of each segment.
Net Sales by Segment (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
|
2003 | |
| |
North America
|
|
$ |
1,668.1 |
|
|
|
$ |
1,569.0 |
|
|
$ |
1,461.0 |
|
Scotts LawnService®
|
|
|
159.8 |
|
|
|
|
135.2 |
|
|
|
110.4 |
|
International
|
|
|
430.3 |
|
|
|
|
405.6 |
|
|
|
373.5 |
|
Corporate & other
|
|
|
159.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
2,417.8 |
|
|
|
|
2,109.8 |
|
|
|
1,944.9 |
|
Roundup® deferred
contribution charge
|
|
|
(45.7 |
) |
|
|
|
|
|
|
|
|
|
Roundup®
amortization
|
|
|
(2.8 |
) |
|
|
|
(3.3 |
) |
|
|
(3.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,369.3 |
|
|
|
$ |
2,106.5 |
|
|
$ |
1,941.6 |
|
|
|
|
|
|
|
|
|
|
|
|
31
Operating Profit by Segment (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
|
2003 | |
| |
North America
|
|
$ |
343.9 |
|
|
|
$ |
306.1 |
|
|
$ |
282.3 |
|
Scotts LawnService®
|
|
|
13.1 |
|
|
|
|
9.4 |
|
|
|
6.0 |
|
International
|
|
|
34.3 |
|
|
|
|
29.3 |
|
|
|
29.4 |
|
Corporate & other
|
|
|
(94.2 |
) |
|
|
|
(70.6 |
) |
|
|
(57.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
297.1 |
|
|
|
|
274.2 |
|
|
|
260.6 |
|
Roundup® deferred
contribution charge
|
|
|
(45.7 |
) |
|
|
|
|
|
|
|
|
|
Roundup®
amortization
|
|
|
(2.8 |
) |
|
|
|
(3.3 |
) |
|
|
(3.3 |
) |
Amortization
|
|
|
(14.8 |
) |
|
|
|
(8.3 |
) |
|
|
(8.6 |
) |
Impairment of intangibles
|
|
|
(23.4 |
) |
|
|
|
|
|
|
|
|
|
Restructuring and other charges
|
|
|
(9.5 |
) |
|
|
|
(9.8 |
) |
|
|
(17.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
200.9 |
|
|
|
$ |
252.8 |
|
|
$ |
231.6 |
|
|
|
|
|
|
|
|
|
|
|
|
North America
North America segment net sales were $1.67 billion in
fiscal 2005, an increase of 6.4% from fiscal 2004. Of the
increase in North America net sales, approximately 2.3% was
attributable to pricing. Within the North America segment,
Gardening Products net sales, which include growing media and
garden fertilizers, increased 9.8% with higher sales of
value-added Miracle-Gro® garden soils and
potting mix, Shake n Feed® continuous
release plant food and Organic Choice® garden
soils. Net sales of Ortho® products increased by
11.0% in fiscal 2005, driven largely by the successful launches
of Home Defense® Max®, Weed B
Gon®
Maxtm,
and Ortho® Season-Long Grass and Weed Killer
concentrate. Excluding the favorable impact of foreign exchange,
the Canadian group of North America posted a 23.0% net sales
increase in fiscal 2005. Unfavorable early season weather
conditions adversely impacted the Lawns group within North
America, resulting in net sales that were flat compared to
fiscal 2004.
During fiscal 2004, North America segment sales increased 7.5%.
Within the North America segment, Lawns net sales increased 4.6%
due to continued strong sales of value-added combination
products, such as Turf Builder® Fertilizer with
Halts® Crabgrass Preventer, Turf
Builder® with Plus 2® Weed
Control and Bonus® S, offset by spreader and
grass seed sales which were essentially flat year-over-year.
Gardening Products sales, which include growing media and garden
fertilizers, increased 3.1% with higher sales of value-added
Miracle-Gro® potting mix and garden soils
partially offset by lower sales of commodity growing media
products. Net sales of Ortho® products increased
a robust 16.1%, driven largely by the successful launches of Bug
B Gon Max®, Ortho® Season-Long
Grass and Weed Killer and a new range of opening price point
weed and insect control products under the
Ortho® Basic Solutions label at a major retailer.
In fiscal 2005, North America segment operating income increased
$37.8 million or 12.3%. Higher sales volume and gross
profits, product price increases, strong performance in the
Roundup® business and moderate increases in
S,G&A spending more than offset higher commodity and fuel
costs, investments in the home center sales team, and in
research and development projects.
During fiscal 2004, North America segment operating income
increased $23.8 million or 8.4%. Higher sales volume,
favorable product mix, largely due to new product introductions
within the Ortho® line, a continued shift to
value-added Growing Media sales, increased penetration of
value-added lawn combination products and warehousing and
distribution efficiencies more than offset higher urea and
freight costs and increased advertising and S,G&A expenses.
Scotts LawnService®
In fiscal 2005, we continued the expansion of our Scotts
LawnService® business. Through acquisitions and
internal growth, revenues have increased from approximately
$42 million in fiscal 2001 to $159.8 million in fiscal
2005. We invested $6.4 million of capital in lawn care
acquisitions in fiscal 2005 and expect to continue to make
selective acquisitions in fiscal 2006 and beyond.
32
Scotts LawnService® segment net sales increased
$24.6 million or 18.2% in fiscal 2005. In fiscal 2004,
Scotts LawnService® net sales increased 22.5% or
$24.8 million. The growth in net sales for both years has
been from increased customer retention, higher new customer
sales during the peak spring selling season, geographic
expansion and the full year impact of recent acquisitions. The
impact of acquisitions contributed approximately 3.6% and 5.4%
of revenue growth in 2005 and 2004, respectively.
Operating income for the Scotts LawnService®
segment increased $3.7 million or 39.4% in fiscal 2005 and
$3.4 million or 56.7% in fiscal 2004. These increases are
the result of revenue growth and improving operating margins
where we are balancing capturing scale economies as we grow with
making the appropriate infrastructure investments to support
future growth and service levels.
International
Fiscal 2005 International segment net sales increased
$24.7 million or 6.1% compared to fiscal 2004. Excluding
the effects of currency fluctuations, the fiscal 2005 net
sales increase was 1.1%. Lower sales in France and the Benelux
countries largely offset higher sales in the International
professional business, Central Europe and the United Kingdom.
Net sales for the International segment in fiscal 2004 grew 8.6%
or $32.1 million compared to fiscal 2003. Excluding the
effects of currency fluctuations and the impact of discontinuing
the sale of certain low margin professional growing media
products, net sales were essentially unchanged in fiscal 2004
versus the prior year. Sales increases in the United Kingdom and
the International professional business were offset by lower
sales in Central Europe and the Benelux countries, principally
due to cold and wet spring weather conditions.
International segment operating income grew $5.0 million or
17.1% in fiscal 2005, compared to fiscal 2004. Excluding
favorable foreign exchange rates, International segment
operating income increased 8.5%. The increase in fiscal 2005
operating income was attributable to modest revenue growth and
reduced S,G&A spending, partially offset by lower gross
margins.
In fiscal 2004, International operating income decreased
$0.1 million, as favorable foreign currency impacts and a
higher Roundup® commission were offset by
increases in media and S,G & A spending.
Corporate & Other
The loss in Corporate & Other increased by
$23.5 million in fiscal 2005. As discussed earlier, this
was largely driven by increased legal and Sarbanes-Oxley
compliance costs.
Managements Outlook
We are very pleased with our performance in fiscal 2005. Despite
upward pressure on commodity raw material costs and poor early
season weather conditions in North America and Europe, we
delivered record net sales and strong earnings for the year. Our
sales results were driven by strong point of sales growth in our
North America business, particularly gardening and control
products, and continued expansion of our Scotts
LawnService® business.
Our strong results in fiscal 2005 have set the stage for another
successful year in 2006. We are committed to executing the
strategic initiatives outlined in
ITEM 1. BUSINESS Strategic
Initiatives, all of which will increase operating profits,
secure future growth opportunities an strengthen the
Companys franchise for our consumers, our retail partners
and our shareholders.
From a financial perspective, the execution of our strategic
plan will also allow us to continue to improve Return on
Invested Capital (ROIC) and free cash flows. Our dividends
and stock repurchase program will allow us to return funds to
shareholders while maintaining our targeted capital structure
and allowing for opportunistic acquisitions.
For certain information concerning our risk factors, see
ITEM 1A. RISK FACTORS.
Liquidity and Capital Resources
Net cash provided from operating activities was
$226.7 million for fiscal 2005, compared to
$214.2 million for fiscal 2004. This strong cash flow
performance was fueled by increased profitability
33
(excluding the non-cash costs related to the $22.0 million
impairment charge for certain U.K. intangible assets) and
reduced working capital associated with higher payroll and
miscellaneous accrued liabilities.
The seasonal nature of our operations generally requires cash to
fund significant increases in working capital (primarily
inventory) during the first half of the year. Receivables and
payables also build substantially in the second quarter of the
year in line with the timing of sales as the spring selling
season begins. These balances liquidate during the June through
September period as the lawn and garden season unwinds. Unlike
our core retail business, Scotts LawnService®
typically has its highest receivables balances in the fourth
quarter because of the seasonal timing of customer applications
and extra services revenues.
Investing activities over the past three years have been
directed towards a number of acquisitions to support the growth
and expansion of our Scotts LawnService®
business. In addition, on October 2, 2004, we acquired all
outstanding shares of Smith & Hawken®
for a total cost of $73.6 million (net of cash acquired).
Capital spending on property, plant and equipment has declined
since fiscal 2003 when major capital investments were made in
the information systems area (principally supply chain related).
The investment and redemption of available-for-sale securities
represents the impact of investing in adjustable rate notes
(Notes) during fiscal 2004. These investments were
made in lieu of investing excess cash in overnight funds as the
Notes offered an improved yield with comparable risk. The Notes
were redeemed and converted into cash on October 1, 2004,
to partially fund the acquisition of Smith &
Hawken®.
Financing activities used cash of $195.2 million and
$133.0 million in fiscal 2005 and fiscal 2004,
respectively. We have aggressively managed our credit agreements
and borrowings to maximize the benefit of our improving capital
structure and debt facilities. To this end, approximately
$211 million of debt was retired in fiscal 2005 in addition
to the approximately $144 million retired in fiscal 2004.
We also paid our first ever common share dividend in the fourth
quarter of fiscal 2005 in the amount of $8.6 million.
Continuation of this dividend will require an ongoing annual
cash cost of approximately $35 million. Offsetting these
financing cash uses was $32.2 million in proceeds from the
exercise of employee stock options in fiscal 2005 in addition to
proceeds of $23.5 million in fiscal 2004.
Our primary sources of liquidity are cash generated by
operations and borrowings under our credit agreements. On
July 21, 2005, we entered into a Revolving Credit Agreement
(the New Credit Agreement), which consists of an
aggregate $1.0 billion multi-currency commitment, that
extends through July 21, 2010. We may also request an
additional $150 million in revolving credit commitments,
subject to approval from our lenders. The New Credit Agreement
provides for tighter borrowing spreads and greater flexibility
to repay debt compared to our previous borrowing arrangement. As
of September 30, 2005, there was $818.7 million of
availability under the New Credit Agreement. As of
September 30, 2005, we also had $200.0 million of
65/8% Senior
Subordinated Notes outstanding. Note 9 of the Notes to
Consolidated Financial Statements provides additional
information pertaining to our current borrowings and debt
refinancing activity during the past two fiscal years. We were
in compliance with all of our debt covenants throughout fiscal
2005.
We have not paid dividends on common shares in the past. Based
on levels of cash flow generated by the business in recent years
and our improving financial condition, on June 22, 2005, we
announced that The Scotts Miracle-Gro Companys Board of
Directors approved an annual dividend of 50-cents per share to
be paid at 12.5-cents each quarter beginning in the fourth
quarter of fiscal 2005. Our first and second quarterly dividends
were paid on September 1, 2005 and December 1, 2005.
In addition to the 2-for-1 stock split noted earlier, on
October 27, 2005, The Scotts Miracle-Gro Company announced
that its Board of Directors had approved a $500.0 million
share repurchase program. This repurchase program is authorized
for five years and we currently anticipate allocating
approximately $100.0 million per year on the program. We
did not repurchase any common shares in fiscal 2005 or fiscal
2004.
The unfunded status of our pension plans deteriorated during
fiscal 2005 after showing an improvement at the end of fiscal
2004. The unfunded status of our curtailed defined benefit plans
in the United States increased from $22.5 million to
$23.6 million at September 30, 2004 and 2005,
respectively. The funded status was negatively impacted by the
$2.3 million curtailment loss resulting from early
retirements and severance in conjunction with our strategic
improvement plan. In addition, plan contributions of
$0.1 million and $9.7 million were made in fiscal 2005
and fiscal 2004, respectively. Our International plans
deficit increased from $50.9 million to $61.8 million
at September 30, 2004 and 2005,
34
respectively. This $10.9 million increase was fueled by
reductions in the discount rates used to measure the projected
benefit obligation, unfavorable foreign currency translation,
and updated mortality assumptions, which more than offset better
than expected investment returns and an increase in employer
contributions.
Our off-balance sheet financing arrangements are in the form of
operating leases that are disclosed in Note 14 of the Notes
to Consolidated Financial Statements.
We are party to various pending judicial and administrative
proceedings arising in the ordinary course of business. These
include, among others, proceedings based on accidents or product
liability claims and alleged violations of environmental laws.
We have reviewed our pending environmental and legal
proceedings, including the probable outcomes, reasonably
anticipated costs and expenses, reviewed the availability and
limits of our insurance coverage and have established what we
believe to be appropriate reserves. We do not believe that any
liabilities that may result from these proceedings are
reasonably likely to have a material adverse effect on our
liquidity, financial condition or results of operations.
The following table summarizes our future cash outflows for
contractual obligations as of September 30, 2005 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period | |
|
|
|
|
| |
|
|
|
|
|
|
More than | |
Contractual Cash Obligations |
|
Total | |
|
Less than 1 year | |
|
1-3 years | |
|
4-5 years | |
|
5 years | |
| |
Long-term debt obligations
|
|
$ |
393.5 |
|
|
$ |
11.1 |
|
|
$ |
8.5 |
|
|
$ |
168.9 |
|
|
$ |
205.0 |
|
Operating lease obligations
|
|
|
165.7 |
|
|
|
42.5 |
|
|
|
47.4 |
|
|
|
28.0 |
|
|
|
47.8 |
|
Rod McClellan Company acquisition
|
|
|
20.8 |
|
|
|
20.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase obligations
|
|
|
662.2 |
|
|
|
550.3 |
|
|
|
94.7 |
|
|
|
17.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual cash obligations
|
|
$ |
1,242.2 |
|
|
$ |
624.7 |
|
|
$ |
150.6 |
|
|
$ |
214.1 |
|
|
$ |
252.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In our opinion, cash flows from operations and capital resources
will be sufficient to meet debt service and working capital
needs during fiscal 2006, and thereafter for the foreseeable
future. However, we cannot ensure that our business will
generate sufficient cash flow from operations or that future
borrowings will be available under our credit facilities in
amounts sufficient to pay indebtedness or fund other liquidity
needs. Actual results of operations will depend on numerous
factors, many of which are beyond our control.
Environmental Matters
We are subject to local, state, federal and foreign
environmental protection laws and regulations with respect to
our business operations and believe we are operating in
substantial compliance with, or taking actions aimed at ensuring
compliance with, such laws and regulations. We are involved in
several legal actions with various governmental agencies related
to environmental matters. While it is difficult to quantify the
potential financial impact of actions involving environmental
matters, particularly remediation costs at waste disposal sites
and future capital expenditures for environmental control
equipment, in the opinion of management, the ultimate liability
arising from such environmental matters, taking into account
established reserves, should not have a material adverse effect
on our financial position. However, there can be no assurance
that the resolution of these matters will not materially affect
our future quarterly or annual results of operations, financial
condition or cash flows. Additional information on environmental
matters affecting us is provided in ITEM 1.
BUSINESS Environmental and Regulatory
Considerations, ITEM 1. BUSINESS
Regulatory Actions and ITEM 3. LEGAL
PROCEEDINGS.
Critical Accounting Policies and Estimates
Our discussion and analysis of financial condition and results
of operations is based upon the Companys consolidated
financial statements, which have been prepared in accordance
with accounting principles generally accepted in the United
States of America (U.S. GAAP). Certain accounting policies
are particularly significant, including those related to revenue
recognition, goodwill and intangibles, certain employee
benefits, and income taxes. We believe these accounting
policies, and others set forth in Note 1 of the Notes to
Consolidated Financial Statements, should be reviewed as they
are integral to
35
understanding our results of operations and financial position.
Our critical accounting policies are reviewed periodically with
the Audit Committee of The Scotts Miracle-Gro Company Board of
Directors.
The preparation of financial statements requires management to
use judgment and make estimates that affect the reported amounts
of assets, liabilities, revenues and expenses, and related
disclosure of contingent assets and liabilities. On an on-going
basis, we evaluate our estimates, including those related to
customer programs and incentives, product returns, bad debts,
inventories, intangible assets, income taxes, restructuring,
environmental matters, contingencies and litigation. We base our
estimates on historical experience and on various other
assumptions that we believe to be reasonable under the
circumstances. Actual results may differ from these estimates
under different assumptions or conditions.
Revenue Recognition
Most of our revenue is derived from the sale of inventory, and
we recognize revenue when title and risk of loss transfer,
generally when products are received by the customer. Provisions
for payment discounts, product returns and allowances are
recorded as a reduction of sales at the time revenue is
recognized based on historical trends and adjusted periodically
as circumstances warrant. Similarly, reserves for uncollectible
receivables due from customers are established based on
managements judgment as to the ultimate collectibility of
these balances. We offer sales incentives through various
programs, consisting principally of volume rebates, cooperative
advertising, consumer coupons and other trade programs. The cost
of these programs is recorded as a reduction of sales. The
recognition of revenues, receivables and trade programs requires
the use of estimates. While we believe these estimates to be
reasonable based on the then current facts and circumstances,
there can be no assurance that actual amounts realized will not
differ materially from estimated amounts recorded.
Long-lived Assets
We have significant investments in property and equipment,
intangible assets and goodwill. Whenever changing conditions
warrant, we review the realizability of the assets that may be
affected. At least annually, we review goodwill and
indefinite-lived intangible assets for impairment. The review
for impairment of long-lived assets, intangibles and goodwill is
based on our estimates of future cash flows, which are based
upon budgets and longer-range strategic plans. These budgets and
plans are used for internal purposes and are also the basis for
communication with outside parties about future business trends.
While we believe the assumptions we use to estimate future cash
flows are reasonable, there can be no assurance that the
expected future cash flows will be realized. As a result,
impairment charges that possibly should have been recognized in
earlier periods may not be recognized until later periods if
actual results deviate unfavorably from earlier estimates.
Inventories
Inventories are stated at the lower of cost or market, the
majority of which are based on the first-in, first-out method of
accounting. Reserves for excess and obsolete inventory are based
on a variety of factors, including product changes and
improvements, changes in active ingredient availability and
regulatory acceptance, new product introductions and estimated
future demand. The adequacy of our reserves could be materially
affected by changes in the demand for our products or regulatory
actions.
Contingencies
As described more fully in Note 16 of the Notes to
Consolidated Financial Statements, we are involved in
significant environmental and legal matters, which have a high
degree of uncertainty associated with them. We continually
assess the likely outcomes of these matters and the adequacy of
amounts, if any, provided for their resolution. There can be no
assurance that the ultimate outcomes will not differ materially
from our assessment of them. There can also be no assurance that
all matters that may be brought against us are known at any
point in time.
Income Taxes
Our annual effective tax rate is established based on our
income, statutory tax rates and the tax impacts of items treated
differently for tax purposes than for financial reporting
purposes. We record
36
income tax liabilities utilizing known obligations and estimates
of potential obligations. A deferred tax asset or liability is
recognized whenever there are future tax effects from existing
temporary differences and operating loss and tax credit
carryforwards. Valuation allowances are used to reduce deferred
tax assets to the balance that is more likely than not to be
realized. We must make estimates and judgments on future taxable
income, considering feasible tax planning strategies and taking
into account existing facts and circumstances, to determine the
proper valuation allowance. When we determine that deferred tax
assets could be realized in greater or lesser amounts than
recorded, the asset balance and consolidated statement of
operations reflect the change in the period such determination
is made. Due to changes in facts and circumstances and the
estimates and judgments that are involved in determining the
proper valuation allowance, differences between actual future
events and prior estimates and judgments could result in
adjustments to this valuation allowance. We use an estimate of
our annual effective tax rate at each interim period based on
the facts and circumstances available at that time, while the
actual effective tax rate is calculated at year-end.
Associate Benefits
We sponsor various post-employment benefit plans. These include
pension plans, both defined contribution plans and defined
benefit plans, and other post-employment benefit
(OPEB) plans, consisting primarily of health care for
retirees. For accounting purposes, the defined benefit pension
and OPEB plans are dependent on a variety of assumptions to
estimate the projected and accumulated benefit obligations
determined by actuarial valuations. These assumptions include
the following: discount rate; expected salary increases; certain
employee-related factors, such as turnover, retirement age and
mortality; expected return on plan assets; and health care cost
trend rates. These and other assumptions affect the annual
expense recognized for these plans.
Assumptions are reviewed annually for appropriateness and
updated as necessary. We base the discount rate assumption on
investment yields available at year-end on corporate long-term
bonds rated AA or the equivalent. The salary growth assumption
reflects our long-term actual experience, the near-term outlook
and assumed inflation. The expected return on plan assets
assumption reflects asset allocation, investment strategy and
the views of investment managers regarding the market.
Retirement and mortality rates are based primarily on actual and
expected plan experience. The effects of actual results
differing from our assumptions are accumulated and amortized
over future periods.
Changes in the discount rate and investment returns can have a
significant effect on the funded status of our pension plans and
shareholders equity. We cannot predict these discount
rates or investment returns with certainty and, therefore,
cannot determine whether adjustments to our shareholders
equity for minimum pension liability in subsequent years will be
significant.
We also award stock options to directors and certain associates.
Beginning in fiscal 2003, we began expensing prospective grants
of employee stock-based compensation awards in accordance with
Statement of Financial Accounting Standards No. 123,
Accounting for Stock-Based Compensation. The fair
value of future awards is being expensed ratably over the
vesting period, which has historically been three years, except
for grants to directors, which have shorter vesting periods.
Stock options granted prior to fiscal 2003 are accounted for
under the intrinsic value recognition and measurement provisions
of Accounting Principles Board (APB) Opinion No. 25,
Accounting for Stock Issued to Employees, and
related interpretations. As those stock options were issued with
exercise prices equal to the market value of the underlying
common shares on the grant date, no compensation expense was
recognized.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
As part of our ongoing business, we are exposed to certain
market risks, including fluctuations in interest rates, foreign
currency exchange rates and commodity prices. We use derivative
financial and other instruments, where appropriate, to manage
these risks. We do not enter into transactions for trading or
speculative purposes.
Interest Rate Risk
We had various debt instruments outstanding at
September 30, 2005 and 2004 that are impacted by changes in
interest rates. As a means of managing our interest rate risk on
these debt instruments, we
37
enter into interest rate swap agreements to effectively convert
certain variable-rate debt obligations to fixed rates.
At September 30, 2005, we had no outstanding interest rate
swaps. At September 30, 2004, we had nine outstanding
interest rate swaps with major financial institutions that
effectively converted a portion of our variable-rate debt to a
fixed rate. The swaps had notional amounts between
$10 million and $50 million ($175 million in
total) with three- to seven-year terms commencing in October
2001. Under the terms of these swaps, we paid fixed rates
ranging from 2.76% to 3.77% and received three-month LIBOR.
The following table summarizes information about our derivative
financial instruments and debt instruments that are sensitive to
changes in interest rates as of September 30, 2005 and
2004. For debt instruments, the table presents principal cash
flows and related weighted-average interest rates by expected
maturity dates. For interest rate swaps, the table presents
expected cash flows based on notional amounts and
weighted-average interest rates by contractual maturity dates.
Weighted-average variable rates are based on implied forward
rates in the yield curve at September 30, 2005 and 2004. A
change in our variable interest rate of 1% would have a
$1.7 million impact on interest expense for the
$166.2 million of our variable-rate debt that had not been
hedged via an interest rate swap at September 30, 2005. The
information is presented in U.S. dollars (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected |
|
|
|
|
|
|
Maturity Date |
|
|
|
|
|
|
|
|
|
|
Fair |
2005 |
|
2010 |
|
After |
|
Total |
|
Value |
|
Long-term debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed rate debt
|
|
|
|
|
|
$ |
200.0 |
|
|
$ |
200.0 |
|
|
$ |
201.5 |
|
|
Average rate
|
|
|
|
|
|
|
6.625 |
% |
|
|
6.625 |
% |
|
|
|
|
|
Variable rate debt
|
|
$ |
166.2 |
|
|
|
|
|
|
$ |
166.2 |
|
|
$ |
166.2 |
|
|
Average rate
|
|
|
3.52 |
% |
|
|
|
|
|
|
3.52 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Maturity Date |
|
|
|
|
|
|
|
|
|
|
Fair |
2004 |
|
2005 |
|
2006 |
|
2007 |
|
2008 |
|
2009 |
|
After |
|
Total |
|
Value |
|
Long-term debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed rate debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
200.0 |
|
|
$ |
200.0 |
|
|
$ |
211.8 |
|
|
Average rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.625 |
% |
|
|
6.625 |
% |
|
|
|
|
|
Variable rate debt
|
|
$ |
4.0 |
|
|
$ |
4.0 |
|
|
$ |
12.8 |
|
|
$ |
43.4 |
|
|
$ |
192.7 |
|
|
$ |
142.1 |
|
|
$ |
399.0 |
|
|
$ |
399.0 |
|
|
Average rate
|
|
|
3.98 |
% |
|
|
3.98 |
% |
|
|
3.98 |
% |
|
|
3.98 |
% |
|
|
3.98 |
% |
|
|
3.98 |
% |
|
|
3.98 |
% |
|
|
|
|
Interest rate derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps based on
U.S. dollar LIBOR
|
|
$ |
1.6 |
|
|
$ |
0.3 |
|
|
$ |
(0.4 |
) |
|
$ |
(0.8 |
) |
|
$ |
(0.2 |
) |
|
|
|
|
|
$ |
0.5 |
|
|
$ |
0.5 |
|
|
Average rate
|
|
|
3.53 |
% |
|
|
3.43 |
% |
|
|
3.43 |
% |
|
|
3.53 |
% |
|
|
3.55 |
% |
|
|
|
|
|
|
3.75 |
% |
|
|
|
|
Other Market Risks
Our market risk associated with foreign currency rates is not
considered to be material. Through fiscal 2005, we had only
minor amounts of transactions that were denominated in
currencies other than the currency of the country of origin. We
are subject to market risk from fluctuating market prices of
certain raw materials, including urea and other chemicals and
paper and plastic products. Our objectives surrounding the
procurement of these materials are to ensure continuous supply
and to minimize costs. We seek to achieve these objectives
through negotiation of contracts with favorable terms directly
with vendors. We do not enter into forward contracts or other
market instruments as a means of achieving our objectives or
minimizing our risk exposures on these materials.
|
|
ITEM 8. |
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
The financial statements and other information required by this
Item are contained in the consolidated financial statements,
notes thereto and schedule listed in the Index to
Consolidated Financial Statements and Financial Statement
Schedule on page 48 herein.
38
|
|
ITEM 9. |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE |
As previously reported in the Current Report on Form 8-K/A
filed by The Scotts Company, the public company predecessor to
the Registrant, on December 17, 2004, at a meeting held on
December 2, 2004, the Audit Committee of the Board of
Directors of The Scotts Company dismissed PricewaterhouseCoopers
LLP as the Companys independent registered public
accounting firm and approved the engagement of Deloitte &
Touche LLP as the Companys independent registered public
accounting firm. Deloitte & Touche LLP accepted the
engagement as the Companys independent registered public
accounting firm effective as of December 17, 2004.
As of the date of PricewaterhouseCoopers LLPs dismissal as
the Companys independent registered public accounting
firm, PricewaterhouseCoopers LLP and the Company had an open
consultation regarding the appropriate accounting treatment for
an approximately $3.0 million liability resulting from a
bonus pool related to an acquisition made during the first
quarter of the Companys 2005 fiscal year. At the time of
their dismissal, PricewaterhouseCoopers LLP did not have
sufficient information to reach a conclusion on the appropriate
accounting for this matter. Since this matter was not resolved
prior to PricewaterhouseCoopers LLPs dismissal, this
matter was considered a reportable event under
Item 304(a)(1)(v)(D) of SEC Regulation S-K.
Based on a thorough review of the facts and circumstances, and
relevant accounting literature regarding this matter, the
Company determined that this liability should be recorded on the
opening balance sheet of Smith & Hawken®.
This liability was based on an incentive agreement between the
prior owners of Smith & Hawken® and their
employees, whereby a portion of the purchase price was to be
paid to the employees upon the sale of the business. No
post-sale service was required in order for the employees to
earn this bonus; therefore, this was considered a liability
assumed by the Company as of the purchase date and not an
expense related to post-acquisition service.
|
|
ITEM 9A. |
CONTROLS AND PROCEDURES |
Evaluation of Disclosure Controls and
Procedures
With the participation of the principal executive officer and
the principal financial officer of The Scotts Miracle-Gro
Company (the Registrant), the Registrants
management has evaluated the effectiveness of the
Registrants disclosure controls and procedures (as defined
in Rule 13a-15(e) under the Securities Exchange Act of
1934, as amended (the Exchange Act), as of the end
of the fiscal year covered by this Annual Report on
Form 10-K. Based upon that evaluation, the
Registrants principal executive officer and principal
financial officer have concluded that:
|
|
|
|
|
information required to be disclosed by the Registrant in this
Annual Report on Form 10-K and the other reports that the
Registrant files or submits under the Exchange Act would be
accumulated and communicated to the Registrants
management, including its principal executive officer and
principal financial officer, as appropriate to allow timely
decisions regarding required disclosure; |
|
|
|
information required to be disclosed by the Registrant in this
Annual Report on Form 10-K and the other reports that the
Registrant files or submits under the Exchange Act would be
recorded, processed, summarized and reported within the time
periods specified in the SECs rules and forms; and |
|
|
|
the Registrants disclosure controls and procedures are
effective as of the end of the fiscal year covered by this
Annual Report on Form 10-K to ensure that material
information relating to the Registrant and its consolidated
subsidiaries is made known to them, particularly during the
period in which the Registrants periodic reports,
including this Annual Report on Form 10-K, are being
prepared. |
Managements Annual Report on
Internal Control Over Financial Reporting
The Annual Report of Management on Internal Control Over
Financial Reporting required by Item 308(a) of SEC
Regulation S-K is included on page 49 of this Annual
Report on Form 10-K.
Attestation Report of Independent
Registered Public Accounting Firm
The Report of Independent Registered Public Accounting
Firm required by Item 308(b) of SEC
Regulation S-K is included on page 52 of this Annual
Report on Form 10-K.
39
Changes in Internal Control Over
Financial Reporting
There were no changes in the Registrants internal control
over financial reporting (as defined in Rule 13a-15(f)
under the Exchange Act) that occurred during the
Registrants fiscal quarter ended September 30, 2005,
that have materially affected, or are reasonably likely to
materially affect, the Registrants internal control over
financial reporting.
ITEM 9B. OTHER INFORMATION
None.
PART III
|
|
ITEM 10. |
DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT |
In accordance with General Instruction G(3) of
Form 10-K, the information regarding directors required by
Item 401 of SEC Regulation S-K is incorporated herein
by reference from the material which will be included under the
caption PROPOSAL NUMBER 1 ELECTION OF
DIRECTORS in the Registrants definitive Proxy
Statement for the 2006 Annual Meeting of Shareholders to be held
on January 26, 2006 (the Proxy Statement). The
information regarding executive officers of the Registrant
required by Item 401 of SEC Regulation S-K is included
in SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE
REGISTRANT. The information required by Item 405 of
SEC Regulation S-K is incorporated herein by reference from
the material which will be included under the caption
BENEFICIAL OWNERSHIP OF SECURITIES OF THE
COMPANY Section 16(a) Beneficial Ownership
Reporting Compliance in the Registrants Proxy
Statement.
Information concerning the Registrants Audit Committee and
the determination by the Registrants Board of Directors
that at least one member of the Audit Committee qualifies as an
audit committee financial expert is incorporated
herein by reference from the information which will be included
under the caption PROPOSAL NUMBER 1
ELECTION OF DIRECTORS Committees and Meetings of the
Board Audit Committee in the Registrants
Proxy Statement. Information concerning the nomination process
for director candidates is incorporated herein by reference from
the information which will be included under the captions
PROPOSAL NUMBER 1 ELECTION OF
DIRECTORS Committees and Meetings of the
Board Governance and Nominating Committee and
PROPOSAL NUMBER 1 ELECTION OF
DIRECTORS Nomination of Directors.
The Board of Directors of the Registrant has adopted charters
for each of the Audit Committee, the Governance and Nominating
Committee, the Compensation and Organization Committee and the
Innovation & Technology Committee.
In accordance with the requirements of Section 303A.10 of
the New York Stock Exchanges Listed Company Manual, the
Board of Directors of the Registrant has adopted a Code of
Business Conduct and Ethics covering the Registrants Board
of Directors members and associates, including, without
limitation, the Registrants principal executive officer,
principal financial officer and principal accounting officer.
The Registrant intends to disclose the following on its Internet
website located at http://www.investor.scotts.com within four
business days following their occurrence: (A) the date and
nature of any amendment to a provision of its Code of Business
Conduct and Ethics that (i) applies to the
Registrants principal executive officer, principal
financial officer, principal accounting officer or controller,
or persons performing similar functions, (ii) relates to
any element of the code of ethics definition enumerated in
Item 406(b) of SEC Regulation S-K, and (iii) is
not a technical, administrative or other non-substantive
amendment; and (B) a description (including the nature of
the waiver, the name of the person to whom the waiver was
granted and the date of the waiver) of any waiver, including an
implicit waiver, from a provision of the Code of Business
Conduct and Ethics to the Registrants principal executive
officer, principal financial officer, principal accounting
officer or controller, or persons performing similar functions
that relates to one or more of the items set forth in
Item 406(b) of SEC Regulation S-K.
The text of the Code of Business Conduct and Ethics, the
Registrants Corporate Governance Guidelines, the Audit
Committee charter, the Governance and Nominating Committee
charter, the Compensation and Organization Committee charter and
the Innovation & Technology Committee charter are
posted under the governance link on the
Registrants Internet website located at
http://www.investor.scotts.com. Interested persons may also
obtain copies of each of these documents
40
without charge by writing to The Scotts Miracle-Gro Company,
Attention: Corporate Secretary, 14111 Scottslawn Road,
Marysville, Ohio 43041. In addition, a copy of the Code of
Business Conduct and Ethics is incorporated by reference in
Exhibit 14 to this Annual Report on Form 10-K.
ITEM 11. EXECUTIVE COMPENSATION
In accordance with General Instruction G(3) of
Form 10-K, the information contained under the captions
EXECUTIVE COMPENSATION Summary of Cash and
Other Compensation, Option Grants in 2005 Fiscal
Year, Option Exercises in 2005 Fiscal Year and 2005
Fiscal Year-End Option/SAR Values, Executive
Retirement Plan, Pension Plans, The Scotts
Miracle-Gro Company Discounted Stock Purchase Plan
and Employment Agreements and Termination of
Employment and Change-in-Control Arrangements,
PROPOSAL NUMBER 1 ELECTION OF
DIRECTORS Compensation of Directors,
PROPOSAL NUMBER 2 APPROVAL OF AMENDMENT
AND RESTATEMENT OF THE SCOTTS MIRACLE-GRO COMPANY DISCOUNTED
STOCK PURCHASE PLAN [description of manner in which The
Scotts Miracle-Gro Company Discounted Stock Purchase Plan
operates] and EXECUTIVE COMPENSATION Report of
the Compensation and Organization Committee on Executive
Compensation for the 2005 Fiscal Year Executive
Incentive Plan in the Registrants Proxy Statement is
incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
In accordance with General Instruction G(3) of
Form 10-K, the information contained under the captions
BENEFICIAL OWNERSHIP OF SECURITIES OF THE COMPANY
and EXECUTIVE COMPENSATION Equity Compensation
Plan Information in the Registrants Proxy Statement
is incorporated herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS
In accordance with General Instruction G(3) of
Form 10-K, the information contained under the captions
BENEFICIAL OWNERSHIP OF SECURITIES OF THE COMPANY,
PROPOSAL NUMBER 1 ELECTION OF
DIRECTORS and CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS in the Registrants Proxy Statement is
incorporated herein by reference.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND
SERVICES
In accordance with General Instruction G(3) of
Form 10-K, the information contained under the captions
AUDIT COMMITTEE MATTERS Fees of the
Independent Registered Public Accounting Firm and
THE SCOTTS MIRACLE-GRO COMPANY THE AUDIT COMMITTEE POLICIES AND
PROCEDURES REGARDING APPROVAL OF SERVICES PROVIDED BY THE
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM in the
Registrants Proxy Statement is incorporated herein by
reference.
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT
SCHEDULES
(a) LIST OF DOCUMENTS FILED AS PART OF THIS REPORT
1 and 2. Financial Statements and Financial Statement Schedule:
|
|
|
The response to this portion of Item 15 is submitted as a
separate section of this Annual Report on Form 10-K.
Reference is made to the Index to Consolidated Financial
Statements and Financial Statement Schedule on
page 48 herein. |
3. Exhibits:
|
|
|
Exhibits filed with this Annual Report on Form 10-K are
attached hereto or incorporated herein by reference. For a list
of such exhibits, see Index to Exhibits beginning at
page 104. The following table provides certain information
concerning executive compensation plans and arrangements
required to be filed as exhibits to this Annual Report on
Form 10-K. |
41
EXECUTIVE COMPENSATORY PLANS AND ARRANGEMENTS
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(a)(1)
|
|
The O.M. Scott & Sons
Company Excess Benefit Plan, effective October 1, 1993
|
|
Incorporated herein by reference to
the Annual Report on Form 10-K for the fiscal year ended
September 30, 1993, of The Scotts Company, a Delaware
corporation (File No. 0-19768) [Exhibit 10(h)]
|
10(a)(2)
|
|
First Amendment to The O.M.
Scott & Sons Company Excess Benefit Plan, effective as
of January 1, 1998
|
|
Incorporated herein by reference to
the Annual Report on Form 10-K for the fiscal year ended
September 30, 2001 of The Scotts Company, an Ohio
Corporation (Scotts) (File No. 1-13292)
[Exhibit 10(a)(2)]
|
10(a)(3)
|
|
Second Amendment to The O.M.
Scott & Sons Company Excess Benefit Plan, effective as
of January 1, 1999
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(a)(3)]
|
10(a)(4)
|
|
Third Amendment to The O.M.
Scott & Sons Company Excess Benefit Plan, effective as
of March 18, 2005
|
|
Incorporated herein by reference to
the Quarterly Report on Form 10-Q for the quarterly period
ended April 2, 2005 of The Scotts Miracle-Gro Company (the
Registrant) (File No. 1-13292)
[Exhibit 10(CC)]
|
10(b)(1)
|
|
The Scotts Company 1992 Long Term
Incentive Plan (as amended through May 15, 2000)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2000 (File
No. 1-13292) [Exhibit 10(b)]
|
10(b)(2)
|
|
The Scotts Company 1992 Long Term
Incentive Plan (2002 Amendment)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended December 28, 2002 (File
No. 1-13292) [Exhibit 10(b)(i)]
|
10(b)(3)
|
|
Amendment to The Scotts Company
1992 Long Term Incentive Plan 2005 Amendment,
effective as of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(y)]
|
42
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(c)(1)
|
|
The Scotts Company Executive Annual
Incentive Plan
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(c)]
|
10(c)(2)
|
|
First Amendment to The Scotts
Company Executive Annual Incentive Plan, effective as of
March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(BB)]
|
10(d)(1)
|
|
The Scotts Company 1996 Stock
Option Plan (as amended through May 15, 2000)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2000 (File
No. 1-13292) [Exhibit 10(d)]
|
10(d)(2)
|
|
The Scotts Company 1996 Stock
Option Plan (2002 Amendment)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended December 28, 2002 (File
No. 1-13292) [Exhibit 10(d)(i)]
|
10(d)(3)
|
|
Amendment to The Scotts Company
1996 Stock Option Plan 2005 Amendment, effective as
of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(z)]
|
10(e)
|
|
Specimen form of Stock Option
Agreement (as amended through October 23, 2001) for
Non-Qualified Stock Options granted to employees under The
Scotts Company 1996 Stock Option Plan, U.S. specimen
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(e)]
|
10(f)
|
|
Specimen form of Stock Option
Agreement (as amended through October 23, 2001) for
Non-Qualified Stock Options granted to employees under The
Scotts Company 1996 Stock Option Plan, French specimen
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(f)]
|
10(g)(1)
|
|
The Scotts Company Executive
Retirement Plan
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 1998 (File No. 1-11593)
[Exhibit 10(j)]
|
43
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(g)(2)
|
|
First Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 1999
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(g)(2)]
|
10(g)(3)
|
|
Second Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 2000
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(g)(3)]
|
10(g)(4)
|
|
Third Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 2003
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2003 (File No. 1-13292)
[Exhibit 10(g)(4)]
|
10(g)(5)
|
|
Fourth Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 2004
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2004 (File No. 1-13292)
[Exhibit 10(g)(5)]
|
10(g)(6)
|
|
Fifth Amendment to The Scotts
Company Executive Retirement Plan, effective as of
March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(DD)]
|
10(h)
|
|
Employment Agreement, dated as of
May 19, 1995, between The Scotts Company and James Hagedorn
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 1995 (File No. 1-11593)
[Exhibit 10(p)]
|
10(i)(1)
|
|
Letter agreement, dated
June 8, 2000, between The Scotts Company and Patrick J.
Norton
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2000 (File No. 1-13292)
[Exhibit 10(q)]
|
10(i)(2)
|
|
Letter agreement, dated
November 5, 2002, pertaining to the terms of employment of
Mr. Norton through December 31, 2005, and superseding
certain provisions of the letter agreement, dated June 8,
2000, between The Scotts Company and Mr. Norton
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2002 (File No. 1-13292)
[Exhibit 10(q)]
|
10(i)(3)
|
|
Letter of Extension, dated
October 25, 2005, between The Scotts Miracle-Gro Company
and Patrick J. Norton
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed December 14, 2005 (File No. 1-13292)
[Exhibit 10.3]
|
10(j)(1)
|
|
Letter Agreement between The Scotts
Company LLC and Dr. Michael P. Kelty dated July 25,
2005
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed December 14, 2005 (File No. 1-13292)
[Exhibit 10.1]
|
44
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(j)(2)
|
|
Separation Agreement and Release of
All Claims between The Scotts Company LLC and Dr. Michael
P. Kelty dated July 25, 2005
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed December 14, 2005 (File No. 1-13292)
[Exhibit 10.2]
|
10(k)
|
|
Written description of employment
terms between the Registrant and David M. Aronowitz,
Christopher L. Nagel and Denise S. Stump
|
|
*
|
10(l)(1)
|
|
The Scotts Company 2003 Stock
Option and Incentive Equity Plan
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended December 28, 2002 (File
No. 1-13292) [Exhibit 10(w)]
|
10(l)(2)
|
|
First Amendment to The Scotts
Company 2003 Stock Option and Incentive Equity Plan, effective
as of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(AA)]
|
10(m)
|
|
Letter agreement, dated
April 23, 2003, between The Scotts Company and Robert F.
Bernstock
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended June 28, 2003 (File
No. 1-13292) [Exhibit 10(x)]
|
10(n)
|
|
Employment Agreement and Covenant
Not to Compete, effective October 1, 2004, between The
Scotts Company and Robert F. Bernstock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.1]
|
10(o)
|
|
First Amendment to Employment
Agreement and Covenant Not to Compete, effective October 1,
2004, between The Scotts Company and Robert F. Bernstock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.2]
|
10(p)
|
|
Second Amendment to Employment
Agreement and Covenant Not to Compete, effective October 1,
2004, between The Scotts Company and Robert F. Bernstock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.3]
|
10(q)
|
|
The Scotts Company 2003 Stock
Option and Incentive Equity Plan Award Agreement for
Nondirectors, effective as of October 1, 2004, between The
Scotts Company and Robert F. Bernstock, in respect of grant
of 25,000 shares of restricted stock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.4]
|
10(r)
|
|
Amendment to The Scotts Company
2003 Stock Option and Incentive Equity Plan Award Agreement for
Nondirectors, effective as of October 1, 2004, between The
Scotts Company and Robert F. Bernstock, in respect of
June 2, 2003 award of freestanding stock appreciation rights
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.5]
|
45
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(s)
|
|
Amendment to The Scotts Company
2003 Stock Option and Incentive Equity Plan Award Agreement for
Nondirectors, effective as of October 1, 2004, between The
Scotts Company and Robert F. Bernstock, in respect of
November 19, 2003 award of freestanding stock appreciation
rights
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.6]
|
10(t)
|
|
Form of 1996 Stock Option Plan
Stock Option Agreement Non-Qualified Stock Option
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.7]
|
10(u)
|
|
Form of 2003 Stock Option and
Incentive Equity Plan Award Agreement for Nondirectors
|
|
*
|
10(v)
|
|
Form of 2003 Stock Option and
Incentive Equity Plan Award Agreement for Directors
|
|
*
|
(b) EXHIBITS
Exhibits filed with this Annual Report on Form 10-K are
attached hereto or incorporated herein by reference. For a list
of such exhibits, see Index to Exhibits beginning at
page 104.
(c) FINANCIAL STATEMENT SCHEDULE
The financial statement schedule filed with this Annual Report
on Form 10-K is submitted in a separate section hereof. For
a description of such financial statement schedule, see
Index to Consolidated Financial Statements and Financial
Statement Schedule on page 48 herein.
46
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this Report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY
|
Dated: December 14, 2005
|
|
By: /s/
James Hagedorn
James
Hagedorn, Chief Executive
Officer and Chairman of the Board
|
Pursuant to the requirements of the Securities Exchange Act of
1934, this Report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
/s/
Mark R. Baker
Mark
R. Baker
|
|
Director
|
|
December 14, 2005
|
|
/s/
Lynn J. Beasley
Lynn
J. Beasley
|
|
Director
|
|
December 14, 2005
|
|
/s/
Gordon F. Brunner
Gordon
F. Brunner
|
|
Director
|
|
December 14, 2005
|
|
/s/
Arnold W. Donald
Arnold
W. Donald
|
|
Director
|
|
December 14, 2005
|
|
/s/
Joseph P. Flannery
Joseph
P. Flannery
|
|
Director
|
|
December 14, 2005
|
|
/s/
James Hagedorn
James
Hagedorn
|
|
Chief Executive Officer
and Chairman of the Board
(Principal Executive Officer)
|
|
December 14, 2005
|
|
/s/
Katherine Hagedorn
Littlefield
Katherine
Hagedorn Littlefield
|
|
Director
|
|
December 14, 2005
|
|
/s/
Karen G. Mills
Karen
G. Mills
|
|
Director
|
|
December 14, 2005
|
|
/s/
Christopher L. Nagel
Christopher
L. Nagel
|
|
Executive Vice President and
Chief
Financial Officer (Principal Financial
and Principal Accounting Officer)
|
|
December 14, 2005
|
|
/s/
Patrick J. Norton
Patrick
J. Norton
|
|
Director
|
|
December 14, 2005
|
|
/s/
Stephanie M. Shern
Stephanie
M. Shern
|
|
Director
|
|
December 14, 2005
|
|
/s/
John M. Sullivan
John
M. Sullivan
|
|
Director
|
|
December 14, 2005
|
|
/s/
John Walker, Ph.D.
John
Walker, Ph.D.
|
|
Director
|
|
December 14, 2005
|
47
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULE
|
|
|
|
|
|
|
|
Page | |
|
|
| |
Consolidated Financial Statements
of The Scotts Miracle-Gro Company and Subsidiaries:
|
|
|
|
|
|
Annual Report of Management on
Internal Control Over Financial Reporting
|
|
|
49 |
|
|
Reports of Independent Registered
Public Accounting Firms
|
|
|
50 |
|
|
Consolidated Statements of
Operations for the fiscal years ended September 30, 2005,
2004 and 2003
|
|
|
54 |
|
|
Consolidated Statements of Cash
Flows for the fiscal years ended September 30, 2005, 2004
and 2003
|
|
|
55 |
|
|
Consolidated Balance Sheets at
September 30, 2005 and 2004
|
|
|
56 |
|
|
Consolidated Statements of
Shareholders Equity for the fiscal years ended
September 30, 2005, 2004 and 2003
|
|
|
57 |
|
Notes to Consolidated Financial
Statements
|
|
|
58 |
|
Schedule Supporting the
Consolidated Financial Statements:
|
|
|
|
|
|
Reports of Independent Registered
Public Accounting Firms on Financial Statement Schedule
|
|
|
102 |
|
|
Schedule II
Valuation and Qualifying Accounts for the fiscal years ended
September 30, 2005, 2004 and 2003
|
|
|
103 |
|
Schedules other than the schedule listed above are omitted since
they are not required or are not applicable, or the required
information is shown in the Consolidated Financial Statements or
Notes thereto.
48
ANNUAL REPORT OF MANAGEMENT ON INTERNAL
CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining
adequate internal control over financial reporting to provide
reasonable assurance regarding the reliability of our financial
reporting and the preparation of financial statements for
external purposes in accordance with accounting principles
generally accepted in the United States of America. Internal
control over financial reporting includes those policies and
procedures that (i) pertain to the maintenance of records
that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of The Scotts
Miracle-Gro Company and our consolidated subsidiaries;
(ii) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with accounting principles generally
accepted in the United States of America, and that receipts and
expenditures of The Scotts Miracle-Gro Company and our
consolidated subsidiaries are being made only in accordance with
authorizations of management and directors of The Scotts
Miracle-Gro Company and our consolidated subsidiaries, as
appropriate; and (iii) provide reasonable assurance
regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the assets of The Scotts
Miracle-Gro Company and our consolidated subsidiaries that could
have a material effect on the consolidated financial statements.
Management, with the participation of our principal executive
officer and principal financial officer, assessed the
effectiveness of our internal control over financial reporting
as of September 30, 2005, the end of our fiscal year.
Management based its assessment on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission. Managements assessment included evaluation of
such elements as the design and operating effectiveness of key
financial reporting controls, process documentation, accounting
policies and our overall control environment. This assessment is
supported by testing and monitoring performed under the
direction of management.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluations of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
Accordingly, even an effective system of internal control over
financial reporting will provide only reasonable assurance with
respect to financial statement preparation.
Based on our assessment, management has concluded that our
internal control over financial reporting was effective as of
September 30, 2005, to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external reporting
purposes in accordance with accounting principles generally
accepted in the United States of America. We reviewed the
results of managements assessment with the Audit Committee
of The Scotts Miracle-Gro Company.
Our independent registered public accounting firm,
Deloitte & Touche LLP, audited managements
assessment and independently assessed the effectiveness of our
internal control over financial reporting. Deloitte &
Touche LLP has issued an attestation report concurring with
managements assessment, as stated in their report which
appears herein.
|
|
|
/s/
James Hagedorn
|
|
/s/
Christopher L. Nagel
|
|
|
|
|
James Hagedorn
Chief Executive Officer
and Chairman of the Board
Dated: December 14, 2005
|
|
Christopher L. Nagel
Executive Vice President
and Chief Financial Officer
Dated: December 14, 2005
|
49
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company
Marysville, Ohio
We have audited the accompanying consolidated balance sheet of
The Scotts Miracle-Gro Company and Subsidiaries (the
Company) as of September 30, 2005, and the
related consolidated statements of operations,
shareholders equity, and cash flows for the year then
ended. These financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of the
Company at September 30, 2005, and the results of its
operations and its cash flows for the year then ended in
conformity with accounting principles generally accepted in the
United States of America.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
effectiveness of the Companys internal control over
financial reporting as of September 30, 2005, based on the
criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission and our report dated
December 14, 2005 expressed an unqualified opinion on
managements assessment of the effectiveness of the
Companys internal control over financial reporting and an
unqualified opinion on the effectiveness of the Companys
internal control over financial reporting.
/s/ Deloitte & Touche LLP
Columbus, Ohio
December 14, 2005
50
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company:
In our opinion, the consolidated balance sheets and the related
consolidated statements of operations, shareholders equity
and cash flows present fairly, in all material respects, the
financial position of The Scotts Miracle-Gro Company at
September 30, 2004 and the results of its operations and
its cash flows for the years ended September 30, 2004 and
2003 in conformity with accounting principles generally accepted
in the United States of America. These financial statements are
the responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits. We conducted our audits of these
statements in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles
used and significant estimates made by management, and
evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for our
opinion.
As discussed in Note 6 to the financial statements,
effective October 1, 2001, the Company adopted Statement of
Financial Accounting Standards No. 142, Goodwill and
Other Intangible Assets. Also, as discussed in Note 1
to the financial statements, effective October 1, 2002, the
Company adopted the prospective method of recognizing the fair
value of stock-based compensation in accordance with Statement
of Financial Accounting Standards No. 123, Accounting
for Stock-Based Compensation.
/s/ PricewaterhouseCoopers LLP
Columbus, OH
November 22, 2004
51
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company
Marysville, Ohio
We have audited managements assessment, included in the
accompanying Annual Report of Management on Internal Control
Over Financial Reporting, that The Scotts Miracle-Gro Company
and Subsidiaries (the Company) maintained effective
internal control over financial reporting as of
September 30, 2005, based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission. The Companys management is responsible for
maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control
over financial reporting. Our responsibility is to express an
opinion on managements assessment and an opinion on the
effectiveness of the Companys internal control over
financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, evaluating
managements assessment, testing and evaluating the design
and operating effectiveness of internal control, and performing
such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable
basis for our opinions.
A companys internal control over financial reporting is a
process designed by, or under the supervision of, the
companys principal executive and principal financial
officers, or persons performing similar functions, and effected
by the companys board of directors, management, and other
personnel to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over
financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements
due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the
effectiveness of the internal control over financial reporting
to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
In our opinion, managements assessment that the Company
maintained effective internal control over financial reporting
as of September 30, 2005 is fairly stated, in all material
respects, based on the criteria established in Internal
Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway
Commission. Also, in our opinion, the Company maintained, in all
material respects, effective internal control over financial
reporting as of September 30, 2005, based on the criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission.
52
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated financial statements as of and for the year ended
September 30, 2005 of the Company and our report dated
December 14, 2005 expressed an unqualified opinion on those
financial statements.
/s/ Deloitte & Touche LLP
Columbus, Ohio
December 14, 2005
53
The Scotts Miracle-Gro Company
Consolidated Statements of Operations
for the fiscal years ended September 30, 2005, 2004 and
2003
(in millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
|
2003 | |
| |
Net sales
|
|
$ |
2,369.3 |
|
|
|
$ |
2,106.5 |
|
|
$ |
1,941.6 |
|
Cost of sales
|
|
|
1,509.2 |
|
|
|
|
1,313.5 |
|
|
|
1,230.8 |
|
Restructuring and other charges
|
|
|
(0.3 |
) |
|
|
|
0.6 |
|
|
|
9.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
860.4 |
|
|
|
|
792.4 |
|
|
|
701.7 |
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
633.8 |
|
|
|
|
540.7 |
|
|
|
472.9 |
|
|
Impairment, restructuring and other
charges
|
|
|
33.2 |
|
|
|
|
9.1 |
|
|
|
8.0 |
|
|
Other income, net
|
|
|
(7.5 |
) |
|
|
|
(10.2 |
) |
|
|
(10.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
200.9 |
|
|
|
|
252.8 |
|
|
|
231.6 |
|
Costs related to refinancings
|
|
|
1.3 |
|
|
|
|
45.5 |
|
|
|
|
|
Interest expense
|
|
|
41.5 |
|
|
|
|
48.8 |
|
|
|
69.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
158.1 |
|
|
|
|
158.5 |
|
|
|
162.4 |
|
Income taxes
|
|
|
57.7 |
|
|
|
|
58.0 |
|
|
|
59.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
100.4 |
|
|
|
|
100.5 |
|
|
|
103.2 |
|
|
|
Income from discontinued operations
|
|
|
0.2 |
|
|
|
|
0.4 |
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
100.6 |
|
|
|
$ |
100.9 |
|
|
$ |
103.8 |
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$ |
1.51 |
|
|
|
$ |
1.55 |
|
|
$ |
1.67 |
|
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
0.01 |
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
1.51 |
|
|
|
$ |
1.56 |
|
|
$ |
1.68 |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$ |
1.47 |
|
|
|
$ |
1.51 |
|
|
$ |
1.61 |
|
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
0.01 |
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
1.47 |
|
|
|
$ |
1.52 |
|
|
$ |
1.62 |
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
54
The Scotts Miracle-Gro Company
Consolidated Statements of Cash Flows
for the fiscal years ended September 30, 2005, 2004 and
2003
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
|
2003 | |
| |
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
100.6 |
|
|
|
$ |
100.9 |
|
|
$ |
103.8 |
|
|
Adjustments to reconcile net income
to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of intangible assets
|
|
|
23.4 |
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to refinancings
|
|
|
1.3 |
|
|
|
|
45.5 |
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
10.7 |
|
|
|
|
7.8 |
|
|
|
4.8 |
|
|
|
Depreciation
|
|
|
49.6 |
|
|
|
|
46.1 |
|
|
|
40.3 |
|
|
|
Amortization
|
|
|
17.6 |
|
|
|
|
11.6 |
|
|
|
11.9 |
|
|
|
Deferred taxes
|
|
|
(13.6 |
) |
|
|
|
17.6 |
|
|
|
48.3 |
|
|
|
Changes in assets and liabilities,
net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(37.9 |
) |
|
|
|
(1.9 |
) |
|
|
(27.3 |
) |
|
|
|
Inventories
|
|
|
(15.8 |
) |
|
|
|
(14.0 |
) |
|
|
(5.3 |
) |
|
|
|
Prepaid and other current assets
|
|
|
8.1 |
|
|
|
|
(16.9 |
) |
|
|
3.7 |
|
|
|
|
Accounts payable
|
|
|
10.3 |
|
|
|
|
(18.7 |
) |
|
|
26.3 |
|
|
|
|
Accrued taxes and liabilities
|
|
|
27.9 |
|
|
|
|
29.5 |
|
|
|
6.6 |
|
|
|
|
Restructuring reserves
|
|
|
10.3 |
|
|
|
|
0.8 |
|
|
|
(7.1 |
) |
|
|
|
Other non-current items
|
|
|
6.6 |
|
|
|
|
(5.8 |
) |
|
|
0.3 |
|
|
|
|
Other, net
|
|
|
27.6 |
|
|
|
|
11.7 |
|
|
|
9.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
226.7 |
|
|
|
|
214.2 |
|
|
|
216.1 |
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in available for sale
securities
|
|
|
|
|
|
|
|
(121.4 |
) |
|
|
|
|
|
Redemption of available for sale
securities
|
|
|
57.2 |
|
|
|
|
64.2 |
|
|
|
|
|
|
Payments on seller notes
|
|
|
|
|
|
|
|
(12.3 |
) |
|
|
(36.7 |
) |
|
Investment in property, plant and
equipment, net
|
|
|
(40.4 |
) |
|
|
|
(35.1 |
) |
|
|
(51.8 |
) |
|
Investments in acquired businesses,
net of cash acquired
|
|
|
(77.7 |
) |
|
|
|
(8.2 |
) |
|
|
(20.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(60.9 |
) |
|
|
|
(112.8 |
) |
|
|
(108.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under revolving and bank
lines of credit
|
|
|
924.2 |
|
|
|
|
648.6 |
|
|
|
801.9 |
|
|
Repayments under revolving and bank
lines of credit
|
|
|
(736.4 |
) |
|
|
|
(646.6 |
) |
|
|
(819.5 |
) |
|
Repayment of term loans
|
|
|
(399.0 |
) |
|
|
|
(827.5 |
) |
|
|
(62.4 |
) |
|
Proceeds from issuance of term loans
|
|
|
|
|
|
|
|
900.0 |
|
|
|
|
|
|
Redemption of
85/8% Senior
Subordinated Notes
|
|
|
|
|
|
|
|
(418.0 |
) |
|
|
|
|
|
Proceeds from issuance of
65/8% Senior
Subordinated Notes
|
|
|
|
|
|
|
|
200.0 |
|
|
|
|
|
|
Financing and issuance fees
|
|
|
(3.6 |
) |
|
|
|
(13.0 |
) |
|
|
(0.4 |
) |
|
Dividends paid
|
|
|
(8.6 |
) |
|
|
|
|
|
|
|
|
|
|
Payments on sellers notes
|
|
|
(6.9 |
) |
|
|
|
|
|
|
|
|
|
|
Cash received from exercise of
stock options
|
|
|
32.2 |
|
|
|
|
23.5 |
|
|
|
21.4 |
|
|
Proceeds from termination of
interest rate swaps
|
|
|
2.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing
activities
|
|
|
(195.2 |
) |
|
|
|
(133.0 |
) |
|
|
(59.0 |
) |
Effect of exchange rate changes
|
|
|
(6.0 |
) |
|
|
|
(8.7 |
) |
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash
|
|
|
(35.4 |
) |
|
|
|
(40.3 |
) |
|
|
56.2 |
|
Cash and cash equivalents,
beginning of year
|
|
|
115.6 |
|
|
|
|
155.9 |
|
|
|
99.7 |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
year
|
|
$ |
80.2 |
|
|
|
$ |
115.6 |
|
|
$ |
155.9 |
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid, net of interest
capitalized
|
|
|
(39.9 |
) |
|
|
|
(50.9 |
) |
|
|
(66.7 |
) |
|
Income taxes paid
|
|
|
(64.0 |
) |
|
|
|
(34.7 |
) |
|
|
(19.5 |
) |
See Notes to Consolidated Financial Statements.
55
The Scotts Miracle-Gro Company
Consolidated Balance Sheets
September 30, 2005 and 2004
(in millions except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
2004 | |
| |
ASSETS
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
80.2 |
|
|
|
$ |
115.6 |
|
|
Investments
|
|
|
|
|
|
|
|
57.2 |
|
|
Accounts receivable, less
allowances of $11.4 in 2005 and $29.0 in 2004
|
|
|
323.3 |
|
|
|
|
292.4 |
|
|
Inventories, net
|
|
|
324.9 |
|
|
|
|
290.1 |
|
|
Prepaid and other assets
|
|
|
59.4 |
|
|
|
|
75.0 |
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
787.8 |
|
|
|
|
830.3 |
|
Property, plant and equipment, net
|
|
|
337.0 |
|
|
|
|
328.0 |
|
Goodwill
|
|
|
432.9 |
|
|
|
|
417.9 |
|
Intangible assets, net
|
|
|
439.5 |
|
|
|
|
431.0 |
|
Other assets
|
|
|
21.7 |
|
|
|
|
40.6 |
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
2,018.9 |
|
|
|
$ |
2,047.8 |
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
Current portion of debt
|
|
$ |
11.1 |
|
|
|
$ |
22.1 |
|
|
Accounts payable
|
|
|
151.7 |
|
|
|
|
130.3 |
|
|
Accrued liabilities
|
|
|
314.7 |
|
|
|
|
261.9 |
|
|
Accrued taxes
|
|
|
8.7 |
|
|
|
|
19.3 |
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
486.2 |
|
|
|
|
433.6 |
|
Long-term debt
|
|
|
382.4 |
|
|
|
|
608.5 |
|
Other liabilities
|
|
|
124.1 |
|
|
|
|
131.1 |
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
992.7 |
|
|
|
|
1,173.2 |
|
|
|
|
|
|
|
|
|
Commitments and contingencies
(Notes 14, 15 and 16)
|
|
|
|
|
|
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
|
|
|
|
Common shares, no par value per
share, $.01 stated value per share, shares issued and
outstanding of 67.8 in 2005 and 65.6 in 2004
|
|
|
0.3 |
|
|
|
|
0.3 |
|
|
Deferred compensation
stock awards
|
|
|
(12.2 |
) |
|
|
|
(10.4 |
) |
|
Capital in excess of stated value
|
|
|
503.2 |
|
|
|
|
443.0 |
|
|
Retained earnings
|
|
|
591.5 |
|
|
|
|
499.5 |
|
|
Accumulated other comprehensive loss
|
|
|
(56.6 |
) |
|
|
|
(57.8 |
) |
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
1,026.2 |
|
|
|
|
874.6 |
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders equity
|
|
$ |
2,018.9 |
|
|
|
$ |
2,047.8 |
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
56
The Scotts Miracle-Gro Company
Consolidated Statements of Shareholders Equity
for the fiscal years ended September 30, 2005, 2004 and
2003
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated | |
|
|
|
|
Common Stock | |
|
|
|
Capital in | |
|
|
|
Treasury Stock | |
|
Other | |
|
|
|
|
| |
|
Deferred | |
|
Excess of | |
|
Retained | |
|
| |
|
Comprehensive | |
|
|
|
|
Shares | |
|
Amount | |
|
Compensation | |
|
Stated Value | |
|
Earnings | |
|
Shares | |
|
Amount | |
|
Income/(loss) | |
|
Total | |
| |
Balance, September 30, 2002
|
|
|
62.7 |
|
|
$ |
0.3 |
|
|
|
|
|
|
$ |
398.6 |
|
|
$ |
294.8 |
|
|
|
(2.4 |
) |
|
$ |
(41.8 |
) |
|
$ |
(58.0 |
) |
|
$ |
593.9 |
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
103.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
103.8 |
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.8 |
) |
|
|
(2.8 |
) |
Unrecognized gain on derivatives,
net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.8 |
|
|
|
0.8 |
|
Minimum pension liability, net of
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.8 |
) |
|
|
(0.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.0 |
|
Stock-based compensation awarded
|
|
|
|
|
|
|
|
|
|
$ |
(13.1 |
) |
|
|
13.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
4.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.8 |
|
Issuance of common shares
|
|
|
1.4 |
|
|
|
|
|
|
|
|
|
|
|
(13.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13.3 |
) |
Treasury stock activity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.4 |
|
|
|
41.8 |
|
|
|
|
|
|
|
41.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2003
|
|
|
64.1 |
|
|
|
0.3 |
|
|
|
(8.3 |
) |
|
|
398.4 |
|
|
|
398.6 |
|
|
|
|
|
|
|
|
|
|
|
(60.8 |
) |
|
|
728.2 |
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.9 |
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.9 |
) |
|
|
(0.9 |
) |
Unrecognized gain on derivatives,
net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.0 |
|
|
|
1.0 |
|
Minimum pension liability, net of
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.9 |
|
|
|
2.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
103.9 |
|
Stock-based compensation awarded
|
|
|
|
|
|
|
|
|
|
|
(12.2 |
) |
|
|
12.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation forfeitures
|
|
|
|
|
|
|
|
|
|
|
1.2 |
|
|
|
(1.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
8.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.9 |
|
Issuance of common shares
|
|
|
1.6 |
|
|
|
|
|
|
|
|
|
|
|
33.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2004
|
|
|
65.7 |
|
|
|
0.3 |
|
|
|
(10.4 |
) |
|
|
443.0 |
|
|
|
499.5 |
|
|
|
|
|
|
|
|
|
|
|
(57.8 |
) |
|
|
874.6 |
|
Net Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.6 |
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.1 |
|
|
|
4.1 |
|
Unrecognized gain on derivatives,
net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1 |
|
|
|
2.1 |
|
Minimum pension liability, net of
tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5.0 |
) |
|
|
(5.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.8 |
|
Stock-based compensation awarded
|
|
|
|
|
|
|
|
|
|
|
(15.1 |
) |
|
|
15.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation forfeitures
|
|
|
|
|
|
|
|
|
|
|
2.6 |
|
|
|
(2.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
10.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7 |
|
Cash dividends paid (12.5 cents per
share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.6 |
) |
Issuance of common shares (net of
tax)
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
47.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2005
|
|
|
67.8 |
|
|
$ |
0.3 |
|
|
$ |
(12.2 |
) |
|
$ |
503.2 |
|
|
$ |
591.5 |
|
|
|
|
|
|
$ |
|
|
|
$ |
(56.6 |
) |
|
$ |
1,026.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57
The Scotts Miracle-Gro Company
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Nature of Operations
The Scotts Miracle-Gro Company and its subsidiaries
(collectively the Company) are engaged in the
manufacture, marketing and sale of lawn and garden care
products. The Companys major customers include home
improvement centers, mass merchandisers, warehouse clubs, large
hardware chains, independent hardware stores, nurseries, garden
centers, food and drug stores, commercial nurseries and
greenhouses, and specialty crop growers. The Companys
products are sold primarily in North America and the European
Union. We also operate the Scotts LawnService®
business which provides lawn and tree and shrub fertilization,
insect control and other related services in the United States.
Effective October 2, 2004, the Company acquired
Smith & Hawken®, a leading brand in the
outdoor living and gardening lifestyle category.
Smith & Hawken® products are sold in
the United States through its 57 retail stores as well as
through catalog and internet sales.
Restructuring Merger
On March 18, 2005, The Scotts Company consummated the
restructuring of its corporate structure into a holding company
structure by merging The Scotts Company into a newly-created,
wholly-owned, second-tier Ohio limited liability company
subsidiary, The Scotts Company LLC, pursuant to the Agreement
and Plan of Merger, dated as of December 13, 2004, by and
among The Scotts Company, The Scotts Company LLC and Scotts
Miracle-Gro (the Restructuring Merger). As a result
of the Restructuring Merger, each of The Scotts Companys
common shares, without par value, issued and outstanding
immediately prior to the consummation of the Restructuring
Merger was automatically converted into one fully paid and
nonassessable common share, without par value, of The Scotts
Miracle-Gro Company. The Scotts Miracle-Gro Company is the
public company successor to The Scotts Company. Following the
consummation of the Restructuring Merger, The Scotts Company LLC
is the successor to The Scotts Company and is a direct,
wholly-owned subsidiary of The Scotts Miracle-Gro Company, the
new parent holding company.
Organization Basis of Presentation and
Reclassifications
The Companys consolidated financial statements are
presented in accordance with accounting principles generally
accepted in the United States of America. The consolidated
financial statements include the accounts of The Scotts
Miracle-Gro Company and all wholly-owned and majority-owned
subsidiaries. All intercompany transactions and accounts are
eliminated in consolidation. The Companys criteria for
consolidating entities is based on majority ownership (as
evidenced by a majority voting interest in the entity) and an
objective evaluation and determination of effective management
control.
Certain revisions and reclassifications have been made to prior
years financial statements to conform to fiscal 2005
classifications. With respect to the Amended and Restated
Exclusive Agency and Marketing Agreement (the Marketing
Agreement) with Monsanto Company (Monsanto),
the Company has made two presentational changes. First, the
Company has reclassified as net sales the amounts previously
reported as net commission from the Marketing Agreement. Second,
net sales and cost of sales have been adjusted to reflect
certain reimbursements and costs associated with the Marketing
Agreement on a gross basis that was previously reported on a net
basis, with no effect on gross profit or net income. See further
details regarding these matters in Note 3 of the Notes to
Consolidated Financial Statements. Furthermore, the Company has
simplified the presentation of Selling, General and
Administrative expenses presented on the face of the
Consolidated Statements of Operations.
Subsequent Event Stock Split
On November 9, 2005, the Company executed a 2-for-1 stock
split for shareholders of record on November 2, 2005. All
share and per share information included in these consolidated
financial statements and notes thereto have been adjusted to
reflect this stock split for all periods presented.
58
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Revenue Recognition
Revenue is recognized when title and risk of loss transfer,
generally when products are received by the customer. Provisions
for estimated returns and allowances are recorded at the time
revenue is recognized based on historical rates and are
periodically adjusted for known changes. Shipping and handling
costs are included in cost of sales. Scotts
LawnService® revenues are recognized at the time
service is provided to the customer.
Under the terms of the marketing agreement between The Scotts
Company and Monsanto, the Company in its role as exclusive agent
performs certain functions, such as sales support,
merchandising, distribution and logistics of Monsanto, and
incurs certain costs in support of the consumer
Roundup® business. The actual costs incurred by
the Company on behalf of Roundup® are recovered
from Monsanto through the terms of the agency agreement. The
reimbursement of costs for which the Company is considered the
primary obligator is included in net sales.
Promotional Allowances
The Company promotes its branded products through cooperative
advertising programs with retailers. Retailers also are offered
in-store promotional allowances and rebates based on sales
volumes. Certain products are promoted with direct consumer
rebate programs and special purchasing incentives. Promotion
costs (including allowances and rebates) incurred during the
year are expensed to interim periods in relation to revenues and
are recorded as a reduction of net sales. Accruals for expected
payouts under the programs are included in the Accrued
liabilities line in the Consolidated Balance Sheets.
Advertising
The Company advertises its branded products through national and
regional media. Advertising costs incurred during the year are
expensed to interim periods in relation to revenues. All
advertising costs, except for external production costs, are
expensed within the fiscal year in which such costs are
incurred. External production costs for advertising programs are
deferred until the period in which the advertising is first
aired. Advertising expenses were $122.5 million in fiscal
2005, $105.0 million in fiscal 2004 and $97.7 million
in fiscal 2003.
Scotts LawnService® promotes its service
offerings through direct response mail campaigns. External costs
associated with these campaigns that qualify as direct response
advertising costs are deferred and recognized as advertising
expense in proportion to revenues over a future period not
beyond the end of the subsequent calendar year. The costs
deferred at September 30, 2005 and 2004 were
$2.4 million and $1.6 million, respectively.
Research and Development
All costs associated with research and development are charged
to expense as incurred. Expense for fiscal 2005, 2004 and 2003
was $30.5 million, $34.4 million and
$30.4 million, respectively.
Environmental Costs
The Company recognizes environmental liabilities when conditions
requiring remediation are probable and the amounts can be
reasonably estimated. Expenditures which extend the life of the
related property or mitigate or prevent future environmental
contamination are capitalized. Environmental liabilities are not
discounted or reduced for possible recoveries from insurance
carriers.
Stock-Based Compensation Awards
In fiscal 2003, the Company began expensing prospective grants
of employee stock-based compensation awards in accordance with
Statement of Financial Accounting Standards
(SFAS) No. 123, Accounting for Stock-Based
Compensation. The fair value of awards is expensed ratably
over the vesting period, generally three years, except for
grants to members of the Board of Directors that have a shorter
vesting period.
59
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In December 2004, the Financial Accounting Standards Board
replaced SFAS 123 with SFAS 123(R), Share-Based
Payment, that the Company is required to adopt effective
October 1, 2005. The Company is already in substantial
compliance with SFAS 123(R) as the standard closely
parallels SFAS 123. The adoption of SFAS 123(R) is not
expected to have a significant effect on the Companys
results of operations.
The Company changed its fair value option pricing model from the
Black-Scholes model to a binomial model for all options granted
on or after October 1, 2004. The fair value of options
granted prior to October 1, 2004, was determined using the
Black-Scholes model. The Company believes the binomial model
considers characteristics of fair value option pricing that are
not available under the Black-Scholes model. Both the
Black-Scholes model and the binomial model take into account a
number of variables such as volatility, risk-free interest rate,
contractual term of the option, the probability that the option
will be exercised prior to the end of its contractual life, and
the probability of termination or retirement of the option
holder in computing the value of the option. However, the
binomial model uses a more refined approach in applying those
variables thereby improving the quality of the estimate of fair
value.
Earnings per Common Share
Basic earnings per common share is computed based on the
weighted-average number of common shares outstanding each
period. Diluted earnings per common share is computed based on
the weighted-average number of common shares and dilutive
potential common shares (stock options, restricted stock and
stock appreciation rights) outstanding each period.
Cash and Cash Equivalents
The Company considers all highly liquid financial instruments
with original maturities of three months or less to be cash
equivalents. The Company maintains cash deposits in banks which
from time to time exceed the amount of deposit insurance
available. Management periodically assesses the financial
condition of the institutions and believes that any potential
credit loss is minimal.
Investments
Investments at September 30, 2004, consisted of adjustable
rate notes issued by a variety of borrowers (the
Notes). The Notes have been accounted for as
available for sale securities in accordance with
Statement of Financial Accounting Standards No. 115,
Accounting for Certain Investments in Debt and Equity
Securities. Cost is equivalent to fair value at the
balance sheet date as the Notes can be put back to a remarketing
agent at any time at 100% of par value. The Notes were secured
by an irrevocable, direct pay letter of credit. The Notes held
at September 30, 2004, in the amount of $57.2 million,
were redeemed on October 1, 2004.
Accounts Receivable and Allowances
Trade accounts receivable are recorded at the invoiced amount
and do not bear interest. Allowances reflect our best estimate
of amounts in our existing accounts receivable that may not be
collected due to customer claims, the return of goods, or
customer inability or unwillingness to pay. We determine the
allowance based on customer risk assessment and historical
experience. We review our allowances monthly. Past due balances
over 90 days and in excess of a specified amount are
reviewed individually for collectibility. All other balances are
reviewed on a pooled basis by type of receivable. Account
balances are charged off against the allowance when we feel it
is probable the receivable will not be recovered. We do not have
any off-balance-sheet credit exposure related to our customers.
Inventories
Inventories are stated at the lower of cost or market,
principally determined by the FIFO method. Certain growing media
inventories are accounted for by the LIFO method. At
September 30, 2005 and 2004, approximately 6% of
inventories, are valued at the lower of LIFO cost or market.
Inventories include the cost of raw materials, labor and
manufacturing overhead. The Company makes provisions for obsolete
60
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
or slow-moving inventories as necessary to properly reflect
inventory at the lower of cost or market value. Reserves for
excess and obsolete inventories were $16.3 million and
$21.3 million at September 30, 2005 and 2004,
respectively.
The Company will be required to adopt the provisions of
SFAS No. 151, Inventory Costs, in the
first quarter of fiscal 2006. SFAS No. 151 amends
ARB 43, Chapter 4, to clarify that abnormal amounts of
idle facility expense, freight, handling costs, and wasted
materials (spoilage) should be recognized as current-period
charges. In addition, this Statement requires that allocation of
fixed production overheads to the costs of conversion be based
on the normal capacity of the production facilities. The Company
has completed its evaluation of the provisions of
SFAS No. 151, and does not expect its adoption to have
a material impact on its financial position or results of
operations.
Long-lived Assets
Property, plant and equipment, are stated at cost. Expenditures
for maintenance and repairs are charged to expense as incurred.
When properties are retired or otherwise disposed of, the cost
of the asset and the related accumulated depreciation are
removed from the accounts with the resulting gain or loss being
reflected in income from operations.
Depreciation of property, plant and equipment is provided on the
straight-line method and is based on the estimated useful
economic lives of the assets as follows:
|
|
|
Land improvements
|
|
10 25 years
|
Buildings
|
|
10 40 years
|
Machinery and equipment
|
|
3 15 years
|
Furniture and fixtures
|
|
6 10 years
|
Software
|
|
3 8 years
|
Interest capitalized on capital projects amounted to
$0.3 million during fiscal 2005. There was no capitalized
interest in fiscal 2004.
Management assesses the recoverability of long-lived assets
being amortized whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be
recoverable. If it is determined that an impairment has
occurred, an impairment loss is recognized for the amount by
which the carrying amount of the asset exceeds its estimated
fair value.
Management also assesses the recoverability of goodwill and
intangible assets whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be
recoverable. Goodwill and intangible assets not being amortized
are reviewed for impairment at least annually during the first
fiscal quarter. If it is determined that an impairment of
intangible assets has occurred (based on undiscounted cash
flows), an impairment loss is recognized for the amount by which
the carrying value of the asset exceeds its estimated fair value.
Internal Use Software
The Company accounts for the costs of internal use software in
accordance with Statement of Position 98-1,
Accounting for the Costs of Computer Software Developed or
Obtained for Internal Use. Accordingly, costs are expensed
or capitalized depending on whether they are incurred in the
preliminary project stage, application development stage or the
post-implementation/operation stage. As of September 30,
2005 and 2004, the Company had $37.4 million and
$40.2 million, respectively, in unamortized capitalized
internal use computer software costs. Amortization of these
costs was $9.6 million, $8.7 million and
$9.0 million during fiscal 2005, 2004 and 2003,
respectively.
Foreign Exchange Instruments
Gains and losses on foreign currency transaction hedges are
recognized in income and offset the foreign exchange gains and
losses on the underlying transactions. Gains and losses on
foreign currency
61
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
firm commitment hedges are deferred and included in the basis of
the transactions underlying the commitments.
All assets and liabilities in the balance sheets of foreign
subsidiaries are translated into U.S. dollar equivalents at
fiscal year-end exchange rates, as their functional currency is
the local currency. Translation gains and losses are accumulated
as a separate component of other comprehensive income and
included in shareholders equity. Income and expense items
are translated at the twelve month average of the month end
exchange rates. Foreign currency transaction gains and losses
are included in the determination of net income.
Derivative Instruments
In the normal course of business, the Company is exposed to
fluctuations in interest rates and the value of foreign
currencies. The Company has established policies and procedures
that govern the management of these exposures through the use of
a variety of financial instruments. The Company employs various
financial instruments, including forward exchange contracts and
swap agreements, to manage certain of the exposures when
practical. By policy, the Company does not enter into such
contracts for the purpose of speculation or use leveraged
financial instruments. The Companys derivative activities
are managed by the Chief Financial Officer and other senior
management of the Company in consultation with the Finance
Committee of the Board of Directors. These activities include
the establishment of a risk-management philosophy and
objectives, providing guidelines for derivative-instrument usage
and establishing procedures for control and valuation,
counterparty credit approval and the monitoring and reporting of
derivative activity.
The Companys objective in managing its exposure to
fluctuations in interest rates and foreign currency exchange
rates is to decrease the volatility of earnings and cash flows
associated with changes in the applicable rates and prices. To
achieve this objective, the Company primarily enters into
forward exchange contracts and swap agreements whose values
change in the opposite direction of the anticipated cash flows.
Derivative instruments related to forecasted transactions are
considered to hedge future cash flows, and the effective portion
of any gains or losses is included in other comprehensive income
until earnings are affected by the variability of cash flows.
Any remaining gain or loss is recognized currently in earnings.
The cash flows of the derivative instruments are expected to be
highly effective in achieving offsetting cash flows attributable
to fluctuations in the cash flows of the hedged risk. If it
becomes probable that a forecasted transaction will no longer
occur, the derivative will continue to be carried on the balance
sheet at fair value, and gains and losses that were accumulated
in other comprehensive income will be recognized immediately in
earnings.
To manage certain of its cash flow exposures, the Company has
entered into forward exchange contracts and interest rate swap
agreements. The forward exchange contracts are designated as
hedges of the Companys foreign currency exposure
associated with future cash flows. The change in the value of
the amounts payable or receivable under forward exchange
contracts are recorded as adjustments to other income or
expense. The interest rate swap agreements are designated as
hedges of the Companys interest rate risk associated with
certain variable rate debt. The change in the value of the
amounts payable or receivable under the swap agreements are
recorded as adjustments to interest expense. Unrealized gains or
losses resulting from valuing these swaps at fair value are
recorded in other comprehensive income.
There have been no significant gains or losses recognized in
earnings for hedge ineffectiveness or due to excluding a portion
of the value from measuring effectiveness.
Use of Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions
that affect the amounts reported in the consolidated financial
statements and accompanying disclosures. Although these
estimates are based on managements best knowledge of
current events and actions the Company may undertake in the
future, actual results ultimately may differ from the estimates.
62
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2. DETAIL OF CERTAIN FINANCIAL STATEMENT
ACCOUNTS
|
|
|
|
|
|
|
|
|
|
|
|
September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
| |
|
|
(In millions) | |
INVENTORIES, NET:
|
|
|
|
|
|
|
|
|
|
Finished goods
|
|
$ |
216.0 |
|
|
$ |
186.6 |
|
|
Work-in-progress
|
|
|
31.4 |
|
|
|
30.7 |
|
|
Raw materials
|
|
|
77.5 |
|
|
|
72.8 |
|
|
|
|
|
|
|
|
|
|
$ |
324.9 |
|
|
$ |
290.1 |
|
|
|
|
|
|
|
|
PROPERTY, PLANT AND EQUIPMENT,
NET:
|
|
|
|
|
|
|
|
|
|
Land and improvements
|
|
$ |
39.6 |
|
|
$ |
42.5 |
|
|
Buildings
|
|
|
131.1 |
|
|
|
128.3 |
|
|
Machinery and equipment
|
|
|
353.7 |
|
|
|
324.8 |
|
|
Furniture and fixtures
|
|
|
35.4 |
|
|
|
40.4 |
|
|
Software
|
|
|
76.6 |
|
|
|
75.7 |
|
|
Construction in progress
|
|
|
23.0 |
|
|
|
17.7 |
|
|
|
|
|
|
|
|
|
|
|
659.4 |
|
|
|
629.4 |
|
|
Less: accumulated depreciation
|
|
|
(322.4 |
) |
|
|
(301.4 |
) |
|
|
|
|
|
|
|
|
|
$ |
337.0 |
|
|
$ |
328.0 |
|
|
|
|
|
|
|
|
ACCRUED LIABILITIES:
|
|
|
|
|
|
|
|
|
|
Payroll and other compensation
accruals
|
|
$ |
62.5 |
|
|
$ |
66.7 |
|
|
Advertising and promotional accruals
|
|
|
114.0 |
|
|
|
85.0 |
|
|
Restructuring accruals
|
|
|
15.6 |
|
|
|
5.3 |
|
|
Other
|
|
|
122.6 |
|
|
|
104.9 |
|
|
|
|
|
|
|
|
|
|
$ |
314.7 |
|
|
$ |
261.9 |
|
|
|
|
|
|
|
|
OTHER NON-CURRENT
LIABILITIES:
|
|
|
|
|
|
|
|
|
|
Accrued pension and postretirement
liabilities
|
|
$ |
102.9 |
|
|
$ |
104.7 |
|
|
Legal and environmental reserves
|
|
|
3.3 |
|
|
|
6.0 |
|
|
Other
|
|
|
17.9 |
|
|
|
20.4 |
|
|
|
|
|
|
|
|
|
|
$ |
124.1 |
|
|
$ |
131.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
|
|
(in millions) | |
ACCUMULATED OTHER COMPREHENSIVE
LOSS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized gain (loss) on
derivatives, net of tax of $(1.2), $0.2 and $0.9
|
|
$ |
1.8 |
|
|
$ |
(0.3 |
) |
|
$ |
(1.3 |
) |
|
Minimum pension liability, net of
tax of $23.7, $22.7 and $24.8
|
|
|
(40.6 |
) |
|
|
(35.6 |
) |
|
|
(38.5 |
) |
|
Foreign currency translation
adjustment
|
|
|
(17.8 |
) |
|
|
(21.9 |
) |
|
|
(21.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(56.6 |
) |
|
$ |
(57.8 |
) |
|
$ |
(60.8 |
) |
|
|
|
|
|
|
|
|
|
|
NOTE 3. MARKETING AGREEMENT
Under the terms of the Marketing Agreement with Monsanto, the
Company is Monsantos exclusive agent for the domestic and
international marketing and distribution of consumer
Roundup® herbicide products. Under the terms of
the Marketing Agreement, the Company is entitled to receive an
annual commission from Monsanto in consideration for the
performance of its duties as agent. The Marketing Agreement also
requires the Company to make annual payments to Monsanto as a
contribution against the overall expenses of the consumer
Roundup business.
63
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The annual gross commission under the Marketing Agreement is
calculated as a percentage of the actual earnings before
interest and income taxes (EBIT), as defined in the Marketing
Agreement, of the consumer Roundup business. Each years
percentage varies in accordance with the terms of the Marketing
Agreement based on the achievement of two earnings thresholds
and on commission rates that vary by threshold and program year.
The annual contribution payment is defined in the Marketing
Agreement as $20 million. However, portions of the annual
payments for the first three years of the Marketing Agreement
were deferred. No payment was required for the first year
(fiscal 1999), a payment of $5 million was required for the
second year and a payment of $15 million was required for
the third year so that a total of $40 million of the
contribution payments was deferred. Beginning in fiscal 2003,
the fifth year of the Marketing Agreement, the annual payments
to Monsanto increased to at least $25 million, which
included per annum interest charges at 8%. The annual payments
were increased above $25 million if certain significant
earnings targets were exceeded.
Through July 2, 2005, the Company recognized a periodic
charge associated with the annual contribution payments equal to
the required payment for that period. The Company had not
recognized a charge for the portions of the contribution
payments that were deferred until the time those deferred
amounts were due under the terms of the Marketing Agreement.
Based on the then available facts and circumstances, the Company
considered this method of accounting for the contribution
payments to be appropriate after consideration of the likely
term of the Marketing Agreement, the Companys ability to
terminate the Marketing Agreement without paying the deferred
amounts (as supported by legal opinion from The Bayard Firm,
P.A.), the Companys assessment that the Marketing
Agreement could have been terminated at any balance sheet date
without incurring significant economic consequences as a result
of such action and the fact that a significant portion of the
deferred amount could never have been paid, even if the
Marketing Agreement is not terminated prior to 2018, unless
significant earnings targets were exceeded.
The Bayard Firm, P.A. was special Delaware counsel retained
during fiscal 2000 solely for the limited purpose of providing
legal opinion in support of the contingent liability treatment
of the deferred contribution amounts under the Marketing
Agreement previously adopted by the Company and has neither
generally represented or advised the Company nor participated in
the preparation or review of the Companys financial
statements of any SEC filings. The terms of such opinion
specifically limit the parties who are entitled to rely on it.
During the quarter ended July 2, 2005, the Company updated
its assessment of the amounts deferred and previously considered
a contingent obligation under the Marketing Agreement. Based on
the recent strong performance of the consumer Roundup business
and other economic developments surrounding the business, the
Company now believes that the deferred contribution amounts
outstanding will be paid in full between 2010 and 2012 under the
terms of the Marketing Agreement. In managements judgment,
it is now probable that the deferred contribution payment that
totaled $45.7 million as of July 2, 2005 will be paid.
As such, the Company recorded this liability with a charge to
net sales in the quarter ended July 2, 2005. This amount
bore interest at 8% until it was paid in October 2005. The
deferred contribution balance is recorded as a current liability
at September 30, 2005.
64
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The elements of the net commission earned under the Marketing
Agreement included in Net sales for the
three years ended September 30, 2005 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Gross commission
|
|
$ |
67.0 |
|
|
$ |
58.2 |
|
|
$ |
45.9 |
|
Contribution expenses
|
|
|
(23.8 |
) |
|
|
(26.4 |
) |
|
|
(25.0 |
) |
Deferred contribution charge
|
|
|
(45.7 |
) |
|
|
|
|
|
|
|
|
Amortization of marketing fee
|
|
|
(2.8 |
) |
|
|
(3.3 |
) |
|
|
(3.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net commission (expense) income
|
|
|
(5.3 |
) |
|
|
28.5 |
|
|
|
17.6 |
|
Reimbursements associated with
marketing agreement
|
|
|
40.7 |
|
|
|
40.1 |
|
|
|
36.3 |
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales associated with
marketing agreement
|
|
$ |
35.4 |
|
|
$ |
68.6 |
|
|
$ |
53.9 |
|
|
|
|
|
|
|
|
|
|
|
For fiscal 2005, the net commission earned under the Marketing
Agreement is included in net sales. Prior to fiscal 2005, the
elements of net commission were previously reported as separate
line items in the Consolidated Statements of Operations. The net
commissions for fiscal years 2004 and 2003 have been
reclassified to net sales to conform to the fiscal 2005
presentation.
In consideration for the rights granted to the Company under the
Marketing Agreement for North America, the Company was required
to pay a marketing fee of $33 million to Monsanto. The
Company has deferred this amount on the basis that the payment
will provide a future benefit through commissions that will be
earned under the Marketing Agreement. Based on managements
updated assessment of the likely term of the Marketing
Agreement, the useful life over which the marketing fee is being
amortized has been adjusted to 20 years. Prior to fiscal
2005, the marketing fee had been amortized over ten years.
Under the terms of the Marketing Agreement between the Company
and Monsanto, the Company performs certain functions, primarily
manufacturing conversion, selling and marketing support costs,
on behalf of Monsanto in the conduct of the consumer Roundup
business. The actual costs incurred for these activities are
charged to and reimbursed by Monsanto, for which the Company
recognizes no gross margin or net income. Prior to fiscal 2005,
these costs were recognized in the Consolidated Statements of
Operations on a net basis as a recovery of incurred costs rather
than separately recognizing the reimbursement of these costs as
revenue. Beginning in fiscal 2005, the Company determined it is
appropriate to record costs incurred under this Agreement for
which it is the primary obligor on a gross basis, recognizing
such costs in Cost of sales and the reimbursement of
these costs in Net sales. The related revenues and
cost of sales were $40.7 million, $40.1 million and
$36.3 million for fiscal 2005, 2004 and 2003, respectively.
All prior periods presented have been reclassified to conform to
the current presentation.
The Marketing Agreement has no definite term except as it
relates to the European Union countries. With respect to the
European Union countries, the term of the Marketing Agreement
has been extended through September 30, 2008 and may be
renewed at the option of both parties for two additional
successive terms ending on September 30, 2015 and 2018,
with a separate determination being made by the parties at least
six months prior to the expiration of each such term as to
whether to commence a subsequent renewal term. If Monsanto does
not agree to the renewal term with respect to the European Union
countries, the commission structure will be renegotiated within
the terms of the marketing agreement. For countries outside of
the European Union, the Marketing Agreement continues
indefinitely unless terminated by either party. The Marketing
Agreement provides Monsanto with the right to terminate the
Marketing Agreement for an event of default (as defined in the
Marketing Agreement) by the Company or a change in control of
Monsanto or the sale of the consumer Roundup®
business. The Marketing Agreement provides the Company with the
right to terminate the Marketing Agreement in certain
circumstances including an event of default by Monsanto or the
sale of the consumer Roundup® business. Unless
Monsanto terminates the Marketing Agreement for an event of
default by the Company, Monsanto is required to pay a
termination fee to the Company that varies by program year. If
Monsanto terminates the Marketing Agreement upon a change of
control of Monsanto or the sale of the consumer
Roundup®
65
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
business prior to September 30, 2008, we will be entitled
to a termination fee in excess of $100 million. If we
terminate the Marketing Agreement upon an uncured material
breach, material fraud or material willful misconduct by
Monsanto, we will be entitled to receive a termination fee in
excess of $100 million if the termination occurs prior to
September 30, 2008. The termination fee declines over time
from $100 million to a minimum of $16 million for
terminations between September 30, 2008 and
September 30, 2018.
|
|
NOTE 4. |
IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES |
2005 Charges
During fiscal 2005, the Company recorded $9.5 million of
restructuring and other charges. The Company recognized
restructuring costs relating primarily to the Companys
strategic improvement plan designed to significantly improve
long-term earnings through a sustained effort to reduce general
and administrative costs. Primarily in relation to the plan, the
Company recognized $26.3 million of severance and related
costs, including curtailment charges relating to a pension plan
and the retiree medical plan. The Company anticipates that
restructuring activities under the strategic improvement plan
will continue through fiscal 2007 and that total costs under the
plan will be in the range of $33 million to
$35 million.
Offsetting these charges was a reserve reversal to restructuring
income of $7.9 million related to the collection of
outstanding accounts receivable due from Central
Garden & Pet Company (Central Garden), and a net
settlement gain of $8.9 million was recorded relating to
the lawsuit against Aventis.
2004 Charges
During fiscal 2004, the Company recorded $9.7 million of
restructuring and other charges. Charges related to our North
America distribution restructuring were classified as cost of
sales in the amount of $0.6 million. Severance costs
related to our International Profit Improvement Plan and the
restructuring of our International team amounted to
$6.1 million. The restructuring of our Global Business
Information Services group amounted to $3.0 million and
related primarily to severance and outside service costs. The
severance costs incurred in fiscal 2004 are related to the
reduction of 75 administrative and production employees.
2003 Charges
During fiscal 2003, the Company recorded $17.1 million of
restructuring and other charges. Costs of $5.3 million for
warehouse lease buyouts and relocation of inventory associated
with exiting certain warehouses in North America, and
$3.8 million related to a plan to optimize our
International supply chain were included in cost of sales.
Severance and consulting costs of $5.3 million for the
continued European integration efforts that began in the fourth
quarter of fiscal 2002, and $2.7 million of administrative
facility exit costs in North America were charged to impairment,
restructuring and other charges. The severance costs incurred in
fiscal 2003 are related to the reduction of 78 administrative
and production employees.
66
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following is the detail of impairment, restructuring, and
other charges and a rollforward of the cash portion of the
restructuring and other charges accrued in fiscal 2005 and 2004
(in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Restructuring:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance
|
|
$ |
15.9 |
|
|
$ |
7.6 |
|
|
$ |
5.3 |
|
|
Facility exit costs
|
|
|
0.1 |
|
|
|
1.0 |
|
|
|
9.1 |
|
|
Central Garden litigation
|
|
|
(7.9 |
) |
|
|
|
|
|
|
|
|
|
Aventis litigation
|
|
|
(8.9 |
) |
|
|
|
|
|
|
|
|
|
Curtailment of pension and retiree
medical plans
|
|
|
4.9 |
|
|
|
|
|
|
|
|
|
|
Other related costs
|
|
|
5.4 |
|
|
|
1.1 |
|
|
|
2.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.5 |
|
|
|
9.7 |
|
|
|
17.1 |
|
|
|
|
|
|
|
|
|
|
|
Asset impairment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other intangibles
|
|
|
23.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total restructuring and asset
impairment expense
|
|
$ |
32.9 |
|
|
$ |
9.7 |
|
|
$ |
17.1 |
|
|
|
|
|
|
|
|
|
|
|
Amounts reserved for restructuring
and other charges at beginning of year
|
|
$ |
5.3 |
|
|
$ |
4.5 |
|
|
$ |
12.0 |
|
|
Restructuring expense
|
|
|
9.5 |
|
|
|
9.7 |
|
|
|
17.1 |
|
|
Receipts, payments and other
|
|
|
0.8 |
|
|
|
(8.9 |
) |
|
|
(24.6 |
) |
|
|
|
|
|
|
|
|
|
|
Amounts reserved for restructuring
and other charges at end of year
|
|
$ |
15.6 |
|
|
$ |
5.3 |
|
|
$ |
4.5 |
|
|
|
|
|
|
|
|
|
|
|
The restructuring activities to which these costs apply are
expected to be largely completed in fiscal 2006. The balance of
the accrued charges at September 30, 2005 and 2004, are
included in Accrued liabilities on the Consolidated
Balance Sheets.
NOTE 5. ACQUISITIONS
Smith & Hawken®
Effective October 2, 2004, the Company acquired all
outstanding shares of Smith & Hawken®,
a leading brand in the outdoor living and gardening lifestyle
category, for a total cost of $73.6 million (net of cash
acquired of $1.3 million). Smith &
Hawken® is the leading brand in outdoor living
and is an outstanding fit with our strategy to extend our reach
into adjacent lawn and garden categories. Final purchase
accounting allocations to assets acquired and liabilities
assumed based on estimated fair values at the date of
acquisition were as follows (in millions):
|
|
|
|
|
Goodwill
|
|
$ |
24.6 |
|
Non-amortizing trademarks
|
|
|
12.4 |
|
Amortizing other intangibles
|
|
|
5.0 |
|
Property, plant and equipment
|
|
|
20.1 |
|
Working capital
|
|
|
5.4 |
|
Deferred taxes
|
|
|
6.1 |
|
|
|
|
|
|
|
$ |
73.6 |
|
|
|
|
|
Amortizing intangibles consist primarily of customer
relationships and favorable leaseholds and are being amortized
over a weighted-average life over approximately 7.5 years.
The goodwill recorded in connection with the Smith &
Hawken® acquisition is not deductible for the
tax purposes.
On a pro forma basis, net sales for the years ended
September 30, 2004, would have been $2,255.0 million
(an increase of $148.5 million) had the acquisition of
Smith & Hawken® occurred as of
67
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
October 1, 2003. Reported net income on a pro forma basis
would have decreased by approximately $1.6 million, or
$0.02 per common share, for the year ended
September 30, 2004.
Scotts LawnService®
From fiscal 2003 through 2005, the Companys Scotts
LawnService® segment acquired 29 individual lawn
service entities for a total cost of approximately
$41.0 million. The following table summarizes the details
of these transactions by fiscal year (dollar amounts in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Number of individual acquisitions
|
|
|
3 |
|
|
|
4 |
|
|
|
22 |
|
Total cost
|
|
|
$6.4 |
|
|
$ |
4.0 |
|
|
$ |
30.6 |
|
Portion of cost paid in cash
|
|
|
4.1 |
|
|
|
3.0 |
|
|
|
17.2 |
|
Notes issued and liabilities assumed
|
|
|
2.3 |
|
|
|
1.0 |
|
|
|
13.4 |
|
Goodwill
|
|
|
4.7 |
|
|
|
3.0 |
|
|
|
22.3 |
|
Other intangible assets
|
|
|
0.9 |
|
|
|
0.6 |
|
|
|
6.2 |
|
Working capital and property, plant
and equipment
|
|
|
0.8 |
|
|
|
0.4 |
|
|
|
2.1 |
|
In addition to the above, the Company acquired the minority
interest in the Scotts LawnService® business
during fiscal 2004 for $5.2 million ($2.0 million in
cash and $3.2 million in seller notes). The purchase price
was allocated to goodwill in the amount of $5.1 million and
other intangible assets in the amount of $0.1.
Substantially all of the recorded goodwill relating to the
Scotts LawnService acquisitions is deductible for tax purposes.
Goodwill is not being amortized for financial reporting
purposes. Other intangible assets consist primarily of customer
lists and non-compete agreements, and are being amortized for
financial reporting purposes over a period of 7 and
3 years, respectively.
During fiscal 2004, the Company acquired the minority interest
in a subsidiary for $3.2 million, the cost of which was
allocated to intangible assets. The Companys North America
segment acquired two entities to enter the pottery business in
fiscal 2003. The aggregate purchase price for these two entities
was $3.2 million, all of which was paid in cash. Goodwill
of $0.8 million pertaining to these acquisitions is tax
deductible. Other intangible assets, primarily customer accounts
of $1.0 million, and inventory of $1.4 million were
also recorded.
These acquisitions are deemed immaterial for pro forma
disclosure.
Transactions Subsequent to September 30, 2005
Effective October 3, 2005, the Company acquired all
outstanding shares of the Rod McLellan Company for a total cost
of $22.0 million in cash. Rod McLellan Company, a provider
of soil and landscape products in the western U.S., operates
three soil-manufacturing facilities in California and Oregon
with approximately 100 employees.
Effective November 18, 2005, the Company acquired all
outstanding shares of Gutwein & Co. Inc. (Gutwein), for
approximately $77.0 million in cash. Gutweins annual
revenues approximate $85 million in the growing wild bird
food category. Gutweins Morning Song®
products are sold at leading mass retailers, grocery, pet and
general merchandise stores. Gutwein has 140 employees and
operates five production facilities.
|
|
NOTE 6. |
GOODWILL AND INTANGIBLE ASSETS, NET |
Goodwill and certain other intangible assets, primarily
tradenames, classified as indefinite-lived assets are not
amortized. Indefinite-lived assets are subject to an annual
impairment test that is performed by the Company in the first
quarter of its fiscal year. If it is determined that an
impairment of an indefinite-lived intangible asset has occurred,
an impairment charge is recognized for the amount by which the
carrying value of the asset exceeds its estimated fair value.
68
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Effective October 1, 2001, Scotts adopted Statement of Financial
Accounting Standards No. 142, Goodwill and Other
Intangible Assets. In accordance with this standard,
goodwill and certain other intangible assets, primarily
tradenames, have been classified as indefinite-lived assets no
longer subject to amortization. Indefinite-lived assets are
subject to impairment testing upon adoption of
SFAS No. 142 and at least annually thereafter. The
initial impairment analysis was completed in the second quarter
of fiscal 2002, taking into account additional guidance provided
by EITF 02-07, Unit of Measure for Testing Impairment of
Indefinite-Lived Intangible Assets. The value of all
indefinite-lived tradenames as of October 1, 2001 was
determined using a royalty savings methodology that
was employed when the businesses associated with these
tradenames were acquired but using updated estimates of sales,
cash flow and profitability. As a result, a pre-tax impairment
loss of $29.8 million was recorded for the writedown of the
value of the tradenames in our International Consumer businesses
in Germany, France and the United Kingdom. This transitional
impairment charge was recorded as a cumulative effect of
accounting change, net of tax, as of October 1, 2001. After
completing this initial valuation and impairment of tradenames,
an initial assessment for goodwill impairment was performed. It
was determined that a goodwill impairment charge was not
required.
Intangible assets with finite lives, and therefore subject to
amortization, include technology (e.g., patents), customer
accounts, and certain tradenames. These intangible assets are
being amortized on the straight-line method over periods ranging
from 3 to 39 years. In addition to the annual impairment
analysis required for goodwill and indefinite-lived intangible
assets, management will assess the recoverability of any
intangible asset whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable.
In the first quarter of fiscal 2005, the Company completed its
annual impairment analysis of goodwill and indefinite-lived
intangible assets and determined that tradenames associated with
the consumer business in the United Kingdom were impaired. The
fair value of the tradenames was determined by estimating the
royalties saved because of the Companys ownership of the
tradenames. The approach uses an estimated royalty rate applied
to projected revenues to develop after-tax cost savings. The
implied savings are then discounted to a present value amount
which is used as the approximation of fair value. The reduction
in the value of the tradenames has resulted primarily from a
decline in the profitability of the U.K. growing media business
and unfavorable category mix trends. Although management is
developing strategies to significantly improve the profitability
of the U.K. business, we believe an impairment charge against
the book value of the indefinite-lived tradenames is
appropriate. Accordingly, an impairment charge of
$22 million was recorded and classified as
Impairment, restructuring, and other charges in the
Consolidated Statement of Operations for fiscal 2005.
The following table presents goodwill and intangible assets as
of September 30, 2005 and 2004 (dollars in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2005 | |
|
September 30, 2004 | |
|
|
|
|
| |
|
| |
|
|
Weighted | |
|
Gross | |
|
|
|
Net | |
|
Gross | |
|
|
|
Net | |
|
|
Average | |
|
Carrying | |
|
Accumulated | |
|
Carrying | |
|
Carrying | |
|
Accumulated | |
|
Carrying | |
|
|
Life | |
|
Amount | |
|
Amortization | |
|
Amount | |
|
Amount | |
|
Amortization | |
|
Amount | |
| |
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
13 |
|
|
$ |
73.3 |
|
|
$ |
(37.1 |
) |
|
$ |
36.2 |
|
|
$ |
69.1 |
|
|
$ |
(26.1 |
) |
|
$ |
43.0 |
|
|
Customer accounts
|
|
|
24 |
|
|
|
44.1 |
|
|
|
(10.9 |
) |
|
|
33.2 |
|
|
|
44.4 |
|
|
|
(8.6 |
) |
|
|
35.8 |
|
|
Tradenames
|
|
|
17 |
|
|
|
11.3 |
|
|
|
(4.2 |
) |
|
|
7.1 |
|
|
|
11.0 |
|
|
|
(3.6 |
) |
|
|
7.4 |
|
|
Other
|
|
|
14 |
|
|
|
89.7 |
|
|
|
(64.9 |
) |
|
|
24.8 |
|
|
|
56.4 |
|
|
|
(41.6 |
) |
|
|
14.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortizable intangible
assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.3 |
|
|
|
|
|
|
|
|
|
|
|
101.0 |
|
69
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2005 | |
|
September 30, 2004 | |
|
|
|
|
| |
|
| |
|
|
Weighted | |
|
Gross | |
|
|
|
Net | |
|
Gross | |
|
|
|
Net | |
|
|
Average | |
|
Carrying | |
|
Accumulated | |
|
Carrying | |
|
Carrying | |
|
Accumulated | |
|
Carrying | |
|
|
Life | |
|
Amount | |
|
Amortization | |
|
Amount | |
|
Amount | |
|
Amortization | |
|
Amount | |
| |
Unamortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tradenames
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
334.8 |
|
|
|
|
|
|
|
|
|
|
|
326.6 |
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
439.5 |
|
|
|
|
|
|
|
|
|
|
|
431.0 |
|
|
Goodwill
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
432.9 |
|
|
|
|
|
|
|
|
|
|
|
417.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total goodwill and intangible
assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
872.4 |
|
|
|
|
|
|
|
|
|
|
$ |
848.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The changes to the net carrying value of goodwill by segment for
the fiscal years ended September 30, 2005 and 2004, are as
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North | |
|
Scotts | |
|
|
|
Other/ | |
|
|
|
|
America | |
|
LawnService® | |
|
International | |
|
Corporate | |
|
Total | |
| |
Balance as of September 30,
2003
|
|
$ |
203.4 |
|
|
$ |
91.4 |
|
|
$ |
111.7 |
|
|
$ |
|
|
|
$ |
406.5 |
|
Increases due to acquisitions
|
|
|
3.2 |
|
|
|
8.9 |
|
|
|
|
|
|
|
|
|
|
|
12.1 |
|
Reduction of final purchase price
of previous acquisitions
|
|
|
(1.8 |
) |
|
|
|
|
|
|
(2.5 |
) |
|
|
|
|
|
|
(4.3 |
) |
Reclassifications
|
|
|
(1.7 |
) |
|
|
|
|
|
|
2.7 |
|
|
|
|
|
|
|
1.0 |
|
Other, primarily cumulative
translation
|
|
|
(4.4 |
) |
|
|
|
|
|
|
7.0 |
|
|
|
|
|
|
|
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30,
2004
|
|
|
198.7 |
|
|
|
100.3 |
|
|
|
118.9 |
|
|
|
|
|
|
|
417.9 |
|
Increases due to acquisitions
|
|
|
|
|
|
|
4.7 |
|
|
|
|
|
|
|
24.6 |
|
|
|
29.3 |
|
Reclassifications
|
|
|
(8.0 |
) |
|
|
|
|
|
|
(2.7 |
) |
|
|
|
|
|
|
(10.7 |
) |
Other, primarily cumulative
translation
|
|
|
0.2 |
|
|
|
|
|
|
|
(3.8 |
) |
|
|
|
|
|
|
(3.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30,
2005
|
|
$ |
190.9 |
|
|
$ |
105.0 |
|
|
$ |
112.4 |
|
|
$ |
24.6 |
|
|
$ |
432.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total amortization expense for the years ended
September 30, 2005, 2004 and 2003 was $17.6 million,
$8.3 million and $8.6 million, respectively. Estimated
amortization expense for amortizable intangible assets recorded
at September 30, 2005, for the following years ended
September 30, is (in millions):
|
|
|
2006
|
|
$11.2
|
2007
|
|
10.9
|
2008
|
|
10.7
|
2009
|
|
9.2
|
2010
|
|
7.3
|
The Company sponsors a defined contribution profit sharing and
401(k) plan for substantially all U.S. associates. The
Company provides a base contribution equal to 2% of compensation
up to 50% of the Social Security taxable wage base plus 4% of
remaining compensation. Associates also may make pretax
contributions from compensation that are matched by the Company
at 100% of the associates initial 3% contribution and 50%
of their remaining contribution up to 5%. The Company recorded
charges of $10.8 million, $9.7 million and
$9.6 million under the plan in fiscal 2005, 2004 and 2003,
respectively.
The Company sponsors two defined benefit plans for certain
U.S. associates. Benefits under these plans have been
frozen and closed to new associates since 1997. The benefits
under the primary plan are based on years of service and the
associates average final compensation or stated amounts.
The Companys funding policy, consistent with statutory
requirements and tax considerations, is based on
70
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
actuarial computations using the Projected Unit Credit method.
The second frozen plan is a non-qualified supplemental pension
plan. This plan provides for incremental pension payments so
that total pension payments equal amounts that would have been
payable from the Companys pension plan if it were not for
limitations imposed by the income tax regulations.
The Company sponsors defined benefit pension plans associated
with its International businesses in the United Kingdom,
Netherlands, Germany, France, and Austria. These plans generally
cover all associates of the respective businesses with
retirement benefits primarily based on years of service and
compensation levels. During fiscal 2004, the U.K. plans were
closed to new participants, but existing participants continue
to accrue benefits. All newly hired associates of Scotts U.K.
now participate in a new defined contribution plan in lieu of
the defined benefit plans.
The following tables present information about benefit
obligations, plan assets, annual expense, assumptions and other
information about the Companys defined benefit pension
plans (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frozen Defined | |
|
International | |
|
|
Benefit Plans | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2005 | |
|
2004 | |
| |
Change in projected benefit
obligation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of
year
|
|
$ |
92.1 |
|
|
$ |
88.7 |
|
|
$ |
130.9 |
|
|
$ |
119.0 |
|
Service cost
|
|
|
|
|
|
|
|
|
|
|
3.3 |
|
|
|
4.1 |
|
Interest cost
|
|
|
5.2 |
|
|
|
5.1 |
|
|
|
7.1 |
|
|
|
6.6 |
|
Plan participants
contributions
|
|
|
|
|
|
|
|
|
|
|
1.1 |
|
|
|
0.9 |
|
Curtailment loss (gain)
|
|
|
2.3 |
|
|
|
|
|
|
|
|
|
|
|
(0.5 |
) |
Actuarial loss (gain)
|
|
|
2.0 |
|
|
|
3.8 |
|
|
|
24.8 |
|
|
|
(3.6 |
) |
Benefits paid
|
|
|
(5.5 |
) |
|
|
(5.5 |
) |
|
|
(4.4 |
) |
|
|
(4.5 |
) |
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
(4.6 |
) |
|
|
8.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligation at end
of year
|
|
$ |
96.1 |
|
|
$ |
92.1 |
|
|
$ |
158.2 |
|
|
$ |
130.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated benefit obligation
at end of year
|
|
$ |
96.1 |
|
|
$ |
92.1 |
|
|
$ |
143.3 |
|
|
$ |
118.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at
beginning of year
|
|
$ |
69.6 |
|
|
$ |
59.2 |
|
|
$ |
80.0 |
|
|
$ |
63.6 |
|
Actual return on plan assets
|
|
|
8.3 |
|
|
|
6.2 |
|
|
|
14.9 |
|
|
|
8.9 |
|
Employer contribution
|
|
|
0.1 |
|
|
|
9.7 |
|
|
|
7.6 |
|
|
|
6.1 |
|
Plan participants
contributions
|
|
|
|
|
|
|
|
|
|
|
1.1 |
|
|
|
0.9 |
|
Benefits paid
|
|
|
(5.5 |
) |
|
|
(5.5 |
) |
|
|
(4.7 |
) |
|
|
(4.5 |
) |
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
(2.5 |
) |
|
|
5.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of
year
|
|
$ |
72.5 |
|
|
$ |
69.6 |
|
|
$ |
96.4 |
|
|
$ |
80.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the
balance sheets consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded Status projected
benefit obligation in excess of plan assets as of
September 30 measurement date
|
|
$ |
(23.6 |
) |
|
$ |
(22.5 |
) |
|
$ |
(61.8 |
) |
|
$ |
(50.9 |
) |
Unrecognized losses
|
|
|
32.1 |
|
|
|
35.6 |
|
|
|
45.4 |
|
|
|
31.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
|
8.5 |
|
|
|
13.1 |
|
|
|
(16.4 |
) |
|
|
(19.0 |
) |
Additional minimum pension liability
|
|
|
(32.1 |
) |
|
|
(35.6 |
) |
|
|
(32.2 |
) |
|
|
(22.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount accrued
|
|
$ |
(23.6 |
) |
|
$ |
(22.5 |
) |
|
$ |
(48.6 |
) |
|
$ |
(41.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average assumptions
used in development of projected benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.63 |
% |
|
|
5.75 |
% |
|
|
4.68 |
% |
|
|
5.35 |
% |
Rate of compensation increase
|
|
|
n/a |
|
|
|
n/a |
|
|
|
3.5 |
% |
|
|
3.7 |
% |
71
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailed Defined | |
|
International | |
|
|
Benefit Plan | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
2005 | |
|
2004 | |
|
2003 | |
| |
Components of net periodic
benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3.3 |
|
|
$ |
4.2 |
|
|
$ |
4.0 |
|
Interest cost
|
|
|
5.2 |
|
|
|
5.1 |
|
|
|
5.0 |
|
|
|
7.1 |
|
|
|
6.6 |
|
|
|
5.8 |
|
Expected return on plan assets
|
|
|
(5.4 |
) |
|
|
(4.5 |
) |
|
|
(3.8 |
) |
|
|
(6.3 |
) |
|
|
(5.3 |
) |
|
|
(4.0 |
) |
Net amortization
|
|
|
2.6 |
|
|
|
2.6 |
|
|
|
1.9 |
|
|
|
1.4 |
|
|
|
1.8 |
|
|
|
2.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
|
2.4 |
|
|
|
3.2 |
|
|
|
3.1 |
|
|
|
5.5 |
|
|
|
7.3 |
|
|
|
8.0 |
|
Curtailment loss (gain)
|
|
|
2.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefit cost
|
|
$ |
4.7 |
|
|
$ |
3.2 |
|
|
$ |
3.1 |
|
|
$ |
5.5 |
|
|
$ |
7.0 |
|
|
$ |
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailed Defined | |
|
International Benefit | |
|
|
Benefit Plan | |
|
Plans | |
|
|
| |
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
2005 | |
|
2004 | |
|
2003 | |
| |
Weighted average assumptions
used in development of net periodic benefit cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.75 |
% |
|
|
6.0 |
% |
|
|
6.75 |
% |
|
|
5.35 |
% |
|
|
5.25 |
% |
|
|
5.5 |
% |
Expected return on plan assets
|
|
|
8.0 |
% |
|
|
8.0 |
% |
|
|
8.0 |
% |
|
|
7.5 |
% |
|
|
7.5 |
% |
|
|
7.5 |
% |
Rate of compensation increase
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
3.7 |
% |
|
|
3.7 |
% |
|
|
3.7 |
% |
Other Information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International | |
|
|
Curtailed Defined | |
|
Benefit | |
|
|
Benefit Plans | |
|
Plans | |
| |
Plan asset allocations:
|
|
|
|
|
|
|
|
|
|
Target for September 30, 2006:
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
60 |
% |
|
|
55 |
% |
|
|
Debt securities
|
|
|
40 |
% |
|
|
45 |
% |
|
September 30, 2005:
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
63 |
% |
|
|
61 |
% |
|
|
Debt securities
|
|
|
36 |
% |
|
|
38 |
% |
|
|
Other
|
|
|
1 |
% |
|
|
1 |
% |
|
September 30, 2004:
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
60 |
% |
|
|
84 |
% |
|
|
Debt securities
|
|
|
39 |
% |
|
|
12 |
% |
|
|
Other
|
|
|
1 |
% |
|
|
4 |
% |
Expected contributions in fiscal
2006:
|
|
|
|
|
|
|
|
|
|
Company
|
|
$ |
0.2 |
|
|
$ |
7.5 |
|
|
Employee
|
|
|
|
|
|
|
1.0 |
|
Expected future benefit payments:
|
|
|
|
|
|
|
|
|
|
2006
|
|
$ |
6.3 |
|
|
$ |
4.5 |
|
|
2007
|
|
|
6.4 |
|
|
|
4.6 |
|
|
2008
|
|
|
6.4 |
|
|
|
4.8 |
|
|
2009
|
|
|
6.5 |
|
|
|
5.0 |
|
|
2010
|
|
|
6.5 |
|
|
|
5.2 |
|
|
Total 2011 to 2015
|
|
|
33.2 |
|
|
|
28.4 |
|
72
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Investment Strategy:
The Company maintains target allocation percentages among
various asset classes based on an individual investment policy
established for each of the various pension plans which are
designed to achieve long term objectives of return, while
mitigating against downside risk and considering expected cash
requirements to fund benefit payments. Our investment policies
are reviewed from time to time to ensure consistency with our
long-term objectives.
Basis for Long-Term Rate of Return on Assets Assumption:
The Companys expected long-term rate of return on assets
assumptions are derived from studies conducted by third parties.
The studies include a review of anticipated future long-term
performance of individual asset classes and consideration of the
appropriate asset allocation strategy given the anticipated
requirements of the plan to determine the average rate of
earnings expected on the funds invested to provide for benefits
under the various pension plans. While the studies give
appropriate consideration to recent fund performance and
historical returns, the assumptions primarily represent
expectations about future rates of return over the long term.
|
|
NOTE 8. |
ASSOCIATE MEDICAL BENEFITS |
The Company provides comprehensive major medical benefits to
certain of its retired associates and their dependents.
Substantially all of the Companys domestic associates who
were hired before January 1, 1998 become eligible for these
benefits if they retire at age 55 or older with more than
ten years of service. The plan requires certain minimum
contributions from retired associates and includes provisions to
limit the overall cost increases the Company is required to
cover. The Company funds its portion of retiree medical benefits
on a pay-as-you-go basis.
73
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table sets forth the information about the retiree
medical plan for domestic associates (in millions):
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
| |
Change in Accumulated Plan
Benefit Obligation (APBO)
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of
year
|
|
$ |
33.8 |
|
|
$ |
31.8 |
|
Service cost
|
|
|
0.7 |
|
|
|
0.5 |
|
Interest cost
|
|
|
2.0 |
|
|
|
2.0 |
|
Plan participants
contributions
|
|
|
0.6 |
|
|
|
0.5 |
|
Loss on curtailment
|
|
|
2.5 |
|
|
|
|
|
Actuarial (gain) loss
|
|
|
(2.1 |
) |
|
|
1.3 |
|
Benefits paid
|
|
|
(2.8 |
) |
|
|
(2.3 |
) |
|
|
|
|
|
|
|
APBO at end of year
|
|
$ |
34.7 |
|
|
$ |
33.8 |
|
|
|
|
|
|
|
|
Change in plan assets
|
|
|
|
|
|
|
|
|
Fair value of plan assets at
beginning of year
|
|
$ |
|
|
|
$ |
|
|
Employer contribution
|
|
|
2.2 |
|
|
|
1.8 |
|
Plan participants
contributions
|
|
|
0.6 |
|
|
|
0.5 |
|
Benefits paid
|
|
|
(2.8 |
) |
|
|
(2.3 |
) |
|
|
|
|
|
|
|
Fair value of plan assets at end of
year
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
Amounts recognized in the
balance sheet consist of:
|
|
|
|
|
|
|
|
|
Funded status as of
September 30 measurement date
|
|
$ |
(34.7 |
) |
|
$ |
(33.8 |
) |
Unrecognized prior loss
|
|
|
6.1 |
|
|
|
8.8 |
|
|
|
|
|
|
|
|
Accrued benefit cost (net amount
recognized)
|
|
$ |
(28.6 |
) |
|
$ |
(25.0 |
) |
|
|
|
|
|
|
|
Discount rate used in
development of APBO
|
|
|
5.51 |
% |
|
|
5.75 |
% |
|
|
|
|
|
|
|
Development of accrued benefit
cost
|
|
|
|
|
|
|
|
|
Accrued benefit cost at beginning
of year
|
|
$ |
25.0 |
|
|
$ |
24.3 |
|
Postretirement benefit cost
|
|
|
3.3 |
|
|
|
2.5 |
|
Curtailment charge
|
|
|
2.5 |
|
|
|
|
|
Employer contributions
|
|
|
(2.2 |
) |
|
|
(1.8 |
) |
|
|
|
|
|
|
|
Accrued benefit cost at end of year
|
|
$ |
28.6 |
|
|
$ |
25.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Components of net periodic
benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$ |
0.7 |
|
|
$ |
0.5 |
|
|
$ |
0.4 |
|
Interest cost
|
|
|
2.0 |
|
|
|
2.0 |
|
|
|
1.9 |
|
Amortization of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
|
0.6 |
|
|
|
0.4 |
|
|
|
0.2 |
|
|
Prior service cost
|
|
|
|
|
|
|
(0.4 |
) |
|
|
(0.7 |
) |
|
|
|
|
|
|
|
|
|
|
Net periodic postretirement benefit
cost
|
|
|
3.3 |
|
|
|
2.5 |
|
|
|
1.8 |
|
Curtailment charge
|
|
|
2.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total postretirement benefit cost
|
|
$ |
5.8 |
|
|
$ |
2.5 |
|
|
$ |
1.8 |
|
|
|
|
|
|
|
|
|
|
|
Discount rate used in
development of net periodic benefit cost
|
|
|
5.75 |
% |
|
|
6.00 |
% |
|
|
6.75 |
% |
On December 8, 2003, the Medicare Prescription Drug,
Improvement and Modernization Act (the Act) became
law. The Act provides for a federal subsidy to sponsors of
retiree health care benefit plans that provide a prescription
drug benefit that is at least actuarially equivalent to the
benefit established by the Act. On May 19, 2004, the FASB
issued Staff Position No. 106-2, Accounting and
Disclosure Requirements Related to the Medicare Prescription
Drug, Improvement and Modernization Act of 2003
74
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(the FSP). The FSP provides guidance on accounting
for the effects of the Act, which the Company adopted at the
beginning of its fourth quarter of fiscal 2004. The APBO at
September 30, 2005, has been reduced by a deferred
actuarial gain in the amount of $5.9 million to reflect the
effect of the subsidy related to benefits attributed to past
service. The amortization of the actuarial gain and reduction of
service and interest costs served to reduce net periodic post
retirement benefit cost for fiscal 2005 and 2004 by $0.2 and
$0.1 million, respectively.
For measurement as of September 30, 2005, management has
assumed that health care costs will increase at an annual rate
of 8.5% in fiscal 2006 (period from October 1, 2005, to
September 30, 2006), decreasing 0.50% per year to an
ultimate trend of 5.00% in 2013. A 1% increase in health cost
trend rate assumptions would increase the APBO as of
September 30, 2005 and 2004 by $0.2 million and
$0.9 million, respectively. A 1% decrease in health cost
trend rate assumptions would decrease the APBO as of
September 30, 2005 and 2004 by $0.2 million and
$1.0 million, respectively. A 1% increase or decrease in
the same rate would not have a material effect on service or
interest costs.
Estimated Future Benefit Payments
The following benefit payments under the plan are expected to be
paid by the Company and the retirees for the fiscal years
indicated (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross | |
|
|
|
Medicare | |
|
Net | |
|
|
Benefit | |
|
Retiree | |
|
Part D | |
|
Company | |
|
|
Payments | |
|
Contributions | |
|
Subsidy | |
|
Payments | |
| |
2006
|
|
$ |
3.4 |
|
|
$ |
(0.8 |
) |
|
$ |
(0.2 |
) |
|
$ |
2.4 |
|
2007
|
|
|
3.9 |
|
|
|
(0.9 |
) |
|
|
(0.3 |
) |
|
|
2.7 |
|
2008
|
|
|
4.1 |
|
|
|
(1.0 |
) |
|
|
(0.3 |
) |
|
|
2.8 |
|
2009
|
|
|
4.3 |
|
|
|
(1.2 |
) |
|
|
(0.3 |
) |
|
|
2.8 |
|
2010
|
|
|
4.5 |
|
|
|
(1.3 |
) |
|
|
(0.4 |
) |
|
|
2.8 |
|
2011-2015
|
|
|
26.7 |
|
|
|
(10.3 |
) |
|
|
(2.7 |
) |
|
|
13.7 |
|
The Company also provides comprehensive major medical benefits
to its associates. The Company is self-insured for certain
health benefits up to $0.3 million per occurrence per
individual. The cost of such benefits is recognized as expense
in the period the claim is incurred. This cost was
$17.9 million, $17.0 million, and $15.4 million
in fiscal 2005, 2004 and 2003, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
| |
|
|
(in millions) | |
Revolver
|
|
$ |
166.2 |
|
|
$ |
|
|
Term loans
|
|
|
|
|
|
|
399.0 |
|
Senior Subordinated Notes:
|
|
|
|
|
|
|
|
|
|
65/8% Notes
|
|
|
200.0 |
|
|
|
200.0 |
|
Notes due to sellers
|
|
|
8.1 |
|
|
|
13.2 |
|
Foreign bank borrowings and term
loans
|
|
|
6.8 |
|
|
|
10.8 |
|
Other
|
|
|
12.4 |
|
|
|
7.6 |
|
|
|
|
|
|
|
|
|
|
|
393.5 |
|
|
|
630.6 |
|
Less current portions
|
|
|
11.1 |
|
|
|
22.1 |
|
|
|
|
|
|
|
|
|
|
$ |
382.4 |
|
|
$ |
608.5 |
|
|
|
|
|
|
|
|
75
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Maturities of short- and long-term debt for the next five fiscal
years and thereafter are as follows (in millions):
|
|
|
|
|
2006
|
|
$ |
11.1 |
|
2007
|
|
|
6.3 |
|
2008
|
|
|
2.2 |
|
2009
|
|
|
1.7 |
|
2010
|
|
|
167.2 |
|
Thereafter
|
|
|
205.0 |
|
|
|
|
|
|
|
$ |
393.5 |
|
|
|
|
|
On July 21, 2005, the Company entered into a Revolving
Credit Agreement (the New Credit Agreement) for the
purpose of (a) repaying in full the loans under its
previous credit agreement dated as of October 22, 2003, as
amended and (b) providing funds for working capital and
other general corporate purposes of the Company and its
subsidiaries.
The New Credit Agreement consists of an aggregate
$1 billion multi-currency revolving credit commitment,
expiring July 21, 2010. Borrowings may be made in United
States dollars, euros and optional currencies including, but not
limited to, British pounds sterling, Australian dollars and
Canadian dollars. The New Credit Agreement provides that up to
$65 million of the $1 billion aggregate commitments
may be used for letters of credit. In addition, the Company may,
at any time prior to July 21, 2010, request additional
revolving credit commitments from the lenders up to an aggregate
amount, when combined with the initial commitments, not to
exceed $1.15 billion. There is no guarantee such additional
loans will be made at the time of the request as prevailing
market conditions may be significantly different than the
present time.
The New Credit Agreement has several borrowing options,
including interest rates that are based on (i) a LIBOR rate
plus a margin based on a Leverage Ratio (as defined) or
(ii) the greater of the prime rate or the Federal Funds
Effective Rate (as defined) plus
1/2
of 1% plus a margin based on a Leverage Ratio. Facility fees are
also based on the Leverage Ratio of the Company and its
subsidiaries on a consolidated basis and, as of July 21,
2005, will accrue at 0.25% of the committed amounts per annum.
Swingline loans are also available under the New Credit
Agreement provided that (i) the aggregate principal amount
of swingline loans outstanding at any time may not exceed
$100 million and (ii) the sum of outstanding letters
of credit, swingline loans and other loans made under the New
Credit Agreement may not exceed $1 billion (or
$1.15 billion if additional revolving credit commitments
have been obtained).
The terms of the New Credit Agreement provide for customary
representations and warranties and affirmative covenants. The
New Credit Agreement also contains customary negative covenants
providing limitations, subject to negotiated carve-outs, on
liens, contingent obligations, fundamental changes,
acquisitions, investments, loans and advances, indebtedness,
restrictions on subsidiary distributions, transactions with
affiliates and officers, sales of assets, sale and leaseback
transactions, changing the Companys fiscal year end,
modification of specified debt instruments, negative pledge
clauses, entering into new lines of business, restricted
payments (including dividend payments currently restricted to
$75 million annually) and redemption of specified
indebtedness. The New Credit Agreement also requires the
maintenance of a Leverage Ratio and Minimum Interest Coverage
(both as defined).
The terms of the New Credit Agreement include customary events
of default such as payment defaults, cross-defaults to other
material indebtedness, bankruptcy and insolvency, the occurrence
of a defined change in control or the failure to observe the
negative covenants and other covenants related to the operation
and conduct of the business of the Company and its subsidiaries.
Upon an event of default, the lenders may, among other things,
terminate their commitments under the New Credit Agreement and
declare any of the then outstanding loans due and payable
immediately.
Borrowings under the New Credit Agreement are guaranteed by the
Company and substantially all of its domestic subsidiaries.
Borrowings under the New Credit Agreement are also
collateralized by a pledge
76
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
by The Scotts Miracle-Gro Company and its domestic subsidiaries
of the capital stock of substantially all of such domestic
subsidiaries and a majority of the capital stock of certain
foreign subsidiaries that are first-tier subsidiaries of such
domestic subsidiaries. The security interest in the
Companys and its domestic subsidiaries personal,
real and intellectual property assets, which had existed under
the prior credit agreement, was not required under the New
Credit Agreement and has been terminated (except as to certain
subsidiary capital stock as described above). The Company and
its subsidiaries also pledged a majority of the capital stock in
foreign subsidiaries that borrow under the New Credit Agreement
and a majority of the capital stock of substantially all of the
first-tier subsidiaries of such foreign subsidiary borrowers.
Revolving credit borrowings under the New Credit Agreement in
the aggregate amount of $195.7 million were combined with
cash on hand in the amount of $200.3 million to repay in
full the outstanding Tranche A Term Loans
($248 million) and Tranche B Term Loans
($148 million) under the prior credit agreement (which was
then terminated). Certain fees in connection with entering into
the New Credit Agreement were also paid from cash on hand. In
addition, letters of credit in the aggregate amount of
$15.6 million were assigned to the New Credit Agreement.
Total fees of approximately $3.6 million have been
capitalized and are being amortized on the straight-line method
over the five year term of the New Credit Agreement.
A loss on the refinancing in the amount of $1.3 million,
representing the write-off of deferred financing costs incurred
related to the Term Loans that were repaid, was recognized in
the fourth quarter of fiscal 2005. In addition, interest rate
swap agreements in the notional amount of $125 million,
that effectively converted a portion of the variable rate Term
Loans to a fixed rate, were unwound, resulting in a gain of
$2.9 million that will be amortized against future interest
expense under the New Credit Agreement.
NOTE 10. SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
2005 |
|
2004 |
|
|
|
(in millions) |
STOCK
|
|
|
|
|
Preferred shares, no par value:
|
|
|
|
|
|
Authorized
|
|
0.2 shares
|
|
0.2 shares
|
|
Issued
|
|
0.0 shares
|
|
0.0 shares
|
Common shares, no par value
|
|
|
|
|
|
Authorized
|
|
100.0 shares
|
|
100.0 shares
|
|
Issued
|
|
67.8 shares
|
|
65.6 shares
|
In fiscal 1995, the Company merged with Sterns Miracle-Gro
Products, Inc. (Miracle-Gro). At September 30, 2005, the
former shareholders of Miracle-Gro, including Hagedorn
Partnership L.P., owned approximately 31% of The Scotts
Miracle-Gro Companys outstanding common shares and, thus,
have the ability to significantly influence the election of
directors and approval of other actions requiring the approval
of The Scotts Miracle-Gro Companys shareholders.
Under the terms of the Miracle-Gro merger agreement, the former
shareholders of Miracle-Gro may not acquire, directly or
indirectly, beneficial ownership of Voting Stock (as that term
is defined in the Miracle-Gro merger agreement) representing
more than 49% of the total voting power of the outstanding
Voting Stock, except pursuant to a tender offer for 100% of that
total voting power, which tender offer is made at a price per
share which is not less than the market price per share on the
last trading day before the announcement of the tender offer and
is conditioned upon the receipt of at least 50% of the Voting
Stock beneficially owned by shareholders of The Scotts
Miracle-Gro Company other than the former shareholders of
Miracle-Gro and their affiliates and associates.
The Company grants share-based awards annually to officers,
other key employees, and non-employee directors. Historically,
these awards primarily include stock options with exercise
prices equal to the market price of the underlying common shares
on the date of grant with a term of 10 years. In recent
years, the Company also has begun to grant awards of restricted
stock. These share-based awards have
77
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
been made under plans approved by the shareholders in 1992,
1996, and 2003. Generally, in respect of grants to employees, a
three-year cliff vesting schedule is used for all share-based
awards unless decided otherwise by the Compensation and
Organization Committee of the Board of Directors. Grants to
non-employee directors typically vest in one year or less. A
maximum of 18 million common shares may be delivered for
issuance under these plans. At September 30, 2005,
approximately 1.1 million common shares are not subject to
outstanding awards and are available to underlie the grant of
new share-based awards. Subsequent to September 30, 2005,
the Company granted a total of 917,300 share-based awards
to key employees. These awards have an estimated fair value of
$17.0 million as of the date of grant.
The following is a recap of the share-based awards granted over
the last three years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Key employees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
965,600 |
|
|
|
118,000 |
|
|
|
809,000 |
|
|
Stock appreciation rights
|
|
|
|
|
|
|
775,500 |
|
|
|
478,000 |
|
|
Restricted stock
|
|
|
101,000 |
|
|
|
|
|
|
|
|
|
Board of Directors
Options
|
|
|
147,000 |
|
|
|
152,500 |
|
|
|
126,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share-based awards
|
|
|
1,213,600 |
|
|
|
1,046,000 |
|
|
|
1,413,000 |
|
|
|
|
|
|
|
|
|
|
|
Fair value at grant dates (in
millions)
|
|
$ |
15.1 |
|
|
$ |
11.0 |
|
|
$ |
13.1 |
|
The exercise price for option awards and the stated price for
stock appreciation rights awards were determined by the closing
price of the Companys common shares on the date of grant.
The related compensation expense recorded in fiscal 2005, fiscal
2004, and fiscal 2003 was $10.7 million, $7.8 million,
and $4.8 million, respectively. Stock appreciation rights
result in less dilution than option awards as the SAR holder
receives a net share settlement upon exercise. Tax benefits
allocated to capital in excess of stated value relating to the
exercise of stock options amounted to $15.5 million in fiscal
2005. The Company also has a phantom option plan for certain
management employees which is payable in cash based on the
increase in the Companys share price over a three-year
vesting period.
Had compensation expense been recognized for unvested stock
options granted prior to the Companys adoption of the
expense recognition provisions of SFAS 123 as of
October 1, 2002, the Company would have recorded net income
and net income per share as follows (in millions, except per
share data):
|
|
|
|
|
|
|
|
|
|
|
|
For the fiscal | |
|
|
Years Ended | |
|
|
September 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
| |
Net income
|
|
$ |
100.9 |
|
|
$ |
103.8 |
|
Stock-based compensation expense
included in reported net income, net of tax
|
|
|
4.9 |
|
|
|
2.9 |
|
Total stock-based employee
compensation expense determined under fair value based method
for all awards, net of tax
|
|
|
(7.1 |
) |
|
|
(7.0 |
) |
|
|
|
|
|
|
|
Net income, as adjusted
|
|
$ |
98.7 |
|
|
$ |
99.7 |
|
|
|
|
|
|
|
|
Net income per share, as reported:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
1.56 |
|
|
$ |
1.68 |
|
|
Diluted
|
|
$ |
1.52 |
|
|
$ |
1.62 |
|
Net income per share, as adjusted:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
1.53 |
|
|
$ |
1.62 |
|
|
Diluted
|
|
$ |
1.48 |
|
|
$ |
1.56 |
|
The as adjusted amounts shown above are not
necessarily representative of the impact on net income in future
periods.
78
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Stock Options/SARs
Aggregate option and stock appreciation right award activity
consists of the following (options/ SARs in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
|
|
|
WTD. | |
|
|
|
WTD. | |
|
|
|
WTD. | |
|
|
|
|
Avg. | |
|
|
|
Avg. | |
|
|
|
Avg. | |
|
|
No. of | |
|
Exercise | |
|
No. of | |
|
Exercise | |
|
No. of | |
|
Exercise | |
|
|
Options/SARs | |
|
Price | |
|
Options/SARs | |
|
Price | |
|
Options/SARs | |
|
Price | |
| |
Beginning balance
|
|
|
7.6 |
|
|
$ |
19.87 |
|
|
|
8.2 |
|
|
$ |
17.50 |
|
|
|
8.4 |
|
|
$ |
15.63 |
|
Awards granted
|
|
|
1.2 |
|
|
$ |
34.56 |
|
|
|
1.2 |
|
|
$ |
29.41 |
|
|
|
1.4 |
|
|
$ |
24.54 |
|
Awards exercised
|
|
|
(2.1 |
) |
|
$ |
15.99 |
|
|
|
(1.6 |
) |
|
$ |
14.67 |
|
|
|
(1.4 |
) |
|
$ |
13.57 |
|
Awards forfeited
|
|
|
(0.3 |
) |
|
$ |
28.06 |
|
|
|
(0.2 |
) |
|
$ |
24.28 |
|
|
|
(0.2 |
) |
|
$ |
18.22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
|
6.4 |
|
|
$ |
23.09 |
|
|
|
7.6 |
|
|
$ |
19.87 |
|
|
|
8.2 |
|
|
$ |
17.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable
|
|
|
3.4 |
|
|
$ |
17.89 |
|
|
|
4.6 |
|
|
$ |
16.97 |
|
|
|
4.8 |
|
|
$ |
15.66 |
|
The following summarizes certain information pertaining to
option and stock appreciation right awards outstanding and
exercisable at September 30, 2005 (options/ SARs in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards Outstanding | |
|
Awards Exercisable | |
|
|
| |
|
| |
|
|
No. of | |
|
WTD. Avg. | |
|
WTD. Avg. | |
|
No. of | |
|
|
Range of |
|
Options/ | |
|
Remaining | |
|
Exercise | |
|
Options/ | |
|
Exercise | |
Exercise Price |
|
SARs | |
|
Life | |
|
Price | |
|
SARS | |
|
Price | |
| |
$ 8.50 $14.72
|
|
|
0.5 |
|
|
|
1.54 |
|
|
$ |
10.90 |
|
|
|
0.5 |
|
|
$ |
10.90 |
|
$15.00 $17.38
|
|
|
1.0 |
|
|
|
3.87 |
|
|
|
15.64 |
|
|
|
0.9 |
|
|
|
15.64 |
|
$17.50 $19.98
|
|
|
1.6 |
|
|
|
4.86 |
|
|
|
18.92 |
|
|
|
1.6 |
|
|
|
18.92 |
|
$20.07 $25.62
|
|
|
1.3 |
|
|
|
7.12 |
|
|
|
24.42 |
|
|
|
0.2 |
|
|
|
24.05 |
|
$29.08 $31.56
|
|
|
1.0 |
|
|
|
8.16 |
|
|
|
29.42 |
|
|
|
0.2 |
|
|
|
34.17 |
|
$32.58 $40.53
|
|
|
1.0 |
|
|
|
9.22 |
|
|
|
34.55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.4 |
|
|
|
|
|
|
$ |
23.09 |
|
|
|
3.4 |
|
|
$ |
17.89 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The fair value of each award granted has been estimated on the
grant date using the Binomial model for fiscal 2005 and the
Black-Scholes option-pricing model for fiscal 2004 and fiscal
2003. The weighted average assumptions for those granted in
fiscal 2005, fiscal 2004 and fiscal 2003 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Market price volatility
|
|
|
23.9 |
% |
|
|
24.3 |
% |
|
|
30.1 |
% |
Risk-free interest rates
|
|
|
3.7 |
% |
|
|
3.3 |
% |
|
|
3.5 |
% |
Expected dividend yield
|
|
|
0.0 |
% |
|
|
0.0 |
% |
|
|
0.0 |
% |
Expected life of options/SARs
|
|
|
6.15 |
|
|
|
6.20 |
|
|
|
7.00 |
|
Estimated weighted-average fair
value per share of options/SARs
|
|
$ |
10.57 |
|
|
$ |
8.86 |
|
|
$ |
9.68 |
|
79
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Restricted Stock
Aggregate restricted stock award activity is as follows:
|
|
|
|
|
|
|
|
|
|
|
No. of | |
|
Fair Value at | |
|
|
Shares | |
|
Date of Grant | |
| |
Beginning balance October 1,
2003
|
|
|
|
|
|
$ |
|
|
|
Granted
|
|
|
30,000 |
|
|
|
0.9 |
|
Fully vested
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance September 30, 2004
|
|
|
30,000 |
|
|
$ |
0.9 |
|
Granted
|
|
|
101,000 |
|
|
|
3.3 |
|
Fully vested
|
|
|
(1,600 |
) |
|
|
(0.1 |
) |
Forfeited
|
|
|
(15,000 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
|
Balance September 30, 2005
|
|
|
114,400 |
|
|
$ |
3.6 |
|
|
|
|
|
|
|
|
The fair value of all share-based awards has been recorded as
unearned compensation and is shown as a separate component of
shareholders equity. Unearned compensation is amortized
over the vesting period for the particular grant, and is
recognized as a component of Selling, general and
administrative expenses within the Consolidated Statements
of Operations.
80
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11. EARNINGS PER COMMON SHARE
The following table (in millions, except per share data)
presents information necessary to calculate basic and diluted
earnings per common share. Basic earnings per common share are
computed by dividing net income by the weighted average number
of common shares outstanding. Diluted earnings per common share
are computed by dividing net income by the weighted average
number of common shares outstanding plus all potentially
dilutive securities. Options to purchase 0.04 million,
0.2 million and 0.2 million common shares for the
years ended September 30, 2005, 2004 and 2003,
respectively, were not included in the computation of diluted
earnings per common share. These options were excluded from the
calculation because the exercise price of these options was
greater than the average market price of the common shares in
the respective periods, and therefore, they were anti-dilutive.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Income from continuing operations
|
|
$ |
100.4 |
|
|
$ |
100.5 |
|
|
$ |
103.2 |
|
|
Income from discontinued operations
|
|
|
0.2 |
|
|
|
0.4 |
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
100.6 |
|
|
$ |
100.9 |
|
|
$ |
103.8 |
|
|
|
|
|
|
|
|
|
|
|
BASIC EARNINGS PER COMMON SHARE:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares
outstanding during the period
|
|
|
66.8 |
|
|
|
64.7 |
|
|
|
61.8 |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$ |
1.51 |
|
|
$ |
1.55 |
|
|
$ |
1.67 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
0.01 |
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
1.51 |
|
|
$ |
1.56 |
|
|
$ |
1.68 |
|
|
|
|
|
|
|
|
|
|
|
DILUTED EARNINGS PER COMMON SHARE:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares
outstanding during the period
|
|
|
66.8 |
|
|
|
64.7 |
|
|
|
61.8 |
|
|
Potential common shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assuming exercise of options/ SARs
|
|
|
1.8 |
|
|
|
1.9 |
|
|
|
2.5 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of common
shares outstanding and dilutive potential common shares
|
|
|
68.6 |
|
|
|
66.6 |
|
|
|
64.3 |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$ |
1.47 |
|
|
$ |
1.51 |
|
|
$ |
1.61 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
0.01 |
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
1.47 |
|
|
$ |
1.52 |
|
|
$ |
1.62 |
|
|
|
|
|
|
|
|
|
|
|
NOTE 12. INCOME TAXES
The provision for income taxes consists of the following (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Currently payable:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$ |
55.9 |
|
|
$ |
33.4 |
|
|
$ |
7.9 |
|
|
State
|
|
|
7.0 |
|
|
|
4.9 |
|
|
|
0.9 |
|
|
Foreign
|
|
|
8.4 |
|
|
|
4.5 |
|
|
|
5.3 |
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(11.8 |
) |
|
|
14.9 |
|
|
|
41.3 |
|
|
State
|
|
|
(1.8 |
) |
|
|
0.2 |
|
|
|
3.8 |
|
|
Foreign
|
|
|
|
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
57.7 |
|
|
$ |
58.0 |
|
|
$ |
59.2 |
|
|
|
|
|
|
|
|
|
|
|
81
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The domestic and foreign components of income before taxes are
as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Domestic
|
|
$ |
170.0 |
|
|
$ |
143.2 |
|
|
$ |
150.7 |
|
Foreign
|
|
|
(11.9 |
) |
|
|
15.3 |
|
|
|
11.7 |
|
|
|
|
|
|
|
|
|
|
|
Income before taxes
|
|
$ |
158.1 |
|
|
$ |
158.5 |
|
|
$ |
162.4 |
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the federal corporate income tax rate and
the effective tax rate on income before income taxes from
continuing operations is summarized below (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Statutory income tax rate
|
|
|
35.0 |
% |
|
|
35.0 |
% |
|
|
35.0 |
% |
Effect of foreign operations
|
|
|
0.2 |
|
|
|
(0.4 |
) |
|
|
(0.1 |
) |
State taxes, net of federal benefit
|
|
|
1.8 |
|
|
|
2.1 |
|
|
|
1.9 |
|
Change in deferred state effective
tax rate
|
|
|
|
|
|
|
|
|
|
|
(1.8 |
) |
Change in state NOL &
credit carry forwards
|
|
|
1.9 |
|
|
|
(0.8 |
) |
|
|
|
|
Change in valuation allowance
|
|
|
|
|
|
|
(0.6 |
) |
|
|
0.6 |
|
Other
|
|
|
(2.4 |
) |
|
|
1.3 |
|
|
|
0.8 |
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
36.5 |
% |
|
|
36.6 |
% |
|
|
36.4 |
% |
|
|
|
|
|
|
|
|
|
|
The net current and non-current components of deferred income
taxes recognized in the Consolidated Balance Sheets are (in
millions):
|
|
|
|
|
|
|
|
|
|
|
September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
| |
Net current deferred tax asset
(classified with prepaid and other assets)
|
|
$ |
15.6 |
|
|
$ |
24.9 |
|
Net non-current deferred tax
liability (classified with other liabilities)
|
|
|
(4.5 |
) |
|
|
(18.6 |
) |
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$ |
11.1 |
|
|
$ |
6.3 |
|
|
|
|
|
|
|
|
82
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The components of the net deferred tax asset are as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
September 30, | |
|
|
| |
|
|
2005 | |
|
2004 | |
| |
DEFERRED TAX ASSETS
|
|
|
|
|
|
|
|
|
|
Inventories
|
|
$ |
11.4 |
|
|
$ |
14.8 |
|
|
Accrued liabilities
|
|
|
54.7 |
|
|
|
38.2 |
|
|
Postretirement benefits
|
|
|
38.4 |
|
|
|
32.5 |
|
|
Accounts receivable
|
|
|
6.5 |
|
|
|
10.6 |
|
|
Other
|
|
|
18.3 |
|
|
|
16.4 |
|
|
|
|
|
|
|
|
|
Gross deferred tax assets
|
|
|
129.3 |
|
|
|
112.5 |
|
|
Valuation allowance
|
|
|
(2.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
126.9 |
|
|
|
112.5 |
|
DEFERRED TAX LIABILITIES
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment
|
|
|
(47.5 |
) |
|
|
(50.6 |
) |
|
Intangible assets
|
|
|
(59.9 |
) |
|
|
(48.8 |
) |
|
Other
|
|
|
(8.4 |
) |
|
|
(6.8 |
) |
|
|
|
|
|
|
|
|
Deferred tax liability
|
|
|
(115.8 |
) |
|
|
(106.2 |
) |
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$ |
11.1 |
|
|
$ |
6.3 |
|
|
|
|
|
|
|
|
Tax benefits relating to state net operating loss carryforwards
were $5.4 million and $5.3 million at
September 30, 2005 and 2004, respectively. State net
operating loss carryforward periods range from 5 to
20 years. Any losses not utilized within a specific
states carryforward period will expire. The tax benefits
relating to state net operating loss carryforwards for fiscal
2005 include $2.4 million relating to the acquisition of
Smith & Hawken® as was recorded as part
of the purchase accounting. As the losses may only be used
against income of Smith & Hawken®, and
cannot be used to offset income of the consolidated group, a
full valuation allowance has been placed on this portion. State
tax credits were $0.4 million and $2.1 million at
September 30, 2005 and 2004, respectively. Any unused
credits will begin to expire starting in fiscal 2006.
Ohio corporate tax legislation enacted on June 30, 2005
phases out the Ohio Corporate Franchise Tax and phases in the
new gross receipts tax called the Commercial Activity Tax (CAT).
The Corporate Franchise Tax was generally based on federal
taxable income, but the CAT is based on sales in Ohio. As
required by SFAS 109, Accounting for Income
Taxes, we recorded the impact of the change in Ohio
legislation in the third quarter of fiscal 2005. The effect of
the change in the law was immaterial to the consolidated
financial statements.
In accordance with APB 23, deferred taxes have not been
provided on unremitted earnings of certain foreign subsidiaries
and foreign corporate joint ventures of approximately
$65.3 million that arose in fiscal years ended on or before
September 30, 2005, since such earnings are considered
permanently reinvested.
The American Jobs Creation Act (the AJCA) provides a
deduction of 85% on certain foreign earnings repatriated. The
Company does not expect to be able to take advantage of this
deduction based upon the Companys current foreign income
and tax rates. The AJCA also provides a deduction calculated as
a percentage of qualified income from manufacturing in the
United States. The percentage increases from 3% to 9% over a
6-year period beginning with the Companys 2006 fiscal
year. In December 2004, the FASB issued a new staff position
providing for this deduction to be treated as a special
deduction, as opposed to a tax rate reduction, in accordance
with SFAS 109. The benefit of this deduction is not
expected to have a material impact on the Companys
effective tax rate in fiscal 2006.
Management judgment is required in determining tax provisions
and evaluating tax positions. Management believes its tax
positions and related provisions reflected in the consolidated
financial statements are fully supportable and appropriate. We
establish reserves for additional income taxes that may become
due if our tax positions are challenged and not sustained. Our
tax provision includes the impact of recording reserves and
changes thereto. The reserves for additional income taxes are
based on
83
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
managements best estimate of the ultimate resolution of
the tax matter. Based on currently available information, we
believe that the ultimate outcomes of any challenges to our tax
positions will not have a material adverse effect on our
financial position, results of operations or cash flows. Our tax
provision includes the impact of recording reserves and changes
thereto.
NOTE 13. FINANCIAL INSTRUMENTS
A description of the Companys financial instruments and
the methods and assumptions used to estimate their fair values
is as follows:
Long-Term Debt
The fair value of the Companys
65/8% Senior
Subordinated Notes was estimated based on recent trading
information. The carrying amounts of variable rate debt,
including borrowings under the Credit Agreement and foreign bank
borrowings and term loans, are considered to approximate their
fair values.
Foreign Currency Swap Agreements
From time to time, the Company enters into foreign currency swap
contracts to manage the exchange rate risk associated with
intercompany loans made to foreign affiliates that are
denominated in dollars. At September 30, 2005, the notional
amount of such foreign currency swap contracts outstanding was
$174.5 million with a fair value of $2.4 million. The
unrealized gain on the swap contracts approximates the
unrealized loss recognized by our foreign affiliates.
Interest Rate Swap Agreements
At September 30, 2005, the Company did not have any
interest rate swaps outstanding. At September 30, 2004, the
Company had nine interest rate swaps outstanding with a total
notional amount of $175.0 million with major financial
institutions that effectively converted a portion of its
variable-rate debt to a fixed rate. The swaps outstanding at
September 30, 2004, had notional amounts between
$10 million and $50 million with three to seven-year
terms commencing in October 2001. Under the terms of these
swaps, the Company paid swap rates ranging from 2.76% to 3.77%
and received three-month LIBOR in return. In November 2005, the
Company entered into four interest rate swaps with a total
notional amount of $100.0 million, each swap having a
notional amount of $25.0 million and a term of three years.
The Company enters into interest rate swap agreements as a means
to hedge its variable interest rate exposure on debt
instruments. Since the interest rate swaps have been designated
as hedging instruments, their fair values are reflected in the
Companys Consolidated Balance Sheets. Net amounts to be
received or paid under the swap agreements are reflected as
adjustments to interest expense. Unrealized gains or losses
resulting from valuing these swaps at fair value are recorded as
elements of Accumulated other comprehensive loss
within the Consolidated Balance Sheets. The fair value of the
swap agreements was determined based on the present value of the
estimated future net cash flows using implied rates in the
applicable yield curve as of the valuation date.
Estimated Fair Values
The estimated fair values of the Companys financial
instruments are as follows for the fiscal years ended
September 30 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
|
|
Carrying | |
|
Fair | |
|
Carrying | |
|
Fair | |
|
|
Amount | |
|
Value | |
|
Amount | |
|
Value | |
| |
Revolving and term loans under
Credit Agreement
|
|
$ |
166.2 |
|
|
$ |
166.2 |
|
|
$ |
399.0 |
|
|
$ |
399.0 |
|
Senior Subordinated Notes
|
|
|
200.0 |
|
|
|
201.5 |
|
|
|
200.0 |
|
|
|
211.8 |
|
Foreign bank borrowings and term
loans
|
|
|
6.8 |
|
|
|
6.8 |
|
|
|
10.8 |
|
|
|
10.8 |
|
Foreign currency swap agreements
|
|
|
2.4 |
|
|
|
2.4 |
|
|
|
|
|
|
|
|
|
Interest rate swap agreements
|
|
|
|
|
|
|
|
|
|
|
0.5 |
|
|
|
0.5 |
|
84
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Excluded from the fair value table above are the following items
that are included in the Companys total debt balances at
September 30, 2005 and 2004 (in millions):
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
| |
Notes due to sellers
|
|
$ |
8.1 |
|
|
$ |
13.2 |
|
Other
|
|
|
12.4 |
|
|
|
7.6 |
|
NOTE 14. OPERATING LEASES
The Company leases certain property and equipment from third
parties under various non-cancelable operating lease agreements
Certain lease agreements contain renewal and purchase options.
The lease agreements generally provide that the Company pay
taxes, insurance and maintenance expenses related to the leased
assets. Future minimum lease payments for non-cancelable
operating leases at September 30, 2005, are as follows (in
millions):
|
|
|
|
|
2006
|
|
$ |
31.4 |
|
2007
|
|
|
25.8 |
|
2008
|
|
|
21.6 |
|
2009
|
|
|
15.9 |
|
2010
|
|
|
12.1 |
|
Thereafter
|
|
|
47.8 |
|
|
|
|
|
Total future minimum lease payments
|
|
$ |
154.6 |
|
|
|
|
|
The Company also leases certain vehicles (primarily cars and
light trucks) under agreements that are cancelable after the
first year, but typically continue on a month-to-month basis
until canceled by the Company. The vehicle leases and certain
other non-cancelable operating leases contain residual value
guarantees that create a contingent obligation on the part of
the Company to compensate the lessor if the leased asset cannot
be sold for an amount in excess of a specified minimum value at
the conclusion of the lease term. If all such vehicle leases had
been canceled as of September 30, 2005, the Companys
residual value guarantee would have approximated
$11.1 million. Other residual value guarantees apply only
at the conclusion of the non-cancelable lease term, as follows:
|
|
|
|
|
|
|
|
|
|
|
Amount of | |
|
Lease | |
|
|
Guarantee | |
|
Termination Date | |
| |
Scotts LawnService®
vehicles
|
|
$ |
4.9 million |
|
|
|
2009 |
|
Corporate aircraft
|
|
|
12.2 million |
|
|
|
2008 and 2010 |
|
Rent expense for fiscal 2005, fiscal 2004 and fiscal 2003
totaled $57.9 million, $44.8 million, and
$40.8 million, respectively.
NOTE 15. COMMITMENTS
The Company has the following unconditional purchase obligations
due during each of the next five fiscal years that have not been
recognized on the balance sheet at September 30, 2005 (in
millions):
|
|
|
|
|
2006
|
|
$ |
96.5 |
|
2007
|
|
|
73.0 |
|
2008
|
|
|
21.7 |
|
2009
|
|
|
13.3 |
|
2010
|
|
|
3.9 |
|
|
|
|
|
|
|
$ |
208.4 |
|
|
|
|
|
85
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 16. CONTINGENCIES
Management continually evaluates the Companys
contingencies, including various lawsuits and claims which arise
in the normal course of business, product and general
liabilities, workers compensation, property losses and
other fiduciary liabilities for which the Company is
self-insured or retains a high exposure limit. Self-insurance
reserves are established based on actuarial estimates. Legal
costs incurred in connection with the resolution of claims,
lawsuits and other contingencies generally are expensed as
incurred. In the opinion of management, its assessment of
contingencies is reasonable and related reserves, in the
aggregate, are adequate; however, there can be no assurance that
future quarterly or annual operating results will not be
materially affected by final resolution of these matters. The
following matters are the more significant of the Companys
identified contingencies.
Environmental Matters
In 1997, the Ohio EPA initiated an enforcement action against
the Company with respect to alleged surface water violations and
inadequate treatment capabilities at the Marysville, Ohio
facility seeking corrective action under the federal Resource
Conservation and Recovery Act. The action related to discharges
from on-site waste water treatment and several discontinued
on-site disposal areas.
Pursuant to a Consent Order entered by the Union County Common
Pleas Court in 2002, the Company is actively engaged in
restoring the site to eliminate exposure to waste materials from
the discontinued on-site disposal areas.
At September 30, 2005, $3.3 million was accrued for
environmental and regulatory matters, primarily related to the
Marysville facility. Most of the accrued costs are expected to
be paid in fiscal 2006 and 2007; however, payments could be made
for a period thereafter. While the amounts accrued are believed
to be adequate to cover known environmental exposures based on
current facts and estimates of likely outcome, the adequacy of
these accruals is based on several significant assumptions:
|
|
|
|
|
that all significant sites that must be remediated have been
identified; |
|
|
|
that there are no significant conditions of contamination that
are unknown to us; and |
|
|
|
that with respect to the agreed judicial Consent Order in Ohio,
potentially contaminated soil can be remediated in place rather
than having to be removed and only specific stream segments will
require remediation as opposed to the entire stream. |
If there is a significant change in the facts and circumstances
surrounding these assumptions, it could have a material impact
on the ultimate outcome of these matters and our results of
operations, financial position and cash flows.
During fiscal 2005, fiscal 2004, and fiscal 2003, we have
expensed approximately $3.7 million, $3.3 million, and
$1.5 million, respectively, for environmental matters.
AgrEvo Environmental Health, Inc. v. The Scotts Company
(Southern District of New York)
The Scotts Company v. Aventis S.A. and Starlink
Logistics, Inc. (Southern District of Ohio)
On September 30, 2005, all litigation among the
aforementioned companies has been concluded with the Company
receiving a payment of approximately $10 million, of this
amount $8.9 million is recorded in Impairment,
restructuring and other charges within the Consolidated
Statements of Operations (see Note 4).
Central Garden & Pet Company
The Scotts Company v. Central Garden, Southern
District of Ohio
Central Garden v. Scotts & Pharmacia,
Northern District of California
All litigation with the Central Garden & Pet Company
(Central Garden) has been concluded. On
July 15, 2005, the Company received approximately
$15 million in satisfaction of the judgment against
86
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Central Garden. The Company has recognized the satisfaction of
this judgment in its financial results for fiscal 2005 as
follows (in millions):
|
|
|
|
|
Reversal of reserve against
outstanding receivables due from Central Garden. The reserve was
initially established through a charge to restructuring and
other charges within selling, general and administrative
expenses; therefore, the reversal of the reserve has been
classified in a like manner. (See Note 4)
|
|
$ |
7.9 |
|
Portion of judgment classified with
other income, net
|
|
|
4.1 |
|
|
|
|
|
Total amount included in income
from operations
|
|
|
12.0 |
|
Portion of judgment applied to
unreserved accounts receivable due from Central Garden
|
|
|
3.0 |
|
|
|
|
|
Total judgment
|
|
$ |
15.0 |
|
|
|
|
|
All pending litigation brought by Central Garden against the
Company has been concluded including the previously pending
antitrust case in the Northern District of California in which
Scotts prevailed.
U.S. Horticultural Supply, Inc. (F/K/A E.C. Geiger,
Inc.)
On November 5, 2004, U.S. Horticultural Supply
(Geiger) filed suit against The Scotts Company in
the U.S. District Court for the Eastern District of
Pennsylvania. This complaint alleges that the Company conspired
with another distributor, Griffin Greenhouse Supplies, Inc., to
restrain trade in the horticultural products market, in
violation of Sections 1 and 57 of the Sherman Antitrust Act.
The Company believes that all of Geigers claims are
without merit and intends to vigorously defend against them. If
any of the above actions are determined adversely to the
Company, the result could have a material adverse effect on
results of operations, financial position and cash flows. Any
potential exposure that the Company may face cannot be
reasonably estimated. Therefore, no accrual has been established
related to this matter.
Other
The Company has been named a defendant in a number of cases
alleging injuries that the lawsuits claim resulted from exposure
to asbestos-containing products, apparently based on the
Companys historic use of vermiculite in certain of its
products. The complaints in these cases are not specific about
the plaintiffs contacts with the Company or its products.
The Company in each case is one of numerous defendants and none
of the claims seeks damages from the Company alone. The Company
believes that the claims against it are without merit and is
vigorously defending them. It is not currently possible to
reasonably estimate a probable loss, if any, associated with the
cases and, accordingly, no accrual or reserves have been
recorded in the consolidated financial statements. There can be
no assurance that these cases, whether as a result of adverse
outcomes or as a result of significant defense costs, will not
have a material adverse effect on the Companys financial
condition or its results of operations.
The Company is reviewing agreements and policies that may
provide insurance coverage or indemnity as to these claims and
is pursuing coverage under some of these agreements, although
there can be no assurance of the results of these efforts.
The Company is involved in other lawsuits and claims which arise
in the normal course of business. These claims individually and
in the aggregate are not expected to result in a material
adverse effect on the Companys results of operations,
financial position or cash flows.
NOTE 17. CONCENTRATIONS OF CREDIT RISK
Financial instruments which potentially subject the Company to
concentration of credit risk consist principally of trade
accounts receivable. The Company sells its consumer products to
a wide variety of retailers, including mass merchandisers, home
centers, independent hardware stores, nurseries, garden outlets,
warehouse clubs and local and regional chains. Professional
products are sold to commercial nurseries, greenhouses,
landscape services, and growers of specialty agriculture crops.
87
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
At September 30, 2005, 76% of the Companys accounts
receivable were due from customers geographically located in
North America. Approximately 83% of these receivables were
generated from the consumer business with the remaining 17% due
from customers of Scotts LawnService®, the
professional businesses (primarily distributors), and
Smith & Hawken®. Our top 3 customers
within the consumer business accounted for 80% of total consumer
accounts receivable.
At September 30, 2004, 71% of the Companys accounts
receivable were due from customers geographically located in
North America. Approximately 84% of these receivable were
generated from the Companys consumer business with the
remaining 16% generated from customers of Scotts
LawnService® and the professional businesses
(primarily distributors). Our top 3 customers within the
consumer business accounted for 68% of total consumer accounts
receivable.
The remainder of the Companys accounts receivable at
September 30, 2005 and 2004, were generated from customers
located outside of North America, primarily retailers,
distributors, nurseries and growers in Europe. No concentrations
of customers or individual customers within this group account
for more than 10% of the Companys accounts receivable at
either balance sheet date.
The Companys two largest customers accounted for the
following percentage of net sales in each respective period:
|
|
|
|
|
|
|
|
|
|
|
Largest | |
|
2nd Largest | |
|
|
Customer | |
|
Customer | |
| |
2005
|
|
|
23.5 |
% |
|
|
11.9 |
% |
2004
|
|
|
25.0 |
% |
|
|
12.9 |
% |
2003
|
|
|
24.5 |
% |
|
|
13.7 |
% |
Sales to the Companys two largest customers are reported
within the Companys North America segment. No other
customers accounted for more than 10% of fiscal 2005, fiscal
2004 or fiscal 2003 net sales.
NOTE 18. OTHER (INCOME) EXPENSE
Other (income) expense consisted of the following for the fiscal
years ended September 30 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Royalty income
|
|
$ |
(6.5 |
) |
|
$ |
(5.4 |
) |
|
$ |
(5.0 |
) |
Gain from peat transaction
|
|
|
(0.8 |
) |
|
|
(2.4 |
) |
|
|
(2.4 |
) |
Franchise fees
|
|
|
(0.3 |
) |
|
|
(1.0 |
) |
|
|
(2.1 |
) |
Foreign currency (gains) losses
|
|
|
2.1 |
|
|
|
(0.7 |
) |
|
|
(0.2 |
) |
Legal settlement
|
|
|
(4.0 |
) |
|
|
|
|
|
|
|
|
Other, net
|
|
|
2.0 |
|
|
|
(0.7 |
) |
|
|
(1.1 |
) |
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
(7.5 |
) |
|
$ |
(10.2 |
) |
|
$ |
(10.8 |
) |
|
|
|
|
|
|
|
|
|
|
NOTE 19. DISCONTINUED OPERATIONS
On September 30, 2004, the Company consummated the sale of
the intangibles comprising its U.S. professional growing
media business for $6.0 million. A gain of
$4.1 million was recognized after associated goodwill in
the amount of $1.9 million was written off. As a result of
the sale, the Company shut down a manufacturing facility and
severed the associates employed in the business. In accordance
with Statement of Financial Accounting Standards No. 144,
Accounting for the Impairment or Disposal Of Long-Lived
Assets, these transactions have been accounted for as the
disposal of a component of the Company. The gain on the sale of
the intangibles and the results of operations of the component
are
88
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
reported as discontinued operations in the accompanying
consolidated Statements of Operations. The detail comprising the
discontinued operations is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Net sales
|
|
$ |
|
|
|
$ |
17.7 |
|
|
$ |
22.4 |
|
Cost of sales
|
|
|
|
|
|
|
(18.9 |
) |
|
|
(20.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
(1.2 |
) |
|
|
1.9 |
|
Selling, general and administrative
|
|
|
0.3 |
|
|
|
(1.1 |
) |
|
|
(1.0 |
) |
Gain on sale
|
|
|
|
|
|
|
4.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations
before income taxes
|
|
|
0.3 |
|
|
|
1.8 |
|
|
|
0.9 |
|
Income taxes
|
|
|
(0.1 |
) |
|
|
(1.4 |
) |
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net income from discontinued
operations
|
|
$ |
0.2 |
|
|
$ |
0.4 |
|
|
$ |
0.6 |
|
|
|
|
|
|
|
|
|
|
|
NOTE 20. VARIABLE INTEREST ENTITIES
In January 2003, the Financial Accounting Standards Board
(FASB) issued FASB Interpretation 46, Consolidation
of Variable Interest Entities, an Interpretation of ARB
No. 51 (FIN 46). In December 2003, the FASB
modified FIN 46 to make certain technical corrections and
address certain implementation issues that had arisen.
FIN 46 provides a new framework for identifying variable
interest entities (VIEs) and determining when a company should
include the assets, liabilities, noncontrolling interests, and
results of operations of a VIE in its consolidated financial
statements.
In general, a VIE is a corporation, partnership, limited
liability company, trust, or any other legal structure used to
conduct activities or hold assets that either (1) has an
insufficient amount of equity to carry out its principal
activities without additional subordinated financial support,
(2) has a group of equity owners that are unable to make
significant decisions about its activities, or (3) has a
group of equity owners that do not have the obligation to absorb
losses or the right to receive returns generated by its
operations.
FIN 46 requires a VIE to be consolidated if a party with an
ownership, contractual or other financial interest in the VIE (a
variable interest holder) is obligated to absorb a majority of
the risk of loss from the VIEs activities, is entitled to
receive a majority of the VIEs residual returns (if no
party absorbs a majority of the VIEs losses), or both. A
variable interest holder that consolidates the VIE is called the
primary beneficiary. Upon consolidation, the primary beneficiary
generally must initially record all of the VIEs assets,
liabilities and noncontrolling interests at fair value and
subsequently account for the VIE as if it were consolidated
based on majority voting interest. FIN 46 also requires
disclosures about VIEs that the variable interest holder is not
required to consolidate but in which it has a significant
variable interest.
The Companys Scotts LawnService® business
sells new franchise territories, primarily in small to mid-size
markets, under arrangements where approximately one-third of the
franchise fee is paid in cash with the balance due under a
promissory note. The Company believes that it may be the primary
beneficiary for certain of its franchisees initially, but ceases
to be the primary beneficiary as the franchisees develop their
businesses and the promissory notes are repaid. At
September 30, 2005, the Company had approximately
$2.1 million in notes receivable from such franchisees. The
effect of consolidating the entities where the Company may be
the primary beneficiary for a limited period of time is not
material to either the Consolidated Statements of Operations or
the Consolidated Balance Sheets.
|
|
NOTE 21. |
SEGMENT INFORMATION |
The Company is divided into the following segments
North America, Scotts LawnService®,
International, and Other/ Corporate. The North America segment
primarily consists of the Lawns, Gardens,
Ortho®, Canada and North American Professional
business groups as well as the North American portion of the
Roundup® commission. This division of reportable
segments is consistent with how the segments
89
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
report to and are managed by senior management of the Company.
Prior year amounts have been reclassified to conform with
certain modifications to the Companys reporting structure
in fiscal 2005.
The North America segment manufactures, markets and sells dry,
granular slow-release lawn fertilizers, combination lawn
fertilizer and control products, grass seed, spreaders,
water-soluble, liquid and continuous-release garden and indoor
plant foods, plant care products, potting, garden and lawn
soils, pottery, mulches and other growing media products,
pesticide products and a full line of horticulture products.
Products are marketed to mass merchandisers, home improvement
centers, large hardware chains, warehouse clubs, distributors,
nurseries, gardens centers and specialty crop growers in the
United States, Canada, Latin America, South America, Australia,
and Asia Pacific.
The Scotts LawnService® segment provides lawn
fertilization, disease and insect control and other related
services such as core aeration, tree and shrub fertilization and
interior barrier pest control service primarily to residential
consumers through company-owned branches and franchises. In most
company-operated locations, Scotts LawnService®
also offers tree and shrub fertilization, disease and insect
control treatments and, in our larger branches, an exterior
barrier pest control service.
The International segment provides products similar to those
described above for the North America segment to consumers
primarily in Europe. The Other/ Corporate segment consists of
the recently-acquired Smith & Hawken®
business and corporate general and administrative expenses.
The following table (dollars in millions) presents segment
financial information in accordance with SFAS No. 131,
Disclosures about Segments of an Enterprise and Related
Information. Pursuant to SFAS No. 131, the
presentation of the segment financial information is consistent
with the basis used by management (i.e., certain costs not
allocated to business segments for internal management reporting
purposes are not allocated for purposes of this presentation).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$ |
1,668.1 |
|
|
$ |
1,569.0 |
|
|
$ |
1,461.0 |
|
|
Scotts LawnService®
|
|
|
159.8 |
|
|
|
135.2 |
|
|
|
110.4 |
|
|
International
|
|
|
430.3 |
|
|
|
405.6 |
|
|
|
373.5 |
|
|
Corporate & Other
|
|
|
159.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
2,417.8 |
|
|
|
2,109.8 |
|
|
|
1,944.9 |
|
|
Roundup® deferred
contribution charge
|
|
|
(45.7 |
) |
|
|
|
|
|
|
|
|
|
Roundup®
amortization
|
|
|
(2.8 |
) |
|
|
(3.3 |
) |
|
|
(3.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,369.3 |
|
|
$ |
2,106.5 |
|
|
$ |
1,941.6 |
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$ |
343.9 |
|
|
$ |
306.1 |
|
|
$ |
282.3 |
|
|
Scotts LawnService®
|
|
|
13.1 |
|
|
|
9.4 |
|
|
|
6.0 |
|
|
International
|
|
|
34.3 |
|
|
|
29.3 |
|
|
|
29.4 |
|
|
Corporate & Other
|
|
|
(94.2 |
) |
|
|
(70.6 |
) |
|
|
(57.1 |
) |
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
297.1 |
|
|
|
274.2 |
|
|
|
260.6 |
|
|
Roundup® deferred
contribution charge
|
|
|
(45.7 |
) |
|
|
|
|
|
|
|
|
|
Roundup®
amortization
|
|
|
(2.8 |
) |
|
|
(3.3 |
) |
|
|
(3.3 |
) |
|
Amortization
|
|
|
(14.8 |
) |
|
|
(8.3 |
) |
|
|
(8.6 |
) |
|
Impairment of intangibles
|
|
|
(23.4 |
) |
|
|
|
|
|
|
|
|
|
Restructuring and other charges
|
|
|
(9.5 |
) |
|
|
(9.8 |
) |
|
|
(17.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
200.9 |
|
|
$ |
252.8 |
|
|
$ |
231.6 |
|
|
|
|
|
|
|
|
|
|
|
90
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
2004 | |
|
2003 | |
| |
Depreciation & amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$ |
30.9 |
|
|
$ |
24.9 |
|
|
$ |
26.2 |
|
|
Scotts LawnService®
|
|
|
3.9 |
|
|
|
3.9 |
|
|
|
3.5 |
|
|
International
|
|
|
11.5 |
|
|
|
12.6 |
|
|
|
8.1 |
|
|
Corporate & Other
|
|
|
20.9 |
|
|
|
16.3 |
|
|
|
14.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
67.2 |
|
|
$ |
57.7 |
|
|
$ |
52.2 |
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$ |
22.6 |
|
|
$ |
21.4 |
|
|
$ |
24.7 |
|
|
Scotts LawnService®
|
|
|
2.1 |
|
|
|
1.5 |
|
|
|
0.8 |
|
|
International
|
|
|
3.5 |
|
|
|
9.2 |
|
|
|
13.3 |
|
|
Corporate & Other
|
|
|
12.2 |
|
|
|
3.0 |
|
|
|
13.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
40.4 |
|
|
$ |
35.1 |
|
|
$ |
51.8 |
|
|
|
|
|
|
|
|
|
|
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$ |
704.7 |
|
|
$ |
702.6 |
|
|
|
|
|
|
Scotts LawnService®
|
|
|
116.8 |
|
|
|
113.0 |
|
|
|
|
|
|
International
|
|
|
262.4 |
|
|
|
301.8 |
|
|
|
|
|
|
Corporate & Other
|
|
|
125.5 |
|
|
|
59.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,209.4 |
|
|
$ |
1,176.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$ |
1,219.3 |
|
|
$ |
1,269.0 |
|
|
|
|
|
|
Scotts LawnService®
|
|
|
146.7 |
|
|
|
134.5 |
|
|
|
|
|
|
International
|
|
|
463.1 |
|
|
|
509.0 |
|
|
|
|
|
|
Corporate & Other
|
|
|
189.8 |
|
|
|
135.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,018.9 |
|
|
$ |
2,047.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nm Not meaningful
Segment operating income (loss) represents earnings before
amortization of intangible assets, interest and taxes, since
this is the measure of profitability used by management.
Accordingly, the Corporate & Other operating loss for the
fiscal years ended September 30, 2005, 2004 and 2003
includes unallocated corporate general and administrative
expenses and certain other income/expense not allocated to the
business segments.
Long-lived assets reported for the Companys operating
segments include goodwill and intangible assets as well as
property, plant and equipment within each segment.
Total assets reported for the Companys operating segments
include the intangible assets for the acquired businesses within
those segments. Corporate & Other assets primarily include
deferred financing and debt issuance costs, corporate intangible
assets as well as deferred tax assets and Smith &
Hawken® assets.
91
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 22. |
QUARTERLY CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED) |
The following is a summary of the unaudited quarterly results of
operations for fiscal 2005 and fiscal 2004 (in millions, except
per share data).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First | |
|
Second | |
|
Third | |
|
Fourth | |
|
|
|
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
Full Year | |
| |
FISCAL 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$ |
246.5 |
|
|
$ |
813.4 |
|
|
$ |
901.2 |
|
|
$ |
408.2 |
|
|
$ |
2,369.3 |
|
Gross profit
|
|
|
61.1 |
|
|
|
327.6 |
|
|
|
333.8 |
|
|
|
137.9 |
|
|
|
860.4 |
|
Income (loss) from continuing
operations
|
|
|
(62.5 |
) |
|
|
83.3 |
|
|
|
88.1 |
|
|
|
(8.4 |
) |
|
|
100.4 |
|
Income from discontinued operations
|
|
|
(0.2 |
) |
|
|
(0.1 |
) |
|
|
0.4 |
|
|
|
|
|
|
|
0.2 |
|
Net income (loss)
|
|
|
(62.7 |
) |
|
|
83.2 |
|
|
|
88.5 |
|
|
|
(8.4 |
) |
|
|
100.6 |
|
Basic earnings (loss) per common
share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
$ |
(0.95 |
) |
|
$ |
1.25 |
|
|
$ |
1.32 |
|
|
$ |
(0.13 |
) |
|
$ |
1.51 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
(0.95 |
) |
|
$ |
1.25 |
|
|
$ |
1.33 |
|
|
$ |
(0.13 |
) |
|
$ |
1.51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares used in basic EPS
calculation
|
|
|
66.0 |
|
|
|
66.6 |
|
|
|
67.0 |
|
|
|
67.4 |
|
|
|
66.8 |
|
Diluted earnings (loss) per common
share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
|
(0.95 |
) |
|
|
1.22 |
|
|
|
1.29 |
|
|
|
(0.13 |
) |
|
|
1.47 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
(0.95 |
) |
|
$ |
1.22 |
|
|
$ |
1.29 |
|
|
$ |
(0.13 |
) |
|
$ |
1.47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares and dilutive
potential common shares used in diluted EPS calculation
|
|
|
66.0 |
|
|
|
68.2 |
|
|
|
68.6 |
|
|
|
67.4 |
|
|
|
68.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First | |
|
Second | |
|
Third | |
|
Fourth | |
|
|
|
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
Quarter | |
|
Full Year | |
| |
FISCAL 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$ |
183.0 |
|
|
$ |
742.4 |
|
|
$ |
803.4 |
|
|
$ |
377.7 |
|
|
$ |
2,106.5 |
|
Gross profit
|
|
|
40.8 |
|
|
|
296.5 |
|
|
|
329.3 |
|
|
|
125.8 |
|
|
|
792.4 |
|
Income (loss) from continuing
operations
|
|
|
(70.6 |
) |
|
|
72.9 |
|
|
|
100.1 |
|
|
|
(1.9 |
) |
|
|
100.5 |
|
Income from discontinued operations
|
|
|
|
|
|
|
0.2 |
|
|
|
|
|
|
|
0.2 |
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(70.6 |
) |
|
|
73.1 |
|
|
|
100.1 |
|
|
|
(1.7 |
) |
|
|
100.9 |
|
Basic earnings (loss) per common
share Income (loss) from continuing operations
|
|
$ |
(1.11 |
) |
|
$ |
1.14 |
|
|
$ |
1.55 |
|
|
$ |
(0.03 |
) |
|
$ |
1.55 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
(1.11 |
) |
|
$ |
1.14 |
|
|
$ |
1.55 |
|
|
$ |
(0.03 |
) |
|
$ |
1.56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares used in basic EPS
calculation
|
|
|
64.0 |
|
|
|
64.4 |
|
|
|
65.0 |
|
|
|
65.2 |
|
|
|
64.7 |
|
Diluted earnings (loss) per common
share Income (loss) from continuing operations
|
|
|
(1.11 |
) |
|
|
1.11 |
|
|
|
1.51 |
|
|
|
(0.03 |
) |
|
|
1.51 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
(1.11 |
) |
|
$ |
1.11 |
|
|
$ |
1.51 |
|
|
$ |
(0.03 |
) |
|
$ |
1.52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares and dilutive
potential common shares used in diluted EPS calculation
|
|
|
64.0 |
|
|
|
66.0 |
|
|
|
66.6 |
|
|
|
65.2 |
|
|
|
66.6 |
|
92
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Common stock equivalents, such as stock awards, are excluded
from the diluted loss per share calculation in periods where
there is a net loss because their effect is anti-dilutive.
The Companys business is highly seasonal with over 70% of
net sales occurring in the second and third fiscal quarters
combined.
Unusual charges during fiscal 2005 consisted of the charge to
record the deferred contribution amounts under the
Roundup® agreement, impairment charges and
restructuring and other costs. These charges are reflected in
the quarterly financial information as follows: first quarter
restructuring and other charges of $0.2 million and
impairment of intangible assets of $22.0 million; second
quarter restructuring and other charges of $0.1 million;
third quarter deferred contribution charge under the
Roundup® marketing agreement of
$45.7 million; and fourth quarter restructuring and other
charges of $8.3 million and impairment of intangible assets
of $1.4 million. Also included in the fourth quarter is
$3.6 million relating to an immaterial correction of prior
periods amortization expense.
Unusual charges during fiscal 2004 consisted of restructuring
and other costs as follows: first quarter $1.0 million;
second quarter $0.4 million; third quarter
$2.6 million; and fourth quarter $5.8 million.
Net sales for the quarters ended January 1, 2005,
April 2, 2005 and July 2, 2005, have been revised from
the amounts previously reported by $9.6 million,
$11.0 million and $12.0 million, respectively, to
reflect certain activity associated with the
Roundup® marketing agreement with Monsanto on a
gross basis that was previously reported on a net basis. Cost of
sales was restated by an equal amount, with no effect on gross
profit or net income. The Company also has revised the
presentation of the fiscal 2004 quarterly amounts to conform to
the current year presentation ($8.7 million, $10.5 million,
$10.9 million and $10.0 million, respectively).
Net sales for the quarters ended January 1, 2005,
April 2, 2005, and July 2, 2005, have been revised
from the amounts previously reported by $(7.1) million,
$15.1 million and $(21.6) million, respectively, to
reflect the net commission (expense) associated with the
Roundup® marketing agreement with Monsanto. The Company
also has revised the presentation of the fiscal 2004 quarterly
amounts to conform to the current year presentation
($(7.1) million, $8.2 million, $23.4 million and
$4.0 million, respectively).
|
|
NOTE 23. |
FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND
NON-GUARANTORS |
The
65/8% Senior
Subordinated Notes are general obligations of The Scotts
Miracle-Gro Company and are guaranteed by all of the existing
wholly-owned, domestic subsidiaries and all future wholly-owned,
significant (as defined in Regulation S-X of the Securities
and Exchange Commission) domestic subsidiaries of The Scotts
Miracle-Gro Company. These subsidiary guarantors jointly and
severally guarantee the obligations of the Company under the
Notes. The guarantees represent full and unconditional general
obligations of each subsidiary that are subordinated in right of
payment to all existing and future senior debt of that
subsidiary but are senior in right of payment to any future
junior subordinated debt of that subsidiary.
The following information presents consolidating Statements of
Operations and Statements of Cash Flows for the three years
ended September 30, 2005, and Balance Sheets as of
September 30, 2005 and 2004.
93
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Statement of Operations
for the fiscal year ended September 30, 2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
Net sales
|
|
$ |
|
|
|
$ |
1,850.8 |
|
|
$ |
518.5 |
|
|
$ |
|
|
|
$ |
2,369.3 |
|
Cost of sales
|
|
|
|
|
|
|
1,172.9 |
|
|
|
336.3 |
|
|
|
|
|
|
|
1,509.2 |
|
Restructuring and other charges
|
|
|
|
|
|
|
(0.4 |
) |
|
|
0.1 |
|
|
|
|
|
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
678.3 |
|
|
|
182.1 |
|
|
|
|
|
|
|
860.4 |
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
|
|
|
|
494.1 |
|
|
|
139.7 |
|
|
|
|
|
|
|
633.8 |
|
|
Impairment, restructuring, and
other charges
|
|
|
|
|
|
|
8.0 |
|
|
|
25.2 |
|
|
|
|
|
|
|
33.2 |
|
Equity income in non-guarantors
|
|
|
(117.8 |
) |
|
|
|
|
|
|
|
|
|
|
117.8 |
|
|
|
|
|
Intercompany allocations
|
|
|
|
|
|
|
(23.5 |
) |
|
|
23.5 |
|
|
|
|
|
|
|
|
|
Other income, net
|
|
|
|
|
|
|
(9.6 |
) |
|
|
2.1 |
|
|
|
|
|
|
|
(7.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
117.8 |
|
|
|
209.3 |
|
|
|
(8.4 |
) |
|
|
(117.8 |
) |
|
|
200.9 |
|
Costs related to refinancings
|
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.3 |
|
Interest expense
|
|
|
15.9 |
|
|
|
16.5 |
|
|
|
9.1 |
|
|
|
|
|
|
|
41.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
100.6 |
|
|
|
192.8 |
|
|
|
(17.5 |
) |
|
|
(117.8 |
) |
|
|
158.1 |
|
Income taxes (benefit)
|
|
|
|
|
|
|
64.1 |
|
|
|
(6.4 |
) |
|
|
|
|
|
|
57.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
|
100.6 |
|
|
|
128.7 |
|
|
|
(11.1 |
) |
|
|
(117.8 |
) |
|
|
100.4 |
|
|
Income from discontinued operations
|
|
|
|
|
|
|
0.2 |
|
|
|
|
|
|
|
|
|
|
|
0.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
100.6 |
|
|
$ |
128.9 |
|
|
$ |
(11.1 |
) |
|
$ |
(117.8 |
) |
|
$ |
100.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
100.6 |
|
|
$ |
128.9 |
|
|
$ |
(11.1 |
) |
|
$ |
(117.8 |
) |
|
$ |
100.6 |
|
|
Adjustments to reconcile net income
(loss) to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of intangible assets
|
|
|
|
|
|
|
|
|
|
|
23.4 |
|
|
|
|
|
|
|
23.4 |
|
|
|
Costs related to refinancings
|
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.3 |
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
10.7 |
|
|
|
|
|
|
|
|
|
|
|
10.7 |
|
|
|
Depreciation
|
|
|
|
|
|
|
42.7 |
|
|
|
6.9 |
|
|
|
|
|
|
|
49.6 |
|
|
|
Amortization
|
|
|
|
|
|
|
9.8 |
|
|
|
7.8 |
|
|
|
|
|
|
|
17.6 |
|
|
|
Deferred taxes
|
|
|
|
|
|
|
(13.6 |
) |
|
|
|
|
|
|
|
|
|
|
(13.6 |
) |
|
|
Equity income in non-guarantors
|
|
|
(117.8 |
) |
|
|
|
|
|
|
|
|
|
|
117.8 |
|
|
|
|
|
|
|
Changes in assets and liabilities,
net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
|
|
|
|
(29.4 |
) |
|
|
(8.5 |
) |
|
|
|
|
|
|
(37.9 |
) |
|
|
|
Inventories
|
|
|
|
|
|
|
(21.0 |
) |
|
|
5.2 |
|
|
|
|
|
|
|
(15.8 |
) |
|
|
|
Prepaid and other current assets
|
|
|
|
|
|
|
(0.2 |
) |
|
|
8.3 |
|
|
|
|
|
|
|
8.1 |
|
|
|
|
Accounts payable
|
|
|
|
|
|
|
19.3 |
|
|
|
(9.0 |
) |
|
|
|
|
|
|
10.3 |
|
|
|
|
Accrued taxes and liabilities
|
|
|
|
|
|
|
28.1 |
|
|
|
(0.2 |
) |
|
|
|
|
|
|
27.9 |
|
|
|
|
Restructuring reserves
|
|
|
|
|
|
|
11.4 |
|
|
|
(1.1 |
) |
|
|
|
|
|
|
10.3 |
|
|
|
|
Other non-current items
|
|
|
|
|
|
|
5.9 |
|
|
|
0.7 |
|
|
|
|
|
|
|
6.6 |
|
|
|
|
Other, net
|
|
|
|
|
|
|
32.3 |
|
|
|
(4.7 |
) |
|
|
|
|
|
|
27.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
(15.9 |
) |
|
|
224.9 |
|
|
|
17.7 |
|
|
|
|
|
|
|
226.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption of available for sale
securities
|
|
|
|
|
|
|
57.2 |
|
|
|
|
|
|
|
|
|
|
|
57.2 |
|
|
Investment in property, plant and
equipment, net
|
|
|
|
|
|
|
(36.9 |
) |
|
|
(3.5 |
) |
|
|
|
|
|
|
(40.4 |
) |
|
Investments in acquired businesses,
net of cash acquired
|
|
|
|
|
|
|
(77.7 |
) |
|
|
|
|
|
|
|
|
|
|
(77.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
|
|
|
|
(57.4 |
) |
|
|
(3.5 |
) |
|
|
|
|
|
|
(60.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under revolving and bank
lines of credit
|
|
|
|
|
|
|
174.3 |
|
|
|
749.9 |
|
|
|
|
|
|
|
924.2 |
|
|
Repayments under revolving and bank
lines of credit
|
|
|
|
|
|
|
(169.4 |
) |
|
|
(567.0 |
) |
|
|
|
|
|
|
(736.4 |
) |
|
Repayment of term loans
|
|
|
(399.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(399.0 |
) |
|
Financing and issuance fees
|
|
|
(3.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3.6 |
) |
|
Dividends paid
|
|
|
(8.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.6 |
) |
|
Payments on seller notes
|
|
|
|
|
|
|
(6.9 |
) |
|
|
|
|
|
|
|
|
|
|
(6.9 |
) |
|
Proceeds from termination of
interest rate swaps
|
|
|
2.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.9 |
|
|
Cash received from exercise of
stock options
|
|
|
|
|
|
|
32.2 |
|
|
|
|
|
|
|
|
|
|
|
32.2 |
|
|
Intercompany financing
|
|
|
424.2 |
|
|
|
(238.0 |
) |
|
|
(186.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing
activities
|
|
|
15.9 |
|
|
|
(207.8 |
) |
|
|
(3.3 |
) |
|
|
|
|
|
|
(195.2 |
) |
Effect of exchange rate changes
|
|
|
|
|
|
|
|
|
|
|
(6.0 |
) |
|
|
|
|
|
|
(6.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
|
|
|
|
(41.2 |
) |
|
|
5.8 |
|
|
|
|
|
|
|
(35.4 |
) |
Cash and cash equivalents,
beginning of year
|
|
|
|
|
|
|
83.7 |
|
|
|
31.9 |
|
|
|
|
|
|
|
115.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
year
|
|
$ |
|
|
|
$ |
42.5 |
|
|
$ |
37.7 |
|
|
$ |
|
|
|
$ |
80.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Balance Sheet
As of September 30, 2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
ASSETS
|
Current Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
|
|
|
$ |
42.5 |
|
|
$ |
37.7 |
|
|
$ |
|
|
|
$ |
80.2 |
|
|
Accounts receivable, net
|
|
|
|
|
|
|
240.3 |
|
|
|
83.0 |
|
|
|
|
|
|
|
323.3 |
|
|
Inventories, net
|
|
|
|
|
|
|
232.5 |
|
|
|
92.4 |
|
|
|
|
|
|
|
324.9 |
|
|
Prepaid and other assets
|
|
|
|
|
|
|
40.1 |
|
|
|
19.3 |
|
|
|
|
|
|
|
59.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
|
|
|
|
555.4 |
|
|
|
232.4 |
|
|
|
|
|
|
|
787.8 |
|
Property, plant and equipment, net
|
|
|
|
|
|
|
294.7 |
|
|
|
42.3 |
|
|
|
|
|
|
|
337.0 |
|
Goodwill
|
|
|
|
|
|
|
314.9 |
|
|
|
118.0 |
|
|
|
|
|
|
|
432.9 |
|
Intangible assets, net
|
|
|
|
|
|
|
315.4 |
|
|
|
124.1 |
|
|
|
|
|
|
|
439.5 |
|
Other assets
|
|
|
10.6 |
|
|
|
10.8 |
|
|
|
0.3 |
|
|
|
|
|
|
|
21.7 |
|
Investment in affiliates
|
|
|
1,660.5 |
|
|
|
|
|
|
|
|
|
|
|
(1,660.5 |
) |
|
|
|
|
Intracompany assets
|
|
|
|
|
|
|
606.9 |
|
|
|
|
|
|
|
(606.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
1,671.1 |
|
|
$ |
2,098.1 |
|
|
$ |
517.1 |
|
|
$ |
(2,267.4 |
) |
|
$ |
2,018.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY
|
Current Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current portion of debt
|
|
$ |
|
|
|
$ |
4.1 |
|
|
$ |
7.0 |
|
|
$ |
|
|
|
$ |
11.1 |
|
|
Accounts payable
|
|
|
|
|
|
|
110.2 |
|
|
|
41.5 |
|
|
|
|
|
|
|
151.7 |
|
|
Accrued liabilities
|
|
|
|
|
|
|
222.5 |
|
|
|
92.2 |
|
|
|
|
|
|
|
314.7 |
|
|
Accrued taxes
|
|
|
|
|
|
|
5.2 |
|
|
|
3.5 |
|
|
|
|
|
|
|
8.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
|
|
|
|
342.0 |
|
|
|
144.2 |
|
|
|
|
|
|
|
486.2 |
|
Long-term debt
|
|
|
200.0 |
|
|
|
16.1 |
|
|
|
166.3 |
|
|
|
|
|
|
|
382.4 |
|
Other liabilities
|
|
|
|
|
|
|
102.2 |
|
|
|
21.9 |
|
|
|
|
|
|
|
124.1 |
|
Intracompany liabilities
|
|
|
444.9 |
|
|
|
|
|
|
|
162.0 |
|
|
|
(606.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
644.9 |
|
|
|
460.3 |
|
|
|
494.4 |
|
|
|
(606.9 |
) |
|
|
992.7 |
|
Shareholders equity
|
|
|
1,026.2 |
|
|
|
1,637.8 |
|
|
|
22.7 |
|
|
|
(1,660.5 |
) |
|
|
1,026.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders equity
|
|
$ |
1,671.1 |
|
|
$ |
2,098.1 |
|
|
$ |
517.1 |
|
|
$ |
(2,267.4 |
) |
|
$ |
2,018.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Statement of Operations
for the fiscal year ended September 30, 2004
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
Net sales
|
|
$ |
1,087.4 |
|
|
$ |
544.2 |
|
|
$ |
474.9 |
|
|
$ |
|
|
|
$ |
2,106.5 |
|
Cost of sales
|
|
|
684.0 |
|
|
|
328.6 |
|
|
|
300.9 |
|
|
|
|
|
|
|
1,313.5 |
|
Restructuring and other charges
|
|
|
0.2 |
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
403.2 |
|
|
|
215.6 |
|
|
|
173.6 |
|
|
|
|
|
|
|
792.4 |
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
345.6 |
|
|
|
53.6 |
|
|
|
141.5 |
|
|
|
|
|
|
|
540.7 |
|
|
Impairment, restructuring and other
charges
|
|
|
4.1 |
|
|
|
0.2 |
|
|
|
4.8 |
|
|
|
|
|
|
|
9.1 |
|
Equity income in non-guarantors
|
|
|
(107.2 |
) |
|
|
|
|
|
|
|
|
|
|
107.2 |
|
|
|
|
|
Intercompany allocations
|
|
|
(27.7 |
) |
|
|
6.7 |
|
|
|
21.0 |
|
|
|
|
|
|
|
|
|
Other income, net
|
|
|
(1.9 |
) |
|
|
(4.5 |
) |
|
|
(3.8 |
) |
|
|
|
|
|
|
(10.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
190.3 |
|
|
|
159.6 |
|
|
|
10.1 |
|
|
|
(107.2 |
) |
|
|
252.8 |
|
Costs related to refinancings
|
|
|
45.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45.5 |
|
Interest (income) expense
|
|
|
52.1 |
|
|
|
(13.1 |
) |
|
|
9.8 |
|
|
|
|
|
|
|
48.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
92.7 |
|
|
|
172.7 |
|
|
|
0.3 |
|
|
|
(107.2 |
) |
|
|
158.5 |
|
Income taxes (benefit)
|
|
|
(8.2 |
) |
|
|
66.1 |
|
|
|
0.1 |
|
|
|
|
|
|
|
58.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
100.9 |
|
|
|
106.6 |
|
|
|
0.2 |
|
|
|
(107.2 |
) |
|
|
100.5 |
|
Income from discontinued operations
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
100.9 |
|
|
$ |
107.0 |
|
|
$ |
0.2 |
|
|
$ |
(107.2 |
) |
|
$ |
100.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2004
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
100.9 |
|
|
$ |
107.0 |
|
|
$ |
0.2 |
|
|
$ |
(107.2 |
) |
|
$ |
100.9 |
|
|
Adjustments to reconcile net income
to net cash provided by (used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to refinancings
|
|
|
45.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45.5 |
|
|
|
Stock-based compensation expense
|
|
|
7.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.8 |
|
|
|
Depreciation
|
|
|
26.4 |
|
|
|
11.3 |
|
|
|
8.4 |
|
|
|
|
|
|
|
46.1 |
|
|
|
Amortization
|
|
|
0.4 |
|
|
|
7.0 |
|
|
|
4.2 |
|
|
|
|
|
|
|
11.6 |
|
|
|
Deferred taxes
|
|
|
17.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.6 |
|
|
|
Equity income in non-guarantors
|
|
|
(107.2 |
) |
|
|
|
|
|
|
|
|
|
|
107.2 |
|
|
|
|
|
|
|
Changes in assets and liabilities,
net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
14.6 |
|
|
|
(20.2 |
) |
|
|
3.7 |
|
|
|
|
|
|
|
(1.9 |
) |
|
|
|
Inventories
|
|
|
10.9 |
|
|
|
(7.2 |
) |
|
|
(17.7 |
) |
|
|
|
|
|
|
(14.0 |
) |
|
|
|
Prepaid and other current assets
|
|
|
(3.3 |
) |
|
|
(2.2 |
) |
|
|
(11.4 |
) |
|
|
|
|
|
|
(16.9 |
) |
|
|
|
Accounts payable
|
|
|
(8.4 |
) |
|
|
(10.7 |
) |
|
|
0.4 |
|
|
|
|
|
|
|
(18.7 |
) |
|
|
|
Accrued taxes and liabilities
|
|
|
25.2 |
|
|
|
2.8 |
|
|
|
1.5 |
|
|
|
|
|
|
|
29.5 |
|
|
|
|
Restructuring reserves
|
|
|
0.6 |
|
|
|
(0.5 |
) |
|
|
0.7 |
|
|
|
|
|
|
|
0.8 |
|
|
|
|
Other non-current items
|
|
|
(9.1 |
) |
|
|
1.4 |
|
|
|
1.9 |
|
|
|
|
|
|
|
(5.8 |
) |
|
|
|
Other, net
|
|
|
6.6 |
|
|
|
3.2 |
|
|
|
1.9 |
|
|
|
|
|
|
|
11.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
operating activities
|
|
|
128.5 |
|
|
|
91.9 |
|
|
|
(6.2 |
) |
|
|
|
|
|
|
214.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in available for sale
securities
|
|
|
(121.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(121.4 |
) |
|
Redemption of available for sale
securities
|
|
|
64.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64.2 |
|
|
Payments on seller notes
|
|
|
(2.0 |
) |
|
|
(10.3 |
) |
|
|
|
|
|
|
|
|
|
|
(12.3 |
) |
|
Investment in property, plant and
equipment, net
|
|
|
(10.7 |
) |
|
|
(15.2 |
) |
|
|
(9.2 |
) |
|
|
|
|
|
|
(35.1 |
) |
|
|
|
Investments in acquired businesses,
net of cash acquired
|
|
|
(0.3 |
) |
|
|
(4.7 |
) |
|
|
(3.2 |
) |
|
|
|
|
|
|
(8.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(70.2 |
) |
|
|
(30.2 |
) |
|
|
(12.4 |
) |
|
|
|
|
|
|
(112.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under revolving and bank
lines of credit
|
|
|
|
|
|
|
|
|
|
|
648.6 |
|
|
|
|
|
|
|
648.6 |
|
|
|
Repayments under revolving and bank
lines of credit
|
|
|
|
|
|
|
|
|
|
|
(646.6 |
) |
|
|
|
|
|
|
(646.6 |
) |
|
|
|
Repayment of term loans
|
|
|
(827.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(827.5 |
) |
|
Proceeds from issuance of term loans
|
|
|
900.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900.0 |
|
|
Redemption of
85/8% Senior
Subordinated Notes
|
|
|
(418.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(418.0 |
) |
|
Proceeds from issuance of
65/8% senior
subordinated notes
|
|
|
200.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200.0 |
|
|
Financing and issuance fees
|
|
|
(13.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13.0 |
) |
|
Cash received from exercise of
stock options
|
|
|
23.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.5 |
|
|
Intercompany financing
|
|
|
27.0 |
|
|
|
(61.6 |
) |
|
|
34.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
(108.0 |
) |
|
|
(61.6 |
) |
|
|
36.6 |
|
|
|
|
|
|
|
(133.0 |
) |
Effect of exchange rate changes
|
|
|
|
|
|
|
|
|
|
|
(8.7 |
) |
|
|
|
|
|
|
(8.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
(49.7 |
) |
|
|
0.1 |
|
|
|
9.3 |
|
|
|
|
|
|
|
(40.3 |
) |
Cash and cash equivalents,
beginning of year
|
|
|
132.1 |
|
|
|
1.2 |
|
|
|
22.6 |
|
|
|
|
|
|
|
155.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
year
|
|
$ |
82.4 |
|
|
$ |
1.3 |
|
|
$ |
31.9 |
|
|
$ |
|
|
|
$ |
115.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Balance Sheet
As of September 30, 2004
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
ASSETS
|
Current Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
82.4 |
|
|
$ |
1.3 |
|
|
$ |
31.9 |
|
|
$ |
|
|
|
$ |
115.6 |
|
|
Investments
|
|
|
57.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57.2 |
|
|
Accounts receivable, net
|
|
|
88.7 |
|
|
|
120.0 |
|
|
|
83.7 |
|
|
|
|
|
|
|
292.4 |
|
|
Inventories, net
|
|
|
132.8 |
|
|
|
57.5 |
|
|
|
99.8 |
|
|
|
|
|
|
|
290.1 |
|
|
Prepaid and other assets
|
|
|
42.7 |
|
|
|
5.7 |
|
|
|
26.6 |
|
|
|
|
|
|
|
75.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
403.8 |
|
|
|
184.5 |
|
|
|
242.0 |
|
|
|
|
|
|
|
830.3 |
|
Property, plant and equipment, net
|
|
|
191.2 |
|
|
|
92.8 |
|
|
|
44.0 |
|
|
|
|
|
|
|
328.0 |
|
Goodwill
|
|
|
18.8 |
|
|
|
244.6 |
|
|
|
154.5 |
|
|
|
|
|
|
|
417.9 |
|
Intangible assets, net
|
|
|
5.7 |
|
|
|
279.1 |
|
|
|
146.2 |
|
|
|
|
|
|
|
431.0 |
|
Other assets
|
|
|
46.0 |
|
|
|
|
|
|
|
(5.4 |
) |
|
|
|
|
|
|
40.6 |
|
Investment in affiliates
|
|
|
1,176.0 |
|
|
|
|
|
|
|
|
|
|
|
(1,176.0 |
) |
|
|
|
|
Intracompany assets
|
|
|
|
|
|
|
394.9 |
|
|
|
|
|
|
|
(394.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
1,841.5 |
|
|
$ |
1,195.9 |
|
|
$ |
581.3 |
|
|
$ |
(1,570.9 |
) |
|
$ |
2,047.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY
|
Current Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current portion of debt
|
|
$ |
5.0 |
|
|
$ |
6.2 |
|
|
$ |
10.9 |
|
|
$ |
|
|
|
$ |
22.1 |
|
|
Accounts payable
|
|
|
61.6 |
|
|
|
16.2 |
|
|
|
52.5 |
|
|
|
|
|
|
|
130.3 |
|
|
Accrued liabilities
|
|
|
133.3 |
|
|
|
29.8 |
|
|
|
98.8 |
|
|
|
|
|
|
|
261.9 |
|
|
Accrued taxes
|
|
|
18.3 |
|
|
|
0.8 |
|
|
|
0.2 |
|
|
|
|
|
|
|
19.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
218.2 |
|
|
|
53.0 |
|
|
|
162.4 |
|
|
|
|
|
|
|
433.6 |
|
Long-term debt
|
|
|
604.8 |
|
|
|
3.6 |
|
|
|
0.1 |
|
|
|
|
|
|
|
608.5 |
|
Other liabilities
|
|
|
113.9 |
|
|
|
1.5 |
|
|
|
15.7 |
|
|
|
|
|
|
|
131.1 |
|
Intracompany liabilities
|
|
|
30.0 |
|
|
|
|
|
|
|
364.9 |
|
|
|
(394.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
966.9 |
|
|
|
58.1 |
|
|
|
543.1 |
|
|
|
(394.9 |
) |
|
|
1,173.2 |
|
Shareholders equity
|
|
|
874.6 |
|
|
|
1,137.8 |
|
|
|
38.2 |
|
|
|
(1,176.0 |
) |
|
|
874.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders equity
|
|
$ |
1,841.5 |
|
|
$ |
1,195.9 |
|
|
$ |
581.3 |
|
|
$ |
(1,570.9 |
) |
|
$ |
2,047.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Statement of Operations
for the fiscal year ended September 30, 2003
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
Net sales
|
|
$ |
1,004.7 |
|
|
$ |
505.1 |
|
|
$ |
431.8 |
|
|
$ |
|
|
|
$ |
1,941.6 |
|
Cost of sales
|
|
|
639.7 |
|
|
|
310.4 |
|
|
|
280.7 |
|
|
|
|
|
|
|
1,230.8 |
|
Restructuring and other charges
|
|
|
5.2 |
|
|
|
|
|
|
|
3.9 |
|
|
|
|
|
|
|
9.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
359.8 |
|
|
|
194.7 |
|
|
|
147.2 |
|
|
|
|
|
|
|
701.7 |
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
300.7 |
|
|
|
51.4 |
|
|
|
120.8 |
|
|
|
|
|
|
|
472.9 |
|
|
Impairment, restructuring and other
charges
|
|
|
2.7 |
|
|
|
0.8 |
|
|
|
4.5 |
|
|
|
|
|
|
|
8.0 |
|
Equity income in non-guarantors
|
|
|
(97.0 |
) |
|
|
|
|
|
|
|
|
|
|
97.0 |
|
|
|
|
|
Intercompany allocations
|
|
|
(18.8 |
) |
|
|
6.0 |
|
|
|
12.8 |
|
|
|
|
|
|
|
|
|
Other income, net
|
|
|
(2.3 |
) |
|
|
(5.0 |
) |
|
|
(3.5 |
) |
|
|
|
|
|
|
(10.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
174.5 |
|
|
|
141.5 |
|
|
|
12.6 |
|
|
|
(97.0 |
) |
|
|
231.6 |
|
Interest (income) expense
|
|
|
70.6 |
|
|
|
(15.4 |
) |
|
|
14.0 |
|
|
|
|
|
|
|
69.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
103.9 |
|
|
|
156.9 |
|
|
|
(1.4 |
) |
|
|
(97.0 |
) |
|
|
162.4 |
|
Income taxes (benefit)
|
|
|
0.1 |
|
|
|
59.6 |
|
|
|
(0.5 |
) |
|
|
|
|
|
|
59.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
|
103.8 |
|
|
|
97.3 |
|
|
|
(0.9 |
) |
|
|
(97.0 |
) |
|
|
103.2 |
|
Income from discontinued
operations, net of tax
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
103.8 |
|
|
$ |
97.9 |
|
|
$ |
(0.9 |
) |
|
$ |
(97.0 |
) |
|
$ |
103.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Scotts Miracle-Gro Company
Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2003
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary | |
|
Non- | |
|
|
|
|
|
|
Parent | |
|
Guarantors | |
|
Guarantors | |
|
Eliminations | |
|
Consolidated | |
| |
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
103.8 |
|
|
$ |
97.9 |
|
|
$ |
(0.9 |
) |
|
$ |
(97.0 |
) |
|
$ |
103.8 |
|
|
Adjustments to reconcile net income
(loss) to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
4.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.8 |
|
|
|
Depreciation
|
|
|
25.3 |
|
|
|
10.7 |
|
|
|
4.3 |
|
|
|
|
|
|
|
40.3 |
|
|
|
Amortization
|
|
|
3.8 |
|
|
|
3.9 |
|
|
|
4.2 |
|
|
|
|
|
|
|
11.9 |
|
|
|
Deferred taxes
|
|
|
48.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48.3 |
|
|
|
Equity income in subsidiaries
|
|
|
(97.0 |
) |
|
|
|
|
|
|
|
|
|
|
97.0 |
|
|
|
|
|
|
|
Changes in assets and liabilities,
net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(6.0 |
) |
|
|
(12.7 |
) |
|
|
(8.6 |
) |
|
|
|
|
|
|
(27.3 |
) |
|
|
|
Inventories
|
|
|
2.1 |
|
|
|
(7.5 |
) |
|
|
0.1 |
|
|
|
|
|
|
|
(5.3 |
) |
|
|
|
Prepaid and other current assets
|
|
|
0.8 |
|
|
|
0.4 |
|
|
|
2.5 |
|
|
|
|
|
|
|
3.7 |
|
|
|
|
Accounts payable
|
|
|
10.1 |
|
|
|
10.0 |
|
|
|
6.2 |
|
|
|
|
|
|
|
26.3 |
|
|
|
|
Accrued taxes and liabilities
|
|
|
(0.5 |
) |
|
|
(2.2 |
) |
|
|
9.3 |
|
|
|
|
|
|
|
6.6 |
|
|
|
|
Restructuring reserves
|
|
|
(4.0 |
) |
|
|
|
|
|
|
(3.1 |
) |
|
|
|
|
|
|
(7.1 |
) |
|
|
|
Other non-current items
|
|
|
4.8 |
|
|
|
(0.7 |
) |
|
|
(3.8 |
) |
|
|
|
|
|
|
0.3 |
|
|
|
|
Other, net
|
|
|
12.4 |
|
|
|
|
|
|
|
(2.6 |
) |
|
|
|
|
|
|
9.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
108.7 |
|
|
|
99.8 |
|
|
|
7.6 |
|
|
|
|
|
|
|
216.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments on seller notes
|
|
|
(11.5 |
) |
|
|
(10.4 |
) |
|
|
(14.8 |
) |
|
|
|
|
|
|
(36.7 |
) |
|
Investment in property, plant and
equipment, net
|
|
|
(19.3 |
) |
|
|
(20.0 |
) |
|
|
(12.5 |
) |
|
|
|
|
|
|
(51.8 |
) |
|
Investments in acquired businesses,
net of cash acquired
|
|
|
(3.8 |
) |
|
|
(16.6 |
) |
|
|
|
|
|
|
|
|
|
|
(20.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(34.6 |
) |
|
|
(47.0 |
) |
|
|
(27.3 |
) |
|
|
|
|
|
|
(108.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under revolving and bank
lines of credit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments under revolving and bank
|
|
|
|
|
|
|
|
|
|
|
801.9 |
|
|
|
|
|
|
|
801.9 |
|
|
|
lines of credit
|
|
|
|
|
|
|
|
|
|
|
(819.5 |
) |
|
|
|
|
|
|
(819.5 |
) |
|
Repayments under term loans
|
|
|
(18.0 |
) |
|
|
|
|
|
|
(44.4 |
) |
|
|
|
|
|
|
(62.4 |
) |
|
Financing and issuance fees
|
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.4 |
) |
|
Cash received from exercise of
stock options
|
|
|
21.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.4 |
|
|
Intercompany financing
|
|
|
0.3 |
|
|
|
(53.6 |
) |
|
|
53.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing
activities
|
|
|
3.3 |
|
|
|
(53.6 |
) |
|
|
(8.7 |
) |
|
|
|
|
|
|
(59.0 |
) |
Effect of exchange rate changes
|
|
|
|
|
|
|
|
|
|
|
8.0 |
|
|
|
|
|
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
77.4 |
|
|
|
(0.8 |
) |
|
|
(20.4 |
) |
|
|
|
|
|
|
56.2 |
|
Cash and cash equivalents,
beginning of year
|
|
|
54.7 |
|
|
|
2.0 |
|
|
|
43.0 |
|
|
|
|
|
|
|
99.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
year
|
|
$ |
132.1 |
|
|
$ |
1.2 |
|
|
$ |
22.6 |
|
|
$ |
|
|
|
$ |
155.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of The Scotts
Miracle-Gro Company
Marysville, OH
We have audited the consolidated financial statements of The
Scotts Miracle-Gro Company and Subsidiaries (the
Company) as of September 30, 2005, and for the
year then ended, managements assessment of the
effectiveness of the Companys internal control over
financial reporting as of September 30, 2005, and the
effectiveness of the Companys internal control over
financial reporting as of September 30, 2005; and have
issued our reports thereon dated December 14, 2005; such
consolidated financial statements and reports are included
elsewhere in this Form 10-K. Our audit also included the
consolidated financial statement schedule of the Company for the
year ended September 30, 2005 listed in the Index to
Consolidated Financial Statements and Financial Statement
Schedule. This consolidated financial statement schedule is the
responsibility of the Companys management. Our
responsibility is to express an opinion based on our audit. In
our opinion, such consolidated financial statement schedule,
when considered in relation to the basic consolidated financial
statements taken as a whole, presents fairly, in all material
respects, the information set forth therein.
/s/ Deloitte & Touche LLP
Columbus, Ohio
December 14, 2005
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of The Scotts Company
Our audits of the consolidated financial statements referred to
in our report dated November 22, 2004 appearing in
Item 15(a)(1) of this Annual Report on Form 10-K, also
included an audit of the financial statement schedule listed in
Item 15(a)(2) of this Form 10-K. In our opinion, this
financial statement schedule presents fairly, in all material
respects, the information set forth therein when read in
conjunction with the related consolidated financial statements.
/s/ PricewaterhouseCoopers LLP
Columbus, Ohio
November 22, 2004
102
The Scotts Miracle-Gro Company
Schedule II Valuation and Qualifying
Accounts
for the fiscal year ended September 30, 2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column A |
|
Column B | |
|
Column C | |
|
Column D | |
|
Column E | |
|
Column F | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
Balance | |
|
|
|
Additions | |
|
Deductions | |
|
|
|
|
at | |
|
|
|
Charged | |
|
Credited | |
|
Balance | |
|
|
Beginning | |
|
Reserves | |
|
to | |
|
and | |
|
at End of | |
Classification |
|
of Period | |
|
Acquired | |
|
Expense | |
|
Write-Offs | |
|
Period | |
| |
Valuation and qualifying accounts
deducted from the assets to which they apply:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
$ |
21.3 |
|
|
$ |
|
|
|
$ |
11.4 |
|
|
$ |
(16.4 |
) |
|
$ |
16.3 |
|
Allowance for doubtful accounts
|
|
|
29.0 |
|
|
|
|
|
|
|
1.9 |
|
|
|
(19.5 |
) |
|
|
11.4 |
|
Income tax valuation allowance
|
|
|
|
|
|
|
2.4 |
|
|
|
|
|
|
|
|
|
|
|
2.4 |
|
Schedule II Valuation and Qualifying
Accounts
for the fiscal year ended September 30, 2004
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column A |
|
Column B | |
|
Column C |
|
Column D | |
|
Column E | |
|
Column F | |
|
|
| |
|
|
|
| |
|
| |
|
| |
|
|
Balance | |
|
|
|
Additions | |
|
Deductions | |
|
|
|
|
at | |
|
|
|
Charged | |
|
Credited | |
|
Balance | |
|
|
Beginning | |
|
Reserves |
|
to | |
|
and | |
|
at End of | |
Classification |
|
of Period | |
|
Acquired |
|
Expense | |
|
Write-Offs | |
|
Period | |
| |
Valuation and qualifying accounts
deducted from the assets to which they apply:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
$ |
22.0 |
|
|
$ |
|
|
|
$ |
11.8 |
|
|
$ |
(12.5 |
) |
|
$ |
21.3 |
|
Allowance for doubtful accounts
|
|
|
29.0 |
|
|
|
|
|
|
|
3.4 |
|
|
|
(3.4 |
) |
|
|
29.0 |
|
Income tax valuation allowance
|
|
|
1.0 |
|
|
|
|
|
|
|
|
|
|
|
(1.0 |
) |
|
|
|
|
Schedule II Valuation and Qualifying
Accounts
for the fiscal year ended September 30, 2003
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column A |
|
Column B | |
|
Column C |
|
Column D | |
|
Column E | |
|
Column F | |
|
|
| |
|
|
|
| |
|
| |
|
| |
|
|
Balance | |
|
|
|
Additions | |
|
Deductions | |
|
|
|
|
at | |
|
|
|
Charged | |
|
Credited | |
|
Balance | |
|
|
Beginning | |
|
Reserves |
|
to | |
|
and | |
|
at End of | |
Classification |
|
of Period | |
|
Acquired |
|
Expense | |
|
Write-Offs | |
|
Period | |
| |
Valuation and qualifying accounts
deducted from the assets to which they apply:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
$ |
25.9 |
|
|
$ |
|
|
|
$ |
5.1 |
|
|
$ |
(9.0 |
) |
|
$ |
22.0 |
|
Allowance for doubtful accounts
|
|
|
33.2 |
|
|
|
|
|
|
|
3.2 |
|
|
|
(7.4 |
) |
|
|
29.0 |
|
Income tax valuation allowance
|
|
|
|
|
|
|
|
|
|
|
1.0 |
|
|
|
|
|
|
|
1.0 |
|
103
The Scotts Miracle-Gro Company
Index to Exhibits
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
2(a)
|
|
Amended and Restated Agreement and
Plan of Merger, dated as of May 19, 1995, among
Sterns Miracle-Gro Products, Inc., Sterns Nurseries,
Inc., Miracle-Gro Lawn Products Inc., Miracle-Gro Products
Limited, Hagedorn Partnership, L.P., the general partners of
Hagedorn Partnership, L.P., Horace Hagedorn, Community Funds,
Inc., and John Kenlon, The Scotts Company and ZYX Corporation
|
|
Incorporated herein by reference to
the Current Report on Form 8-K dated May 31, 1995 and
filed June 2, 1995, of The Scotts Company, an Ohio
corporation (Scotts) (File No. 0-19768)
[Exhibit 2(b)]
|
|
2(b)
|
|
First Amendment to Amended and
Restated Agreement and Plan of Merger, made and entered into as
of October 1, 1999, among The Scotts Company, Scotts
Miracle-Gro Products, Inc. (as successor to ZYX Corporation and
Sterns Miracle-Gro Products, Inc.), Miracle-Gro Lawn
Products Inc., Miracle-Gro Products Limited, Hagedorn
Partnership, L.P., Community Funds, Inc., Horace Hagedorn and
John Kenlon, and James Hagedorn, Katherine Hagedorn Littlefield,
Paul Hagedorn, Peter Hagedorn, Robert Hagedorn and Susan Hagedorn
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated
October 4, 1999 and filed October 5, 1999 (File
No. 1-11593) [Exhibit 2]
|
|
2(c)
|
|
Agreement and Plan of Merger, dated
as of December 13, 2004, by and among The Scotts Company,
The Scotts Company LLC and The Scotts Miracle-Gro Company
|
|
Incorporated herein by reference to
the Current Report on Form 8-K of The Scotts Miracle-Gro
Company (the Registrant) dated February 1, 2005
and filed February 2, 2005 (File No. 1-13292))
[Exhibit 2.1]
|
|
3(a)
|
|
Initial Articles of Incorporation
of The Scotts Miracle-Gro Company as filed with Ohio Secretary
of State on November 22, 2004
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed March 24, 2005 (File No. 1-13292)
[Exhibit 3.1]
|
|
3(b)
|
|
Certificate of Amendment by
Shareholders to Articles of Incorporation of The Scotts
Miracle-Gro Company as filed with Ohio Secretary of State on
March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed March 24, 2005 (File No. 1-13292)
[Exhibit 3.2]
|
|
3(c)
|
|
Code of Regulations of The Scotts
Miracle-Gro Company
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed March 24, 2005 (File No. 1-13292)
[Exhibit 3.3]
|
|
4(a)
|
|
INDENTURE, dated as of
October 8, 2003, between The Scotts Company; the Guarantors
identified therein; and U.S. Bank National Association, as
Trustee
|
|
Incorporated herein by reference to
Scotts Annual Report on 10-K for the fiscal year ended
September 30, 2003 (File No. 1-13292)
[Exhibit 4(n)]
|
4(b)
|
|
Registration Rights Agreement,
dated October 8, 2003, among The Scotts Company; the
Guarantors identified therein; and Citigroup Global Markets
Inc., Banc of America Securities LLC and J.P. Morgan
Securities Inc. as representatives for the initial purchasers of
the 6.625% Senior Subordinated Notes due 2013 described
therein
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2003 (File No. 1-13292)
[Exhibit 4(o)]
|
104
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
4(c)
|
|
Supplemental Indenture, dated as of
October 15, 2004, between Smith & Hawken, Ltd., as
a guaranteeing subsidiary, and U.S. Bank National
Association, as Trustee
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed March 24, 2005 (File No. 1-13292)
[Exhibit 4.2]
|
|
4(d)
|
|
Second Supplemental Indenture,
dated as of March 18, 2005, among The Scotts Company; The
Scotts Miracle-Gro Company; The Scotts Company LLC; the other
subsidiaries identified as Guarantors therein; and
U.S. Bank National Association, as Trustee
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed March 24, 2005 (File No. 1-13292)
[Exhibit 4.3]
|
|
4(e)
|
|
Joinder Agreement, dated as of
March 18, 2005, among The Scotts Miracle-Gro Company, The
Scotts Company and JPMorgan Chase Bank, N.A. (formerly known as
JPMorgan Chase Bank), as Administrative Agent
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed March 24, 2005 (File No. 1-13292)
[Exhibit 4.1]
|
|
10(a)(1)
|
|
The O.M. Scott & Sons
Company Excess Benefit Plan, effective October 1, 1993
|
|
Incorporated herein by reference to
the Annual Report on Form 10-K for the fiscal year ended
September 30, 1993, of The Scotts Company, a Delaware
corporation (File No. 0-19768) [Exhibit 10(h)]
|
|
10(a)(2)
|
|
First Amendment to The O.M.
Scott & Sons Company Excess Benefit Plan, effective as
of January 1, 1998
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(a)(2)]
|
|
10(a)(3)
|
|
Second Amendment to The O.M.
Scott & Sons Company Excess Benefit Plan, effective as
of January 1, 1999
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(a)(3)]
|
|
10(a)(4)
|
|
Third Amendment to The O.M.
Scott & Sons Company Excess Benefit Plan, effective as
of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(CC)]
|
|
10(b)(1)
|
|
The Scotts Company 1992 Long Term
Incentive Plan (as amended through May 15, 2000)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2000 (File
No. 1-13292) [Exhibit 10(b)]
|
|
10(b)(2)
|
|
The Scotts Company 1992 Long Term
Incentive Plan (2002 Amendment)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended December 28, 2002 (File
No. 1-13292) [Exhibit 10(b)(i)]
|
|
10(b)(3)
|
|
Amendment to The Scotts Company
1992 Long Term Incentive Plan 2005 Amendment,
effective as of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(y)]
|
105
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(c)(1)
|
|
The Scotts Company Executive Annual
Incentive Plan
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(c)]
|
|
10(c)(2)
|
|
First Amendment to The Scotts
Company Executive Annual Incentive Plan, effective as of
March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(BB)]
|
|
10(d)(1)
|
|
The Scotts Company 1996 Stock
Option Plan (as amended through May 15, 2000)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended April 1, 2000 (File
No. 1-13292) [Exhibit 10(d)]
|
|
10(d)(2)
|
|
The Scotts Company 1996 Stock
Option Plan (2002 Amendment)
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended December 28, 2002 (File
No. 1-13292) [Exhibit 10(d)(i)]
|
|
10(d)(3)
|
|
Amendment to The Scotts Company
1996 Stock Option Plan 2005 Amendment, effective as
of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(z)]
|
|
10(e)
|
|
Specimen form of Stock Option
Agreement (as amended through October 23, 2001) for
Non-Qualified Stock Options granted to employees under The
Scotts Company 1996 Stock Option Plan, U.S. specimen
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(e)]
|
|
10(f)
|
|
Specimen form of Stock Option
Agreement (as amended through October 23, 2001) for
Non-Qualified Stock Options granted to employees under The
Scotts Company 1996 Stock Option Plan, French specimen
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(f)]
|
|
10(g)(1)
|
|
The Scotts Company Executive
Retirement Plan
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 1998 (File No. 1-11593)
[Exhibit 10(j)]
|
|
10(g)(2)
|
|
First Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 1999
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(g)(2)]
|
|
10(g)(3)
|
|
Second Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 2000
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2001 (File No. 1-13292)
[Exhibit 10(g)(3)]
|
106
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(g)(4)
|
|
Third Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 2003
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2003 (File No. 1-13292)
[Exhibit 10(g)(4)]
|
|
10(g)(5)
|
|
Fourth Amendment to The Scotts
Company Executive Retirement Plan, effective as of
January 1, 2004
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2004 (File No. 1-13292)
[Exhibit 10(g)(5)]
|
|
10(g)(6)
|
|
Fifth Amendment to The Scotts
Company Executive Retirement Plan, effective as of
March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(DD)]
|
|
10(h)
|
|
Employment Agreement, dated as of
May 19, 1995, between The Scotts Company and James Hagedorn
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 1995 (File No. 1-11593)
[Exhibit 10(p)]
|
|
10(i)(1)
|
|
Letter agreement, dated
June 8, 2000, The Scotts Company and Patrick J. Norton
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2000 (File No. 1-13292)
[Exhibit 10(q)]
|
|
10(i)(2)
|
|
Letter agreement, dated
November 5, 2002, pertaining to the terms of employment of
Mr. Norton through December 31, 2005, and superseding
certain provisions of the letter agreement, dated June 8,
2000, between The Scotts Company and Mr. Norton
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2002 (File No. 1-13292)
[Exhibit 10(q)]
|
|
10(i)(3)
|
|
Letter of Extension, dated
October 25, 2005, between The Scotts Miracle-Gro Company
and Patrick J. Norton
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed December 14, 2005 (File No. 1-13292)
[Exhibit 10.3]
|
|
10(j)(1)
|
|
Letter Agreement between The Scotts
Company LLC and Dr. Michael P. Kelty dated July 25,
2005
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed December 14, 2005 (File No. 1-13292)
[Exhibit 10.1]
|
|
10(j)(2)
|
|
Separation Agreement and Release of
All Claims between The Scotts Company LLC and Dr. Michael
P. Kelty dated July 25, 2005
|
|
Incorporated herein by reference to
the Registrants Current Report on Form 8-K dated and
filed December 14, 2005 (File No. 1-13292)
[Exhibit 10.2]
|
|
10(k)
|
|
Written description of employment
terms between the Registrant and David M. Aronowitz,
Christopher L. Nagel and Denise S. Stump
|
|
*
|
107
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(l)(1)
|
|
The Scotts Company 2003 Stock
Option and Incentive Equity Plan
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended December 28, 2002 (File
No. 1-13292) [Exhibit 10(w)]
|
|
10(l)(2)
|
|
First Amendment to The Scotts
Company 2003 Stock Option and Incentive Equity Plan, effective
as of March 18, 2005
|
|
Incorporated herein by reference to
the Registrants Quarterly Report on Form 10-Q for the
quarterly period ended April 2, 2005 (File
No. 1-13292) [Exhibit 10(AA)]
|
|
10(m)
|
|
Letter agreement, dated
April 23, 2003, between The Scotts Company and Robert F.
Bernstock
|
|
Incorporated herein by reference to
Scotts Quarterly Report on Form 10-Q for the
quarterly period ended June 28, 2003 (File
No. 1-13292) [Exhibit 10(x)]
|
|
10(n)
|
|
Employment Agreement and Covenant
Not to Compete, effective October 1, 2004, between The
Scotts Company and Robert F. Bernstock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.1]
|
|
10(o)
|
|
First Amendment to Employment
Agreement and Covenant Not to Compete, effective October 1,
2004, between The Scotts Company and Robert F. Bernstock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.2]
|
|
10(p)
|
|
Second Amendment to Employment
Agreement and Covenant Not to Compete, effective October 1,
2004, between The Scotts Company and Robert F. Bernstock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.3]
|
|
10(q)
|
|
The Scotts Company 2003 Stock
Option and Incentive Equity Plan Award Agreement for
Nondirectors, effective as of October 1, 2004, between The
Scotts Company and Robert F. Bernstock, in respect of grant of
25,000 shares of restricted stock
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.4]
|
|
10(r)
|
|
Amendment to The Scotts Company
2003 Stock Option and Incentive Equity Plan Award Agreement for
Nondirectors, effective as of October 1, 2004, between The
Scotts Company and Robert F. Bernstock, in respect of
June 2, 2003 award of freestanding stock appreciation rights
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.5]
|
|
10(s)
|
|
Amendment to The Scotts Company
2003 Stock Option and Incentive Equity Plan Award Agreement for
Nondirectors, effective as of October 1, 2004, between The
Scotts Company and Robert F. Bernstock, in respect of
November 19, 2003 award of freestanding stock appreciation
rights
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.6]
|
|
10(t)
|
|
Form of 1996 Stock Option Plan
Stock Option Agreement Non-Qualified Stock Option
|
|
Incorporated herein by reference to
Scotts Current Report on Form 8-K dated and filed
November 19, 2004 (File No. 1-13292)
[Exhibit 10.7]
|
|
10(u)
|
|
Form of 2003 Stock Option and
Incentive Equity Plan Award Agreement for Nondirectors
|
|
*
|
108
|
|
|
|
|
Exhibit |
|
|
|
|
No. |
|
Description |
|
Location |
|
10(v)
|
|
Form of 2003 Stock Option and
Incentive Equity Plan Award Agreement for Directors
|
|
*
|
|
10(w)
|
|
Exclusive Distributor
Agreement Horticulture, effective as of
June 22, 1998, between The Scotts Company and AgrEvo USA
Company
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 1998 (File No. 1-11593)
[Exhibit 10(v)]
|
|
10(x)
|
|
Amended and Restated Exclusive
Agency and Marketing Agreement, dated as of September 30,
1998, between Monsanto Company (now Pharmacia Corporation) and
the Registrant
|
|
*
|
|
14
|
|
Code of Business Conduct and Ethics
of the Registrant
|
|
Incorporated herein by reference to
Scotts Annual Report on Form 10-K for the fiscal year
ended September 30, 2003 (File No. 1-13292)
[Exhibit 14]
|
|
21
|
|
Subsidiaries of the Registrant
|
|
*
|
|
23(a)
|
|
Consent of Independent Registered
Public Accounting Firm Deloitte & Touche LLP
|
|
*
|
|
23(b)
|
|
Consent of Independent Registered
Public Accounting Firm PricewaterhouseCoopers LLP
|
|
*
|
|
31(a)
|
|
Rule 13a-14(a)/15d-14(a)
Certification (Principal Executive Officer)
|
|
*
|
|
31(b)
|
|
Rule 13a-14(a)/15d-14(a)
Certification (Principal Financial Officer)
|
|
*
|
|
32
|
|
Section 1350 Certification
(Principal Executive Officer and Principal Financial Officer)
|
|
*
|
109
EX-10(K)
Exhibit 10(k)
The Compensation and Organization Committee of the Board of Directors of
The Scotts Miracle-Gro Company (the Company) has approved certain employment, severance and change in
control terms applicable to David M. Aronowitz, Christopher L. Nagel and Denise S. Stump. Pursuant
to these terms, if the employment of any of these executive officers is terminated by the Company,
other than for cause, within 18 months following a change in control of the Company (as defined in
each of the 1996 Plan and the 2003 Plan), such executive officer will be entitled to receive a lump
sum payment within 90 days after termination equal to two times the executive officers base salary
plus two times the executive officers target incentive under the Executive Incentive Plan or any
successor incentive compensation plan, in each case as in effect at the date of termination. If the
employment of any of these executive officers is terminated by the Company prior to a change in
control, other than for cause, such executive officer will be entitled to receive two times the
executive officers base salary in effect at the date of termination in a lump sum within 90 days
after termination.
EX-10(U)
Exhibit 10(u)
THE SCOTTS MIRACLE-GRO COMPANY
2003 STOCK OPTION AND INCENTIVE EQUITY PLAN
AWARD AGREEMENT FOR NONDIRECTORS
The Scotts Miracle-Gro Company (Company) believes that its business interests are best served by
ensuring that you have an opportunity to share in the Companys business success. To this end, the
Company sponsors the 2003 Stock Option and Incentive Equity Plan (Plan) through which key
employees, like you, may acquire (or share in the appreciation of) common shares of the Company.
We cannot guarantee that the value of your Award (or the value of the common shares you acquire
through an Award) will increase. This is because the value of the Companys common shares is
affected by many factors. However, the Company believes that your efforts contribute to the value
of the Companys common shares and that the Plan (and the Awards made through the Plan) is an
appropriate means of sharing with you the value of your contribution to the Companys business
success.
This Agreement describes the type of Award that you have been granted and the conditions that must
be met before you may receive the value associated with your Award. To ensure you fully understand
these terms and conditions, you should:
|
|
|
Carefully read this Award Agreement and the attached copies of the Plan and
Prospectus; and |
|
|
|
|
Call us at ___if you have any questions about your Award. Or, you may
send a written inquiry to: |
[Insert Address]
Description of Your Incentive Stock Options
You have been awarded Incentive Stock Options (or ISOs) to purchase ___common shares of the
Company. You may purchase one of the Companys common shares for each ISO, but only if you pay
$___(Exercise Price) for each common share you purchase and meet the terms and conditions
described in this Agreement and in the Plan and the Prospectus.
Special (and favorable) income tax rules apply to ISOs, but only if certain conditions are met and
the ISOs are exercised before ___(Expiration Date). These conditions and other terms
affecting your ISOs are described in this Agreement and in the Plan and the Prospectus.
Limits on Exercising Your ISOs
Your ISOs will vest (and be exercisable) on ___.
This does not mean that you must exercise your ISOs on this date; this is merely the first date
that you may do so. However, your ISOs will expire unless they are exercised on or before the
Expiration Date.
There are some special situations in which your ISOs may vest earlier. These are described later
in this Agreement.
At any one time you may not exercise ISOs to buy fewer than 100 common shares of the Company (or,
if smaller, the number of your outstanding vested ISOs). Also, you may never exercise an ISO to
purchase a fractional common share of the Company; ISOs for fractional common shares will always be
redeemed for cash.
Exercising Your ISOs
After they vest, you may exercise your ISOs by completing a form. This form, and other procedures
that you must follow, are available from Merrill Lynch or by contacting us at the number (or
address) shown above.
There are three exercise methods available to you. You will decide on the method at the time of
exercise.
|
|
Cashless Exercise and Sell; You will settle in shares of Company
Stock. This will result in a cash payment (net of taxes) at
settlement. The number of shares required to settle costs and taxes
is equal to the stock price appreciation at the time of exercise. |
|
|
|
Combination Exercise (Exercise and sell enough shares to cover cost
and taxes); You have no out of pocket costs for doing the
transaction, and hold a smaller number of shares than exercised. |
|
|
|
Exercise and Hold; You come up with the monies to cover the exercise
cost and taxes, and you will receive the shares exercised on
settlement. |
If you do not elect one of these methods, we will apply the Cashless Exercise and Sell method
described above.
Description of Your Nonqualified Stock Options
You have been awarded Nonqualified Stock Options (or NSOs) to purchase ___common shares of
the Company. You may purchase one of the Companys common shares for each NSO, but only if you pay
$___(Exercise Price) for each common share purchased, you exercise the NSOs on or before
___(Expiration Date) and meet the terms and conditions described in this Agreement and in
the Plan and in the Prospectus.
Limits on Exercising Your NSOs
Your NSOs will vest (and be exercisable) on ___.
This does not mean that you must exercise your NSOs on this date; this is merely the first date
that you may do so. However, your NSOs will expire unless they are exercised on or before the
Expiration Date.
There also are some special situations in which your NSOs may vest earlier. These are described
later in this Agreement.
At any one time you may not exercise NSOs to buy fewer than 100 common shares of the Company (or,
if smaller, the number of your outstanding vested NSOs). Also, you may never exercise an NSO to
purchase a fractional common share of the Company; NSOs for fractional common shares will always be
redeemed for cash.
Exercising Your NSOs
After they vest, you may exercise your NSOs by completing a form. This form, and other procedures
that you must follow, are available from Merrill Lynch or by contacting us at the number (or
address) shown above.
There are three exercise methods available to you. You will decide on the method at the time of
exercise.
|
|
Cashless Exercise and Sell; You will settle in shares of Company
Stock. This will result in a cash payment (net of taxes) at
settlement. The number of shares required to settle costs and taxes
is equal to the stock price appreciation at the time of exercise. |
|
|
|
Combination Exercise (Exercise and sell enough shares to cover cost
and taxes); You have no out of pocket costs for doing the
transaction, and hold a smaller number of shares than exercised. |
|
|
|
Exercise and Hold; You come up with the monies to cover the exercise
cost and taxes, and you will receive the shares exercised on
settlement. |
If you do not elect one of these methods, we will apply the Cashless Exercise and Sell method
described above.
Description of Your Affiliated Stock Appreciation Rights
You have been awarded ___Affiliated Stock Appreciation Rights (or ASARs). ASARs are
associated with options that also were granted on the date of this Agreement.
ASARs will automatically be exercised when you exercise the affiliated options. When this happens,
the difference between the value of one of the Companys common shares on the date of this
Agreement and the date the ASAR is exercised will be applied against the price you must pay to
exercise the affiliated option.
However, if you do not exercise the affiliated option on or before ___(Expiration Date),
the ASARs will expire and may not be exercised at a later date.
Limits on Exercising Your ASARs
Your ASARs will vest on ___.
This does not mean that you must exercise the affiliated option on this date to realize the benefit
of your ASAR; this is merely the first date that you may do so. However, your ASARs (and the
affiliated options) will expire unless they are exercised on or before the Expiration Date.
There also are some special situations in which your ASARs may vest earlier. These are described
later in this Agreement.
Tax Treatment of Your ASARs
This brief discussion of the federal tax rules that affect your ASARs is provided as general
information (not as personal tax advice) and is based on the Companys understanding of federal tax
laws and regulations in effect as of the date of this Agreement.
You should consult with a tax or financial adviser to ensure you fully understand the tax
ramifications of your ASARs.
You are not required to pay ordinary income taxes on the value of an ASAR when it is awarded or
when it vests (there are no tax consequences if your ASARs expire without being exercised).
However, you are required to pay income tax (at ordinary income tax rates) when an ASAR is
exercised. This tax is calculated by applying ordinary income tax rates to the difference between
the value of a common share of the Company when the ASAR is exercised and the value of a common
share of the Company on the date of this Agreement.
Description of Your Freestanding Stock Appreciation Rights
You have been awarded ___Freestanding Stock Appreciation Rights (or FSARs). Each FSAR
enables you to receive the difference between the value of one of the Companys common shares when
the FSAR is exercised and the value of one of the Companys common shares on the date of this
Agreement. And you may realize this appreciation without making any cash investment. However, you
must exercise your FSARs no later than ___(Expiration Date). If you do not exercise
your FSARs on or before this date, they will expire and may not be exercised at a later date.
Limits on Exercising Your FSARs
Your FSARs will vest (and be exercisable) on ___.
This does not mean that you must exercise your FSARs on this date; this is merely the first date
that you may do so. However, your FSARs will expire unless they are exercised before the
Expiration Date.
There also are some special situations in which your FSARs may vest earlier. These are described
later in this Agreement.
Exercising Your FSARs
After they vest, you may exercise your FSARs by delivering a signed exercise notice to us at the
address shown above. Contact us for a copy of this notice.
Tax Treatment of Your FSARs
This brief discussion of the federal tax rules that affect your FSARs is provided as general
information (not as personal tax advice) and is based on the Companys understanding of federal tax
laws and regulations in effect as of the date of this Agreement.
You should consult with a tax or financial adviser to ensure you fully understand the tax
ramifications of your FSARs.
You are not required to pay ordinary income taxes on the value of a FSAR when it is awarded or when
it vests. However, you are required to pay income tax (at ordinary income tax rates) when you
exercise your FSAR (there are no tax consequences if your FSAR expires without being exercised).
If your FSAR is exercised and paid in common shares of the Company, your taxes are calculated by
applying ordinary income tax rates to the value (on the date your FSAR is exercised) of the common
shares of the Company you receive. Any subsequent appreciation in the value of these common shares
will be taxed at capital gains rates when the common shares are sold. If your FSAR is exercised
and paid in cash, your taxes are calculated by applying ordinary income tax rates to the amount of
cash you receive.
Description of Your Tandem Stock Appreciation Rights
You have been awarded ___Tandem Stock Appreciation Rights (or TSARs). TSARS are
associated with options and enable you to receive the difference between the value of one of the
Companys common shares when the TSAR is exercised and the value of one of the Companys common
shares on the date of this Agreement.
You may realize the appreciated value of your TSAR without making any cash investment but only if
you exercise your TSARs on or before ___(Expiration Date). If you do not exercise your
TSARs on or before this date, they will expire and may not be exercised at a later date.
You have a choice to make when your TSARs (and the associated options) vest:
|
|
|
You may exercise a TSAR without actually spending any money; or |
|
|
|
|
You may exercise the option associated with your TSAR, in which case you will
receive one common share of the Company for each option exercised, although you will be
required to actually pay the options Exercise Price. |
Also, if you decide to exercise a TSAR, the associated option will expire automatically and, if you
exercise the option, the associated TSAR will expire automatically.
Limits on Exercising Your TSARs
Your TSARs will vest (and be exercisable) on ___.
This does not mean that you must exercise your TSARs on this date; this is merely the first date
that you may do so. However, your TSARs will expire unless they are exercised before the
Expiration Date.
There also are some special situations in which your TSARS may vest earlier. These are described
later in this Agreement.
Exercising Your TSARs
After they vest, you may exercise your TSARs by delivering a signed exercise notice to us at the
address shown above. Contact us for a copy of this notice.
Tax Treatment of Your TSARs
This brief discussion of the federal tax rules that affect your TSARs is provided as general
information (not as personal tax advice) and is based on the Companys understanding of federal tax
laws and regulations in effect as of the date of this Agreement.
You should consult with a tax or financial adviser to ensure you fully understand the tax
ramifications of your TSARs.
You are not required to pay ordinary income taxes on the value of a TSAR when it is awarded or when
it vests. However, you are required to pay income tax (at ordinary income tax rates) when you
exercise your TSAR. There are no tax consequences if your TSAR expires without being exercised or
if your TSAR is cancelled because you exercised the related option, although there may be tax
consequences associated with the exercise of the related option. If your TSAR is exercised and
paid in common shares of the Company, your taxes are calculated by applying ordinary income tax
rates to the value (on the date your TSAR is exercised) of the Companys common shares you receive.
Any subsequent appreciation in the value of these common shares will be taxed at capital gains
rates when the common shares are sold. If your TSAR is exercised and paid in cash, your taxes are
calculated by applying ordinary income tax rates to the amount of cash you receive.
Description of Your Restricted Stock
You have been awarded ___shares of Restricted Stock which will mature into an equal number
of common shares of the Company if you are actively employed on ___(Expiration Date)
and have met all other Plan conditions.
Insert description of applicable restrictions.
Your Rights in Restricted Stock Before the Expiration Date
Until all restrictions and conditions have been met, your Restricted Stock certificates will be
held in escrow. Also, the Company will defer distribution of any dividends that are declared on
your Restricted Stock until the Expiration Date. These dividends will be distributed to you as of
the Expiration Date if all the restrictions and conditions are met or will be forfeited if these
restrictions and conditions have not been met.
However, you may vote your Restricted Stock before all the terms and conditions described in this
Agreement are met. This is the case even though your Restricted Stock will not be distributed to
you until the Expiration Date.
Tax Treatment of Your Restricted Stock
This brief discussion of the federal tax rules that affect your Restricted Stock is provided as
general information (not as personal tax advice) and is based on the Companys understanding of
federal tax laws and regulations in effect as of the date of this Agreement.
You should consult with a tax or financial adviser to ensure you fully understand the tax
ramifications of your Restricted Stock.
You are not required to pay income taxes on your Restricted Stock at this time. However, you will
be required to pay income taxes (at ordinary income tax rates) when (and if) applicable
restrictions and conditions are met. The amount of ordinary income you will recognize is the value
of your Restricted Stock when the terms and conditions described in this Agreement lapse. Any
subsequent appreciation of the common shares will be taxed at capital gains rates when you sell the
common shares. If applicable restrictions and conditions are not met before the Expiration Date,
your Restricted Stock will expire and no taxes will be due.
You may increase the portion of your Awards value that is subject to capital gains tax rates by
making a special election [known as a Code § 83(b) election] within 30 days of the date of this
Agreement. However, there are important tax and investment issues that you must consider before
making a Code § 83(b) election. These should be discussed with your personal tax and investment
adviser.
Description of Your Performance Shares
You have been awarded ___Performance Shares which will mature into an equal number of
common shares of the Company if the following performance goals are met before ___
(Measurement Date) and you meet all other Plan conditions:
Insert description of applicable performance goals these should be specific to the grantee and
relate to one or more of the criteria listed in the Plan.
Your Rights in Performance Shares Before the Measurement Date
Until all performance goals and applicable conditions have been met, your Performance Share
certificates will be held in escrow. Also, the Company will defer distribution of any dividends
that are declared on your Performance Shares until the Measurement Date. These dividends will be
distributed as of the Measurement Date if all the performance goals are met or will be forfeited if
the performance goals have not been met.
However, you may vote your Performance Shares before all the performance goals described in this
Agreement are met. This is the case even though your Performance Shares will not be distributed to
you until the Measurement Date.
Tax Treatment of Your Performance Shares
This brief discussion of the federal tax rules that affect your Performance Shares is provided as
general information (not as personal tax advice) and is based on the Companys understanding of
federal tax laws and regulations in effect as of the date of this Agreement.
You should consult with a tax or financial adviser to ensure you fully understand the tax
ramifications of your Performance Shares.
You are not required to pay income taxes on your Performance Shares at this time. However, you
will be required to pay income taxes (at ordinary income tax rates) when (and if) applicable
performance goals are certified as being met. The amount of ordinary income you will recognize is
the value of your Performance Shares when the performance goals described in this Agreement are
certified as being met. Any subsequent appreciation of the common shares will be taxed at capital
gains rates when you sell the common shares. If applicable performance goals are not met before
the Measurement Date, your Performance Shares will expire and no taxes will be due.
GENERAL TERMS AND CONDITIONS
These terms and conditions apply to all Awards issued under this Award Agreement. This is merely a
summary of these important terms and conditions; you are urged to read the entire Plan and
Prospectus (copies of which are attached), all of the terms of which are incorporated by reference
into this Award Agreement.
1.00 Loss of an Award. There are ways in which you may forfeit an Award.
[1] If You Terminate Employment . . .
Normally, your Awards will be cancelled on the date specified earlier in this Agreement unless all
conditions to your acquiring the common shares or other amounts subject to your Awards have been
satisfied before that date. However, these Awards may be cancelled earlier than that date if you
terminate employment (as defined in the Plan).
[a] If your employment is terminated by the Company or a Subsidiary for cause (as defined in
the Plan), the Awards will expire on the date your employment ends; or
[b] If you terminate employment because you [i] die or [ii] become disabled (as defined in
the Plan), the Awards will expire no later than 60 months after you terminate (12 months in
the case of any ISOs); or
[c] If you terminate after reaching either [i] age 55 and completing at least 10 years of
employment or [ii] age 62 regardless of your years of service, the Awards will expire no
later than 60 months after you terminate (three months in the case of ISOs); or
[d] If you terminate employment for any other reason, your Awards will expire no later than
90 days after you terminate.
Note, it is your responsibility to keep track of when your Awards expire.
[2] If You Engage in Conduct That is Harmful to the Company (or Subsidiary) . . .
You also will forfeit any outstanding Awards and must return to the Company all common shares and
other amounts you have received through the Plan if, without our consent, you do any of the
following within 180 days before and 730 days after terminating employment with the Company:
[a] You serve (or agree to serve) as an officer, director, consultant or employee of any
proprietorship, partnership or corporation or become the owner of a business or a member of
a partnership that competes with any portion of the Companys (or a Subsidiarys) business
with which you have been involved anytime within five years before termination of employment
or render any service (including without limitation, advertising or business consulting) to
entities that compete with any portion of the Companys (or a Subsidiarys) business with
which you have been involved anytime within five years before termination of employment;
[b] You refuse or fail to consult with, supply information to or otherwise cooperate with
the Company after having been requested to do so;
[c] You deliberately engage in any action that we conclude has caused substantial harm to
the interests of the Company or any Subsidiary;
[d] On your own behalf or on behalf of any other person, partnership, association,
corporation or other entity, solicit or in any manner attempt to influence or induce any
employee of the Company or a Subsidiary to leave the Companys or Subsidiarys employment or
use or disclose to any person, partnership, association, corporation or other entity any
information obtained while an employee of the Company or any Subsidiary concerning the names
and addresses of the Companys and any Subsidiarys employees;
[e] You disclose confidential and proprietary information relating to the Companys and its
Subsidiaries business affairs (Trade Secrets), including technical information, product
information and formulae, processes, business and marketing plans, strategies, customer
information and other information concerning the Companys and Subsidiaries products,
promotions, development, financing, expansion plans, business policies and practices,
salaries and benefits and other forms of information considered by the Company to be
proprietary and confidential and in the nature of Trade Secrets;
[f] You fail to return all property (other than personal property), including keys, notes,
memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks,
cards, surveys, maps, logs, machines, technical data, formulae or any other tangible
property or document and any and all copies, duplicates or reproductions that you have
produced or received or have otherwise been submitted to you in the course of your
employment with the Company or any Subsidiary; or
[g] You engaged in conduct that the Committee reasonably concludes would have given rise to
a termination for cause (as defined in the Plan) had it been discovered before you
terminated.
2.00 Buy Out/Cancellation Of Awards By Company. We may decide at any time to buy out your Awards.
This may happen without your consent and at any time. If we decide to buy out your Awards, we will
pay you the difference between the value of Awards that are exercisable (or vested) at that time
and that are being bought out and the Exercise Price associated with those Awards. However, no
payment will be made for any cancelled Awards that are not vested (and not exercisable) on the
cancellation date.
3.00 Amendment/Termination. We may amend or terminate the Plan at any time.
# # #
You must sign this Agreement; if you do not, your Award will be cancelled. By signing this
Agreement, you acknowledge that this Award is granted under and is subject to the terms and
conditions described in this Agreement and in the Plan.
|
|
|
|
|
|
|
OPTIONEE/GRANTEE |
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(date signed)
|
|
|
|
(date signed) |
|
|
|
|
|
|
|
|
|
EX-10(V)
Exhibit 10(v)
THE SCOTTS MIRACLE-GRO COMPANY
2003 STOCK OPTION AND INCENTIVE EQUITY PLAN
AWARD AGREEMENT FOR DIRECTORS
The Scotts Miracle-Gro Company (Company) believes that its business interests are best served by
ensuring that you have an opportunity to share in the Companys business success. To this end, the
Company sponsors the 2003 Stock Option and Incentive Equity Plan (Plan) through which its
directors may acquire (or share in the appreciation of) common shares of the Company.
We cannot guarantee that the value of your options (or the value of the common shares you acquire
through an option) will increase. This is because the value of the Companys common shares is
affected by many factors. However, the Company believes that your efforts contribute to the value
of the Companys common shares and that the Plan (and the options granted through the Plan) is an
appropriate means of sharing with you the value of your contribution to the Companys business
success.
This Agreement describes the type of options that you have been granted and the conditions that
must be met before you may receive the value associated with your options. To ensure you fully
understand these terms and conditions, you should:
|
|
|
Carefully read this Award Agreement and the attached copies of the Plan and
Prospectus; and |
|
|
|
|
Call us at (937) 644-0011 if you have any questions about your options. Or,
you may send a written inquiry to: |
The Scotts Miracle-Gro Company
Attn: Vice President Human Resources
14111 Scottslawn Road
Marysville, OH 43041
Description of Your Nonqualified Stock Options
You have been awarded Nonqualified Stock Options (or NSOs) to purchase ___common shares of the
Company. You may purchase one of the Companys common shares for each NSO, but only if you pay
$___(Exercise Price) for each common share purchased, you exercise the NSOs on or before
___(Expiration Date) and meet the terms and conditions described in this Agreement
and in the Plan and in the Prospectus.
Limits on Exercising Your NSOs
Your NSOs will vest (and be exercisable) on ___[6 months from grant date] [12 months
from grant date].
This does not mean that you must exercise your NSOs on this date; this is merely the first date
that you may do so. However, your NSOs will expire unless they are exercised on or before the
Expiration Date.
There are some special situations in which your NSOs may vest earlier. These are described later
in this Agreement.
At any one time you may not exercise NSOs to buy fewer than 100 common shares of the Company (or,
if smaller, the number of your outstanding vested NSOs). Also, you may never exercise an NSO to
purchase a fractional common share of the Company; NSOs for fractional common shares will always be
redeemed for cash.
Exercising Your NSOs
After they vest, you may exercise your NSOs by completing a form. This form, and other procedures
that you must follow, are available from Merrill Lynch or by contacting us at the number (or
address) shown above.
There are three exercise methods available to you. You will decide on the method at the time of
exercise.
|
|
Cashless Exercise and Sell; You will settle in shares of Company
Stock. This will result in a cash payment (net of taxes) at
settlement. The number of shares required to settle costs and taxes
is equal to the stock price appreciation at the time of exercise. |
|
|
|
Combination Exercise (Exercise and sell enough shares to cover cost
and taxes); You have no out of pocket costs for doing the
transaction, and hold a smaller number of shares than exercised. |
|
|
|
Exercise and Hold; You come up with the monies to cover the exercise
cost and taxes, and you will receive the shares exercised on
settlement. |
If you do not elect one of these methods, we will apply the Cashless Exercise and Sell method
described above.
-2-
GENERAL TERMS AND CONDITIONS
These terms and conditions apply to all awards issued under this Award Agreement. This is merely a
summary of these important terms and conditions; you are urged to read the entire Plan and
Prospectus (copies of which are attached), all of the terms of which are incorporated by reference
into this Award Agreement.
1.00 Loss of an NSO. There are ways in which you may forfeit your NSOs.
[1] If Your Directorship Terminates . . .
Normally, your NSOs will expire on the Expiration Date specified earlier in this Agreement.
However, these NSOs may expire earlier than their Expiration Date if your directorship terminates
(as defined in the Plan).
[a] If your directorship is terminated by the Company for cause (as defined in the Plan),
the options will expire on the date your directorship ends; or
[b] If your directorship terminates because you [i] die or [ii] become disabled (as defined
in the Plan), the NSOs will expire no later than 60 months after your directorship
terminates; or
[c] If your directorship terminates after you served one full term as a director, the NSOs
will expire no later than five years after your directorship terminates; or
[d] If your directorship terminates for any other reason, your NSOs will expire no later
than one year after your directorship terminates.
Note, it is your responsibility to keep track of when your NSOs expire.
[2] If You Engage in Conduct That is Harmful to the Company (or Subsidiary) . . .
You also will forfeit any outstanding NSOs and must return to the Company all common shares and
other amounts you have received through the Plan if, without our consent, you do any of the
following within 180 days before and 730 days after your directorship terminates:
[a] You serve (or agree to serve) as an officer, director, consultant or employee of any
proprietorship, partnership or corporation or become the owner of a business or a member of
a partnership that competes with any portion of the Companys (or a Subsidiarys) business
with which you have been involved anytime within five years before your directorship
terminates or render any service (including, without limitation, advertising or business
consulting) to entities that compete with any portion of the Companys (or a Subsidiarys)
business with which you have been involved anytime within five years before your
directorship terminates;
[b] You refuse or fail to consult with, supply information to or otherwise cooperate with
the Company after having been requested to do so;
-3-
[c] You deliberately engage in any action that we conclude has caused substantial harm to
the interests of the Company or any Subsidiary;
[d] On your own behalf or on behalf of any other person, partnership, association,
corporation or other entity, solicit or in any manner attempt to influence or induce any
employee of the Company or a Subsidiary to leave the Companys or Subsidiarys employment or
use or disclose to any person, partnership, association, corporation or other entity any
information obtained during your directorship concerning the names and addresses of the
Companys and any Subsidiarys employees;
[e] You disclose confidential and proprietary information relating to the Companys and its
Subsidiaries business affairs (Trade Secrets), including technical information, product
information and formulae, processes, business and marketing plans, strategies, customer
information and other information concerning the Companys and Subsidiaries products,
promotions, development, financing, expansion plans, business policies and practices,
salaries and benefits and other forms of information considered by the Company to be
proprietary and confidential and in the nature of Trade Secrets;
[f] You fail to return all property (other than personal property), including keys, notes,
memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks,
cards, surveys, maps, logs, machines, technical data, formulae or any other tangible
property or document and any and all copies, duplicates or reproductions that you have
produced or received or have otherwise been submitted to you in the course of your
directorship; or
[g] You engaged in conduct that we reasonably conclude would have given rise to a
termination of your directorship for cause (as defined in the Plan) had it been discovered
before your directorship terminated.
2.00 Buy Out/Cancellation Of NSOs By Company. We may decide at any time to buy out your NSOs.
This may happen without your consent and at any time. If we decide to buy out your NSOs, we will
pay you the difference between the fair market value of the common shares underlying the NSOs that
are exercisable (or vested) at that time and that are being bought out and the Exercise Price
associated with those NSOs. However, no payment will be made for any cancelled NSOs that are not
vested (and not exercisable) on the cancellation date.
3.00 Amendment/Termination. We may amend or terminate the Plan at any time.
# # #
-4-
You must sign this Agreement; if you do not, your NSOs will be cancelled. By signing this
Agreement, you acknowledge that these NSOs are granted under and are subject to the terms and
conditions described in this Agreement and in the Plan.
|
|
|
|
|
|
|
OPTIONEE/GRANTEE |
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(date signed)
|
|
|
|
(date signed) |
|
|
|
|
|
|
|
|
|
-5-
EX-10(X)
Exhibit 10(x)
AMENDED AND RESTATED
EXCLUSIVE AGENCY AND
MARKETING AGREEMENT
by and between
MONSANTO COMPANY
and
THE SCOTTS COMPANY
SEPTEMBER 30, 1998
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page |
|
ARTICLE 1- DEFINITIONS AND RULES OF CONSTRUCTION |
|
|
2 |
|
|
|
Section 1.1. |
|
Definitions |
|
|
2 |
|
|
|
Section 1.2. |
|
Rules of Construction and Interpretation |
|
|
10 |
|
ARTICLE 2 - EXCLUSIVE AGENCY AND DISTRIBUTORSHIP |
|
|
10 |
|
|
|
Section 2.1. |
|
Appointment of the Exclusive Agent |
|
|
10 |
|
|
|
Section 2.2. |
|
The Agents Obligations and Standards |
|
|
11 |
|
|
|
Section 2.3 |
|
Appointment of Sub-Agents and Sub-Distributors |
|
|
15 |
|
|
|
Section 2.4 |
|
Limitations on Agent |
|
|
15 |
|
ARTICLE 3 - ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS |
|
|
16 |
|
|
|
Section 3.1. |
|
Bookkeeping and Financial Reporting |
|
|
16 |
|
|
|
Section 3.2. |
|
Ordering, Invoicing and Cash Flow Cycle |
|
|
17 |
|
|
|
Section 3.3. |
|
Expenses and Allocation Rules |
|
|
18 |
|
|
|
Section 3.4. |
|
Resolution of Disputes Arising under Article 3 |
|
|
19 |
|
|
|
Section 3.5. |
|
Fixed Contribution to Expenses |
|
|
20 |
|
|
|
Section 3.6. |
|
Commission |
|
|
21 |
|
|
|
Section 3.7. |
|
Marketing Fee |
|
|
23 |
|
|
|
Section 3.8. |
|
Additional Commission |
|
|
23 |
|
ARTICLE 4 - ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE |
|
|
25 |
|
|
|
Section 4.1. |
|
Underlying principles for the Roundup L&G Business Management Structure |
|
|
25 |
|
|
|
Section 4.2. |
|
Steering Committee |
|
|
26 |
|
|
|
Section 4.3. |
|
Business Units |
|
|
27 |
|
i
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page |
|
|
|
Section 4.4. |
|
Global Support Team |
|
|
28 |
|
ARTICLE 5 - DUTIES AND OBLIGATIONS OF MONSANTO |
|
|
29 |
|
|
|
Section 5.1. |
|
Monsantos Obligations and Rights |
|
|
29 |
|
|
|
Section 5.2. |
|
Warranties |
|
|
30 |
|
ARTICLE 6 - REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES |
|
|
30 |
|
|
|
Section 6.1. |
|
Cooperation |
|
|
30 |
|
|
|
Section 6.2. |
|
Use of EDI |
|
|
30 |
|
|
|
Section 6.3. |
|
The Agents Systems and Reporting Obligation |
|
|
30 |
|
|
|
Section 6.4. |
|
Employee Incentives |
|
|
31 |
|
|
|
Section 6.5. |
|
Insurance |
|
|
31 |
|
|
|
Section 6.6. |
|
Liens |
|
|
31 |
|
|
|
Section 6.7. |
|
Promoting Safe Use-Practices |
|
|
32 |
|
|
|
Section 6.8. |
|
Monsanto Inspection Rights |
|
|
32 |
|
|
|
Section 6.9. |
|
Recalls |
|
|
32 |
|
|
|
Section 6.10. |
|
New Roundup Products |
|
|
32 |
|
|
|
Section 6.11. |
|
Confidentiality |
|
|
33 |
|
|
|
Section 6.12. |
|
Noncompetition |
|
|
33 |
|
|
|
Section 6.13. |
|
Industrial Property |
|
|
35 |
|
|
|
Section 6.14. |
|
Conflicts of Interest |
|
|
36 |
|
|
|
Section 6.15. |
|
Records Retention |
|
|
37 |
|
ARTICLE 7 - CENTRAL AGREEMENTS |
|
|
37 |
|
|
|
Section 7.1. |
|
Acknowledgment of Central Agreements |
|
|
37 |
|
|
|
Section 7.2. |
|
Notice of Termination |
|
|
37 |
|
|
|
Section 7.3. |
|
Conflict |
|
|
37 |
|
ii
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page |
|
|
|
Section 7.4. |
|
Action by Parties and Assignment of Rights |
|
|
37 |
|
ARTICLE 8 - REPRESENTATIONS, WARRANTIES, AND COVENANTS |
|
|
38 |
|
|
|
Section 8.1. |
|
The Agents Representations and Warranties |
|
|
38 |
|
|
|
Section 8.2. |
|
Monsantos Representations and Warranties |
|
|
39 |
|
ARTICLE 9 - INDEMNIFICATION |
|
|
39 |
|
|
|
Section 9.1. |
|
Indemnification and Claims Procedure |
|
|
39 |
|
ARTICLE 10 - TERMS, TERMINATION, AND FORCE MAJEURE |
|
|
41 |
|
|
|
Section 10.1. |
|
Terms |
|
|
41 |
|
|
|
Section 10.2. |
|
EU Initial Term and Renewal |
|
|
41 |
|
|
|
Section 10.3. |
|
Procedure to Renew |
|
|
41 |
|
|
|
Section 10.4. |
|
Termination by Monsanto |
|
|
41 |
|
|
|
Section 10.5. |
|
Termination by the Agent |
|
|
48 |
|
|
|
Section 10.6. |
|
Roundup Sale |
|
|
49 |
|
|
|
Section 10.7. |
|
Effect of Termination |
|
|
49 |
|
|
|
Section 10.8. |
|
Force Majeure |
|
|
50 |
|
|
|
Section 10.9. |
|
Special Termination Provisions |
|
|
50 |
|
ARTICLE 11 - MISCELLANEOUS |
|
|
52 |
|
|
|
Section 11.1. |
|
Relationship of the Parties |
|
|
52 |
|
|
|
Section 11.2. |
|
Interpretation in accordance with GAAP |
|
|
52 |
|
|
|
Section 11.3. |
|
Currency |
|
|
52 |
|
|
|
Section 11.4. |
|
Monsanto Obligations |
|
|
53 |
|
|
|
Section 11.5. |
|
Expenses |
|
|
53 |
|
|
|
Section 11.6. |
|
Entire Agreement |
|
|
53 |
|
|
|
Section 11.7. |
|
Modification and Waiver |
|
|
53 |
|
iii
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page |
|
|
|
Section 11.8. |
|
Assignment |
|
|
53 |
|
|
|
Section 11.9. |
|
Notices |
|
|
54 |
|
|
|
Section 11.10. |
|
Severability |
|
|
55 |
|
|
|
Section 11.11. |
|
Equal Opportunity |
|
|
55 |
|
|
|
Section 11.12. |
|
Governing Law |
|
|
55 |
|
|
|
Section 11.13. |
|
Public Announcements |
|
|
56 |
|
|
|
Section 11.14. |
|
Counterparts |
|
|
56 |
|
iv
LIST OF EXHIBITS
Exhibit A: Central Agreements
Exhibit B: Termination Notice Regarding Central Agreements
Exhibit C: Letter Agreement Regarding Plastid Transformation Technology and Associated Genes
Exhibit D: Permitted Products
LIST OF SCHEDULES
|
|
|
|
|
|
|
Schedule 1.1(a):
|
|
Included Markets |
|
|
Schedule 1.1(b):
|
|
Roundup Products |
|
|
Schedule 2.2(a)(ii):
|
|
Transition Services (to be provided) |
|
|
Schedule 2.2(a):
|
|
Annual Business Plan Format |
|
|
Schedule 3.1:
|
|
Services Outside North America (to be provided) |
|
|
Schedule 3.2(d):
|
|
Cash Flow Chart |
|
|
Schedule 3.3(c):
|
|
Income Statement Definitions and Allocation Methods |
|
|
Schedule 3.8:
|
|
Current Sales of 2.5 Gallon SKU into the Lawn & Garden Channels |
|
|
Schedule 4.1(a):
|
|
Management Structure |
|
|
Schedule 4.2(a):
|
|
Steering Committee |
|
|
Schedule 4.3(b):
|
|
Assigned Employees |
|
|
Schedule 4.4(a):
|
|
Global Support Team |
v
AMENDED AND RESTATED
EXCLUSIVE AGENCY AND
MARKETING AGREEMENT
THIS AMENDED AND RESTATED EXCLUSIVE AGENCY AND MARKETING AGREEMENT by and between Monsanto
Company, a Delaware corporation (Monsanto), and The Scotts Company, an Ohio corporation (the
Agent), shall be deemed effective as of September 30, 1998, and amended and restated as of
November 11, 1998, and shall supersede in its entirety the previous such agreement between the
parties hereto, dated as of September 30, 1998. Monsanto and the Agent are some times referred to
herein as the parties.
WITNESSETH:
WHEREAS, Monsanto is engaged in the research, development, and commercialization of certain
agricultural products;
WHEREAS, Monsanto has developed and sells Roundup Products (as defined below) and is the
exclusive owner of all rights, patents, licenses, and trademarks associated therewith, and
possesses the knowledge, know-how, technical information, and expertise regarding the process and
manufacture of Roundup Products;
WHEREAS, the Agent has certain expertise in the promotion, distribution, marketing, and sale
of home and garden products;
WHEREAS, except to the extent that Central (as defined below) remains a nonexclusive agent and
distributor of Roundup Products prior to the termination of the Central Agreements (as defined
below), Monsanto does not currently possess, nor desire to establish, a distribution system for
Roundup Products;
WHEREAS, the Agents distribution system is well-suited for the promotion, distribution,
marketing, and sale of Roundup Products;
WHEREAS, Monsanto desires that the Agent serve as Monsantos exclusive agent for the marketing
and distribution of Roundup Products, and the Agent desires to so serve, all on the terms set forth
in this Agreement; and
NOW, THEREFORE, in consideration of the foregoing, the terms and provisions contained herein,
and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:
ARTICLE 1 DEFINITIONS AND RULES OF CONSTRUCTION
Section 1.1. Definitions. As used herein, the following terms shall have the meanings
ascribed to them below:
Acquiror shall have the meaning as set forth in the definition of a Change of Significant
Ownership.
Affiliate of a person or entity shall mean: (i) any other person or entity directly, or
indirectly through one or more intermediaries, controlling, controlled by, or under common control
with such person or entity, (ii) any officer, director, partner, member, or direct or indirect
beneficial owner of any 10% or greater of the equity or voting interests of such person or entity,
or (iii) any other person or entity for which a person or entity described in clause (ii) acts in
such capacity.
Agent means The Scotts Company, an Ohio corporation.
Ag Market means professionals who purchase and use Roundup Ag Products for Ag, professional
and industrial uses.
Annual Business Plan shall have the meaning set forth in Section 2.2(a) hereof.
Approved Expense shall have the meaning set forth in Section 3.3(a) hereof.
Allocated means allocated pursuant to the Allocation Rules set forth in Schedule 3.3(c)
hereof.
Assigned Employees shall have the meaning set forth in Section 4.3(b) hereof.
Budget shall have the meaning set forth in Section 3.3(a) hereof.
Business Unit shall have the meaning set forth in Section 4.3(a).
Central means Central Garden & Pet Company, a Delaware corporation.
Central Agreements means collectively, that certain Master Agreement by and between The
Solaris Group (Solaris), a strategic business unit of Monsanto, and Central, dated as of July 21,
1995; that certain Exclusive Agency and Distributor Agreement by and between Solaris and Central,
dated as of July 21, 1995; that Compensation Agreement by and between Solaris and Central, dated as
of July 21, 1995; that Implementation and Transition Agreement by and between Solaris and Central,
dated as of July 21, 1995.
Change of Control means, with respect to a Person, (i) the acquisition after the date hereof
by any individual (or group of individuals acting in concert), corporation, company,
2
association, joint venture or other entity, of beneficial ownership of 50% or more of the
voting securities of such Person; or (ii) the consummation by such Person of a reorganization,
merger or consolidation, or exchange of shares or sale or other disposition of all or substantially
all of the assets of such Person, if immediately after giving effect to such transaction the
individuals or entities who beneficially own voting securities immediately prior to such
transaction beneficially own in the aggregate less than 50% of such voting securities immediately
following such transaction excluding the merger or similar transaction currently contemplated
between Monsanto and American Home Products; or (iii) the consummation by such Person of the sale
or other disposition of all or substantially all of the assets of such Person other than to an
Affiliate of such Person; or (iv) the consummation by such Person of a plan of complete liquidation
or dissolution of such Person.
Change of Significant Ownership means, with respect to a Person, (i) the acquisition (by
purchase, reorganization, merger, consolidation, exchange of shares, or otherwise), by any
individual (or group of individuals acting in concert), corporation, company, association, joint
venture, or other entity (collectively, the Acquiror), but excluding any member of the Hagedorn
family or their respectively controlled entities, of beneficial ownership of 25% or more of the
voting securities of such Person; and (ii) such Acquiror (A) currently engages (directly or
through its Affiliates) in the manufacture, sale, marketing, or distribution of any product
containing Glyphosate or any similar active ingredient, or (B) currently sells, markets, or
distributes (directly or through its Affiliates) any product(s) in the Lawn and Garden Channels for
Lawn and Garden Use, which such product(s), in Monsantos reasonable commercial opinion, compete in
a material manner with Roundup Products, or (C) may, in Monsantos reasonable commercial opinion,
materially detract from, or diminish, the Agents ability to fulfill its duties and obligations
with regard to the Roundup Business, or (D) competes in any material respect with Monsanto in
Monsantos Ag (including seed) or biotech businesses.
Commission shall have the meaning set forth in Section 3.6(a) hereof.
Commission Statement means, for any given Program Year, the statement prepared by the Agent
on behalf of Monsanto pursuant to Section 3.6(c) detailing Program EBIT and the amount of the
Commission for such Program Year.
Conflict shall have the meaning set forth in Section 7.1 hereof.
Conflicting Provision shall have the meaning set forth in Section 7.3 hereof.
Contribution Payment shall have the meaning set forth in Section 3.5(a) hereof.
Cost of Goods Sold means, for any given Program Year, the aggregate cost, as determined in
accordance with GAAP applied on a consistent basis, of Roundup Products sold for such Program Year;
provided, however, in computing this amount, the cost of Glyphosate, which is a component of this
Cost of Goods Sold, shall equal the amount set forth in the Transfer Price, for such Program Year.
3
Customers means, with respect to the Included Markets, any Lawn and Garden Channel purchaser
of Roundup Products for resale to the Lawn and Garden Market.
EDI means electronic data interchange.
Effective Date means September 30, 1998.
Egregious Injury means the occurrence of an event (caused directly or indirectly by an act
or omission of the Agent, its officers, directors, or Affiliates), that in Monsantos reasonable
commercial opinion, has a material adverse effect on the Roundup L&G Business, the Roundup brand or
the agricultural Roundup market; provided, however, no such event shall be deemed to be an
Egregious Injury if such event (or the act or omission resulting in such event) resulted from the
exercise by Monsantos Ag president of his or her right of veto, or was caused primarily by an act
or omission of Monsanto or its Affiliates, and such result or causal link, as the case may be,
shall be demonstrated by the Agent.
EU Countries means each country belonging (by treaty or otherwise) to the world organization
commonly known as the European Union.
EU Term shall have the meaning set forth in Section 10.1 hereof.
Event of Default shall have the meaning set forth in Section 10.4(b) hereof.
Excluded Markets means each country not expressly set forth in the Included Markets.
Expense(s) shall mean any expense or cost, direct or Allocated, incurred by either party in
connection with the Roundup L&G Business, including (i) general, marketing, administrative and
technical costs or expenses which shall include (a) 50% of the Allocated cost of the salary and
bonus of the members of the Global Support Team, (b) 100% of the Allocated cost of the salary and
bonus of the Assigned Employees and (c) the Allocated portion of the salary and bonus of the
employees of Agents Business Units to the extent such employees are working on matters related to
the Roundup L&G Business, (ii) service costs directly related to the Roundup L&G Business,
including any expenses due under the Central Agreement, and (iii) any capital expenses approved by
the Steering Committee.
FIFRA means the Federal Insecticide, Fungicide and Rodenticide Act, 7 U.S.C.A. §135, et
seq., as amended.
Formulation Agreement means that certain Formulation Agreement by and between Monsanto and
the Agent for the manufacture and packaging by the Agent of Roundup Products solely for North
America to be entered by the parties upon closing of the sale of the Non-Roundup Assets.
4
GAAP means generally accepted accounting principles as applied as of the Effective Date, as
referred to in paragraphs 10 and 11 of the American Institute of Certified Public Accountants
Statement on Auditing Standards No. 69.
Global Support Team shall have the meaning set forth in Section 4.4(a) hereof.
Glyphosate means N-phosphonomethylglycine in any form, including, but not limited to its
acids, esters, and salts.
Import Price means an amount within $0.75 of the weighted average import statistics price on
approved Glyphosate, expressed in U.S. Dollars per kg of Glyphosate acid equivalent 100%; provided,
however, if such statistic is not available for a particular country within the Included Markets,
then the amount shall be within $0.75 of the weighted average price on approved Glyphosate for
Argentina, plus such additional amounts which Monsanto reasonably determines to equal all
additional costs which it would otherwise incur to import Glyphosate to such country (including,
without limitation, import duties, shipping, and broker fees).
Included Markets means each country listed on Schedule 1.1(a); provided, however, Schedule
1.1(a) may be amended from time to time in the reasonable discretion of the Steering Committee,
upon either the Agent, Monsanto, or the Global Support Team proposing to the Steering Committee
such terms and conditions of amendment, including a proposed (i) term (i.e., duration of
amendment), (ii) adjustment to the calculation for the Commission, and (iii) adjustment to the
Commission Thresholds, provided, however, the proposal for inclusion of a new country demonstrates,
in the reasonable opinion of the Steering Committee (x) the existence of, or the potential for, a
distinct and profitable Lawn & Garden market, (y) the value added by the Agent in terms of sales
and distribution network and synergies, and (z) the lack of adverse impact on Monsantos existing
agricultural Roundup market.
Income Taxes means federal, state, local, or foreign taxes imposed on net income or profits;
provided, however, such term shall not include any sales or use taxes or ad valorem taxes (as
such terms are customarily used) imposed on or resulting from the sale of Roundup Products.
Industrial Property shall have the meaning set forth in Section 6.14 hereof.
Insolvency of the Agent means that the Agent is generally not paying its debts as they
become due, or admits in writing its inability to pay its debts generally, or makes a general
assignment for the benefit of creditors or institutes any proceeding or voluntary case seeking to
adjudicate it a bankrupt or insolvent or seeking liquidation, winding up, reorganization,
arrangement, adjustment, protection, relief or composition of it or its debts under any law
relating to bankruptcy, insolvency or reorganization or relief or protection of debtors, or seeks
the entry of any order for relief or the appointment of a receiver, trustee, custodian or other
similar official for it or for any substantial part of its property; or the Agent takes any action
to authorize any of the actions described above in this definition, or any proceeding is instituted
against the Agent
5
seeking to adjudicate it a bankrupt or insolvent or seeking liquidation, winding
up, reorganization, arrangement, adjustment, protection, relief or composition of it or its debts under any law
relating to bankruptcy, insolvency or reorganization or relief or protection of debtors, or seeking
the entry of an order for relief or the appointment of a receiver, trustee, custodian or other
similar official for it or for any substantial part of its property, and, as to any such
proceeding, if being contested by the Agent in good faith, such proceedings remain undismissed or
unstayed for a period of sixty (60) days.
Lawn and Garden Channels include: (i) retail outlets primarily serving the Lawn and Garden
Market; (ii) independent nurseries and hardware co-ops; (iii) home centers (like Home Depot or
Lowes); (iv) mass merchants (like Wal-Mart or K-Mart); (v) membership/warehouse clubs serving the
Lawn and Garden Market; and (vi) other current or future channels of trade generally accepted and
practiced as Lawn and Garden channels in the industry as may be determined from time to time by the
Steering Committee.
Lawn and Garden Employee shall have the meaning set forth in Section 6.13(e).
Lawn and Garden Market means non-professionals who purchase and use Roundup Products for
Lawn and Garden Uses.
Lawn and Garden Use means (a) Residential Use as defined in 40 C.F.R. 152.3(u), and (b) any
use for which a pesticide can be registered for use under FIFRA or other statutes, rules and
regulations throughout the Included Markets in connection with vegetation control in, on or around
homes, residential lawns, and residential gardens.
Laws shall mean, with respect to any country, such countrys statutes, regulations, rules,
ordinances, or all other applicable laws.
MM means after each number million in U.S. Dollars.
Marketing Fee shall have the meaning as set forth in Section 3.7 hereof.
MAT Expenses means the expenses related to the Roundup L&G Business specified as such in
Schedule 3.3(c).
Material Breach shall mean:
(a) as to the Agent, a breach of this Agreement, which, as initially determined by Monsanto,
with the written agreement of the Agent, or as determined by the Arbitrators pursuant to Section
10.4(g) of this Agreement: (i) is material; (ii) has not been cured within ninety (90) days after
written notice thereof has been provided to Agent in accordance with Section 11.9 hereof; and (iii)
is not remediable either by the payment of damages by Agent to Monsanto or by a decree of specific
performance issued against Agent.
6
(b) as to Monsanto, a breach of this Agreement, which, as initially determined by Agent, with
the written agreement of Monsanto, or as determined by the Arbitrators pursuant to Section 10.4(g)
of this Agreement: (i) is material; (ii) has not been cured within ninety (90) days after written
notice thereof has been provided to Monsanto in accordance with Section 11.9 hereof; and (iii) is
not remediable either by the payment of damages by Monsanto to Agent or by a decree of specific
performance issued against Monsanto.
Material Fraud shall mean:
(a) as to Agent, one or more fraudulent acts or omissions committed by Agent or its officers
or employees, which, as initially determined by Monsanto, with the written agreement of the Agent,
or as determined by the Arbitrators pursuant to Section 10.4(g) of this Agreement: (i) is material;
(ii) was engaged in with the intent to deceive Monsanto; and (iii) either a) has not been cured
within ninety (90) days after written notice thereof has been provided to Agent in accordance with
Section 11.9 hereof, or b) cannot be cured in the commercially reasonable opinion of Monsanto, and,
if applicable, the Arbitrators.
(b) as to Monsanto, one or more fraudulent acts or omissions committed by Monsanto or its
officers or employees, which, as initially determined by Agent, with the written agreement of
Monsanto, or as determined by the Arbitrators pursuant to Section 10.4(g) of this Agreement: (i) is
material; (ii) was engaged in with the intent to deceive Agent; and (iii) either a) has not been
cured within ninety (90) days after written notice thereof has been provided to Monsanto in
accordance with Section 11.9 hereof, or b) cannot be cured in the commercially reasonable opinion
of Agent, and, if applicable, the Arbitrators.
Material Willful Misconduct shall mean:
(a) as to Agent, one or more acts or omissions committed by Agent or its officers or
employees, which, as initially determined by Monsanto, with the written agreement of the Agent, or
as determined by the Arbitrators pursuant to Section 10.4(g) of this Agreement: (i) is material;
(ii) constitutes willful misconduct; and (iii) either a) has not been cured within ninety (90) days
after written notice thereof has been provided to Agent in accordance with Section 11.9 hereof, or
b) cannot be cured in the commercially reasonable opinion of Monsanto, and, if applicable, the
Arbitrators.
(b) as to Monsanto, one or more acts or omissions committed by Monsanto or its officers or
employees, which, as initially determined by Agent, with the written agreement of Monsanto, or as
determined by the Arbitrators pursuant to Section 10.4(g) of this Agreement: (i) is material; (ii)
constitutes willful misconduct; and (iii) either a) has not been cured within ninety (90) days
after written notice thereof has been provided to Monsanto in accordance with Section 11.9 hereof,
or b) cannot be cured in the commercially reasonable opinion of Agent, and, if applicable, the
Arbitrators.
7
Monsanto means Monsanto Company, a Delaware corporation.
Netbacks means the expenses related to the Roundup L&G Business specified as such in
Schedule 3.3(c).
Net Commission shall have the meaning set forth in Section 3.5(b) hereof.
New Product shall have the meaning set forth in Section 6.11 hereof.
Non-Roundup Assets means the Lawn and Garden business of the Solaris division of Monsanto,
comprised of all products other than the Roundup Products being sold separately to the Agent by
Monsanto.
North America means the United States of America, Canada and Puerto Rico.
Person means an individual, partnership, limited liability company, joint venture,
association, corporation, trust, or any other legal entity.
Prime Rate means, on any given date, the prime rate as published in the Wall Street
Journal, for such date or, if not published therein, in another publication having national
distribution.
Product Offer shall have the meaning set forth in Section 6.11 hereof.
Program EBIT means, for any given Program Year, the amount of Program Sales Revenues for
such Program year, less the amount of Program Expenses for such Program Year, provided, however,
for purposes of determining the Agents Commission, (i) the amount of the Program EBIT for the 1999
Program Year (as otherwise determined herein) shall be increased by an amount equal to $15MM, (ii)
the portion of the aggregate amount representing product returns, inventory not salable in the
ordinary course of business, bad debts on trade accounts receivable or any other charge-offs of
trade or other receivables which in total exceeds $4MM for the Program Year 1999 shall not be part
of the Program Expenses for such Program Year, and (iii) any and all expenses with respect to any
Program Year prior to 1999 shall be excluded from Program Expenses for the 2000 Program Year and
thereafter, except to the extent any such item is fully reserved as of the Effective Date.
Program Expenses means, for any given Program Year, applied on a consistent basis and in
accordance with GAAP and the terms of this Agreement, the sum (without duplication) of (i) the
aggregate Approved Expenses for such Program Year and (ii) the Cost of Goods Sold for such Program
Year.
Program Sales Revenue means, for any given Program Year, applied on a consistent basis and
in accordance with GAAP, all revenues received or accrued by any party hereto from
8
the sale of Roundup Products, less reasonable amounts for returns and credits, consistent with past practice.
Program Year means the period of time beginning on October 1st of a specific calendar year
and ending on September 30th of the immediately following calendar year, or such shorter period if
a particular Program Year starts or ends in the middle of such Program Year. For example, the
first Program Year during the term of this Agreement shall be the 1999 Program Year (i.e.,
commencing October 1, 1998 and ending September 30, 1999).
Quarter means any consecutive three-month period of a calendar year.
Roundup L&G Business means the marketing, sale, and distribution of Roundup Products through
Lawn and Garden Channels to the Lawn and Garden Market for Lawn and Garden Uses.
Roundup Bank Accounts shall have the meaning set forth in section 3.2(d) hereof.
Roundup P&L shall have the meaning set forth in Section 3.2(a) hereof.
Roundup Products means (i) for each of the specific countries part of the Included Markets
the products registered for sale solely for Lawn and Garden Uses under a primary or alternate brand
now containing the Roundup or Ortho Kleeraway trademarks as listed on Schedule 1.1(d) attached
hereto in the specific container sizes and formulations described thereon, it being understood that
any change of container size or formulation in any given country part of the Included Markets shall
require the approval of the Steering Committee, and (ii) such products as may be added from time to
time by mutual agreement of the parties in accordance with the terms of this Agreement.
Roundup Records shall have the meaning as set forth in Section 6.4 hereof.
Roundup Sale means (i) any sale, transfer, assignment or other disposition of all or
substantially all of the assets or capital stock of the Roundup L&G Business or (ii) the license of
all or substantially all of the Industrial Property.
Sell-Through Business means, with respect to any region, unit volume sales determined by
Program Year point-of-sale unit movement at those Customers for which measurable data on a
consistent basis is reasonably available and which (i) are among the top 20 Customers in such
region for each of the Program Years in question and (ii) provide measurable data on a consistent
basis for each of the Program Years in question. Such point-of-sale information shall be based on
census data gathered from such top 20 Customers and transmitted via electronic data interchange
(EDI) on a weekly reported basis.
Significant Deviation shall have the meaning set forth in Section 4.3(c) hereof.
9
Steering Committee shall have the meaning set forth in Section 4.1 hereof.
Transfer Price equals, for any given Program Year, expressed in kg of Glyphosate acid on a
100% acid equivalent basis, the following amounts:
Program Years 1999-2001: Transfer Price equals $6.65; and
Program Year 2002 and each subsequent Program Year: Transfer Price equals the
Import Price.
USEPA means the United States Environmental Protection Agency.
Section 1.2. Rules of Construction and Interpretation.
(a) Section References. When a reference is made in this Agreement to an Article, Section,
Paragraph, Exhibit or Schedule such reference shall be to an Article, Section or Paragraph of, or
an Exhibit or Schedule to, this Agreement unless otherwise indicated. Unless otherwise indicated,
the words herein, hereof, hereunder and other words of similar import refer to this Agreement
as a whole, and not to any particular Article, Section, Paragraph or clause in this Agreement.
(b) Construction. Unless the context of this Agreement clearly requires otherwise: (i)
references to the plural include the singular and vice versa, (ii) including is not limiting and
(iii) or has the inclusive meaning represented by the phrase and/or.
(c) Headings. The headings contained in this Agreement are for reference purposes only and
shall not affect in any way the meaning or interpretation of this Agreement.
(d) No Interpretation against Author. For purposes of contract interpretation the parties to
this Agreement agree they are joint authors and draftspersons of this Agreement.
(e) Conflicts with related Documents. The parties contemplate that various forms, including
forms for submitting purchase orders, acceptance of orders, shipping and transportation, will be
used in carrying out this Agreement. In the event of conflict between any such forms or other
documents of like import and this Agreement, the provisions of this Agreement shall be controlling.
ARTICLE 2 EXCLUSIVE AGENCY AND DISTRIBUTORSHIP
Section 2.1. Appointment of the Exclusive Agent. Subject to the terms and conditions hereof,
Monsanto hereby appoints and agrees to use the Agent, and the Agent hereby agrees to serve, as
Monsantos exclusive agent in the Lawn and Garden Market, commencing on the Effective Date, to
provide certain services in connection with Monsantos marketing, sales, and distribution of
Roundup Products to Customers within the Included Markets. Except as
10
otherwise provided in this
Agreement, commencing on the Effective Date, Monsanto shall exclusively use the Agent for the
performance of all of the services contemplated by this Agreement.
Section 2.2. The Agents Obligations and Standards.
(a) Services to be Performed by the Agent.
|
(i) |
|
It is the anticipation of the parties that for the duration of
the term of the Central Agreements, Central and its subagents and
subdistributors will continue to perform its duties and obligations under the
Central Agreements, and Monsantos payments to Central for services provided by
Central, subagents and subdistributors with respect to the 1999 Program Year
only, under the Central Agreements as amended or renegotiated, it being the
intention of the parties to amend or terminate the Central Agreements prior to
the end of the 1999 Program Year, shall be included in the Expenses payable
under this Agreement. |
|
|
(ii) |
|
It is the understanding of the parties that the Agent currently
is not able to perform all or part of the services described hereunder and that
Monsanto shall perform such services, or have such services performed, during a
certain transition period which may vary according to region and service being
contemplated. Accordingly the parties agree to negotiate in good faith and
agree, within ninety (90) days from the date of this Agreement, on the terms
and conditions pursuant to which Monsanto shall continue to perform or have
performed on its behalf, all or part of the services referred to hereunder,
provided (x) Monsanto shall provide such services on a basis necessary to
service the Customers needs and in accordance with the Budget prescribed in
the 1999 Program Year Annual Business Plan, and (y) Monsanto shall be solely
responsible for any MAT Expenses in excess of the amount provided therefor in
such Budget incurred with respect to any such transition services wherever
performed. Upon agreement of the parties, such terms and conditions shall be
attached as Schedule 2.2(a)(ii) and shall be deemed to form a part of this
Agreement ab initio. Such Schedule 2.2(a)(ii) shall contain but not be limited
to, the allocation rules applicable in any such region, the prior written
notice to be given by the Agent to Monsanto prior to taking over the
performance of any given service, the amount of severance cost, if any, which
shall be shared by the Agent in case of termination of such Monsanto
employee(s) in charge of performing the service being terminated, the
obligations of each party with regard to data information, order processing and
invoicing, and the Agents right of audit. |
11
Notwithstanding the foregoing, and excluding any duties or obligations which Central continues
to perform for the duration of the Central Agreements or Monsanto during the above-mentioned
transition period, the Agent shall perform some or all of the following duties
and obligations within the parameters and to the extent required to implement the Annual
Business Plan approved by the Steering Committee:
(1) Sales. Pursuant to the Annual Business Plan, the Agent shall perform selling, sales
management, and other services related to the sale of Roundup Products.
(2) Merchandising and In-Facility Services. The Agent shall perform in-store merchandising,
store set-up, and other services related to the in-store promotion of Roundup Products.
(3) Warehousing and Inventory.
(i) Warehousing. The Agent shall arrange for warehouse services for all Roundup Products
until such time as the products are delivered to proper carriers. The Agent agrees to comply with
all applicable environmental rules and regulations in owning or operating any warehouse.
(ii) Inventory. The Agent shall be responsible for:
|
|
|
coordinating and staffing annual physical inventory for
all Roundup Products (including raw materials, packaging-
when the Agent shall formulate under the Formulation
Agreement- and finished goods). Physical inventories shall
be conducted by September 30 of every calendar year and
Monsanto shall have the right to request physical counts on
specific product at any time upon reasonable request (which
shall be at Monsantos cost if there are more than two such
counts in any Program Year) and to observe or conduct
physical counts with Monsantos representatives; |
|
|
|
|
reconciling the physical inventory to perpetual records; |
|
|
|
|
physically moving the Roundup Products out of the
warehouse by following a First In, First Out (FIFO)
policy; and |
|
|
|
|
arranging for warehousing of adequate inventory levels of
Roundup Products in sufficient quantities to satisfy the
criteria set forth in the Annual Business Plan. |
12
(4) Order and General Administration. The Agent shall have the authority and shall so perform
all order taking, order processing, invoicing, collection, reconciliation, general administration,
and other related services necessary for the marketing, sales, and distribution of Roundup
Products, all of which shall be subject to the Annual Business
Plan and the terms of this Agreement. Pursuant to the terms of this Agreement, the Agent
shall be responsible for the following obligations:
(i) The Agent shall offer to the Customers Roundup Products at such price and under such terms
as set forth in the Annual Business Plan or as otherwise established by the Steering Committee.
(ii) The Agent shall accept orders for the sale of Roundup Products; provided, however, the
Agent shall accept all such orders subject to the availability of Roundup Products on the requested
delivery dates.
(iii) The Agent shall administer all claims and adjustments for Roundup Products which are
damaged during shipment or warehousing.
(iv) Subject to Section 5.1, the Agent shall (i) maintain or contract for adequate facilities
and technologies to manage consumer information and complaint calls or written correspondence and
(ii) be responsible for all reports relating thereto, including (without limitation) reports to any
regulatory or governmental authority pursuant to any applicable Law.
(5) Returns of Roundup Products. The Agent shall manage requests by Customers that Roundup
Products, previously sold or shipped, should be returned for credit, either because such Roundup
Products are defective or for some other reason. The Agent shall receive any such returned Roundup
Products into its warehouses and prepare the appropriate credit memos, subject to the joint
approval of the Business Unit and the Global Support Team for any return exceeding $500,000.
(6) Information on Roundup Products and Consumer Inquiries. The Agent shall provide Customers
or potential customers with detailed information concerning the characteristics, uses and
availability of Roundup Products as shall be supplied by the Global Support Team. The Agent shall
be responsible for maintaining a consumer response center relating to Roundup Products; provided
that, unless the Business Unit and the Global Support Team otherwise agree, any human and
animal-related health calls shall be automatically or via operator forwarded, with respect (i) to
human emergency calls to the Cardinal Glennon Poison Control Center and (ii) to animal emergency
calls to the National Animal Poison Control Center.
(7) Promotion of Roundup Products. Continuously throughout the term of this Agreement, the
Agent shall promote the sale of Roundup Products no less aggressively than any other product or
product line that the Agent sells and shall perform its
13
duties as Agent in such a manner as to
promote goodwill, and particularly customer goodwill, toward Monsanto and Roundup Products.
(8) Advertising and Promotional Programs to Customers. The Agent shall provide Customers with
detailed information concerning the advertising and
promotional programs of Roundup Products and facilitate the use by its Customers of such
programs to the fullest extent possible (as set forth in the Annual Business Plan).
(9) Roundup Brand Image and Stewardship. The Agent, in consultation with the Global Support
Team, shall promote, in accordance with the Annual Business Plan or as directed by the Steering
Committee, the sales and consumer acceptance of Roundup Products using messages and vehicles that
are not inconsistent with the brand image established by Monsantos Ag division in support of its
Roundup branded products and seeds, including but not limited to:
(i) Advertising in local and national media;
(ii) Providing suitable training of the Agents representatives or employees in the areas of
product knowledge, product stewardship, sales training, display techniques, promotion and
advertising;
(iii) Determining the description of consumer and trade communication programs to Customers
regarding the sales and distribution of Roundup Products; and
(iv) The handling of product complaints with the intent of achieving consumer satisfaction.
(10) Retail Relationships. The Agent shall maintain retail relationships between the Agent
and the Customers, including relationships at headquarters and regional stores.
(11) Merchandising and Display Techniques. The Agent shall provide Customers with full
information concerning the merchandising and display techniques as set forth in the Annual Business
Plan. The Agent shall use, fully support and recommend, that Customers fully utilize all such
merchandising and display techniques.
(12) Annual Business Plan. The Business Units, jointly and in cooperation with the Global
Roundup Support Team, shall, prepare and deliver to the Steering Committee (i) a preliminary draft
for the annual business plan no later than June 15 of each Program Year and (ii) a definitive
version thereof no later than September 15 of each Program Year (the Annual Business Plan), which
establishes the general marketing, distribution, sales information, and specifications of Roundup
Products for such Program Year (or shorter period, if applicable) including the Agents short and
long-term sales goals with respect to Roundup
14
Products for such Program Year, and more specifically
all of the items listed on Schedule 2.2(a). Notwithstanding the foregoing, for the 1999 Program
Year, the parties shall have sixty (60) days to agree to the detailed costs and sales components of
the Annual Business Plan. Upon approval by the Steering Committee, the Annual Business Plan shall
serve as the Agents parameters for implementing the day-to-day operation of the Roundup Business;
any Significant Deviations from such Annual Business Plan shall require the prior approval of the
Steering Committee unless already approved by the Global Support Team and the Business Unit
pursuant to Section 4.2.(c ).
(13) Additional Actions. The Agent shall perform such additional actions, consistent with
this Agreement, as directed by the Steering Committee, to implement any Significant Deviations from
the Annual Business Plans.
(b) Employee Performance Standards. The Annual Business Plan shall set forth the employee
performance standards required in the parties opinion to promote the achievement of the income
targets for the Roundup L&G Business in each given Program Year. The Annual Business Plan shall
also specify the impact which the failure to meet such performance standards may have on the
incentive schemes and bonus plans of the individual members of the Global Support Team and those
employees who are part of the Business Units in charge of the Roundup L&G Business.
Section 2.3 Appointment of Sub-Agents and Sub-Distributors. The Agent shall have the right to
delegate part of its obligations under this Article 2 to sub-agents and sub-distributors; provided,
however, the Agent shall remain primarily liable for all of its obligations hereunder and shall be
primarily liable for any act or omission of any such sub-agent or sub-distributor. To the extent
this Agreement creates any obligations on the Agent, such obligations shall apply with respect to
any sub-agents or sub-distributors, as the case may be. In connection with the foregoing, any
reports or other information to be given to Monsanto shall be given by the Agent and shall include
any information applicable to sub-agents or sub-distributors, as the case may be. Notwithstanding
the foregoing, the Steering Committee shall have the exclusive right to approve the appointment or
termination of any sub-agent or sub-distributor and the terms of any sub-agency or
sub-distributorship agreement (including any change or amendment thereto).
Section 2.4 Limitations on Agent. Notwithstanding anything in this Agreement to the contrary,
the Agent shall not, without the written consent of the Steering Committee, take (or initiate) any
of the following actions:
(a) Sell Roundup Products at a price or under terms not permitted under the Annual Business
Plan;
(b) Possess or use any property of Monsanto, except to the extent necessary for Agent to
perform its duties and obligations hereunder (e.g., in-store displays);
15
(c) Hold itself out as authorized to make on behalf of Monsanto any oral or written warranty
or representation regarding Roundup Products other than what is stated on the applicable Roundup
Products label or in other written material furnished to the Agent by Monsanto; or
(d) Intentionally dilute, contaminate, adulterate, or substitute any Roundup Products or sell
any Roundup Products for which the indicated measure or any other information on the label is known
to the Agent to be grossly false, misleading, or inadequate.
ARTICLE 3 ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS
The accounting and cash flow procedures and services described in this Article 3 are intended
to govern North America only, it being the understanding of the parties that different procedures
and services (including the terms thereof) are required in regions other than North America. In
addition, the parties understand and agree that the services described in this Article 3 with
respect to North America will continue to be provided by Monsanto until and unless the Agent
acquires the Non-Roundup Assets. Accordingly, the parties agree to negotiate in good faith and
agree, within ninety (90) days from the date of this Agreement, on the terms and conditions
pursuant to which Monsanto shall perform the services contemplated by this Article 3 in regions
other than North America. Upon agreement of the parties, such terms and conditions shall be
attached as Schedule 3.1 and shall be deemed to form a part of this Agreement ab initio. Until the
Agent assumes the performance of the services described in this Article 3 with respect to North
America and the services to be described in Schedule 3.1 with respect to all other regions,
Monsanto shall continue to provide the services contemplated by this Article 3 on a basis necessary
to service the Customers needs and in accordance with the Budget prescribed in the Annual Business
Plan for the 1999 Program Year, including the $35 MM cap on MAT Expenses.
Section 3.1. Bookkeeping and Financial Reporting.
(a) Bookkeeping. The Agent shall, on behalf of Monsanto, be responsible for all the
bookkeeping for the Roundup L&G Business, which shall include, but not be limited to, (i) setting
up a separate set of accounting records reflecting all the items of income, profit, gain, loss and
deduction with respect to the Roundup L&G Business, including a profit and loss statement (Roundup
P&L) and all other records relating to the Roundup L&G Business including sales invoices and
customer data (the Roundup Records) in accordance with the written set of accounting policies
(including the currency exchange methodology used by Monsanto) as shall be provided by Monsanto;
provided, that if any change in Monsantos accounting policies would adversely affect the Agents
Commission (other than in a de minimis amount), the parties shall negotiate in good faith to change
the thresholds and/or the Commission, as appropriate, to eliminate such adverse affect; (ii)
collecting, recording and safeguarding receipts of all receivables and payables, costs or expenses
either directly incurred by the Roundup L&G Business or Allocated thereto by either party pursuant
to the terms of Section
16
3.3 hereof. At all times, the Agent shall make available via computer
and/or original documentation, to the Assigned Employees designated by Monsanto continuous access
to the Roundup Records as appropriate on a need-to-know basis, such access shall include, but not
be limited to, daily sales updates.
(b) Financial Reporting. The Agent shall provide to Monsanto monthly financial statements,
including (i) the Roundup P&L, balance sheet and cash flow statements, (ii) the Netback expense
detail (accruals and actuals), (iii) all other Expense detail (accruals and actuals), and (iv) Cost
of Goods Sold detail. Such monthly financial statements shall be provided
(i) in their preliminary form, no later than four (4) business days following the end of the
calendar month, and (ii) in their final form, together with an estimate of sales for the current
month, no later than six (6) business days following the end of the calendar month.
(c) Audit. Monsanto shall have the right to periodically audit or have an independent
accountant audit, on Monsantos behalf, all the Roundup Records. The audit shall be at the cost of
Monsanto unless any material error has been committed by the Agent, in which case the Agent shall
bear the cost of the audit. Upon exercise of its right of audit, and discovery of any disputed
item, Monsanto shall provide written notice of dispute to the Agent. The parties shall resolve
such dispute in the manner set forth in Section 3.4 hereof.
Section 3.2. Ordering, Invoicing and Cash Flow Cycle.
(a) Ordering and Invoicing. The Agent shall perform, on behalf of Monsanto, all order taking,
order processing and invoicing for the Roundup Products, it being understood that orders filled for
Roundup Products shall be invoiced on the invoices used by the Agent for its other non-Roundup
products provided such invoices or their EDI version shall (i) identify the Agent as an agent for
Monsanto for the sale of all Roundup Products and Monsanto as the actual transferor of title to
Roundup Products; (ii) direct payment of such invoice to be made directly to the account designated
by the Agent; and (iii) include all taxes (other than Income Taxes), duties, and other charges
imposed by governmental authorities based on the production or sale of Roundup Products or their
ownership or transportation to the place and time of sale
(b) Customer Remittances. Customers of Roundup Products shall be directed, as per the
invoices, to remit directly the invoiced amounts for all Roundup Products to the Agents designated
bank account.
(c) Daily Receipts. On or before October 31, 1998, the parties shall determine, based on the
Program Year ending on September 30, 1998, the average daily pro rata share of Customers
remittances for the purchase of Roundup Products versus the non-Roundup products sold by Monsanto
to said Customers during such period. Using said daily pro rata share, the Agent shall, on a daily
basis, remit to the account designated by Monsanto for such purposes, the estimated portion of
Customers remittances for the Roundup Products. At the end of each month, the Agent shall verify
the actual amount of the Customers remittances for the Roundup Products paid over the past month
and shall send to Monsanto a monthly reconciliation
17
statement, either with a check in the event the
actual amount exceeds the total daily prorated estimate paid out to Monsanto for such month or with
an adjustment request in the event the actual amount is below the total daily prorated estimate
paid out to Monsanto for such month. Customer payment deductions that do not initially, clearly
apply to Roundup Products shall not be withheld by the Agent from the daily remittances to
Monsanto. If the Agent subsequently determines any of such payment deductions apply to sales of
Roundup Products, the Agent shall be reimbursed therefor as part of the monthly cash
reconciliation. Monsanto and the Agent agree that general Customer payment deductions will be
prorated based on applicable sales, for which the Agent will also be
reimbursed in the monthly cash reconciliation. Any non-Roundup Product payment deductions, for
whatever reason, shall not be applied against Roundup Products.
(d) Roundup Bank Accounts. Monsanto shall establish or use existing bank accounts (the
Roundup Bank Accounts) to serve as the bank accounts dedicated exclusively to the Roundup L&G
Business (i) for the receipt of Monsantos daily disbursements as described in Section 3.2(c), and
(ii) for making any and all payments incurred in connection with the Roundup L&G Business either as
direct Expenses of the Roundup L&G Business or as reimbursements to either party for services
rendered or out of pocket costs related to the Roundup L&G Business as described more particularly
in Section 3.3 hereof. Monsanto shall grant the Agents nominee the authority to manage the
Roundup Bank Accounts on Monsantos behalf, and more generally take any and all actions requested
for the payment of all the Roundup L&G Business Expenses in compliance with the terms of Section
3.3 hereunder as per the Cash Flow Chart attached hereto as Schedule 3.2(d); provided that checks
in an amount over $25,000 shall also require the co-signature of an Assigned Employee or a member
of the Global Support Team. Monsanto shall further cause such Roundup Bank Accounts to have at all
times a zero balance account but to receive immediate and automatic funding upon presentation of
any checks. Monsanto may perform its own reconciliation of the Roundup Bank Accounts and may
conduct a weekly review of the check register.
Section 3.3. Expenses and Allocation Rules
(a) Expenses. Each and every Expense, either as a direct expense or an allocated one, shall
only be charged to the Roundup L&G Business and consequently taken into account in the Program EBIT
statements set forth in Section 3.6(c) hereto if part of a category of Expenses specifically
authorized by the terms of the Annual Business Plan and within the aggregate amount prescribed in
the Annual Business Plan for such category of Expense (Budget) (Approved Expense). Any Expense
which shall exceed its prescribed Budget shall solely be the responsibility of the party incurring
it unless such expense is required to implement an approved Significant Deviation from the Annual
Business Plan or is necessary to support sales orders above budgeted sales pursuant to sales
programs contemplated by the Annual Business Plan.
(b) Direct vs. Allocated. Each party shall have the right to verify whether any particular
Expense is an Approved Expense by sending a written inquiry to that effect to the Agents nominee.
The party incurring an Expense shall endeavor to promptly provide upon
18
request of the Agents
nominee the appropriate documentary evidence supporting such Expense. Upon failure by the said
party to provide the appropriate documentary evidence, the inquiring party shall have the right to
send a written notice of dispute to the other party and the parties shall resolve such dispute in
the manner set forth in Section 3.4 hereof. Upon determination by such Independent Accountant (as
defined below) that the Expense was not Approved, such Expense shall be deducted from the Program
Expenses and the party having incurred such Expense shall either promptly reimburse it to the
Roundup Bank Account, or shall withdraw its request for reimbursement if not reimbursed yet.
Expenses shall be classified into (i) direct expenses of the Roundup L&G Business payable to
vendors, which shall be submitted directly to the Agents nominee for payment out of the Roundup
Bank Account or (ii) as Allocated Expenses which shall be submitted by either party to the Agents
nominee for reimbursement out of the Roundup Bank Account. Payment of any direct expenses incurred
by either party on behalf of the Roundup L&G Business shall be made as they become due in
accordance with the applicable commercial terms agreed upon with each vendor.
Allocated Expenses shall be paid on the fifteenth (15th) day of each month provided
such allocated Expenses shall be submitted in writing no more than five (5) days after the end of
each month to the Agents nominee in charge of the Roundup Bank Account.
(c) Allocation Rules. In the performance of their obligations under this Agreement, each
party shall incur allocated Expenses directly related to the Roundup L&G Business. Each allocated
Approved Expense, regardless of the party incurring it, shall be reimbursed as described in Section
3.5(b) provided such expense shall be allocated in accordance with the Allocation Rules set forth
for each category of cost and service per country or region, as the case may be, in Schedule 3.3(c)
attached hereto (Allocated Expense).
Section 3.4. Resolution of Disputes Arising under Article 3. Unless otherwise agreed by the
parties, each party shall have the right, within twenty (20) days of receipt of the quarterly or
annual financial statements to send a written notice of dispute to the other party. Upon receipt
of such notices of dispute, the parties shall undertake the following steps:
(i) First, for a period of fifteen (15) days, the parties shall negotiate in good faith for
the purposes of attempting to mutually agree upon the item in dispute;
(ii) Second, if parties are unable to mutually agree upon the item in dispute, then within
seven (7) business days following the expiration of such fifteen (15) day period, the parties shall
agree in writing upon the selection of a nationally recognized independent accounting firm (the
Independent Accountant) to resolve the dispute. If the parties cannot agree upon such Independent
Accountant within such time frame, then the Independent Accountant shall thereupon be selected by
the American Arbitration Association (the AAA), with preference being given by the AAA in making
such selection to any one of the Big Five accounting firms (except for any firm which performs
accounting services for either party)
19
willing to perform the services required hereunder. The
Independent Accountant shall be instructed to act within thirty (30) days to resolve the dispute,
and its decisions with respect to the dispute shall be final and binding upon the parties. The
fees and expenses of the Independent Accountant with respect to the settlement of the dispute shall
be borne equally by the parties.
Section 3.5. Fixed Contribution to Expenses
(a) Amount and Purpose. Each Program Year the Agent shall make a fixed contribution to the
overall Expenses of the Roundup L&G Business in an amount equal to twenty million U.S. Dollars
($20,000,000) (Contribution Payment). Such Contribution Payment shall be payable by the Agent to
Monsanto in twelve equal monthly installments which shall be due on the first day of each month and
shall not be subject to any set-off.
(b) Temporary Deferral. Notwithstanding the foregoing, but subject to Section 10.9, for the
first three Program Years, all or part of the Contribution Payment shall be deferred as shown in
Table 1 set forth below. Such forty million U.S. Dollars ($40,000,000) deferral shall not be
deemed to constitute a loan by either party but a mere cash flow adjustment between the parties.
Table 1
|
|
|
|
|
Year |
|
Contribution Payment |
|
Amount Deferred |
1999 |
|
-0- |
|
$20MM |
2000 |
|
$5MM |
|
$15MM |
2001 |
|
$15MM |
|
$ 5MM |
2002 |
|
$20MM |
|
|
2003-18 |
|
$25MM until the full $40MM bearing an 8% interest (starting to run on the
date each monthly installment would otherwise be due) is entirely
recovered by Monsanto, at which point the Contribution Payment shall
revert to $20MM per Program Year. |
|
|
Notwithstanding the above payment schedule shown in Table 1 beginning in Program Year 2001,
recovery of such deferral shall be accelerated with the Contribution Payment being increased by 50%
of the amount by which the Agents Net Commission exceeds the amounts shown in Table 2 set forth
below. Any such increase of the Contribution Payment shall be paid by adjusting the latest monthly
installment upon receipt of the final Program EBIT statement by November 30 of every calendar year.
For purposes of this Section 3.5(b), Net Commission means the Commission as determined pursuant
to the terms of Section 3.6(a) less the Contribution Payment applicable pursuant to this Section
3.5.
20
Table 2
|
|
|
|
|
Year |
|
Net Commission Level |
2001 |
|
$32.5MM |
2002 |
|
$28.1MM |
2003 |
|
$26.7MM |
2004 |
|
$30.5MM |
2005 |
|
$34.6MM |
2006 |
|
$38.9MM |
2007 |
|
$43.5MM |
2008 |
|
$49.0MM |
Upon termination of this Agreement for any reason other than Egregious Injury, Material Fraud
or Material Willful Misconduct on the part of the Agent, Monsanto shall forfeit recovery of any
portion of the $40MM (or interest thereon) unpaid on the date of termination.
Section 3.6. Commission.
(a) Amount of Commission. In consideration to the Agent for performance of its duties and
obligations hereunder, the Agent shall be entitled to a Commission (Commission). Such Commission
shall represent a percentage of the Program EBIT realized by the Roundup L&G Business, which
percentage shall vary in accordance with the formula set forth below.
|
|
|
|
|
|
|
|
|
|
|
Amount of Program EBIT |
Year |
|
First Commission Threshold |
|
Second Commission Threshold |
1999-2000 |
|
$ |
30,000,000 |
|
|
$80MM |
2001 |
|
$ |
31,250,000 |
|
|
$80MM |
2002 |
|
$ |
32,531,250 |
|
|
$80MM |
2003 |
|
$ |
33,844,531 |
|
|
$80MM |
2004 |
|
$ |
35,190,645 |
|
|
$80MM |
2005 |
|
$ |
36,570,411 |
|
|
$80MM |
2006 |
|
$ |
37,984,471 |
|
|
$80MM |
2007 |
|
$ |
39,434,288 |
|
|
$80MM |
2008 |
|
$ |
40,920,145 |
|
|
$80MM |
2009+ |
|
$ |
30,000,000 |
|
|
$80MM |
21
The Commission shall be equal to:
|
|
|
|
|
Amount of Program EBIT |
|
Multiplied By |
(1) |
|
0 - First Commission Threshold: |
|
0% |
|
|
|
|
|
(2) |
|
Second Commission Threshold less |
|
|
|
|
First Commission Threshold: |
|
46% in Program Year 1999* |
|
|
|
|
44% in Program Year 2000 |
|
|
|
|
40% thereafter |
|
|
|
|
|
(3) |
|
Above the Second Commission |
|
|
|
|
Threshold: |
|
50%** |
|
|
|
* |
|
1999 Program EBIT shall be increased by $15MM. |
|
** |
|
subject to Section 3.5(b). |
Provided both the First and Second Commission Thresholds set forth above may be amended from time
to time by mutual agreement of the parties following the inclusion or exclusion of either new or
existing countries in the Included Markets. In the event of a Regional Performance Default in the
UK or in France, there shall be no adjustment to either the First Commission Threshold or the
Second Commission Threshold. In the event of a Regional Performance Default in any region other
than the UK and France, both thresholds shall be reduced by such regions pro rata contribution to
the preceding Program EBIT. Notwithstanding the foregoing, in the event of the non-renewal of the
EU Term due to Monsanto, the First Commission Threshold shall be reduced to -0- for the remainder
of the term of this Agreement.
(b) Payment of Commission. Within thirty (30) days following the end of each month, the
Agent, on behalf of Monsanto shall determine whether a Commission becomes payable, i.e., whether
the cumulative Program EBIT for the Program Year up to the preceding month equals an amount in
excess of the First Commission Threshold. If so, the Agent, on behalf of Monsanto shall by check
or wire transfer, to the Agents designated account for the payment of the applicable Commission
pursuant to the formula set forth in Section 3.6(a) subject to any adjustments pursuant to Section
3.6(c).
(c) Final Determination. Within fifteen (15) days following the end of each Program Year, the
Agent shall deliver to Monsanto a Commission statement which shall contain the final determination
of the Commission due at the expiry of the Program Year and shall set forth any eventual
adjustments, to the amounts paid up to the Agent under Section 3.6(b) during the preceding Program
Year. If within fifteen (15) days following the receipt of such Commission statement by the Agent,
Monsanto does not provide the Agent written notice of objection to the Commission statement, the
amount of the Commission for such Program Year shall be as provided thereon. If within such
fifteen (15) days following receipt of such
22
Commission statement by Monsanto, Monsanto does provide
the Agent written notice of objection to the
Commission statement, the parties shall resolve such dispute in the manner set forth in Section 3.4
hereof.
Section 3.7. Marketing Fee. In consideration for the rights and benefits granted to the Agent
hereunder exclusively for North America as hereby expressly acknowledged and agreed to by both
parties, the Agent shall pay to Monsanto, on or before September 30, 1998, an amount equal to
thirty-two million U.S. Dollars ($32,000,000) (the Marketing Fee) in immediately available funds.
Section 3.8. Additional Commission
(a) The parties acknowledge that Monsanto currently sells Glyphosate-based products current
under the Roundup trademark, directly or indirectly, to professional, industrial and agricultural
users (Roundup Ag Products). Monsanto acknowledges that one of such Roundup Ag Products, the 2.5
gallon SKU containing 41% concentration of Glyphosate (the 2.5 Gallon SKU), is currently being
sold through those certain Lawn and Garden Channels in the United States set forth on Schedule 3.8
attached hereto and may be purchased by consumers in the Lawn and Garden Market. Schedule 3.8 also
sets forth Monsantos (but not its distributions) sales into Lawn and Garden Channels in the U.K.
and France. Monsanto also acknowledges its obligations pursuant to Section 6.13(b) hereof.
(b) On and after the Effective Date, the Agent shall support and manage the sale of the 2.5
Gallon SKUs that were previously being sold directly by Monsanto through such Lawn and Garden
Channels. As compensation therefor, in addition to the Commission otherwise payable to the Agent
hereunder, the Agent shall be paid a 10% commission on all such sales of 2.5 Gallon SKUs sold
through the Lawn and Garden Channels in the United States set forth on Schedule 3.8. The parties
acknowledge that the sales resulting from such 2.5 Gallon SKUs shall not be included in the Program
Sales Revenues hereunder.
(c) Except to the extent provided in Section 3.8(b) above, on and after the Effective Date,
Monsanto shall use its reasonable efforts to ensure that Roundup Ag Products are not sold, directly
or indirectly, through Lawn and Garden Channels to consumers in the Lawn and Garden Market in the
Included Markets. In the event that in the normal course of business the Agent determines based on
satisfactory evidence that a material amount of the 2.5 Gallon SKU is being sold directly by
Monsanto through Lawn and Garden Channels for Lawn and Garden Use in the United States other than
as set forth on Schedule 3.8 or a material amount of additional Roundup Ag Products above
historical sales levels as of the date of this Agreement is being sold through Lawn and Garden
Channels to consumers for Lawn and Garden Use in the Included Markets, the parties shall negotiate
in good faith to include, subject to the principles set forth in Section 3.8(e), an appropriate
percentage of such incremental sales to reflect such Lawn and Garden Use within the definition of
Program Sales Revenues so that the Agent receives credit therefor for purposes of calculating the
Agents Commission.
23
(d) Prior to the finalization of the Annual Business Plan for each program Year, Monsanto
shall provide the Agent with notice of any significant changes in the pricing of any Roundup Ag
Product that may be sold through Lawn and Garden Channels for Lawn and Garden Use in any Included
Market during such Program Year. For the thirty (30) days after receipt of such notice, the
parties shall negotiate in good faith, and the Steering Committee shall affect, if so agreed, an
appropriate adjustment to the Agents Commission and/or Thresholds to address the impact of such
proposed pricing changes on the Annual Business Plan for such Program Year. In the event the
parties are unable to reach agreement within such thirty (30) day period, the Agents Commission
and/or Thresholds shall remain unchanged provided that at the end of the such Program Year the
Agent shall have the right to request a retroactive adjustment of the Commission or Threshold for
such Program Year upon demonstrating , based on actual numbers for such Program Year, a significant
impact on the Roundup Lawn and Garden Business.
(e) In implementing the foregoing, the parties shall follow the following principles: (i)
that Monsantos sales of Roundup Ag products are not intended for Lawn and Garden Use and that
Monsanto shall not sell Roundup Ag Products directly or promote the indirect sale thereof, through
Lawn and Garden Channels to consumers for Lawn and Garden Use in the Included Markets and (ii)
that there shall be no transfer of historical or future sales of Roundup Ag products in the Ag
Market into Program Sales Revenues. Furthermore, the parties acknowledge that Roundup Ag Products
having a formulation consisting of 41% or more Glyphosate and in container sizes over 2.5 gallons
in the United States or over one liter in the other Included Markets shall be presumed to have no
Lawn and Garden Use and therefor that sales of such Roundup Ag Products shall not be deemed to
compete with Roundup Products in a manner that would justify adjustment of the calculation of
Program Sales Revenues; provided that if the Agent is able to demonstrate to the Steering Committee
that a material change in the amount of such Roundup Ag Products above historical sales levels as
of the date of this Agreement are being sold through Lawn and Garden Channels to consumers for Lawn
and Garden Use in the Included Markets, the parties shall negotiate in good faith pursuant to
Section 3.8(c) to adjust the calculation of Program Sales Revenues.
(f) In order to demonstrate the foregoing, by way of example only: (i) Assume that sales of
2.5 Gallon SKUs in the U.S. by Monsanto, directly or indirectly, through Lawn and Garden Channels
in the Included Markets set forth on Schedule 3.8 for the 1999 Program Year are $10MM; (ii) assume
that the sales of such 2.5 Gallon SKUs for the corresponding period from October 1, 1997 through
September 30, 1998 were $6MM; and (iii) assume that of such incremental $4MM of sales in the 1999
Program Year, 40% are to consumers in the Lawn and Garden Market and 60% are to consumers in the Ag
Market. In such event, with respect to the 1999 Program Year, the Agent would be entitled to an
additional commission equal to $840,000, comprised of 10% of $6MM (the historical sale level of 2.5
Gallon SKUs) and 10% of $2.4MM (60% of the $4MM in incremental sales of 2.5 Gallon SKUs), and that
Program Sales Revenues for the 1999 Program year will be increased by $1.6MM (40% of the
incremental $4MM in sales). A similar analysis would apply to sales of other Roundup Ag Products,
other than the 2.5 Gallon SKU, through Lawn and Garden Channels to consumers in the Lawn and Garden
Market.
24
ARTICLE 4 ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE
Section 4.1. Underlying principles for the Roundup L&G Business Management Structure
(a) The Roundup L&G Business management structure, as described in this Article and in
Schedule 4.1(a), has been created for the purposes of fostering and promoting the following
interests of the parties:
|
(A) |
|
achieve the maximum volume and profit levels
for the Roundup Business; |
|
|
(B) |
|
continue to strengthen the Roundup brand; and |
|
|
(C) |
|
leverage the strengths of both parties while
working together in a constructive and harmonious way. |
|
(ii) |
|
Monsantos Interests: |
|
(A) |
|
retain ability to resume full management of the
Roundup Business upon termination of this Agreement; |
|
|
(B) |
|
retain control over key business decisions; and |
|
|
(C) |
|
provide global stewardship of the Roundup
brand. |
|
(iii) |
|
The Agents Interests: |
|
(A) |
|
manage the Roundup Business within the
parameters of approved Annual Business Plans; |
|
|
(B) |
|
have clear reporting relationship to Business
Units heads for all Assigned Employees within the Business Units; and |
|
|
(C) |
|
have clear definition of roles and
responsibilities for all Assigned Employees within the Business Units. |
(b) The parties understand that such structure may be amended from time to time by mutual
agreement of the parties provided any such change shall take into account the respective interests
of each party as described hereunder.
25
Section 4.2. Steering Committee.
(a) Appointment. Monsanto and the Agent shall each appoint by April 1 of each year two (2)
executives to a steering committee (Steering Committee) provided, however, any vacancy shall be
filled in such a manner that the parties shall maintain their respective proportionate
representation on the Steering Committee and that upon failure by either party to appoint said two
(2) executives by such time, the two (2) executives previously appointed by such party shall be
deemed appointed for another Program Year. Notwithstanding the foregoing, the members of the
Steering Committee for the Program Year 1999 shall be the individuals whose names are set forth as
Schedule 4.2(a) attached hereto. In addition, the head of the North America Business Unit shall be
entitled to participate, with no voting right, at every meeting of the Steering Committee, and to
invite, as the need may arise, the heads of the other Business Units to said meetings (equally
without voting rights).
(b) Meetings, Quorum and Voting Requirements.
(1) Meetings. The Steering Committee shall meet at least once a year for purposes of
approving the Annual Business Plan no later than September 15 of every calendar year. Any member
of the Steering Committee shall have the right to call a special meeting of the Steering Committee
provided a prior written notice of at least fifteen (15) days shall be given to each member
together with an agenda for such meeting.
(2) Quorum and Voting Requirements. The quorum for any meeting of the Steering Committee
shall require the participation of all four (4) members except that any member shall be deemed
present when participating via phone or video conference. Any decisions by the Steering Committee
may be taken by the affirmative vote of a majority of three (3) of the members of the Steering
Committee. In the event of a deadlock, when a particular vote is divided equally between the four
members, the matter shall be submitted to the president of Monsantos Ag division, who shall have
the exclusive discretion to resolve the matter and such decision shall bind the Steering Committee
to such action or inaction. Notwithstanding any future assignment of this Agreement to a third
party by reason of a Roundup Sale, the President of Monsantos Ag division shall retain its right
of veto in case of deadlock of the Steering Committee.
For every meeting of the Steering Committee, minutes shall be kept and circulated for approval
to all four members. Every decision of the president of Monsantos Ag division shall also be
recorded in writing and distributed to the members of the Steering Committee.
(c) Authority. The Steering Committee shall:
|
(i) |
|
approve all Annual Business Plans, and any Significant
Deviations (as described in Section 4.3(c)) therefrom not previously approved
jointly by the Business Units and the Global Support Team; |
26
|
(ii) |
|
approve any and all strategic plans; |
|
|
(iii) |
|
review monthly reports submitted by the Business Units for the
purposes of monitoring achievement and redirecting the Business Units by
issuing a formal amendment to the Annual Business Plan then in effect; |
|
|
(iv) |
|
monitor and redirect, if need be, the performance of the Global
Support Team; |
|
|
(v) |
|
approve any decisions relating to key personnel assigned to the
Roundup Business within the Business Units, including Monsantos and the
Agents employees; |
|
|
(vi) |
|
resolve any disagreement occurring between a Business Unit and
the Global Support Team; and |
|
|
(vii) |
|
decide any other matter mutually agreed upon by Monsanto and
the Agent. |
Section 4.3. Business Units.
(a) Role and Reporting. The Roundup L&G Business shall be managed, on behalf of the Agent, by
its respective pesticide business units in North America, Europe and Asia (Business Units)
provided that, for the management of the Roundup L&G Business, the head of each of the three
Business Units shall report directly to the Steering Committee.
(b) Monsantos Assigned Employees. For the term of this Agreement, Monsanto shall assign the
equivalent of fifteen (15) of its own employees (Assigned Employees) to fulfill the functions set
forth in Schedule 4.3(b) within the three Business Units. The number of said Assigned Employees
may vary from time to time upon mutual agreement. Monsanto may, from time to time, with the
Agents written approval, substitute individuals to serve as the Assigned Employees, by providing
prior written notice thereof to the Agent. The Assigned Employees shall serve under the guidance
and supervision of the Business Unit head of the Business Unit they shall join.
Monsanto shall remain the employer of the Assigned Employees for all purposes of any and all
liability and health insurance, employee benefit plans, and workers compensation coverage, and
shall be responsible for all compensation and other benefits. Performance reviews shall be first
recommended by the Business Unit head in charge of such Assigned Employees.
(c) Duties. The three Business Units shall be responsible for:
|
(i) |
|
taking any and all necessary actions to implement the approved
Annual Business Plan and strategic plans, as may be amended from time to time, |
27
|
|
|
either by mutual agreement of the Business Unit and the Global Support Team or
by the Steering Committee as described in Section 4.2(c); |
|
|
(ii) |
|
managing the day-to-day Roundup L&G Business; |
|
|
(iii) |
|
developing and submitting, in cooperation with the Global
Support Team all strategic and Annual Business Plans; |
|
|
(iv) |
|
communicating, in writing or via meetings, on a regular basis,
with the Global Support Team on all significant issues affecting the Roundup
L&G Business; and |
|
|
(v) |
|
notifying the Global Support Team of any deviation to the
Annual Business Plan, which, in their view, is reasonably likely to have a
financial impact on the Program EBIT of at least $500,000 or constitutes a
significant deviation from a non-financial item approved in the Annual Business
Plan (Significant Deviation). |
Section 4.4. Global Support Team.
(a) Appointment. Monsanto shall name three (3) individual employees of Monsanto to form a
support team (the Global Support Team) whose names and individual responsibilities are described
on Schedule 4.4(a) as attached hereto. Monsanto may from time to time substitute any individual
serving on the Global Support Team, with the written approval of the Agent, by providing a prior
written notice to the Agent to such effect.
(b) Duties. The Global Support Team shall be responsible to:
|
(i) |
|
participate actively in the development of all strategic and
Annual Business Plans; |
|
|
(ii) |
|
act as a liaison between any of Monsantos functions or
departments providing a support service to the Roundup Business (such as R&D,
regulatory, etc.) and monitor the quality of services rendered; |
|
|
(iii) |
|
provide stewardship for the Roundup brand image worldwide; |
|
|
(iv) |
|
prepare internal assessments of the performance of the Roundup
L&G Business for Monsanto management; |
|
|
(v) |
|
review, and approve any performance reviews prepared by the
Business Unit head for any of the Assigned Employees; |
28
|
(vi) |
|
participate in planned key customer interactions and program
presentations, either by participation in meetings or in preparatory sessions
therefor; |
|
|
(vii) |
|
review and approve any material change or deviation in
consumer communication, mass media, packaging design or any other marketing
tactic that directly impacts the consumer perception and interface with the
brand which may occur from time to time; |
|
|
(viii) |
|
review and approve any Significant Deviation from the Annual Business Plan;
and upon failure to agree with the Business Unit, prepare a recommendation to
submit to the Steering Committee for resolution, provided that the Business
Unit may similarly prepare a recommendation to submit to the Steering
Committee. |
ARTICLE 5 DUTIES AND OBLIGATIONS OF MONSANTO
Section 5.1. Monsantos Obligations and Rights. Subject to Section 2.2(a)(ii) and Article 3,
unless and until expressly directed otherwise by the Business Units, with the prior written
approval of the Steering Committee Monsanto shall continue to support the Roundup L&G Business by
performing necessary services. Notwithstanding the foregoing, at all times during the term of this
Agreement, Monsanto shall be solely responsible for the following functions:
(a) Research and Development. Monsanto shall, in its sole discretion, continue to develop new
Glyphosate-based herbicide formulations more particularly as described in Section 6.10 hereof;
(b) Regulatory Compliance. Monsanto shall be responsible for ensuring that all Roundup
Products and the labels for such products comply with the USEPA and applicable Laws of each state
and country within the Included Markets, including obtaining and maintaining all governmental
registrations, registration applications, temporary registrations, all data pertaining to such
registrations as submitted to governmental agencies, experimental use permits, applications and
emergency use exemptions, all with respect to the Roundup Products;
(c) FIFRA 6(a)(2). Monsanto shall be responsible for maintaining a customer response center
relating to Roundup Products, which will solely manage the medical response calls (including human
and animal health-related calls) and related FIFRA 6(a)(2) issues (the CRC). Monsanto shall be
responsible for all reports related thereto, including (without limitation) reports to any
regulatory or government authority pursuant to any applicable Law; and
(d) Sales Promotion. Monsanto shall, in accordance with the Annual Business Plan, promote the
sales and consumer acceptance of Roundup Products by:
29
(i) providing suitable training to the Agents representatives or employees in the areas of
product knowledge and product stewardship; and
(ii) providing the Agent and Customers with technical and product information, manuals,
promotional bulletins, presentation kits and other sales aid materials.
Section 5.2. Warranties. For Roundup Products with which Monsanto offers a written
warranty, whether within the meaning of the Magnuson-Moss WarrantyFederal Trade Commission
Improvement Act, 15 United States Code Annotated, Section 2301, or otherwise, Monsanto shall honor
those warranties in accordance with such terms.
ARTICLE 6 REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES
Section 6.1. Cooperation. The Agent and Monsanto shall cooperate with each other so as to
facilitate the objectives set forth in this Agreement and shall act in good faith and in a
commercially reasonable manner in performing their respective duties hereunder.
Section 6.2. Use of EDI. Monsanto, the Agent, the Steering Committee, and the Global Support
Team will exchange a broad range of operating data on a periodic basis. The method of exchange
will be approved by the Steering Committee and will include both file transfer and EDI protocol.
Section 6.3. The Agents Systems and Reporting Obligation. The Agent shall establish and
maintain all such systems and procedures (financial, logistical, or otherwise) as reasonably
requested by Monsanto or the Steering Committee in connection with the Agents performance under
this Agreement. For all reports, the data will include current period and current YTD; and
comparisons with same period and YTD for the year previous. Specifically, the Agent shall provide
the following reports:
(a) Weekly Reports. On the second business day of each week, the Agent shall provide to the
Global Support Team update reports for the prior week, showing: (i) dollar and case shipments by
the top 25 Customers and by SKU (stock keeping unit), (ii) inventory levels by SKU for North
America, (iii) collection activities by the top 25 Customers, (iv) agency fill rate for the top 10
Customers (Roundup Products ordered by Customers and shipped by the Agent by line item, unit and
dollar amount), and (v) POS sell-through by SKU by the top 7 Customers that provide such
information.
(b) Monthly Reports. On the sixth business day of each Month, the Agent shall provide to the
Steering Committee and Monsanto (i) the type of data contained in the weekly reports (as set forth
in Section 6.3(a)) for the prior calendar month and the current year-to-date, (ii) full P&L,
balance sheets and cash flow statements, (iii) Netback expense detail (accruals and actuals), (iv)
Expense detail (accruals and actuals), (v) Cost of Goods Sold detail, in each case comparing such
information against budget, and against the previous year.
30
(c) Quarterly Reports. The Agent shall provide to the Steering Committee and Monsanto, on a
Quarterly basis and on a form provided by the Steering Committee (i) a summary of purchases of
Roundup Products, in total cases or units, made by each Customer which is designated by the
Steering Committee, (ii) inventory level by SKU by Customer and (iii) updated full year forecast.
(d) Annual Reports. The Agent shall provide to the Steering Committee and Monsanto, on an
Annual basis and on a form provided by the Steering Committee (i) bridge and tracking capability
from Program Year to calendar year, (ii) a budget and (iii) a long range plan.
(e) Other Reports. In addition, the Agent shall provide Monsanto or the Steering Committee
with such other reports as may be reasonably requested within a period not to exceed thirty (30)
days from such request.
Section 6.4. Employee Incentives. Recognizing that, as Monsantos exclusive agent for sale
and distribution of Roundup Products, the Agent is to promote the sale of Roundup Products no less
aggressively than any other product or product line that the Agent sells, the Agent shall cause its
appropriate officers and other management to devote an appropriate portion of their personal
efforts to the sale and distribution of Roundup Products covered by this Agreement. Further, the
Agent shall ensure that the appropriate personnel are compensated in a manner to encourage them to
promote the sale of Roundup Products no less aggressively than any other product or product line
that the Agent sells.
Section 6.5. Insurance. The Agent, shall, during the term of this Agreement, maintain full
insurance against the risk of loss or damages to the Roundup Products for any Agents warehouse
where Roundup Products are under the custody of the Agent and, upon request, shall furnish Monsanto
with satisfactory evidence of the maintenance of said insurance. Further, each party shall make
all contributions and pay all payroll taxes required under federal social security laws and state
unemployment compensation laws or other payments under any laws of a similar character as to its
own personnel involved in the Roundup L&G Business (including any purported independent
contractors subsequently classified by any authority under any Law, as an employee) in connection
with the performance of this Agreement.
Section 6.6. Liens. Subject to the provisions of any existing intercreditor agreement to
which Monsanto is currently a party (as the same may be amended, modified or terminated) and except
as may otherwise be agreed to by Monsanto, which agreement shall not be unreasonably withheld in
the case of similar arrangements with existing or future institutional lenders, the Agent agrees
not to allow any liens or encumbrances of any nature to attach to Roundup Products. At Monsantos
request, the Agent, sub-agent, or sub-distributor shall execute such financing statements, security
agreements and other documents as Monsanto may reasonably request to create, perfect, and continue
in effect its security interests hereunder.
31
Section 6.7. Promoting Safe Use-Practices. Roundup Products may be or become hazardous unless
used in strict accordance with Monsantos product labels. The Agent shall use commercially
reasonable methods to inform and familiarize its employees, agents, Customers, contractors
(including warehousemen and transporters) and others who may handle or use Roundup Products of the
potential hazards pertaining thereto (including accidental breakage or fire), and shall stress the
safe use and application of Roundup Products in strict accordance with Monsantos product labels.
In addition, the Agent shall provide HM126F training to its personnel as required by the United
States Department of Transportation (and such other training as may be required by other countries
within the Included Markets). The Agent shall have the responsibility to dispose of waste
materials in accordance with all applicable Laws.
Section 6.8. Monsanto Inspection Rights. From time to time, as Monsanto or the Steering
Committee may request, the Agent shall permit, upon reasonable request and during normal business
hours, representatives of Monsanto or the Steering Committee to inspect, with regard to Roundup
Products, the Agents inventories, warehousing, and shipping procedures.
Section 6.9. Recalls. The Agent shall cooperate with Monsanto, and promptly take such actions
as requested by Monsanto, with respect to any defective product including any stop-sales or
recalls for Roundup Products.
Section 6.10. New Roundup Products. During the term of this Agreement, Monsanto covenants and
agrees to first offer (the Product Offer) to the Agent the exclusive agency and distribution
rights to any newly created non-selective herbicide product, which is not marketed for Lawn and
Garden Use as of the date of this Agreement, and which Monsanto, in its exclusive, reasonable
discretion, determines to be suitable for sale as a new product for Lawn and Garden Use (the New
Product); provided, however, that for the Lawn and Garden Market, that any new product containing
Glyphosate or another non-selective herbicide shall be considered to be a New Product. The Product
Offer shall be in writing, shall be in sufficient detail describing such New Product, and shall be
made within sixty (60) days of the date of commercialization of such New Product for uses other
than Lawn and Garden Use. In no event shall Monsanto, directly or indirectly, commercialize any
New Product for Lawn and Garden Use without first offering such New Product to the Agent pursuant
to the terms of this Section 6.10. If the Agent agrees in writing within ninety (90) days of
receipt of the Product Offer to accept the New Product, then such New Product shall be, without
further action or amendment, included within the definition of Roundup Products and be subject to
the terms and conditions of this Agreement. In such event, the parties shall adjust the Commission
Thresholds to reflect this additional source of revenue unless the New Product is a
Glyphosate-based product or an improvement of any existing Roundup Products in which case the
Commission Thresholds shall remain the same. If the Agent fails to agree in writing to accept the
Product Offer within such ninety (90) days of receipt, then Monsanto shall have the exclusive right
to manufacture, package, promote, distribute, and sell such New Product, regardless of any actual
or potential conflict with the terms of Agreement.
Section 6.11. [Intentionally Omitted.]
32
Section 6.12. Confidentiality. Except as necessary for its performance under this Agreement,
except as may be required by the federal securities laws or other applicable laws and except to the
extent required under certain existing agreements to which Monsanto is a party (i.e., AHP
Merger Agreement), neither party shall at any time or in any manner, either directly or indirectly,
and neither party shall permit its employees to use, divulge, disclose or communicate to any person
or entity any confidential information of the other party. For purposes of this Section 6.12,
confidential information includes any information of any kind, nature, or description that is
proprietary, treated as confidential by, owned by, used by, or concerning any matters affecting or
relating to the business of a party or the subject matter of this Agreement, including but not
limited to, the names, business patterns and practices of any of its customers, its marketing
methods and related data, the names of any of its vendors and suppliers, the prices it obtains or
has obtained or at which it sells or has sold products or services, lists, other written records,
and information relating to its manner of operation. Notwithstanding the foregoing, confidential
information shall not include any information which (i) is or becomes public knowledge through no
fault or wrongful act of the party disclosing such information or its employees, (ii) was known by
such party prior to any agency or distributor relationship with the other party or any predecessor,
(iii) is received by such party pursuant to the Formulation Agreement and which is not otherwise
confidential information, or (iv) is received from a third party who is not obligated to keep such
information confidential. All confidential information in any form (electronic or otherwise)
shall be and remain the sole property of the party possessing such information and shall be
returned to such party upon the termination of this Agreement upon such partys reasonable request.
Section 6.13. Noncompetition.
(a) Noncompetition Period. The Noncompetition Period shall be the term of this Agreement,
and for the two-year period following the termination, cancellation or non-renewal of this
Agreement; provided, however, that in the event (i) Monsanto terminates this Agreement
pursuant to Section 10.4(a)(2), (ii) Monsanto does not renew the EU Term pursuant to Section 10.2
or (iii) the Agent terminates this Agreement pursuant to Section 10.5(a), the Noncompetition Period
shall be deemed to terminate simultaneously upon the effective date of the termination of this
Agreement or, in the case of non-renewal of any EU Term pursuant to Section 10.2 upon termination
thereof with respect to EU Countries only.
(b) Monsanto Covenant. Except as provided for in Section 3.8, Monsanto covenants and agrees
that for the Noncompetition Period, Monsanto will not, nor will it permit any Affiliate to,
directly or indirectly, own, manage, operate or control, or participate in the ownership,
management, operation or control of, or be connected with or have any interest in, as a
shareholder, partner, creditor or otherwise, any Competitive Business. A Competitive Business
shall be any business which, anywhere within the Included Markets, (x) manufactures, sells, markets
or distributes any non-selective weed control product, whether residual or non-residual, for Lawn
and Garden Use or (y) competes with the Roundup L&G Business; provided,
however, this Section 6.13(b) shall not apply to those actions of Monsanto or any Affiliate
(i) to
33
the extent such actions are expressly contemplated by this Agreement, for the duration of
this Agreement, (ii) to the extent that immediately upon termination of this Agreement for whatever
reason Monsanto or any Affiliates or successor to the Roundup L&G Business shall continue to
operate the Roundup L&G Business without infringing this covenant, or (iii) to the extent that
Monsantos interest in a Competitive Business, as a shareholder, partner, creditor or otherwise, is
equal to or less than 5%. Furthermore, this Section 6.13(b) shall not apply to any actions taken
by Monsanto as authorized by Section 10.7(a) during and after any period when Monsanto has given
notice of termination in accordance with Section 10.4(b).
(c) Agents Covenant. The Agent covenants and agrees that during the Noncompetition Period,
the Agent will not, nor will it permit any Affiliate to, directly or indirectly, own, manage,
operate or control, or participate in the ownership, management, operation or control of, or be
connected with or have any interest in, as a shareholder, partner, creditor or otherwise, any
Competitive Business; provided, however, this Section 6.13(c) shall not apply to those
actions of the Agent or any Affiliate (i) to the extent such actions are expressly contemplated by
this Agreement, for such term of this Agreement; (ii) to the extent such actions relate to the
products listed on Exhibit D hereto in the countries listed therein, the products that the
Agent either owns, has contracted to purchase or entered into a letter of intent with respect to as
of the Effective Date and such additional products as the parties may from time to time agree (the
Permitted Products); (iii) to the extent that the Agents interest in a Competitive Business, as
a shareholder, partner, creditor or otherwise, is equal to or less than 5%; or (iv) to any separate
agreement with Monsanto with respect to transgenic technology sharing. The parties agree to compile
a list of the Permitted Products within sixty (60) days after the Effective Date which shall be
substituted as Exhibit D.
(d) Non-Solicitation by Monsanto. Monsanto agrees that for the duration of the Noncompetition
Period and for the two years thereafter, without the prior written consent of the Agent, it will
not, nor will it permit any of its Affiliates to (i) solicit for employment any person then
employed by the Agent or any of its Affiliates or (ii) knowingly employ any employee of the Agent
or any of its Affiliates who voluntarily terminates such employment with the Agent (or such
Affiliate) after the Effective Date, until three months have passed following termination of such
employment.
(e) Non-Solicitation by the Agent. The Agent agrees that for the duration of the
Noncompetition Period, without the prior written consent of Monsanto, it will not, nor will it
permit any of its Affiliates to (i) solicit for employment any person then employed who works
primarily with Roundup Products or with other products with Lawn & Garden Uses (Lawn & Garden
Employee) by Monsanto or any of its Affiliates or (ii) knowingly employ any Lawn & Garden Employee
of Monsanto or any of its Affiliates who voluntarily terminates such employment with Monsanto (or
such Affiliate) after the Effective Date, until three months have passed following termination of
such employment.
(f) Consideration. The consideration for the agreements contained in this Section 6.13 are
the mutual covenants contained herein, the agreement of the parties to
34
consummate the purchase of the Non-Roundup Assets, and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged.
(g) Modification. In the event a court (or other authority) refuses to enforce the covenants
and agreements contained in this Section 6.13, either because of the scope of the geographical area
specified in this Section 6.13, the duration of the restrictions, or otherwise, the parties hereto
expressly confirm their intention that the geographical areas covered hereby, the time period of
the restrictions, or such other provision, be deemed automatically reduced to the minimum extent
necessary to permit enforcement.
(h) Injunctive Relief. The parties acknowledge and agree that the extent of damages to one
party (the non-breaching party) in the event of an actual or threatened breach of this Section
6.13 by the other party (the breaching party) may be impossible to ascertain and there may be
available to the non-breaching party no adequate remedy at law to compensate the non-breaching
party in the event of such an actual or threatened breach by the breaching party. Consequently,
the parties agree that, in the event that either party breaches or threatens to breach any such
covenant or agreement, the non-breaching party shall be entitled, in addition to any other remedy
or relief to which it may be entitled, including without limitation, money damages, to seek to
enforce any or all of such agreements or covenants against the breaching party by injunctive or
other equitable relief ordered by any court of competent jurisdiction.
Section 6.14. Industrial Property.
(a) Monsanto represents and warrants that Monsanto or Affiliates are the exclusive owners of
the trademarks, trade names, packages, copyrights and designs used in the sale of Roundup Products
(hereinafter referred to as Industrial Property). To Monsantos knowledge, the conduct of the
Roundup L&G Business as now being conducted and the use of the Industrial Property in the conduct
of the Roundup L&G Business, do not infringe or otherwise conflict with any trademarks,
registrations, or other intellectual property or proprietary rights of others, nor has any claim
been made that the conduct of the Roundup L&G Business as now being conducted infringes or
otherwise is covered by the intellectual property of a third party, except for any conflict or
infringement which would not have a material adverse effect. To the knowledge of Monsanto, none of
the Industrial Property is currently being infringed upon by a third party.
(b) The Agent acknowledges the validity of the trademarks which designate and identify Roundup
Products. The Agent further acknowledges that Monsanto is the exclusive owner of the Industrial
Property.
(c) The Agent agrees that, to the extent it uses Industrial Property, such Industrial Property
shall be used in its standard form and style as it appears upon Roundup Products or as instructed
in writing by Monsanto. No other letter(s), word(s), design(s), symbol(s) or other matter of any
kind shall be superimposed upon, associated with or shown in such proximity to the Industrial
Property so as to tend to alter or dilute such Industrial Property,
35
and the Agent further agrees
not to combine or associate any of such Industrial Property with any
other industrial property. The generic or common name of Roundup must always follow Roundup
Products trademarks.
(d) In all advertisements, sales and promotional or other printed matter in which any
Industrial Property appears, the Agent shall identify itself by full name and address and state its
relationship to Monsanto. In all such material, the Roundup trademark shall be identified as a
trademark owned by Monsanto Company. In the case of a registered trademark, a ® shall be placed
adjacent to the trademark with the ® referring to a footnote reading ® Registered trademark of
Monsanto Company. In the case of unregistered trademarks, a TM shall be placed adjacent to the
trademark with the TM referring to a footnote reading TM Trademark of Monsanto Company.
(e) On its letterheads, business cards, invoices, statements, etc., the Agent may identify
itself as a distributor for the Industrial Property.
(f) The Agent agrees that it will never use any Industrial Property or any simulation of such
Industrial Property as part of the Agents corporate or other trading name or designation of any
kind.
(g) Upon expiration or in the event of any termination of this Agreement, the Agent shall
promptly discontinue every use of the Industrial Property and any language stating or suggesting
the Agent is a distributor for Roundup Products. All advertising and promotional materials which
use Industrial Property shall be destroyed.
(h) The Agent shall not use or facilitate the use of promotional materials which disparage
Roundup Products or Industrial Property. If the Agent should become aware of any suspected
counterfeiting of Roundup Products or Industrial Property, the Agent shall promptly notify Monsanto
of such suspected counterfeiting. The Agent shall cooperate in any investigation or legal
proceedings that Monsanto deems desirable to protect its rights in the Industrial Property. The
Agent shall not promote the sale of products using trademarks, packages or designs which are in
Monsantos opinion deceptively similar to Industrial Property.
Section 6.15. Conflicts of Interest. Conflicts of interest relating to this Agreement are
strictly prohibited. Except as otherwise expressly provided herein, neither party nor any of its
directors, employees or agents, or its subcontractors or vendors shall give to or receive from any
director, employee or agent of the other party any gift, entertainment or other favor of
significant value, or any commission, fee or rebate. Likewise, neither party nor its directors,
employees or agents or its subcontractors or vendors shall, without prior written notification
thereof to the other party, enter into any business relationship with any director, employee, or
agent of the other party or any of its Affiliates unless such person is acting for and on behalf of
such party. Each party shall promptly notify the other of any violation of this Section 6.15 and
any consideration received as a result of such violation shall be paid over or credited to the
other party.
36
Section 6.16. Records Retention. The Agent and Monsanto shall each maintain true and complete
records in connection with this Agreement and shall retain all such records for at least
forty-eight (48) months following the termination or expiration of this Agreement. This obligation
shall survive the termination or expiration of this Agreement.
ARTICLE 7 CENTRAL AGREEMENTS
Section 7.1. Acknowledgment of Central Agreements. The parties acknowledge that Monsanto is a
party to, and bound by the terms and obligations of, the Central Agreements (which are attached
hereto as Exhibit A). Accordingly, the parties acknowledge that (i) some of the terms and
conditions of this Agreement may conflict with the terms and conditions of the Central Agreements,
and/or (ii) some of the terms and conditions of the Central Agreements may conflict with, or be
prohibited by, the terms and conditions of this Agreement. (Every such conflict or prohibited term
or condition within the meaning of clause (i) or (ii) of this Section 7.1 shall collectively be
referred to as a Conflict). This Article 7 sets forth the parties agreement as to the effect on
this Agreement of such a Conflict.
Section 7.2. Notice of Termination. Monsanto hereby represents and warrants to the Agent that
on June 26, 1998, Monsanto provided to Central proper notice of Monsantos intent to terminate the
Central Agreements, effective September 30, 1999, which such notice is attached hereto as
Exhibit B.
Section 7.4. Conflict. Notwithstanding anything in this Agreement (or any agreement between
the parties) to the contrary, during the duration of the term of the Central Agreements (as may be
further amended subject to the prior written consent of the Agent), to the extent that any term or
provision (taken alone or in conjunction with any other term or provision) of this Agreement
results in a Conflict (such term(s) or provision(s) being referred to herein as a Conflicting
Provision), (i) the provision(s) of the Central Agreement shall control and such Conflicting
Provision shall be unenforceable against all parties to this Agreement during the pendency of such
Conflict, and (ii) neither party shall be considered to be in breach or default of any such
Conflicting Provision, either directly or as a result of such Conflict, on any other terms and
conditions of this Agreement; provided, however, in such instance of a Conflict, all other
provisions of this Agreement (i.e. all provisions, excluding all Conflicting Provisions) shall be
interpreted and enforced in such manner as is reasonable and necessary to further the intentions
and contemplations of this Agreement.
Section 7.6. Action by Parties and Assignment of Rights. The parties covenant and agree to
jointly develop an approach to establishing arrangements or relationships with Central to account
for any Conflicting Provisions. In this regard, Monsanto covenants and agrees that, upon
notification by the Agent of a Conflict, the Agent may, to the extent reasonable and with the
Steering Committees prior written consent (which such consent shall not be unreasonably held),
enter into a contract (or other arrangement) directly (or on behalf of Monsanto) with Central for such
time until September 30, 1999, as the Agent deems necessary so that the parties to this Agreement
can further the intentions and contemplations hereof. Furthermore, Monsanto
37
covenants and agrees
that, to the extent reasonable and pre-approved by the Steering Committee (which such approval
shall not be unreasonably held), Monsanto will assign to the Agent any and all rights it has
pursuant to the Central Agreements, which the Agent reasonably requests, if such assignment would
benefit the parties in furthering the intentions and contemplations hereof.
ARTICLE 8 REPRESENTATIONS, WARRANTIES, AND COVENANTS
Section 8.1. The Agents Representations and Warranties. The Agent hereby represents and
warrants that all of the following are true:
(a) The Agent is a corporation duly incorporated, validly existing and in good standing under
the laws of Ohio and has all requisite corporate power and authority to carry on and conduct its
business as it is now being conducted, to own or lease its assets and properties and is duly
qualified and in good standing in every jurisdiction in which the conduct of its business or
ownership of its assets requires it to be so qualified.
(b) (i) The Agent has the full authority and legal right to carry out the terms of this
Agreement; (ii) the terms of this Agreement will not violate the terms of any other material
agreement, contract or other instrument to which it is a party, and no consent or authorization of
any other person, firm, or corporation is a condition precedent to the Agents execution of this
Agreement; (iii) it has taken all action necessary to authorize the execution and delivery of this
Agreement; and (iv) this Agreement is a legal, valid, and binding obligation of the Agent,
enforceable in accordance with its terms.
(c) The Agent is in compliance in all material respects with all applicable Laws relating to
its business.
(d) There is no material suit, investigation, action or other proceeding pending or threatened
before any court, arbitration tribunal, or judicial, governmental or administrative agency, against
the Agent which would have a material adverse effect on the ability of the Agent to perform its
obligations hereunder or which seeks to prevent the consummation of the transactions contemplated
herein.
(e) The Agent has available, and will have available on September 30, 1998, sufficient
immediately available funds to enable the Agent to pay the Marketing Fee to Monsanto and to effect
the consummation of the transactions described herein.
(f) There are no material disputes with underwriters under the Agents insurance policies;
each such policy is valid and enforceable in accordance with its terms and is in full force and
effect; there exists no default by the Agent under any such policy, and there has
been no material misrepresentation or inaccuracy in any application therefor, which default,
misrepresentation or inaccuracy would give the insurer the right to terminate such policy, binder,
or fidelity bond or to refuse to pay a claim thereunder; and the Agent has not received notice of
cancellation or non-renewal of any such policy.
38
Section 8.2. Monsantos Representations and Warranties. Monsanto hereby represents and
warrants that all of the following are true:
(a) Monsanto is a corporation duly incorporated, validly existing and in good standing under
the laws of Delaware and has all requisite corporate power and authority to carry on and conduct
its business as it is now being conducted, to own or lease its assets and properties and is duly
qualified and in good standing in every jurisdiction in which the conduct of its business or
ownership of its assets requires it to be so qualified.
(b) (i) Monsanto has the full authority and legal right to carry out the terms of this
Agreement; (ii) the terms of this Agreement will not violate the terms of any other material
agreement, contract or other instrument to which it is a party, and no consent or authorization of
any other person, firm, or corporation is a condition precedent to this Agreement; (iii) it has
taken all action necessary to authorize the execution and delivery of this Agreement; and (iv) this
Agreement is a legal, valid, and binding obligation of Monsanto, enforceable in accordance with its
terms.
(c) Monsanto is in compliance, in all material respects, with all applicable Laws relating to
its business.
(d) There is no material suit, investigation, action or other proceeding pending or threatened
before any court, arbitration tribunal, or judicial, governmental or administrative agency, against
Monsanto which would have a material adverse effect on the ability of Monsanto to perform its
obligations hereunder or which seeks to prevent the consummation of the transactions contemplated
herein.
ARTICLE 9 INDEMNIFICATION
Section 9.1. Indemnification and Claims Procedure.
(a) Indemnification. Each party hereto agrees to indemnify, defend and hold harmless the
other party and its employees, officers, directors, agents and assigns from and against any and all
loss (including reasonable attorneys fees), damage, injury or liability and asserted by or on
behalf of a third party for injury to or death of a person for loss of or damage to property,
including employees and property of the indemnified party (Loss), to the extent resulting
directly or indirectly from the indemnifying partys (i) breach of a duty, representation, or
obligation of this Agreement, or (ii) negligence or willful misconduct in the performance of its
obligations under this Agreement, except to the extent that such indemnification is void or
otherwise unenforceable under applicable law in effect on or validly retroactive to the date
of this Agreement.
(b) Claims Procedure. Promptly after receipt by either party hereto (the Indemnitee) of any
notice of any demand, claim or circumstances which, with the lapse of
39
time, would or might give
rise to a claim or the commencement (or threatened commencement) of any action, proceeding or
investigation (an Asserted Liability) that may result in a Loss, the Indemnitee shall give notice
thereof (the Claims Notice) to the party obligated to provide indemnification pursuant to Section
9.1(a). The Claims Notice shall describe the Asserted Liability in reasonable detail, and shall
indicate the amount (estimated, if necessary to the extent feasible) of the Loss that has been or
may be suffered by the Indemnitee. Thereafter, the following procedures shall apply:
(1) The indemnifying party may elect to compromise or defend, at its own expense by its own
counsel, any Asserted Liability;
(2) If the indemnifying party elects to compromise or defend such Asserted Liability, it shall
within thirty (30) days (or sooner if the nature of the Asserted Liability so requires) notify the
Indemnitee of its intent to do so, and the Indemnitee shall cooperate, at the expense of the
indemnifying party, in the compromise of, or defense against, such Asserted Liability, and shall
make available to the indemnifying party any books, records or other documents within its control
that are necessary or appropriate for such defense;
(3) If the indemnifying party has elected to defend the Asserted Liability, any offer to
compromise or settle transmitted to the indemnifying party shall thereafter be transmitted in
writing to the Indemnitee. If, after a reasonable period of time to consider such offer which
time shall be deemed to be ten (10) days from the date of transmittal of such offer using the
notice procedures set forth in Section 11.9, unless the circumstances otherwise require the
Indemnitee refuses to give consent to the settlement or compromise of the Asserted Liability, then
the liability of the indemnifying party with respect to such Asserted Liability shall be thereafter
limited to the amount of the offer of settlement or compromise. This cap on liability shall not be
applicable if the Indemnifying Party does not elect to defend Indemnitee against the Asserted
Liability;
(4) Notwithstanding the foregoing, neither the indemnifying party nor the Indemnitee may
settle or compromise any claim over the objection of the other, provided however, that consent to
settlement or compromise shall not be unreasonably withheld;
(5) If the indemnifying party elects not to compromise or defend the Asserted Liability, fails
to notify the Indemnitee of its election as herein provided, or contests its obligation to
indemnify under this Agreement, the Indemnitee may pay, compromise or defend such Asserted
Liability, with a reservation of all rights to seek indemnification hereunder against the
indemnifying party; and
(6) Notwithstanding the foregoing, the Indemnitee and the indemnifying party may participate,
in all instances, and at their own expense, in the defense of any Asserted Liability.
40
ARTICLE 10 TERMS, TERMINATION, AND FORCE MAJEURE
Section 10.1. Terms. Notwithstanding anything in this Agreement to the contrary, for all EU
Countries within the Included Markets, this Agreement shall be subject to the initial term and the
renewal terms, as set forth in Section 10.2(a) (collectively, the EU Term). For all other
countries within the Included Markets, excluding the EU Countries, this Agreement shall commence as
of the Effective Date and shall continue unless and until terminated as provided herein.
Section 10.2. EU Initial Term and Renewal.
(a) For each of the EU Countries within the Included Markets, the initial term of this
Agreement shall commence as of the Effective Date, and continue through September 30, 2005, unless
and until sooner terminated as provided herein. Following the initial term of this Agreement, the
parties have the following options to renew the EU Term of this Agreement, subject to Section 10.3
below, under the same terms and conditions of this Agreement, unless and until sooner terminated as
provided herein:
(1) The parties may mutually agree to renew the initial EU Term of this Agreement for three
(3) years, unless otherwise prohibited herein;
(2) Following the renewal of the EU Term pursuant to Section 10.2(a)(1), the parties may
mutually agree to renew the EU Term of this Agreement for an additional seven (7) years, unless
otherwise prohibited herein; and
(3) Following the renewal of the EU Term pursuant to Section 10.2(a)(2), the parties may
mutually agree to renew the EU Term of this Agreement for three (3) years, unless otherwise
prohibited herein.
Section 10.3. Procedure to Renew.
EU Term. Not later than 6 months preceding the date in which the initial EU Term, or any
renewal EU Term, of this Agreement terminates pursuant to section 10.2(a), the parties may (if
otherwise permitted herein), mutually agree in writing to renew the EU Term of this Agreement as
provided in Section 10.2(a).
Section 10.4. Termination by Monsanto.
(a) Termination Rights. In addition to its right to terminate this Agreement pursuant to
Section 10.9, Monsanto shall have the right to terminate this Agreement by giving the Agent a
termination notice specified for each termination event upon the occurrence and continuance of
either of the following:
(1) An Event of Default occurring at any time; or
41
(2) A Change of Control with respect to Monsanto (excluding the merger currently contemplated
with American Home Products) or a Roundup Sale by giving the Agent a notice of termination, which
termination shall be effective at the end of the later of twelve (12) months or the next Program
Year, provided that in the event of a Change of Control or a Roundup Sale, neither Monsanto nor the
successor to the Roundup L&G Business shall have the right to terminate this Agreement prior to the
end of the fifth (5th) Program Year.
(b) Event of Default. An Event of Default shall mean any of the following occurrences:
(1) a Material Breach of this Agreement committed by the Agent and established in accordance
with the provisions of Section 10.4(g) of this Agreement;
(2) a Material Fraud committed by the Agent and established in accordance with the provisions
of Section 10.4(g) of this Agreement;
(3) Material Willful Misconduct committed by the Agent and established in accordance with the
provisions of Section 10.4(g) of this Agreement;
(4) (i) the occurrence of an Egregious Injury which is not cured within ninety (90) days
following the Agents receipt of written notice thereof, or (ii) the occurrence of an Egregious
Injury which, in the commercially reasonable opinion of Monsanto cannot be cured within a ninety
(90) day period;
(5) subject to Section 10.8, any decline of the Sell-Through Business on a three (3) Program
Years cumulative basis or two (2) consecutive Program Years with a decline in the Sell-Through
Business in each Program Year in excess of five percent (5%) either in North America, the UK or
France or in the Rest of the World, (Regional Performance Default) unless Agent demonstrates to
the Arbitrators in accordance with Section 10.4(g), in any manner reasonably requested by the
Arbitrators that (A) such decline is directly caused by the exercise by Monsantos Ag president of
his or her right of veto as provided for in Section 4.2(b) or (B) such decline was caused primarily
by a severe decline of the general economic conditions or an overall severe decline in the market
for lawn and garden consumables products in such region rather than by the Agents failure to
perform its duties hereunder and further provided that any Regional Performance Default shall only
cause the termination of this Agreement with respect to the region where such Regional Performance
Default occurs;
(6) the Insolvency of Agent;
(7) the occurrence of a Change of Control of the Agent, without the prior written consent of
Monsanto; provided that the Acquiror in such Change of Control (i) currently engages (directly or
through its Affiliates) in the manufacture, sale, marketing, or distribution of any product
containing Glyphosate or any similar active ingredient, or (ii) currently sells, markets, or
distributes (directly or through its Affiliates) any product(s) in the
42
Lawn and Garden Channels for
Lawn and Garden Use, which such product(s), in Monsantos reasonable commercial opinion, compete in
a material manner with Roundup Products, or (iii) may, in Monsantos reasonable commercial opinion,
materially detract from, or diminish, the Agents (or such successors) ability to fulfill its
duties and obligations with regard to the Roundup Business, or (iv) competes in any material
respect with Monsanto in Monsantos Ag (including seed) or biotech businesses.
(8) the occurrence of a Change of Significant Ownership of the Agent, without the prior
written consent of Monsanto; or
(9) except to the extent permitted herein, (i) the assignment of all, or substantially all, of
the Agents rights, or (ii) the delegation of all, or substantially all, of the Agents obligations
hereunder, in either instance without the prior written consent of Monsanto.
As to any Event of Default defined in Sections 10.4(b)(1)-(4), such termination shall take
effect on the later of the first business day following the thirtieth (30th) day after
the sending of a termination notice to the Agent in accordance with the provisions of Section 11.9,
or the date designated by Monsanto in said termination notice. As to an Event of Default defined
in Section 10.4(b)(5), such termination shall take effect at the later of twelve (12) months or the
end of the next Program Year. As to any Event of Default defined in Sections 10.4(b)(6)-(9), such
termination shall take effect on the later of the first business day following the seventh
(7th) day after the sending of a termination notice to Agent, or the date designated by
Monsanto in said notice of termination.
(c) Payment of Termination Fee. Except for termination of this Agreement by Monsanto upon any
Event of Default, a Termination Fee (as specified in Section 10.4.(d)) shall only be paid either by
Monsanto or by the successor to the Roundup Business, as the case may be, upon the following terms
and conditions:
|
(1) |
|
in the event the Agreement is effectively
terminated by either Monsanto or its successor or by the Agent upon
Material Breach, Material Fraud or Material Willful Misconduct by
Monsanto as provided for in Section 10.5.(c); |
|
|
(2) |
|
no later than the effective date of the
applicable termination notice and no later than the effective date of
the termination; and |
|
|
(3) |
|
only in the event the Agent does not become the
successor to the Roundup Business, in which case the Termination Fee
shall not be paid but shall be credited against the purchase price as
described in Section 10.4(d). |
43
(d) Termination Fee.
Monsanto and the Agent stipulate and agree that the injury which will be caused to the Agent
by the termination of this Agreement under the circumstances which shall give rise to the payment
of the Termination Fee are difficult or impossible of accurate estimation; that by establishing the
Termination Fee they intend to provide for the payment of damages and not a penalty; and that the
sum stipulated for the Termination Fee is a reasonable pre-estimate of the probable loss which will
be suffered by the Agent in the event of such termination.
The Termination Fee payable shall vary in accordance with the Table hereunder:
|
|
|
Program Year |
|
Termination Fee |
0-5
|
|
$150MM* |
6
|
|
$140MM |
7
|
|
$130MM |
8
|
|
$120MM |
9
|
|
$110MM |
10
|
|
$100MM |
11-20
|
|
Seven and a half percent (7.5%) of the portion of the
purchase price for the Roundup Sale above $1.2 billion (which
shall be no less than $16MM in any event) provided that in
the event of a Change of Control and subsequent termination
of this Agreement by the successor to the Roundup Business
and the absence of any purchase price, the fair market value
of the Roundup Business shall be determined by an independent
accounting firm mutually agreeable to the parties. |
|
|
|
* |
|
$185MM if Monsanto or any successor terminates within the first five (5) years for anything other
than an Event of Default on the part of the Agent. |
(e) Remedies for Monsanto. Subject to Section 10.4(g), in case of termination by Monsanto
upon any of the Events of Default by the Agent specified in Section 10.4(b)(1)-(4), Monsanto shall
be entitled to exercise all remedies available to it, either at law or in equity. In case of
termination by Monsanto upon the Event of Default by the Agent specified in Section 10.4(b)(5),
termination of this Agreement shall be the exclusive remedy of Monsanto. In
44
the case of
termination by Monsanto upon any of the Events of Default specified in
Sections 10.4(b)(6)-(9), the remedies of Monsanto shall be limited to (i) termination of this
Agreement and (ii) the recovery of reasonable and customary out-of-pocket expenses incurred by
Monsanto in transferring the Agents duties hereunder to a new agent; provided that in no case
shall the amount of expenses recoverable under this provision exceed $20MM.
(f) Exclusive Remedy. The payment of a Termination Fee to the Agent under Section 10.4(c)
shall be deemed to constitute the exclusive remedy for any damages resulting out of the termination
of this Agreement by Monsanto or the successor to the Roundup Business pursuant to Section 10.4(c)
and the Agent shall waive its right to exercise any other remedies otherwise available at law or in
equity.
(g) Arbitration. In the event either party claims that a Material Breach, a Material Fraud,
or Material Willful Misconduct has been committed by the other party (the Breaching Party), the
following procedures shall apply:
(1) After the asserted occurrence of a Material Breach, a Material Fraud, or Material Willful
Misconduct, the party who contends that such breach, fraud or misconduct has occurred (the
Claimant) shall send to the Breaching Party a notice, in accordance with the notice provisions of
Section 11.9 of this Agreement, in which the Claimant shall: (i) identify the Material Breach,
Material Fraud, or Material Willful Misconduct which it contends has occurred; (ii) appoint an
arbitrator; and (iii) demand that the Breaching Party appoint an arbitrator.
(2) Within fifteen (15) days after receipt of the notice, the Breaching Party shall send a
response to the Claimant, in accordance with the notice provisions of Section 11.9 of this
Agreement, in which the Breaching Party shall: (i) indicate whether it contests the asserted
occurrence of the Material Breach, Material Fraud, or Material Willful Misconduct, as the case may
be; and (ii) if it does contest such asserted occurrence, appoint a second arbitrator. The failure
on the part of the Breaching Party to timely respond to the notice, and/or to timely appoint its
arbitrator, shall be deemed to constitute acceptance of the arbitrator designated by the Claimant
as the sole arbitrator.
(3) If the Breaching Party appoints an arbitrator, then within fifteen (15) days after the
receipt of the Breaching Partys response by the Claimant, the two arbitrators shall jointly
appoint a third arbitrator. If the arbitrators selected by the parties are unable or fail to agree
upon the third arbitrator, the third arbitrator shall be selected by the American Arbitration
Association. Upon their selection by either means, the three arbitrators (the Arbitrators) shall
expeditiously proceed to determine whether a Material Breach, Material Default or Material Willful
Misconduct has occurred, in accordance with the procedures hereafter set forth.
(4) Except as specifically modified herein, the arbitration proceeding contemplated by this
section (the Arbitration) shall be conducted in accordance with Title 9 of the US Code (United
States Arbitration Act) and the Commercial Arbitration Rules of the American Arbitration
Association, and judgment on the award rendered by the arbitrators may be
45
entered in any court
having jurisdiction thereof. The cost of the Arbitration shall be borne equally by the parties,
with the understanding that the Arbitrators may reimburse the prevailing party, if
any, as determined by the Arbitrators for that partys cost of the Arbitration in connection with
the award made by the Arbitrators as described below.
(5) The award shall be made within three (3) months after the appointment of the third
Arbitrator, and each of the Arbitrators shall agree to comply with this schedule before accepting
appointment. However, this time limit may be extended by agreement of the parties or by the
Arbitrators, if necessary.
(6) Consistent with the expedited nature of arbitration, each party will, upon the written
request of the other party, promptly provide the other with copies of documents relevant to the
issues raised by the notice or the response, including those documents on which the producing party
may rely in support of or in opposition to any claim or defense. Any dispute regarding discovery,
or the relevance or scope thereof, shall be determined by the Arbitrators, which determination
shall be conclusive. All discovery shall be completed within 60 days following the appointment of
the third Arbitrator.
(7) At the request of a party, the Arbitrators shall have the discretion to order examination
by deposition of witnesses to the extent the Arbitrators deem such additional discovery relevant
and appropriate. Depositions shall be held within 30 days of the making of a request, and shall be
limited to a maximum of number of hours duration as may be mutually agreed to by the parties, or
in the absence of such agreement as may be determined by the Arbitrators. All objections are
reserved for the arbitration hearing, except for objections based on privilege and proprietary or
confidential information.
(8) Either party may apply to the Arbitrators seeking injunctive relief until the arbitration
award is rendered or the controversy is otherwise resolved. Either party also may, without waiving
any remedy under this Agreement, seek from any court having jurisdiction any interim or provisional
relief that is necessary to protect the rights or property of that party, pending the establishment
of the arbitral tribunal (or pending the arbitral tribunals determination of the merits of the
controversy).
(9) The scope of the Arbitration shall include the following:
(a) a determination as to whether the act(s) or omission(s) set forth by the Claimant have
occurred;
(b) a determination as to whether those act(s) or omissions(s) determined to have occurred
constitute a breach of this Agreement, fraudulent conduct in connection with this Agreement, or
willful misconduct in connection with this Agreement, as the case may be;
46
(c) a determination as to whether those act(s) or omissions(s) determined to have occurred
constitute a Material Breach, a Material Fraud, or Material Willful Misconduct, as the case may be;
(d) a determination as to the amount of monetary damages, if any, suffered by the Claimant, as
a result of those act(s) or omissions(s) determined to have occurred which constitute a breach of
this Agreement, fraudulent conduct in connection with this Agreement, or willful misconduct in
connection with this Agreement, as the case may be, regardless of whether such act(s) or
omission(s) rise to the level of Material Breach, Material Fraud, or Material Willful Misconduct,
as the case may be;
(e) a determination, to the extent applicable, of the specific performance which could and
should be decreed to correct any breach, fraud or material misconduct which the Arbitrators
determine can be cured by the issuance of such decree;
(f) a determination as to which party, if any, is the prevailing party in the Arbitration, and
the amount of such partys costs and fees. Costs and fees means all reasonable pre-award expenses
of the arbitration, including the arbitrators fees, administrative fees, travel expenses,
out-of-pocket expenses such as copying and telephone, court costs, witness fees, and attorneys
fees; and
(g) a determination as to such matters as the Arbitrators deem necessary and appropriate to
carry out their duties in connection with the Arbitration.
(10) The Arbitrators award shall be in writing, shall be signed by a majority of the
Arbitrators, and shall include a statement regarding the reasons for the disposition of any claim.
(11) The Arbitrators award shall, as applicable, include the following:
(a) to the extent that the Arbitrators determine that the Claimant has suffered monetary
damages as a result of those act(s) or omissions(s) determined to have occurred which constitute a
breach of this Agreement, fraudulent conduct in connection with this Agreement, or willful
misconduct in connection with this Agreement, as the case may be, a monetary award in the amount of
those damages;
(b) to the extent that the Arbitrators determine that the harm resulting from those act(s) or
omissions(s) determined to have occurred can be cured, in whole or in part by a decree of specific
performance, such a decree of specific performance implementing such determination as can be
submitted to and made the order of a Court of competent jurisdiction;
(c) to the extent that the Arbitrators determine that those act(s) or omissions(s) determined
to have occurred constitute a Material Breach, a Material Fraud, or Material Willful Misconduct, as
the case may be, an award authorizing the Claimant to
47
immediately terminate this Agreement,
together with damages or specific performance, if determined by the Arbitrators to be appropriate;
(d) to the extent that the Arbitrators determine that there is a prevailing party, and that
said prevailing party should receive an award of its Costs and Fees, such award to the prevailing
party; and
(e) such other matters as the Arbitrators deem necessary and appropriate to implement their
determinations made in the Arbitration.
(12) The written determination of the Arbitrators shall be made and delivered promptly to the
parties to the Arbitration and shall be final and conclusive upon the parties to the Arbitration.
(13) Except as may be required by law, neither a party nor an Arbitrator may disclose the
existence, content, or results of any Arbitration hereunder without the prior written consent of
both parties.
Section 10.5. Termination by the Agent.
(a) Material Breach, Material Fraud and Material Willful Misconduct. The Agent may terminate
this Agreement in accordance with the provisions of Section 10.4(g) upon :
(1) a Material Breach of this Agreement committed by Monsanto and established in accordance
with the provisions of Section 10.4(g) of this Agreement;
(2) a Material Fraud committed by Monsanto and established in accordance with the provisions
of Section 10.4(g) of this Agreement;
(3) Material Willful Misconduct committed by Monsanto and established in accordance with the
provisions of Section 10.4(g) of this Agreement.
Such termination shall take effect on the later of the first business day following the thirtieth
(30th) day after the sending of a termination notice to Monsanto in accordance with the provisions
of Section 11.9, or the date designated by the Agent in said termination notice.
(b) Roundup Sale. The Agent may terminate this Agreement by written notice thereof to
Monsanto upon receipt of notice of a Roundup Sale as described in Section 10.6.
(c) Termination Fee. Upon termination of this Agreement by the Agent pursuant to Section
10.5(a), Monsanto shall pay to the Agent the Termination Fee applicable pursuant to the Table set
forth in Section 10.4.(c).
48
Section 10.6. Roundup Sale.
(a) Notice of Sale; Quiet Period. Monsanto agrees to provide the Agent with prior written
notice of any contemplated Roundup Sale. Thereafter, the Agent shall be entitled to participate in
the Roundup Sale process, and the parties agree to negotiate in good faith with respect thereto. In
the event of an auction in connection with a contemplated Roundup Sale, the Agent shall be entitled
to submit a bid and additionally shall be entitled to a fifteen (15) day exclusive negotiation
period following the receipt and review by Monsanto of all bids (the Quiet Period), provided that
the Agents bid shall not be discounted by any Termination Fee and that during the Quiet Period,
the Agent shall have the right to revise its original bid but shall not have the right to review
the terms of any other bids.
(b) Credit of Termination Fee. In the event that the Agent or any of its Affiliates acquires
the Roundup Business in a Roundup Sale, the Termination Fee that would have been payable to the
Agent upon a termination pursuant to Section 10.4(a)(2) shall be credited against the purchase
price to be paid by the Agent or such Affiliate in the Roundup Sale.
(c) Agents Election. In the event that Monsanto determines to consummate a Roundup Sale with
a party other than the Agent, Monsanto shall deliver the Agent notice thereof and of the identity
of such other party. Within thirty (30) days of receipt of such notice, the Agent shall deliver
written notice to Monsanto stating either that:
(1) The Agent intends to terminate this Agreement pursuant to Section 10.5(b), in which case
such notice shall constitute a termination notice for purposes of this Agreement provided that the
termination shall be effective at the end of the Third Program Year following the Program Year in
which the Agent delivers its Notice of Termination pursuant to this provision; or
(2) The Agent will not terminate this Agreement pursuant to Section 10.5(b) and agrees to
continue the performance of its obligations under the Agreement unless and until the Agent receives
a termination notice delivered in accordance with the terms of this Agreement by the successor to
the Roundup Business.
(d) Successor. Upon consummation of a Roundup Sale to a party other than the Agent,
Monsantos successor to the Roundup L&G Business shall assume all rights and responsibilities of
Monsanto under this Agreement.
Section 10.7. Effect of Termination.
(a) Nonexclusive Status. Notwithstanding anything contained in this Agreement to the
contrary, during and after any period when Monsanto has given notice of termination in accordance
with Section 10.4(b)(5), (i) Monsanto may make this Agreement nonexclusive with respect to the
sales and marketing services to be provided by the Agent
49
hereunder, provided that the sales revenues generated by such second agent shall be included
in Program Sales Revenues and any commercially reasonable commission payable to such second agent
shall be included in Program Expense, (ii) Monsanto shall have access to all information held by
the Agent with respect to the subject matter of this Agreement, and (iii) the Agent shall cooperate
with Monsanto to establish an alternative distribution system for Roundup Products.
(b) Prior Obligations and Shipments. Termination shall not affect obligations of Monsanto or
of the Agent which have arisen prior to the effective date of termination.
(c) Representations and Materials. Upon termination of this Agreement for any reason, the
Agent shall not continue to represent itself as Monsantos authorized agent to deal in Roundup
Products, and shall remove, so far as practical, any printed material relating to such products
from its salespersons manuals and shall discontinue the use of any display material on or about
the Agents premises containing any reference to Roundup Products.
(d) Return of Books, Records, and other Property. To the extent not otherwise provided
herein, upon termination of this Agreement, the Agent shall immediately deliver to Monsanto all
records, books, and other property of Monsanto.
Section 10.8. Force Majeure.
If either party is prevented or delayed in the performance of any of its obligations by force
majeure and if such party gives written notice thereof to the other party within twenty (20) days
of the first day of such event specifying the matters constituting force majeure, together with
such evidence as it reasonably can give, then the party so prevented or delayed will be excused
from the performance or punctual performance, as the case may be, as from the date of such notice
for so long as such cause of prevention or delay continues. For the purpose of this Agreement, the
term force majeure will be deemed to include an act of God, war, hostilities, riot, fire,
explosion, accident, flood or sabotage; lack of adequate fuel, power, raw materials, containers or
transportation for reasons beyond such partys reasonable control; labor trouble, strike, lockout
or injunction (provided that neither party shall be required to settle a labor dispute against its
own best judgment); compliance with governmental laws, regulations, or orders; breakage or failure
of machinery or apparatus; or any other cause whether or not of the class or kind enumerated above,
including, but not limited to, a severe economic decline or recession, which prevents or materially
delays the performance of this Agreement in any material respect arising from or attributable to
acts, events, non-happenings, omissions, or accidents beyond the reasonable control of the party
affected.
Section 10.9. Special Termination Provisions.
(a) In the event the parties fail to close the sale by Monsanto to the Agent of the
Non-Roundup Assets by the later of March 31, 1999 or such later date as mutually agreed upon by the
parties, the parties agree:
50
(1) Monsanto may elect to terminate this Agreement by giving notice of such termination to the
Agent in accordance with the provisions of Section 11.9 of this Agreement on the later of (k) March
31, 1999 and (y) fifteen (15) calendar days after termination of the Asset Purchase Agreement
between Monsanto and the Agent, with respect to the sale of the Non-Roundup Assets, pursuant to the
terms thereof to Agent in accordance with the provisions of Section 11.9 of this Agreement. Any
such termination shall be effective on September 30, 1999. In such event, (i) there shall be no
deferral under Section 3.5(b) of the Contribution Payment required to be made by Agent, (ii) the
MAT Expenses in the Annual Business Plan for the 1999 Program Year shall be $35MM, and the Netbacks
for the 1999 Program Year shall not exceed twelve percent (12%) of Program Sales Revenues unless
already committed as the Effective Date and (iii) the Agents Commission specified in Section 3.6
shall not be applicable and, in lieu thereof, the Agents commission shall, effective as of October
1, 1998, be twenty-eight percent (28%) of Program Sales Revenue, payable quarterly within fifteen
(15) days following the end of each quarter, with each quarterly payment being in an amount not to
exceed the cumulative percentage of the maximum applicable commission apportioned at twenty-five
percent (25%) per quarter, subject to the following limitations:
(A) A maximum commission of $52MM per Program Year if such closing does not occur because the
Agent has not sold or divested its Finale business or otherwise disposed of the Finale business in
a manner satisfactory to Monsanto;
(B) A maximum commission of $55MM per Program Year if such closing does not occur because the
Federal Trade Commission issues an order prohibiting the purchase of the Non-Roundup Assets by the
Agent; and
(C) A maximum commission of $53.5MM per Program Year if such closing does not occur for any
other reason than specified in clauses (A) or (B) above.
(b) In the event that Monsanto terminates this Agreement pursuant to Section 10.9(a)(1), the
provisions of this Section 10.9 shall supersede Section 3.6 and Section 10.4 in their entirety.
(c) In the event that Monsanto elects not to terminate this Agreement pursuant to Section
10.9(a)(1), (i) there shall be no deferral under Section 3.5(b) of the Contribution Payment, (ii)
the Agents commission shall, for Program Year 1999, be calculated as provided in Section
10.9(a)(1) at a maximum commission of $53.5MM and in Program Year 2000 and thereafter the Agents
commission shall be the Commission specified in Section 3.6; (iii) Section 10.4(a)(2) shall be
amended to the effect that Monsanto or any successor shall have the right to terminate this
Agreement at any time upon a Change of Control with respect to Monsanto or a Roundup Sale by giving
the Agent a notice of termination which shall be effective at the end of the later of twelve (12)
months or the next Program Year; and (iv) the Agent shall not be entitled to any the Termination
Fee as specified in Section 10.4(d), but rather, subject to Section 10.4(g), the Agent shall be
entitled to exercise all remedies available to it either at law or in equity for any breach of this
Agreement by Monsanto.
51
ARTICLE 11 MISCELLANEOUS
Section 11.1. Relationship of the Parties. Notwithstanding anything herein to the contrary,
the parties status with respect to each other shall be, at all times during the term of this
Agreement, that of independent contractors retaining complete control over and complete
responsibility for their respective operations and employees. Except as expressly provided herein,
this Agreement shall not confer, nor shall be construed to confer, on either party any right, power
or authority (express or implied) to act or make representations for, or on behalf of, or to assume
or create any obligation on behalf of, or in the name of the other party. Nothing in this
Agreement shall confer, or shall be construed to: (i) confer on the Agent any mutual proprietary
interest in, or subject the Agent to any liability for, the business, assets, profits, losses, or
obligations associated with Monsantos manufacture, marketing, distribution and sales of Roundup
Products; (ii) otherwise make either party a partner, member, or joint venturer of the other party
(A) for purposes of the tax laws of the United States or any other country, or (B) for any other
purposes under any other Laws; or (iii) create a franchise relationship between the parties. The
parties expressly agree that at no time during the term of this Agreement, shall either party
through its officers, directors, agents, employees, independent contractors or other
representatives or through their respective representatives on the Steering Committee or Global
Roundup Team take any action inconsistent with the foregoing expression of the nature of their
relationship, except as required pursuant to applicable governmental authority under applicable Law
or with the express written consent of the other party. Accordingly, the parties expressly agree
to cooperate and communicate with the Steering Committee and the Global Roundup Support Team from
time to time and in all events, annually, to ensure that both parties actions are in compliance
with this Section 11.1
Section 11.2. Interpretation in accordance with GAAP. The parties acknowledge that several
terms and concepts (such as various financial and accounting terms and concepts) used or referred
to herein are intended to have specific meanings and are intended to be applied in specific ways,
but they are not so expressly and fully defined and explained in this Agreement. In order to
supplement definitions and other provisions contained in this Agreement and to provide a means for
interpreting undefined terms and applying certain concepts, the parties agree that, except as
expressly provided herein, when costs are to be determined or other financial calculations are to
be made, GAAP as well as the partys past accounting practices shall be used to interpret and
determine such terms and to apply such concepts. For example, when actual costs and expenses are
referred to herein, they are not intended to contain any margin or profit for the party incurring
such costs or expenses.
Section 11.3. Currency. All amounts payable and calculations under this Agreement shall be in
United States dollars. As applicable, Program Sales Revenue, Program Expenses, Cost of Goods Sold,
Service Costs, and Program EBIT shall be translated into United States dollars at the rate of
exchange at which United States dollars are listed in International Financial Statistics
(publisher, International Monetary Fund) or if it is not available, The Wall Street
52
Journal
for the currency of the country in which the sales were made or
the transactions occurred at the average rate of exchange for the Quarter in which such sales
were made or transactions occurred.
Section 11.4. Monsanto Obligations. All permits, licenses, and registrations needed for the
sale of Roundup Products shall be obtained by Monsanto. Monsanto shall assume the cost of all
federal and state registration fees related to the sale of Roundup Products, with such costs being
included within Program Expenses.
Section 11.5. Expenses. Except as otherwise specifically provided in this Agreement, the
Agent and Monsanto will each pay all costs and expenses incurred by each of them, or on their
behalf respectively, in connection with this Agreement and the transactions contemplated hereby,
including fees and expenses of their own financial consultants, accountants and counsel.
Section 11.6. Entire Agreement. This Agreement, together with all respective exhibits and
schedules hereto, constitutes the entire agreement between the parties hereto pertaining to the
subject matter hereof and supersedes all representations, warranties, understandings, terms or
conditions on such subjects that are not set forth herein or therein. Agreements on other
subjects, such as security and other credit agreements or arrangements, shall remain in effect
according to their terms. The parties recognize that, from time to time, purchase orders, bills of
lading, delivery instructions, invoices and similar documentation will be transmitted by each party
to the other to facilitate the implementation of this Agreement. Any terms and conditions
contained in any of those documents which are inconsistent with the terms of this Agreement shall
be null, void and not enforceable. This Agreement is for the benefit of the parties hereto and is
not intended to confer upon any other person any rights or remedies hereunder. The provisions of
this Agreement shall apply to each division or subsidiary of the Agent and Monsanto and either the
Agent or Monsanto may seek enforcement of the provisions of this Agreement on behalf of or with
respect to a particular subsidiary or division without changing the rights and obligations of the
parties under this Agreement as to other aspects of the Agents or Monsantos business.
Section 11.7. Modification and Waiver. No conditions, usage of trade, course of dealing or
performance, understanding or agreement purporting to modify, vary, explain or supplement the terms
or conditions of the Agreement and no amendment to or modification of this Agreement, and no waiver
of any provision hereof, shall be effective unless it is in writing and signed by each party
hereto. No waiver by either Monsanto or the Agent, with respect to any default or breach or of any
right or remedy, and no course of dealing shall be deemed to constitute a continuing waiver of any
other breach or default or of any other right or remedy, unless such waiver be expressed in writing
signed by the party to be bound.
Section 11.8. Assignment. This Agreement is personal to the Agent and, except as set forth in
Section 2.3, the Agent shall not assign any rights or delegate any duties that the Agent has or may
have under this Agreement, either voluntarily,
involuntarily by operation of law or otherwise by sale, assignment, transfer, delegation or
other arrangement having similar effect, without Monsantos prior written consent except as
specifically provided herein.
53
The Agent agrees to the assignment of the Agreement to the new legal entity that shall be
formed as a result of the merger between Monsanto Company and American Home Products.
Section 11.9. Notices. All notices and other communications hereunder shall be in writing and
shall be deemed given on the same business day if delivered personally or sent by telefax with
confirmation of receipt, on the next business day if sent by overnight courier, or on the earlier
of actual receipt as shown on the registered receipt or five business days after mailing if mailed
by registered or certified mail (return receipt requested) to the parties at the addresses set
forth below (or at such other address for a party as shall be specified by like notice):
|
|
|
|
|
|
|
If to the Agent, to:
|
|
The Scotts Company |
|
|
|
|
14111 Scottslawn Road |
|
|
|
|
Marysville, OH 43041 |
|
|
|
|
Attn: President |
|
|
|
|
Telephone: (937) 644-0011 |
|
|
|
|
Facsimile No.: (937) 644-7136 |
|
|
|
|
|
|
|
with a copy to:
|
|
Vorys, Sater, Seymour and Pease LLP |
|
|
|
|
52 East Gay Street |
|
|
|
|
Columbus, Ohio 43215 |
|
|
|
|
Attn: Ronald A. Robins, Jr. |
|
|
|
|
Telephone: (614) 464 6223 |
|
|
|
|
Facsimile: (614) 464 6350 |
|
|
|
|
|
|
|
If to Monsanto, to:
|
|
Monsanto Company |
|
|
|
|
800 North Lindbergh Boulevard |
|
|
|
|
St. Louis, MO 63167 |
|
|
|
|
Attn: Monsanto Ag President |
|
|
|
|
Telephone: (314) 694-1000 |
|
|
|
|
Facsimile No.: (314) 694-2120 |
|
|
|
|
|
|
|
with a copy to:
|
|
Monsanto Company |
|
|
|
|
800 North Lindbergh Boulevard |
|
|
|
|
St. Louis, Missouri 63167 |
|
|
|
|
Attn: Ag Counsel |
|
|
|
|
Telephone: (314)694-2851 |
|
|
|
|
Facsimile No.: (314) 694 2920 |
If any notice required or permitted hereunder is to be given a fixed amount of time before a
specified event, such notice may be given any time before such fixed amount of time (e.g., a
54
notice
to be given 30 days prior to an event may be given at any time longer than 30 days prior to such
event).
Section 11.10. Severability. If any provision of this Agreement is determined to be invalid
or unenforceable, in whole or in part, under a judgment, Law or statute now or hereafter in effect,
the remainder of this Agreement shall not thereby be impaired or affected.
Section 11.11. Equal Opportunity. To the extent applicable to this Agreement, Monsanto and
the Agent shall each comply with the following clauses contained in the Code of Federal Regulations
and incorporated herein by reference: 48 C.F.R. §52.203-6 (Subcontractor Sales to Government); 48
C.F.R. §52.219-8, 52.219-9 (Utilization of Small and Small Disadvantaged Business Concerns); 48
C.F.R. §52.219-13 (Utilization of Women-Owned Business Concerns); 48 C.F.R. §52.222-26 (Equal
Opportunity); 48 C.F.R. §52.222-35 (Disabled and Vietnam Era Veterans); 48 C.F.R. §52.222-36
(Handicapped Workers); 48 C.F.R. §52.223-2 (Clean Air and Water); and 48 C.F.R. §52.223-3
(Hazardous Material Identification and Material Safety Data). Unless previously provided, if the
value of this Agreement exceeds $10,000, the Agent shall provide a Certificate of Nonsegregated
Facilities to Monsanto. Furthermore, Monsanto and the Agent shall each comply with the Immigration
Reform and Control Act of 1986 and all rules and regulations issued thereunder. Each party hereby
certifies, agrees and covenants that none of its employees or employees of its subcontractors who
perform work under this Agreement is or shall be unauthorized aliens as defined in the Immigration
Reform and Control Act of 1986, and each party shall defend, indemnify and hold the other party
harmless from any and all liability incurred by or sought to be imposed on the other party as a
result of the first partys failure to comply with the certification, agreement and covenant made
by such party in this Section.
Section 11.12. Governing Law.
(a) The validity, interpretation and performance of this Agreement and any dispute connected
with this Agreement will be governed by and determined in accordance with the statutory, regulatory
and decisional law of the State of Delaware (exclusive of such states choice of laws or conflicts
of laws rules) and, to the extent applicable, the federal statutory, regulatory and decisional law
of the United States.
(b) Any suit, action or proceeding against any party hereto with respect to the subject matter
of this Agreement, or any judgment entered by any court in respect thereof, must be brought or
entered in the United States District Court for the District of Delaware, and each such party
hereby irrevocably submits to the jurisdiction of such court for the purpose of any such suit,
action, proceeding or judgment. If such court does not have jurisdiction over the subject matter
of such proceeding or, if such jurisdiction is not available, then such action or proceeding
against any party hereto shall be brought or entered in the Court of Chancery of the State of
Delaware, County of New Castle, and each party hereby irrevocably submits to the
jurisdiction of such court for the purpose of any such suit, action, proceeding or judgment.
Each party hereto hereby irrevocably waives any objection which either of them may now or hereafter
55
have to the laying of venue of any suit, action or proceeding arising out of or relating to this
Agreement brought as provided in this subsection, and hereby further irrevocably waives any claim
that any such suit, action or proceeding brought in any such court has been brought in an
inconvenient forum. To the extent each party hereto has or hereafter may acquire any immunity from
jurisdiction of any court or from legal process with respect to itself or its property, each party
hereto hereby irrevocably waives such immunity with respect to its obligations under this
subsection. Except as otherwise provided herein, the parties hereto agree that exclusive
jurisdiction of all disputes, suits, actions or proceedings between the parties hereto with respect
to the subject matter of this Agreement lies in the United States District Court for Delaware, or
the Court of Chancery of the State of Delaware, County of new Castle, as hereinabove provided. The
Agent hereby irrevocably appoints CT Corporation, having an address at 1209 Orange Street,
Wilmington, Delaware 19801 and Monsanto hereby irrevocably appoints CT Corporation, having an
address at 1209 Orange Street, Wilmington, Delaware 19801, as its agent to receive on behalf of
each such party and its respective properties, service of copies of any summons and complaint and
any other pleadings which may be served in any such action or proceedings. Service by mailing (by
certified mail, return receipt requested) or delivering a copy of such process to a party in care
of its agent for service of process as aforesaid shall be deemed good and sufficient service
thereof, and each party hereby irrevocably authorizes and directs its respective agent for service
of process to accept such service on its behalf.
Section 11.13. Public Announcements. No public announcement may be made by any person with
regard to the transactions contemplated by this Agreement without the prior consent of the Agent
and Monsanto, provided that either party may make such disclosure if advised by counsel that it is
required to do so by applicable law or regulation of any governmental agency or stock exchange upon
which securities of such party are registered. The Agent and Monsanto will discuss any public
announcements or disclosures concerning the transactions contemplated by this Agreement with the
other parties prior to making such announcements or disclosures.
Section 11.14. Counterparts. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which taken together shall be constitute one and
the same agreement.
[signature page to follow]
56
IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly
authorized representatives as of the day and year first above mentioned.
|
|
|
|
|
|
|
|
|
|
|
THE MONSANTO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Arnold W. Donald |
|
|
|
|
|
|
|
|
|
|
|
Name: Arnold W. Donald |
|
|
|
|
Title: Senior Vice-President |
|
|
|
|
|
|
|
|
|
|
|
|
|
THE SCOTTS COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ James Hagedorn |
|
|
|
|
|
|
|
|
|
|
|
Name: |
|
James Hagedorn |
|
|
|
|
Title: |
|
Executive Vice President, |
|
|
|
|
|
|
|
|
U.S. Business Groups |
|
|
57
LIST OF EXHIBITS TO AMENDED AND RESTATED EXCLUSIVE AGENCY AND MARKETING AGREEMENT
Dated as of September 30, 1998
Between Monsanto Company and The Scotts Company
Exhibit A: Central Agreements
Exhibit B: Termination Notice Regarding Central Agreements
Exhibit C: Letter Agreement Regarding Plastid Transformation Technology and Associated Genes
Exhibit D: Permitted Products
LIST OF SCHEDULES
|
|
|
|
|
|
|
Schedule 1.1(a):
|
|
Included Markets |
|
|
Schedule 1.1(b):
|
|
Roundup Products |
|
|
Schedule 2.2(a)(ii):
|
|
Transition Services (to be provided) |
|
|
Schedule 2.2(a):
|
|
Annual Business Plan Format |
|
|
Schedule 3.1:
|
|
Services Outside North America (to be provided) |
|
|
Schedule 3.2(d):
|
|
Cash Flow Chart |
|
|
Schedule 3.3(c):
|
|
Income Statement Definitions and Allocation Methods |
|
|
Schedule 3.8:
|
|
Current Sales of 2.5 Gallon SKU into the Lawn & Garden Channels |
|
|
Schedule 4.1(a):
|
|
Management Structure |
|
|
Schedule 4.2(a):
|
|
Steering Committee |
|
|
Schedule 4.3(b):
|
|
Assigned Employees |
|
|
Schedule 4.4(a):
|
|
Global Support Team |
The Schedules, Exhibits and Channels to the Amended and Restated Exclusive Agency and Marketing
Agreement have not been filed. Titles to the omitted Schedules, Exhibits and Channels appear
above. The Registrant hereby agrees to furnish supplementally a copy of any omitted Schedule or
Exhibit to the Securities and Exchange Commission upon its request.
[confidentiality request, to come]
58
SCHEDULE 1.1(a)
Included Markets
U.S.
Belgium
Denmark
Norway
Sweden
EIRE
France
Germany
Netherlands
Canada
Australia
Puerto Rico
U.K.
Austria
Finland
Luxemburg
SCHEDULE 1.1(b)
Roundup Products
|
|
|
|
|
|
|
|
|
Formulation |
|
Size |
United States and Puerto Rico |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup RTU
|
|
|
2% or less
|
|
2 gal or less |
Roundup Concentrate
|
|
|
18%
|
|
1 gal or less |
Roundup Tough Weed
|
|
|
27%
|
|
1 gal or less |
Roundup Super Conc.
|
|
|
41%
|
|
1 gal or less |
Roundup Aerosol
|
|
|
2% or less
|
|
2 gal or less |
Roundup Edger
|
|
|
2% or less
|
|
2 gal or less |
Kleeraway RTU
|
|
|
1% or less
|
|
1 gal or less |
Kleeraway Conc.
|
|
|
7.5% or less
|
|
1/2 gal or less |
Growers Choice |
|
|
|
|
|
|
Pennington Pride
|
|
|
1% or less RTU
|
|
1 gal or less RTU |
Green Charm Knock Out
|
|
|
7.5% or less Conc.
|
|
1/2 gal or less Conc. |
Bullseye |
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Alphee
|
|
|
7.2 g/l |
|
|
3 1 or less |
Roundup 60
|
|
|
60 g/l |
|
|
500 ml or less |
Roundup 120
|
|
|
120 g/l |
|
|
500 ml or less |
Roundup Ultra
|
|
|
360 g/l |
|
|
500 ml or less |
Howdown
|
|
|
120 g/l |
|
|
500 ml or less |
Quickclaim
|
|
|
120 g/l |
|
|
500 ml or less |
|
|
|
|
|
|
|
Denmark |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Spray
|
|
|
7.2 g/l |
|
|
3 1 or less |
Roundup Gdn Plus
|
|
|
120 g/l |
|
|
1 1 or less |
|
|
|
|
|
|
|
Norway |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Spray
|
|
|
7.2 g/l |
|
|
3 l or less |
Roundup Garden
|
|
|
120 g/l |
|
|
250 ml or less |
|
|
|
|
|
|
|
Sweden |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Spray
|
|
|
7.2 g/l |
|
|
3 l or less |
Roundup Garden
|
|
|
120 g/l |
|
|
1 l or less |
|
|
|
|
|
|
|
EIRE |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup RTU
|
|
|
7.2 g/l |
|
|
3 1 or less |
Roundup GC
|
|
|
120 g/l |
|
|
500 ml or less |
|
|
|
|
|
|
|
France |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Alphee
|
|
|
7.2 g/l |
|
|
3 l or less |
Roundup Pro 2
|
|
|
360 g/l |
|
|
1 l or less |
Roundup 3 p
|
|
|
170 g/l |
|
|
1 l or less |
Roundup GT
|
|
|
400 g/l |
|
|
.91, 451 |
Goliath
|
|
|
360 g/l |
|
|
500 ml or less |
Goliath CJ
|
|
|
120 g/l |
|
|
1 l or less |
Herbivorax 90
|
|
|
90 g/l |
|
|
1 l or less |
Kommando
|
|
|
100 g/l |
|
|
1 l or less |
|
|
|
|
|
|
|
Germany |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Alphee
|
|
|
7.2 g/l |
|
|
1 l or less |
Roundup L B Plus
|
|
|
360 g/l |
|
|
125 ml or less |
Roundup Ultra Gran
|
|
|
420 g/l |
|
|
15.5g |
|
|
|
|
|
|
|
Netherlands |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup RTU
|
|
|
7.2 g/l |
|
|
1 l or less |
Roundup H&T
|
|
|
360 g/l |
|
|
125 ml |
|
|
|
|
|
|
|
Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup RTU
|
|
2% or less |
|
|
4 l or less |
Roundup Concentrate
|
|
|
18% |
|
|
1 l or less |
Roundup Super Conc.
|
|
|
41% |
|
|
1 l or less |
|
|
|
|
|
|
|
Australia |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup RTU
|
|
|
7.2 g/l |
|
|
3 l or less |
Roundup
|
|
|
360 g/l |
|
|
1 l or less |
|
|
|
|
|
|
|
United Kingdom |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup RTU
|
|
|
7.2 g/l |
|
|
3 l or less |
Roundup Brushkiller
|
|
|
120 g/l |
|
|
1 l or less |
Roundup Brushkiller RTU
|
|
|
7.2 g/l |
|
|
1 l or less |
Roundup GC Biactive
|
|
|
120 g/l |
|
|
1 l or less |
Roundup Ultra 3000
|
|
|
360 g/l |
|
|
1 l or less |
B&Q Complete Weed Killer RTU
|
|
|
7.2 g/l |
|
|
3 l or less |
|
|
|
|
|
|
|
B&Q Complete Weed Killer
|
|
|
45.2 g/l |
|
|
1 l or less |
|
|
|
|
|
|
|
Austria |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup LB Plus
|
|
|
360 g/l |
|
|
125 ml or less |
|
|
|
|
|
|
|
Finland |
|
|
|
|
|
|
|
|
|
|
|
|
|
Roundup Spray
|
|
|
7.2 g/l |
|
|
3 l or less |
Roundup Bio
|
|
|
120 g/l |
|
|
1 l or less |
SCHEDULE 2.2(a)
Annual Business Plan Template
1) |
|
Mission Statement and Explanation: Answers questions: What business are we in? Why does the
business exist? |
2) |
|
Category Definition/Growth Trend: Also need to address related categories and their
potential interaction with the target category |
|
a) |
|
Assessment of growth potential
|
|
|
b) |
|
Competitor evaluation/assessment of threat |
3) |
|
Business Review: Summary of a process that will occur in each preceding January |
|
a) |
|
Critical learning from prior year
|
|
|
b) |
|
Key Implications from learning: Arranged by key functional area |
|
a) |
|
Consumer Target: Demographics, Psychographics, use Segmentation |
|
|
b) |
|
Key feature(s), Attribute(s) and Benefits delivered (for brand and sub-brands) |
|
|
c) |
|
Brand Character/Imagery: Describe the personification of the brand/sub-brands |
|
i) |
|
This section should also specifically address the degree to
which the proposed positioning is consistent with the Brands historical image |
|
a) |
|
Financial: Historical trend and three year projections of Equivalent Case
Volume, Net Sales, EBIT and ACM |
|
|
b) |
|
Competitive: |
|
i) |
|
Market Share Goal and trend
|
|
|
ii) |
|
Advertising Share of Voice Goal and trend |
|
c) |
|
Consumer: Critical behavioral and attitudinal measures that describe the
development of the Brand which could include: |
|
i) |
|
Penetration |
|
|
ii) |
|
Unaided awareness |
|
|
iii) |
|
Annual usage |
|
|
iv) |
|
Seasonal usage |
|
i) |
|
% ACV Distribution by Channel |
|
|
ii) |
|
Fill Rates by Top 10 customers (with detailed definition of
what constitutes an on-time shipment) |
|
|
iii) |
|
Display achievement
|
|
|
iv) |
|
Other measurable customer satisfaction measures |
6) |
|
Major Strategies to achieve Key Goals (some examples include...) |
|
a) |
|
Product Line: What products/drive groups/lines to focus on |
|
|
b) |
|
Significant new product launches |
|
|
c) |
|
Private Label at a Key Account(s) |
|
|
d) |
|
Marketing Support focus: Example would be a shift from advertising to
promotion |
|
|
e) |
|
New Consumer Uses: Extended use campaign, new forms
|
|
|
f) |
|
Geographic focus including a new regional/market emphasis. CDI/BDI analysis |
|
|
g) |
|
Seasonal focus including new emphasis if relevant. Weekly seasonality by
region and drive group/item. |
|
|
h) |
|
Channel/Customer including new/alternative channels if relevant |
|
|
i) |
|
Operational strategies to address quality, capacity, cost position, service,
technology application, etc., including fill rates, inventory levels and turns |
|
|
j) |
|
Acquisition/divestiture strategies to improve market position |
7) |
|
Functional Operating Plans: This is a lengthy section that lays out a detailed annual
operating plan for each functional area in the business (including rationale where
appropriate) and that pays particular attention to changes in that plan from the prior years
plans and results. Each section will contain a detailed budget with direct and assigned
expenses shown. |
|
a) |
|
General Management: Description of Business Unit Management team and planned
costs |
|
i) |
|
Performance standards for all employees |
|
|
ii) |
|
Description of employee performance incentives and link to
performance standards |
|
i) |
|
Organization Plan |
|
|
ii) |
|
Spending allocation: Total spending by marketing support
category including working and non-working media, consumer promotion, public
relations, market research, etc. |
|
|
iii) |
|
Advertising: Preliminary media plan including spending trends,
creative strategy and discussion of any planned/contemplated changes to that
strategy. |
|
|
iv) |
|
Consumer Promotion: Promotion objectives, key plan elements
and payout calculations |
|
|
v) |
|
POP Plan: Focus on Key changes versus prior year plan
|
|
|
vi) |
|
Pricing: To include trends and competitive benchmarks |
|
|
vii) |
|
Packaging graphic and physical: Changes planned along with
specific costs, implementation timing and risk factors |
|
|
viii) |
|
Market Research plan: List all studies, cost estimate and
rationale for each, including tracking |
|
|
ix) |
|
Public Relations
|
|
|
x) |
|
Test plans (applies to all of above) |
|
i) |
|
Organization Plan
|
|
|
ii) |
|
Top 5 Account Plans |
|
(1) |
|
Program changes anticipated |
|
|
(2) |
|
Planned Net Sales trends by drive group/item
(with historical trend) |
|
|
(3) |
|
Profitability analysis
|
|
|
(4) |
|
Category Management plans |
|
iii) |
|
Five year sales goals
|
|
|
iv) |
|
Private Label/control brand opportunities |
|
|
v) |
|
Headquarter Sales Presentation plan with a focus on what the
key messages are and discussion of any unique methods of communication to
customers |
|
|
vi) |
|
Retail Merchandising Support including planned in-house,
distributor and contracted merchandising services. Focus on in-store
merchandising and display techniques as well as pre-season store set plans |
|
(1) |
|
Share of shelf
|
|
|
(2) |
|
Share of off-shelf |
|
vii) |
|
Other selling services plans as appropriate
|
|
|
viii) |
|
Product Knowledge Plan including principle target(s) and vehicles |
|
i) |
|
Organization Plan |
|
|
ii) |
|
Key Manufacturing initiatives such as: Cost savings, capacity
planning, make/buy analyses, etc. |
|
|
iii) |
|
Distribution/Warehousing Plan |
|
|
iv) |
|
Inventory plan by month (versus prior year) that balances the
need for high fill rates with a product utilization of working capital.
Targets to be included in plan. |
|
v) |
|
Purchasing: Including Key supplier relationship development |
|
|
vi) |
|
Quality: Measurement and delivery against objectives from
balanced scorecard |
|
|
vii) |
|
Capital Plan with capital expenditure detail |
|
e) |
|
Research & Development: |
|
i) |
|
Organization/Staffing Plan |
|
|
ii) |
|
Priority projects and innovation pipeline new product portfolio review |
|
|
iii) |
|
Innovation launch timeline |
|
|
iv) |
|
Product specifications and planned changes |
|
|
v) |
|
Pioneering Research |
|
i) |
|
Organization Plan
|
|
|
ii) |
|
Special Programs such as telemarketing |
|
|
iii) |
|
Discussion of and key changes to order taking, order processing
invoicing, collection, reconciliation (to original P0 and program) procedures |
|
i) |
|
Organization plan including a discussion of outsourced versus
in-house services |
|
|
ii) |
|
Call volume and measurement of answering efficiency and
effectiveness |
|
|
iii) |
|
Plan for communicating to marketing and operations any
significant consumer complaints |
8) |
|
Detailed Financials Prior Year, Current Year, Future Year |
|
a) |
|
Income Statement (annual and monthly), cash flow and balance sheet |
|
|
b) |
|
Net Sales and margins by key drive group/item, and including product mix
analysis |
|
|
c) |
|
Selling and Marketing Expenses by key line item |
|
|
d) |
|
Assignment of Shared Services: This section will discuss the agreed upon
allocation methodology for shared services to their respective Business Unit statements
and highlights any proposed changes to that methodology |
|
|
e) |
|
Anticipated changes form prior year
|
|
|
f) |
|
Financial Metrics |
|
ii) |
|
Days Sales Outstanding (DSO) |
|
|
iii) |
|
Obsolete inventory charge |
|
|
iv) |
|
Bad debt allowance |
|
|
v) |
|
Netbacks, MAT and COGS detail prior, current and next year |
9) |
|
Approved amendments: This section will show any amendments approved by senior management (or
the Steering Committee) |
|
a) |
|
Includes spending at levels above those established in the annual business plan. |
SCHEDULE 2.2(a)(ii)
Transition Services
The parties agree that it is unnecessary to describe in detail the transition services called
for by this Schedule 2.2(a)(ii); rather, the parties agree that these services shall be provided in
good faith based on the past practices of the Solaris business unit of Monsanto.
SCHEDULE 3.1(a)
Accounting And Cash Flow Procedures Outside The United States
I. Europe
The following terms shall govern operations of the Roundup L&G Business in Europe in place of
Sections 3.1 through 3.3 of the Agreement. The remainder of the terms of Article 3 of the
Agreement shall apply to the operations for the European Roundup L&G Business.
Section 3.1. Bookkeeping and Financial Reporting.
(a) Bookkeeping. Monsanto shall be responsible for all the bookkeeping for the Roundup L&G
Business, which shall include, but not be limited to, (i) setting up a separate set of accounting
records reflecting all the items of income, profit, gain, loss and deduction with respect to the
Roundup L&G Business, including a profit and loss statement (Roundup P&L) and all other records
relating to the Roundup L&G Business, including sales invoices and customer data (the Roundup
Records) in accordance with Monsantos accounting policies (including the currency exchange
methodology used by Monsanto); provided, that if any change in Monsantos accounting policies would
adversely affect the Agents Commission (other than in a de minimis amount), the parties shall
negotiate in good faith to change the thresholds and/or the Commission, as appropriate, to
eliminate such adverse affect; (ii) collecting, recording and safeguarding receipts of all
receivables and payables, costs or expenses either directly incurred by the Roundup L&G Business or
Allocated thereto by either party pursuant to the terms of Section 3.3 hereof. At all times,
Monsanto shall make available via computer and/or original documentation, to the Agents employees
designated by the Agent, access to the Roundup Records as appropriate on a need-to-know basis, and
such access shall include, but not be limited to, daily sales updates.
(b) Financial Reporting. Monsanto shall provide to the Agent financial reports for the
Roundup L&G Business based on Monsantos current practice and timing.
(c) Audit. The Agent shall have the right to periodically audit or have an independent
accountant audit, on the Agents behalf, all the Roundup Records. The audit shall be at the cost
of the Agent unless any material error has been committed by Monsanto, in which case Monsanto shall
bear the cost of the audit. Upon exercise of its right of audit, and discovery of any disputed
item, the Agent shall provide written notice of dispute to Monsanto. The parties shall resolve
such dispute in the manner set forth in Section 3.4 hereof.
Section 3.2. Ordering, Invoking and Cash Flow Cycle.
(a) Ordering and Invoicing. Monsanto shall perform all order taking, order processing and
invoicing for the Roundup Products. Orders filled for Roundup Products shall be invoiced on
invoices, or an EDI version thereof, which shall include all taxes (other than Income Taxes),
duties, and other charges imposed by governmental authorities based on the production or sale of
Roundup Products or their ownership or transportation to the place and time of sale, based on
Monsantos past practices for such products.
(b) Customer Remittances. Customers of Roundup Products shall be directed, as per the
invoices, to remit directly the invoiced amounts for all Roundup Products to Monsantos designated
bank account.
(c) Roundup Bank Accounts. Monsanto shall establish or use existing bank accounts (the
Roundup Europe Bank Accounts) to serve as the bank accounts for the Roundup L&G Business in
Europe (i) for the receipt of Customer remittances as described in Section 3 22(b), and (ii) for
making any and all payments incurred in connection with the Roundup L&G Business either as direct
Expenses of the Roundup L&G Business or as reimbursements to either party for services rendered or
out of pocket costs related to the Roundup L&G Business as described more particularly in Section
3.3 hereof.
Section 3.3. Expenses and Allocation Rules.
(a) Expenses. Each and every Expense, either as a direct expense or an allocated one, shall
only be charged to the Roundup L&G Business and consequently taken into account in the Program EBIT
statements set forth in Section 3.6(c) hereto if part of a category of Expenses specifically
authorized by the terms of the Annual Business Plan and within the aggregate amount prescribed in
the Annual Business Plan for such category of Expense (Budget) (Approved Expense). Any Expense
which shall exceed its prescribed Budget shall solely be the responsibility of the party incurring
it unless such expense is required to implement an approved Significant Deviation from the Annual
Business Plan or is necessary to support sales orders above budgeted sales pursuant to sales
programs contemplated by the Annual Business Plan.
(b) Direct vs. Allocated. Each party shall have the right to verify whether any particular
Expense is an Approved Expense by sending a written inquiry to that effect to the Agents nominee.
The party incurring an Expense shall endeavor to promptly provide upon request of the Agents
nominee the appropriate documentary evidence supporting such Expense. Upon failure by the said
party to provide the appropriate documentary evidence, the inquiring party shall have the right to
send a written notice of dispute to the other party and the parties shall resolve such dispute in
the manner set forth in Section 3.4 hereof. Upon determination by such Independent Accountant (as
defined in Section 3.4) that the Expense was not Approved, such Expense shall be deducted from the
Program Expenses and the party having incurred such Expense shall either promptly reimburse it to
the Roundup Europe Bank Account, or shall withdraw its request for reimbursement if not reimbursed
yet.
Expenses shall be classified into (i) direct expenses of the Roundup L&G Business payable to
vendors, which shall be submitted directly to Monsanto for payment out of the Roundup Europe Bank
Account or (ii) as Allocated Expenses which shall be submitted by either party to Monsanto for
reimbursement out of the Roundup Europe Bank Account. Payment of any direct expenses incurred by
either party on behalf of the Roundup L&G Business shall be made as they become due in accordance
with the applicable commercial terms agreed upon with each vendor.
Allocated Expenses shall be paid on the fifteenth (15th) day of each month provided such
allocated Expenses shall be properly supported and submitted in writing no more than three (3) days
after the end of each month to Monsanto.
(c) Allocation Rules. In the performance of their obligations under this Agreement, each
party shall incur allocated Expenses directly related to the Roundup L&G Business. Each allocated
Approved Expense, regardless of the party incurring it, shall be reimbursed as described in Section
3.5(b) provided such expense shall be allocated in accordance with the Allocation Rules set forth
for each category of cost and service per country or region, as the case may be, in Schedule 3.3(c)
attached hereto (Allocated Expense).
II. Canada
The following terms shall govern operations of the Roundup L&G Business in Canada in place of
Sections 3.1 through 3.3 of the Agreement. The remainder of the terms of Article 3 of the
Agreement shall apply to Canadian Roundup L&G Business operations.
Section 3.1. Bookkeeping and Financial Reporting.
(a) Bookkeeping. The Agent shall, on behalf of Monsanto, be responsible for all the
bookkeeping for the Roundup L&G Business, which shall include, but not be limited to, (i) setting
up a separate set of accounting records reflecting all the items of income, profit, gain, loss and
deduction with respect to the Roundup L&G Business, including a profit and loss statement (Roundup
P&L) and all other records relating to the Roundup L&G Business including sales invoices and
customer data (the Roundup Records) in accordance with the written set of accounting policies
(including the currency exchange methodology used by Monsanto) as shall be provided by Monsanto;
provided, that if any change in Monsantos accounting policies would adversely affect the Agents
Commission (other than in a de minimis amount), the parties shall negotiate in good faith to change
the thresholds and/or the Commission, as appropriate, to eliminate such adverse effect; (ii)
collecting, recording and safeguarding receipts of all receivables and payables, costs or expenses
either directly incurred by the Roundup L&G Business or Allocated thereto by either party pursuant
to the terms of Section 3.3 hereof. At all times, the Agent shall make available via computer
and/or original documentation, to the Assigned Employees designated by Monsanto, continuous access
to the Roundup Records as appropriate on a need-to-know basis; such access shall include, but not
be limited to, daily sales updates.
(b) Financial Reporting. The Agent shall provide to Monsanto monthly financial statements,
including (i) the Roundup P&L, balance sheet and cash flow statements, (ii) the Netback expense
detail (accruals and actuals), (iii) all other Expense detail (accruals and actuals), and (iv) Cost
of Goods Sold detail. Such monthly financial statements shall be provided (i) in their preliminary
form, no later than four (4) business days following the end of the calendar month, and (ii) in
their final form, together with an estimate of sales for the current month, no later than six (6)
business days following the end of the calendar month.
(c) Audit. Monsanto shall have the right to periodically audit or have an independent
accountant audit, on Monsantos behalf, all the Roundup Records. The audit shall be at the cost of
Monsanto unless any material error has been committed by the Agent, in which case the Agent shall
bear the cost of the audit. Upon exercise of its right of audit, and discovery of any disputed
item, Monsanto shall provide written notice of dispute to the Agent. The parties shall resolve
such dispute in the manner set forth in Section 3.4 hereof.
Section 3.2. Ordering, Invoicing and Cash Flow Cycle.
(a) Ordering and Invoicing. The Agent shall perform, on behalf of Monsanto, all order taking,
order processing and invoicing for the Roundup Products, it being understood that orders filled for
Roundup Products shall be invoiced on the invoices used by the Agent for its other non-Roundup
products provided such invoices or their EDI version shall (i) identify the Agent as an agent for
Monsanto for the sale of all Roundup Products and Monsanto as the actual transferor of title to
Roundup Products; (ii) direct payment of such invoice to be made directly to the account designated
by the Agent; and (iii) include all taxes (other than Income taxes), duties, and other charges
imposed by governmental authorities based on the production or sale of Roundup Products or their
ownership or transportation to the place and time of sale.
(b) Customer Remittances. Customers of Roundup Products shall be directed, as per the
invoices, to remit directly the invoiced amounts for all Roundup Products to the Roundup Canada
Bank Account (defined below).
(c) Roundup Bank Accounts. Monsanto shall establish or use existing bank accounts (the
Roundup Canada Bank Accounts) to serve as the bank accounts for the Roundup L&G Business (i) for
the receipt of Customer remittances as described in Section 3.2(b), and (ii) for making any and all
payments incurred in connection with the Roundup L&G Business either as direct Expenses of the
Roundup L&G Business or as reimbursements to either party for services rendered or out of pocket
costs related to the Roundup L&G Business as described more particularly in Section 3.3 hereof.
Monsanto shall grant the Agents nominee the authority to manage the Roundup Canada Bank Accounts
on Monsantos behalf as it relates to the Roundup L&G Business in Canada, and more generally take
any and all actions requested for the payment of all the Roundup L&G Business Expenses in
compliance with the terms of Section 3.3 hereunder as per the Cash Flow Chart attached hereto as
Schedule 3.2(d); provided that checks in an amount over $25,000 shall also require the co-signature
of an Assigned Employee or a member of the Global Support Team or such other employee of Monsanto
as is designated by a member of the Global Support Team.
Section 3.3. Expenses and Allocation Rules.
(a) Expenses. Each and every Expense, either as a direct expense or an allocated one, shall
only be charged to the Roundup L&G Business and consequently taken into account in the Program EBIT
statements set forth in Section 3.6(c) hereto if part of a category of Expenses specifically
authorized by the terms of the Annual Business Plan and within the aggregate amount prescribed in
the Annual Business Plan for such category of Expense (Budget) (Approved Expense). Any Expense
which shall exceed its prescribed Budget shall solely be the responsibility of the party incurring
it unless such expense is required to implement an approved Significant Deviation from the Annual
Business Plan or is necessary to support sales orders above budgeted sales pursuant to sales
programs contemplated by the Annual Business Plan.
(b) Direct vs. Allocated. Each party shall have the right to verify whether any particular
Expense is an Approved Expense by sending a written inquiry to that effect to the Agents nominee.
The party incurring an Expense shall endeavor to promptly provide upon request of the Agents
nominee the appropriate documentary evidence supporting such Expense. Upon failure by the said
party to provide the appropriate documentary evidence, the inquiring party shall have the right to
send a written notice of dispute to the other party and the parties shall resolve such dispute in
the manner set forth in Section 3.4 hereof. Upon determination by such Independent Accountant (as
defined in Section 3.4) that the Expense was not Approved, such Expense shall be deducted from the
Program Expenses and the party having incurred such Expense shall either promptly reimburse it to
the Roundup Canada Bank Account, or shall withdraw its request for reimbursement if not reimbursed
yet.
Expenses shall be classified into (i) direct expenses of the Roundup L&G Business payable to
vendors, which shall be submitted directly to the Agents nominee for payment out of the Roundup
Canada Bank Account or (ii) as Allocated Expenses which shall be submitted by either party to the
Agents nominee for reimbursement out of the Roundup Canada Bank Account. Payment of any direct
expenses incurred by either party on behalf off the Roundup L&G Business shall be made as they
become due in accordance with the applicable commercial terms agreed upon with each vendor.
Allocated Expenses shall be paid on the fifteenth (15th) day of each month provided
such allocated Expenses shall be properly supported and submitted in writing no more than five (5)
days after the end of each month to the Agents nominee in charge of the Roundup Canada Bank
Account.
(c) Allocation Rules. In the performance of their obligations under this Agreement, each
party shall incur allocated Expenses directly related to the Roundup L&G Business. Each allocated
Approved Expense, regardless of the party incurring it, shall be reimbursed as described in Section
3.5(b), provided such expense shall be allocated in accordance with the Allocation Rules set forth
for each category of cost and service per country or region, as the case may be, in Schedule 3.3(c)
attached hereto (Allocated Expense).
III. Australia
The following terms shall govern operations of the Roundup L&G Business in Australia in place of
Sections 3.1 through 3.3 of the Agreement. The remainder of the
terms of Article 3 of the Agreement shall apply to Australian Roundup L&G Business operations.
Section 3.1. Bookkeeping and Financial Reporting.
(a) Bookkeeping. The Agent shall, on behalf of Monsanto, be responsible for all the
bookkeeping for the Roundup L&G Business, which shall include, but not be limited to, (i) setting
up a separate set of accounting records reflecting all the items of income, profit, gain, loss and
deduction with respect to the Roundup L&G Business, including a profit and loss statement (Roundup
P&L) and all other records relating to the Roundup L&G Business, including sales invoices and
customer data (the Roundup Records) in accordance with the written set of accounting policies
(including the currency exchange methodology used by Monsanto) as shall be provided by Monsanto;
provided, that if any change in Monsantos accounting policies would adversely affect the Agents
Commission (other than in a de minimis amount), the parties shall negotiate in good faith to change
the thresholds and/or the Commission, as appropriate, to eliminate such adverse effect; (ii)
collecting, recording and safeguarding receipts of all receivables and payables, costs or expenses
either directly incurred by the Roundup L&G Business or Allocated thereto by either party pursuant
to the terms of Section 3.3 hereof. At all times, the Agent shall make available via computer
and/or original documentation, to the Assigned Employees designated by Monsanto continuous access
to the Roundup Records as appropriate on a need-to-know basis; such access shall include, but not
be limited to, daily sales updates.
(b) Financial Reporting. The Agent shall provide to Monsanto monthly financial statements,
including (i) the Roundup P&L, balance sheet and cash flow statements, (ii) the Netback expense
detail (accruals and actuals), (iii) all other Expense detail (accruals and actuals), and (iv) Cost
of Goods Sold detail. Such monthly financial statements shall be provided (i) in their preliminary
form, no later than four (4) business days following the end of the calendar month, and (ii) in
their final form, together with an estimate of sales for the current month, no later than six (6)
business days following the end of the calendar month.
(c) Audit. Monsanto shall have the right to periodically audit or have an independent
accountant audit, on Monsantos behalf, all the Roundup Records. The audit shall be at the cost of
Monsanto unless any material error has been committed by the Agent, in which case the Agent shall
bear the cost of the audit. Upon exercise of its right of audit and discovery of any disputed
item, Monsanto shall provide written notice of dispute to the Agent. The parties shall resolve
such dispute in the manner set forth in Section 3.4 hereof.
Section 3.2. Ordering, Invoking and Cash Flow Cycle.
(a) Ordering and Invoicing. The Agent shall perform, on behalf of Monsanto, all order taking,
order processing and invoicing for the Roundup Products, it being understood that orders filled for
Roundup Products shall be invoiced on the invoices used by the Agent for its other non-Roundup
products provided such invoices or their EDI version shall (i) identify the Agent as an agent for
Monsanto for the sale of all Roundup Products and Monsanto as the actual transferor of title to
Roundup Products; (ii) direct payment of such invoice to be made directly to the account designated
by the Agent; and (iii) include all taxes (other than Income Taxes), duties, and other charges
imposed by governmental authorities based on the production or sale of Roundup Products or their
ownership or transportation to the place and time of sale.
(b) Customer Remittances. Customers of Roundup Products shall be directed, as per the
invoices, to remit directly the invoiced amounts for all Roundup Products to the Agents designated
bank account.
(c) Receipts. At the end of each month, the Agent shall remit to the account designated by
Monsanto for such purposes, the actual amount of the Customers remittances for the Roundup
Products paid over the past month. Customer payment deductions that do not initially, clearly
apply to Roundup Products shall not be withheld by the Agent from the remittances to Monsanto. If
the Agent subsequently determines any of such payment deductions apply to sales of Roundup
Products, the Agent shall be reimbursed therefor as part of the monthly cash reconciliation.
Monsanto and the Agent agree that general Customer payment deductions will be prorated based on
applicable sales, for which the Agent will also be reimbursed in the monthly cash reconciliation.
Any non-Roundup Product payment deductions, for whatever reason, shall not be applied against
Roundup Products.
(d) Roundup Bank Accounts. Scotts shall establish or use existing bank accounts (the Roundup
Australia Bank Accounts) to serve as the bank accounts for the Roundup L&G Business (i) for the
receipt of Customer remittances as described in Section 3.2(b), and (ii) for making any and all
payments incurred in connection with the Roundup L&G Business either as direct Expenses of the
Roundup L&G Business or as reimbursements to either party for services rendered or out of pocket
costs related to the Roundup L&G Business as described more particularly in Section 3.3 hereof.
The Agent shall take any and all actions requested for the payment of all the Roundup L&G Business
Expenses in compliance with the terms of Section 3.3 hereunder as per the Cash Flow Chart attached
hereto as Schedule 3.2(d). Monsanto may perform its own reconciliation of the Roundup Australia
Bank Accounts and may conduct a weekly review of the check register.
Section 3.3 Expenses and Allocation Rules.
(a) Expenses. Each and every Expense, either as a direct expense or an allocated one, shall
only be charged to the Roundup L&G Business and consequently taken into account in the Program EBIT
statements set forth in Section 3.6(c) hereto if part of a category of Expenses specifically
authorized by the terms of the Annual Business Plan and within the aggregate amount prescribed in
the Annual Business Plan for such category of Expense (Budget) (Approved Expense). Any Expense
which shall exceed its prescribed Budget shall solely be the responsibility of the party incurring
it unless such expense is required to implement an approved Significant Deviation from the Annual
Business Plan or is necessary to support sales orders above budgeted sales pursuant to sales
programs contemplated by the Annual Business Plan.
(b) Direct vs. Allocated. Each party shall have the right to verify whether any particular
Expense is an Approved Expense by sending a written inquiry to that effect to the Agents nominee.
The party incurring an Expense shall endeavor to promptly provide upon request of the Agents
nominee the appropriate documentary evidence supporting such Expense Upon failure by the said
party to provide the appropriate documentary evidence, the inquiring party shall have the right to
send a written Section 3.4 hereof. Upon determination by such Independent Accountant (as defined
in Section 3.4) that notice of dispute to the other party and the parties shall resolve such
dispute in the manner set forth in the Expense was not Approved, such Expense shall be deducted
from the Program Expenses and the party having incurred such Expense shall either promptly
reimburse it to the Roundup Australia Bank Account, or shall withdraw its request for reimbursement
if not reimbursed yet.
Expenses shall be classified into (i) direct expenses of the Roundup L&G Business payable to
vendors, which shall be submitted directly to the Agents nominee for payment out of the Roundup
Australia Bank Account or (ii) as Allocated Expenses which shall be submitted by either party to
the Agents nominee for reimbursement out of the Roundup Australia Bank Account. Payment of any
direct expenses incurred by either party on behalf of the Roundup L&G Business shall be made as
they become due in accordance with the applicable commercial terms agreed upon with each vendor.
Allocated Expenses shall be paid on the fifteenth (15th) day of each month provided
such allocated Expenses shall be properly supported and submitted in writing no more than three (3)
days after the end of each month to the Agents nominee in charge of the Roundup Australia Bank
Account.
(c) Allocation Rules. In the performance of their obligations under this Agreement, each
party shall incur allocated Expenses directly related to the Roundup L&G Business. Each allocated
Approved Expense, regardless of the party incurring it, shall be reimbursed as described in Section
3.5(b), provided such expense shall be allocated in accordance with the Allocation Rules set forth
for each category of cost and service per country or region, as the case may be, in Schedule 3.3(c)
attached hereto (Allocated Expense).
SCHEDULE 3.2(d)
Cash Flow Chart
Schedule 3.2(d) Cash Flow U.K. Only
|
|
|
|
|
DESCRIPTION |
|
ACCTING ENTRI |
|
Monsanto plc receipt |
|
|
|
|
- direct payments to bank |
|
|
|
|
- cheques received and banked / cheque register created |
|
|
|
|
- RIP credited |
|
cr to 11125839 |
|
|
|
|
|
Roundup / Non Roundup invoices cleared from SAP according customer
remittance advice / Deductions entered in accordance with attached agreement
This allocation debits Mplc / Phostrogen RIP. |
|
dr to 11125839 |
|
|
|
|
|
Phostrogen related cash placed in holding account |
|
cr to ???? |
|
|
|
|
|
Cash paid on the 20th of the month following receipt |
|
dr to ???? |
|
|
|
|
|
Non Roundup receipts |
|
|
|
|
- direct payments to bank |
|
|
|
|
- cheques received and banked / cheque register created |
|
|
|
|
- RIP credited |
|
cr to 11125839 |
|
|
|
|
|
Roundup / Non Roundup invoices cleared from SAP according to customer
remittance advice / Deductions entered in accordance with attached agreement
This allocation debits Mplc / Phostrogen RIP. |
|
dr to 11125839 |
|
|
|
|
|
Phostrogen Limited receipt |
|
|
|
|
|
|
|
|
|
Cheques received payable to Phostrogen Limited forwarded to Corwen immediately
and no accounting entries made |
|
|
|
|
|
|
|
|
|
Cheque banked into Phostrogen bank account by Corwen |
|
|
|
|
|
|
|
|
|
Customer accounts cleared in Corwen and deductions booked in accordance with
agreement |
|
|
|
|
Schedule 3.2 (d) Australia
|
|
|
Monsanto
|
|
Example C3 |
Roundup Australia |
|
|
Date |
|
|
Cash Flow Statement |
|
|
|
|
|
|
|
|
|
|
|
|
|
Month |
|
|
YTD |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net (Loss)/Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
|
|
|
|
|
|
Amortization |
|
|
|
|
|
|
|
|
Extraordinary loss |
|
|
|
|
|
|
|
|
(Gain)/Loss on sale of property |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in working capital: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
|
|
|
|
|
|
Inventories |
|
|
|
|
|
|
|
|
Prepaids |
|
|
|
|
|
|
|
|
Accounts payable |
|
|
|
|
|
|
|
|
Accrued liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other, net |
|
|
|
|
|
|
|
|
Net cash provided by / (used in) operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Capital Expenditures |
|
|
|
|
|
|
|
|
Proceeds on
Sale of Property Acquisitions |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Net cash provided by / (used in) investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Borrowings operations funding |
|
|
|
|
|
|
|
|
Borrowings acquisitions |
|
|
|
|
|
|
|
|
Dividends paid |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Net cash provided by / (used in) financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, end of period |
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
SCHEDULE 3.3(c)
INCOME STATEMENT DEFINITIONS
AND
ALLOCATION METHODS
|
|
|
Monsanto and Scotts
Exclusive Agency and Marketing Agreement for Roundup
Income Statement Definitions and Allocation Methods
|
|
Schedule 3.3(c)
Page 4 of 11
RUPPLDefinitions.xls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anticipated Source |
Revenue/Expense Category |
|
Definition |
|
Determination/Allocation Method |
|
Roundup |
|
SMG |
|
MTC |
Toller variances
|
|
Differences between
actual standard
costs of products
at toll
manufacturers
|
|
Direct; default based on % of
Roundup cases produced at
specific toll manufacturer
|
|
X
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
Price variances
|
|
Differences between
actual and standard
costs of raw and
packaging materials
acquired for
production
|
|
Direct; default based on % of
Roundup purchases related to
price variance drivers
|
|
X
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
Net sales less
product and
non-standard cost
of good sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MAT-Marketing
|
|
Functional areas
responsible for
creating brand
Image, developing
brand awareness
strategies and
promotions. Also
includes all sales
activities
performed by
business unit
personnel. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct marketing
|
|
Marketing
activities
associated expenses
which can be
directly traced to
Roundup |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advertising
|
|
Includes network,
spot and cable TV,
radio, print media,
advertising
production costs,
and advertising
agency fees
|
|
Actual default based on % of
direct media spending
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public relations
|
|
Includes expenses
related to public
relations (indirect
advertising) and
related agency fees
|
|
Actual
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer promotion
|
|
Includes consumer
directed rebates,
in-stores
promotional
activities and
give-aways, and
point-of-purchase
materials
|
|
Actual
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade promotion
|
|
Any trade directed promotions (not
already included in MDF), including related agency fees
|
|
Actual
|
|
X |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brand specific market research
|
|
Market research directed toward the Roundup brand |
|
Actual
|
|
X |
|
|
|
|
|
|
|
Monsanto and Scotts
Exclusive Agency and Marketing Agreement for Roundup
Income Statement Definitions and Allocation Methods
|
|
Schedule 3.3(c)
Page 5 of 11
RUPPLDefinitions.xls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anticipated Source |
Revenue/Expense Category |
|
Definition |
|
Determination/Allocation Method |
|
Roundup |
|
SMG |
|
MTC |
Brand specific marketing management
|
|
Primarily personnel
and related support
cost (salaries,
incentives,
fringes, travel &
entertainment,
computers,
communications, and
space & supplies)
of marketing
personnel dedicated
to L&G Roundup
|
|
Actual
|
|
x
|
|
x
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
Allocated marketing
|
|
Marketing activities
managed on a shared
services basis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketing management
|
|
Primarily personnel
and related support
cost (salaries,
incentives,
fringes,
relocation, travel
& entertainment,
computers,
communications, and
space & supplies)
of marketing
management group
overseeing L&G
Roundup and related
products
|
|
Based on managements
assessment of % of time of
general marketing management
group spend on
Roundup activities
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketing support functions
|
|
Functions included
innovation, market
research and
creative services.
Principally
personnel costs
(salaries,
incentives,
fringes, travel &
entertainment,
computers,
communications, and
space & supplies)
of the marketing
support functions
|
|
Based on managements
assessment of % of time
marketing support function
groups spend on
Roundup activities
|
|
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other marketing expenses
|
|
All other
marketing related
expenses, excluding
advertising,
promotions and
personnel costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Innovation projects
|
|
Consulting material
and other
non-personnel
related costs
associated with
package design
|
|
Direct default based on
overall % of innovation group
activities directed toward
Roundup
|
|
x
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
|
|
Package design
|
|
Agency fees,
supplies and
material and other
non-personnel
related cost
associated with
package design
|
|
Direct default based on
overall % of creative service
group activities directed
toward Roundup
|
|
x
|
|
x
|
|
x |
|
|
|
|
|
|
|
|
|
|
|
Market research services
|
|
Fees and other
non-personnel costs
associated with
non-brand specific
market research
(POS data, usage
and attitudes
studies, etc.)
|
|
Direct default based on
overall % of market research
group activities directed
toward Roundup
|
|
x
|
|
x |
|
|
|
|
|
|
|
Monsanto and Scotts
|
|
|
Schedule 3.3(c) |
|
Exclusive Agency and Marketing
Agreement for Roundup
|
|
|
page 8 of 11 |
|
Income Statement Definitions and
Allocation Methods
|
|
|
RUPPLDefinitions.xls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anticipated Source | |
|
|
|
|
|
|
|
Revenue/Expense Category |
|
Definition |
|
Determination/Allocation Method |
|
Roundup |
|
SMG |
|
MTC |
|
|
|
|
|
|
|
|
|
|
|
SVP and general management
|
|
Primarily personnel and related
support costs (salaries, incentives, fringes, travel &
entertainment, computers, communications, and space &
supplies) of the business unit general management group. Also
includes general costs of operating the business unit not
otherwise assigned or classified
|
|
Direct for Roundup assigned
employees, including reasonable charges for fringe benefits and
related support costs.
Scotts costs will be allocated based on agreed to % of actual
business unit general support costs
|
|
|
|
|
|
|
X |
|
|
|
X |
|
|
Information technology
|
|
Personnel and related support costs
(salaries, incentives, fringes, travel & entertainment,
computers, communications, and space & supplies) of the
information technology function supporting the business unit
which manages the L&G Roundup brand. Costs also include
depreciation and annual software license fees, hardware
depreciation and rental, outside service fees and contracts and
other non-personnel costs associated with operating the
information technology group.
|
|
Scotts costs will be allocated
based on agreed to % of actual business unit information
technology costs, net of developmental costs, but including
service costs
|
|
|
|
|
|
|
X |
|
|
|
|
|
|
Finance and accounting
|
|
Personnel and related support costs
(salaries, incentives, fringes, travel & entertainment,
computers, communications, and space & supplies) of the
finance and accounting functions supporting the business unit
which manages the L&G Roundup brand. Functions include
financial planning and analysis, general accounting,
order-to-cash functions assigned to finance, accounts payable
and payroll. Costs will also include internal and external audit
fees, specialized IT services, and corporate treasury, tax and
controllership functions.
|
|
Direct for Roundup seconded people,
including reasonable charges for fringe benefits and related
support costs.
Scotts costs will be allocated based on agreed to % of actual
business unit finance and accounting costs
|
|
|
|
|
|
|
X |
|
|
|
X |
|
SCHEDULE
4.2(A)
STEERING
COMMITTEE
|
|
|
|
|
For the Agent:
|
|
|
|
|
|
Charles Berger
|
|
|
|
|
Jim Hagedorn
|
|
|
|
|
|
For Monsanto:
|
|
|
|
|
|
Arnold W. Donald
|
|
|
|
|
Jim Neal
|
|
|
|
|
Schedule 3.8 U.S.
Monsanto Direct Sales of Roundup AG Products into the Lawn and Garden Channel
Sort by: Product Parent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oct 97 |
|
Oct 97 |
|
Oct 97 |
|
Jan 98 |
|
Jan 98 |
|
Jan 98 |
|
|
|
|
|
|
|
|
|
|
to Sep 98 |
|
to Sep 98 |
|
to Sep 98 |
|
to Dec 98 |
|
to Dec 98 |
|
to Dec 98 |
Product |
|
Description |
Parent |
Description |
|
Ship $ |
|
Ship QtyEA |
|
Ship Cost |
|
Ship $ |
|
Ship QtyEA |
|
Ship Cost |
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
1446 |
|
|
Costco
|
|
|
1,108,248 |
|
|
|
8,640 |
|
|
|
1,048,232 |
|
|
|
834,179 |
|
|
|
6,432 |
|
|
|
781,006 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
2886 |
|
|
Navy Norioi rent
|
|
|
272 |
|
|
|
2 |
|
|
|
243 |
|
|
|
272 |
|
|
|
2 |
|
|
|
243 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
10542 |
|
|
Tru Serve Corp party
|
|
|
276,674 |
|
|
|
2,128 |
|
|
|
257,624 |
|
|
|
251,121 |
|
|
|
1,954 |
|
|
|
238,479 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
11339 |
|
|
Home Depot
|
|
|
1,556,696 |
|
|
|
11,478 |
|
|
|
1,393,109 |
|
|
|
1,648,968 |
|
|
|
12,206 |
|
|
|
1,482,114 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
11465 |
|
|
Lowes Companies Inc
|
|
|
1,217,734 |
|
|
|
9,038 |
|
|
|
1,098,436 |
|
|
|
1,207,974 |
|
|
|
8,928 |
|
|
|
1,084,082 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
12384 |
|
|
Tru Serv Corp east
|
|
|
1,560 |
|
|
|
12 |
|
|
|
1,457 |
|
|
|
1,560 |
|
|
|
12 |
|
|
|
1,457 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13141 |
|
|
Wal-Mart
|
|
|
(737 |
) |
|
|
(6 |
) |
|
|
(729 |
) |
|
|
(737 |
) |
|
|
(6 |
) |
|
|
(729 |
) |
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13346 |
|
|
Ace Hardware Corp
|
|
|
405,686 |
|
|
|
3,182 |
|
|
|
385,664 |
|
|
|
436,995 |
|
|
|
3,470 |
|
|
|
421,345 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13501 |
|
|
Handy Hdwe Wholesale Inc
|
|
|
41,247 |
|
|
|
320 |
|
|
|
38,856 |
|
|
|
47,635 |
|
|
|
370 |
|
|
|
44,927 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13508 |
|
|
Do It Best Corporation
|
|
|
76,060 |
|
|
|
604 |
|
|
|
73,341 |
|
|
|
65,325 |
|
|
|
508 |
|
|
|
61,684 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13509 |
|
|
Our Own Hardw 720
|
|
|
1,560 |
|
|
|
12 |
|
|
|
1,443 |
|
|
|
- |
|
|
|
- |
|
|
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13627 |
|
|
Sams Club
|
|
|
180,940 |
|
|
|
1,236 |
|
|
|
150,324 |
|
|
|
159,120 |
|
|
|
1,224 |
|
|
|
148,624 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13631 |
|
|
Sample Deferred Account
|
|
|
- |
|
|
|
2 |
|
|
|
121 |
|
|
|
- |
|
|
|
2 |
|
|
|
121 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13660 |
|
|
Tru Serv Corp
|
|
|
69,827 |
|
|
|
536 |
|
|
|
84,899 |
|
|
|
51,979 |
|
|
|
400 |
|
|
|
48,570 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
13710 |
|
|
United Hardward Distributing
|
|
|
280 |
|
|
|
2 |
|
|
|
248 |
|
|
|
260 |
|
|
|
2 |
|
|
|
243 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
72320 |
|
|
Jerrys Bldg Materials Inc
|
|
|
17,266 |
|
|
|
128 |
|
|
|
15,338 |
|
|
|
17,058 |
|
|
|
128 |
|
|
|
15,300 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
77404 |
|
|
CGP Buy/Sell Distr
|
|
|
91,164 |
|
|
|
712 |
|
|
|
86,066 |
|
|
|
71,200 |
|
|
|
560 |
|
|
|
67,998 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
81121 |
|
|
Payless Cashways Inc
|
|
|
(266 |
) |
|
|
(8 |
) |
|
|
(765 |
) |
|
|
24,304 |
|
|
|
172 |
|
|
|
20,885 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
81264 |
|
|
Orgill, Inc.
|
|
|
85,020 |
|
|
|
654 |
|
|
|
79,316 |
|
|
|
115,587 |
|
|
|
906 |
|
|
|
110,011 |
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E
|
|
|
81719 |
|
|
Tru Serv Corporation
|
|
|
(1,366 |
) |
|
|
- |
|
|
|
- |
|
|
|
(283 |
) |
|
|
- |
|
|
|
50326
|
|
ROUNDUP PRO 2/2.5 GAL PL E****
|
|
|
|
|
|
*TOTAL*
|
|
|
5,109,834 |
|
|
|
38,674 |
|
|
|
4,689,219 |
|
|
|
4,932,493 |
|
|
|
37,278 |
|
|
|
4,526,360 |
|
1
Schedule 3.8 U.K.
Monsanto direct sales of Roundup AG Products into Lawn and Garden Channels for the U.K.
Special Accounts of Interest:
|
|
|
|
|
B&Q |
|
|
0 |
|
Do-It-All |
|
|
0 |
|
GT Mills |
|
|
0 |
|
Home Base |
|
|
0 |
|
Wickes |
|
|
0 |
|
Asda |
|
|
0 |
|
Tesco |
|
|
0 |
|
Makro |
|
|
0 |
|
Wilkinsons |
|
|
0 |
|
Woolworths |
|
|
0 |
|
Schedule 3.8 France
(Volume in Units)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96/97 |
|
|
|
|
|
|
97/98 |
|
Total Sales of Roundup |
|
|
429,720 |
|
|
|
|
|
|
|
322,908 |
|
1L Bioforce including AG |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nielsen tracked |
|
|
140,000 |
|
|
|
|
|
|
|
64,000 |
|
L&G Roundup |
|
|
|
|
|
|
|
|
|
|
|
|
Bioforce Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agreed Benchmark |
|
|
|
|
|
|
102,000 |
|
|
|
|
|
Roundup Bioforce |
|
|
|
|
|
|
|
|
|
|
|
|
1L Sales into |
|
|
|
|
|
|
|
|
|
|
|
|
L&G Channel |
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 3.8 France
Monsanto Direct Sales of Roundup AG Products into Lawn and Garden Channels for France:
Specific Accounts of Interest:
|
|
|
|
|
|
|
|
|
(Volume) |
|
96/97 |
|
|
97/98 |
|
Leclerc |
|
|
0 |
|
|
|
0 |
|
Gamm Vert (Uncaa) |
|
|
137,364 |
|
|
|
110,124 |
|
Tripode |
|
|
0 |
|
|
|
0 |
|
Carrefour |
|
|
0 |
|
|
|
0 |
|
Briomarche |
|
|
0 |
|
|
|
0 |
|
Apex (Coopagri) |
|
|
13,584 |
|
|
|
11,568 |
|
Casino |
|
|
0 |
|
|
|
0 |
|
Intermarche |
|
|
0 |
|
|
|
0 |
|
Castorama |
|
|
0 |
|
|
|
0 |
|
Promodes |
|
|
0 |
|
|
|
0 |
|
Schedule 3.8
France Total Roundup Bioforce 1 L Sales, Including AG Channel Sales
Sales Bio 1 L
France
Sales Bioforce 1 L
Avg. NSP in USD at budget parity
9697=5.071 FF 9798=5.80 FF
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Invoiced Customers |
|
Volume |
|
|
N.S. |
|
|
|
9697 |
|
|
9798 |
|
|
9697 |
|
|
9798 |
|
UNCAA |
|
|
137,364 |
|
|
|
110,124 |
|
|
|
2,358,023 |
|
|
|
1,939,277 |
|
DE SANGOSSE |
|
|
139,500 |
|
|
|
85,116 |
|
|
|
2,394,690 |
|
|
|
1,498,888 |
|
LESEUR |
|
|
23,400 |
|
|
|
21,600 |
|
|
|
401,690 |
|
|
|
380,375 |
|
GRUEL-FAYER |
|
|
4,632 |
|
|
|
1,860 |
|
|
|
79,514 |
|
|
|
32,754 |
|
DISPAGRI |
|
|
52,176 |
|
|
|
44,232 |
|
|
|
895,666 |
|
|
|
778,923 |
|
SANE-DAGRIL |
|
|
12,000 |
|
|
|
4,284 |
|
|
|
205,995 |
|
|
|
75,441 |
|
AGRIDIS |
|
|
10,176 |
|
|
|
3,120 |
|
|
|
174,684 |
|
|
|
54,943 |
|
PKD |
|
|
50,472 |
|
|
|
52,572 |
|
|
|
866,414 |
|
|
|
925,790 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
429,720 |
|
|
|
322,908 |
|
|
|
7,376,676 |
|
|
|
5,686,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.17 |
|
|
|
17.61 |
|
SCHEDULE 4.1(a)
Management Structure
Roundup® Management Structure
Steering Committee: The Board of Directors
|
|
2 from MTC, 2 from OMS |
|
|
|
Disputes decided by President of Monsanto Ag |
Global Support Team (GST): Global Coordination, Communication and Stewardship of Roundup L&G Business
|
|
3 members, all from MTC |
Business Units (RUs): Country/Region Line Management
|
|
Business Unit Head, Marketing, Sales, Finance, Operations and Other functional areas (including seconded MTC employees) |